assays_ss_tp,assays_cnfdnc_scr,assays_b_frmt,assays_dscrptn,assays_ss_d,assays_ss_rgnsm,assays_td,assays_src_ss_d,assays_vrnt_d,assays_ss_tss,assays_ss_cll_tp,assays_rltnshp_tp,assays_dc_d,assays_ss_strn,assays_cll_d,assays_ss_ctgr,assays_tss_d,assays_ss_tst_tp,assays_src_d,assays_ss_tx_d,assays_chmbl_d,assays_crtd_b,assays_ss_sbclllr_frctn
A,1,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7524,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL618647,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,7525,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL618648,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,7526,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL618649,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7527,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL618650,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,7528,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL618651,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,7529,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL876497,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7530,Rattus norvegicus,50597,,,Lung,,N,9866,,,,2048.0,In vivo,1,10116.0,CHEMBL618652,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,7531,Rattus norvegicus,50597,,,Lung,,N,9866,,,,2048.0,In vivo,1,10116.0,CHEMBL618653,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,7532,Rattus norvegicus,50597,,,Lung,,N,9866,,,,2048.0,In vivo,1,10116.0,CHEMBL618654,Intermediate,
A,1,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,7533,Rattus norvegicus,50597,,,,,N,6351,,,,,,1,10116.0,CHEMBL618655,Intermediate,
A,1,BAO_0000218,Compound was tested for solubility in water,7534,Rattus norvegicus,50597,,,,,N,1465,,,,,,1,10116.0,CHEMBL618656,Intermediate,
P,0,BAO_0000100,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),7535,,22229,,,,,U,5182,,,,,,1,,CHEMBL618657,Intermediate,
A,1,BAO_0000218,Solubility was determined,7536,Rattus norvegicus,50597,,,,,N,17847,,,,,,1,10116.0,CHEMBL618658,Intermediate,
A,1,BAO_0000218,solubility in water (ug/mL) at 37 degree C.,7537,Rattus norvegicus,50597,,,,,N,15339,,,,,,1,10116.0,CHEMBL618659,Intermediate,
A,1,BAO_0000218,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,7538,Rattus norvegicus,50597,,,,,N,5202,,,,,,1,10116.0,CHEMBL618660,Intermediate,
A,1,BAO_0000218,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,7539,Rattus norvegicus,50597,,,,,N,1088,,,,,,1,10116.0,CHEMBL618661,Intermediate,
A,1,BAO_0000218,Half life in rats,7540,Rattus norvegicus,50597,,,,,N,3169,,,,,,1,10116.0,CHEMBL873807,Intermediate,
A,1,BAO_0000218,Half life in Dawley rat,7541,Rattus norvegicus,50597,,,,,N,5353,,,,,,1,10116.0,CHEMBL618662,Intermediate,
A,1,BAO_0000218,Half life period after 3 mg/kg iv administration,7542,Rattus norvegicus,50597,,,,,N,2864,,,,,In vivo,1,10116.0,CHEMBL618663,Intermediate,
A,1,BAO_0000218,Half life period after 3 mg/kg iv administration in rat,7543,Rattus norvegicus,50597,,,,,N,2864,,,,,In vivo,1,10116.0,CHEMBL618664,Intermediate,
A,1,BAO_0000218,Half life period after 3 mg/kg iv administration in the rat,7544,Rattus norvegicus,50597,,,,,N,2864,,,,,In vivo,1,10116.0,CHEMBL618665,Intermediate,
A,1,BAO_0000218,Half life period in female Sprague-Dawley rats,7545,Rattus norvegicus,50597,,,,,N,6362,,,,,,1,10116.0,CHEMBL876498,Intermediate,
A,1,BAO_0000218,Half life period in rat,7546,Rattus norvegicus,50597,,,,,N,6249,,,,,,1,10116.0,CHEMBL618666,Intermediate,
A,1,BAO_0000218,Half-life in rats was determined,7547,Rattus norvegicus,50597,,,,,N,3169,,,,,,1,10116.0,CHEMBL620440,Intermediate,
A,1,BAO_0000218,Half-life in rats with metabolic oxidation,7548,Rattus norvegicus,50597,,,,,N,3169,,,,,,1,10116.0,CHEMBL620441,Intermediate,
A,1,BAO_0000218,Half-life in rats,7549,Rattus norvegicus,50597,,,,,N,3169,,,,,,1,10116.0,CHEMBL620442,Intermediate,
A,1,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7550,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL620443,Intermediate,
A,1,BAO_0000218,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7551,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL620444,Intermediate,
A,1,BAO_0000218,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7552,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL620445,Intermediate,
A,1,BAO_0000218,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7553,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL620446,Intermediate,
A,1,BAO_0000218,Biological half-life measured in plasma of rat,7554,Rattus norvegicus,50597,,,Plasma,,N,2879,,,,1969.0,,1,10116.0,CHEMBL620447,Intermediate,
A,1,BAO_0000218,Biological half-life measured in plasma of rat; 22-25,7555,Rattus norvegicus,50597,,,Plasma,,N,2879,,,,1969.0,,1,10116.0,CHEMBL621129,Intermediate,
A,1,BAO_0000218,Biological half-life measured in plasma of rat; 9-16,7556,Rattus norvegicus,50597,,,Plasma,,N,2879,,,,1969.0,,1,10116.0,CHEMBL621130,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its half life when administered intravenously in rat,7557,Rattus norvegicus,50597,,,,,N,3184,,,,,In vivo,1,10116.0,CHEMBL873808,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,7558,Rattus norvegicus,50597,,,,,N,4891,,,,,In vivo,1,10116.0,CHEMBL876598,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,7559,Rattus norvegicus,50597,,,,,N,429,,,,,In vivo,1,10116.0,CHEMBL621131,Intermediate,
A,1,BAO_0000218,Half life (T1/2) after oral administration in rat,7560,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL621132,Intermediate,
A,1,BAO_0000218,Half life of compound after iv administration of 20 mg/kg dose in rat,7561,Rattus norvegicus,50597,,,,,N,4413,,,,,In vivo,1,10116.0,CHEMBL621133,Intermediate,
A,1,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7562,Rattus norvegicus,50597,,,,,N,3598,,,,,In vivo,1,10116.0,CHEMBL621312,Expert,
A,1,BAO_0000218,Half life of compound was determined in rat,7563,Rattus norvegicus,50597,,,,,N,17267,,,,,,1,10116.0,CHEMBL621313,Intermediate,
A,1,BAO_0000218,Half life of compound was determined in rat blood,7564,Rattus norvegicus,50597,,,Blood,,N,4727,,,,178.0,,1,10116.0,CHEMBL621314,Intermediate,
A,1,BAO_0000218,Half life at 1 mg/kg was determined in rat,7565,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL621315,Intermediate,
A,1,BAO_0000218,Half life at 10 mg/kg was determined in rat,7566,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL621316,Intermediate,
A,1,BAO_0000218,Half life in rats,7567,Rattus norvegicus,50597,,,,,N,401,,,,,,1,10116.0,CHEMBL621317,Intermediate,
A,1,BAO_0000218,Half life in rats in hours,7568,Rattus norvegicus,50597,,,,,N,4942,,,,,,1,10116.0,CHEMBL621318,Intermediate,
A,1,BAO_0000218,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7569,Rattus norvegicus,50597,,,,,N,17735,,,,,In vivo,1,10116.0,CHEMBL621319,Intermediate,
A,1,BAO_0000218,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,7570,Rattus norvegicus,50597,,,,,N,6056,,,,,In vivo,1,10116.0,CHEMBL621377,Intermediate,
A,1,BAO_0000218,Half life was determined,7571,Rattus norvegicus,50597,,,,,N,5213,,,,,,1,10116.0,CHEMBL621378,Intermediate,
A,1,BAO_0000218,Half life after i.v. administration,7572,Rattus norvegicus,50597,,,,,N,6616,,,,,In vivo,1,10116.0,CHEMBL876599,Intermediate,
A,1,BAO_0000218,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,7573,Rattus norvegicus,50597,,,,,N,5937,,,,,In vivo,1,10116.0,CHEMBL621379,Intermediate,
A,1,BAO_0000218,Half life in rat plasma,7574,Rattus norvegicus,50597,,,Plasma,,N,5819,,,,1969.0,,1,10116.0,CHEMBL621380,Intermediate,
A,1,BAO_0000218,Half life in rat plasma; Not detected,7575,Rattus norvegicus,50597,,,Plasma,,N,5819,,,,1969.0,,1,10116.0,CHEMBL621381,Intermediate,
A,1,BAO_0000218,Half life in rats,7576,Rattus norvegicus,50597,,,,,N,6803,,,,,,1,10116.0,CHEMBL618515,Intermediate,
A,1,BAO_0000218,Half life period of compound was determined after peroral administration,7577,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL618516,Intermediate,
A,1,BAO_0000218,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,7578,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL618517,Intermediate,
A,1,BAO_0000218,Half life period in rat,7579,Rattus norvegicus,50597,,,,,N,5948,,,,,,1,10116.0,CHEMBL618518,Intermediate,
A,1,BAO_0000218,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7580,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL618519,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,7581,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL618698,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,7582,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL618862,Intermediate,
A,1,BAO_0000218,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,7583,Rattus norvegicus,50597,,,,,N,4890,,,,,In vivo,1,10116.0,CHEMBL618863,Intermediate,
A,1,BAO_0000218,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,7584,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL618864,Intermediate,
A,1,BAO_0000218,Half life time in rat the dose of 2 mg/kg,7585,Rattus norvegicus,50597,,,,,N,4727,,,,,In vivo,1,10116.0,CHEMBL618865,Intermediate,
A,1,BAO_0000218,Half-life 24 hr after 10 mg/kg iv administration in rats,7586,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL618866,Intermediate,
A,1,BAO_0000218,Half-life 24 hr after 2 mg/kg iv administration in rats,7587,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL618867,Intermediate,
A,1,BAO_0000218,Half-life consistent with the observed metabolic steady state in rats,7588,Rattus norvegicus,50597,,,,,N,6597,,,,,,1,10116.0,CHEMBL875828,Intermediate,
A,1,BAO_0000218,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,7589,Rattus norvegicus,50597,,,,,N,17735,,,,,In vivo,1,10116.0,CHEMBL618868,Intermediate,
A,1,BAO_0000218,Half-life for oxidative metabolic stability was determined using male human,7590,Rattus norvegicus,50597,,,,,N,6597,,,,,,1,10116.0,CHEMBL618869,Intermediate,
A,1,BAO_0000218,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",7591,Rattus norvegicus,50597,,,,,N,17670,,,,,In vivo,1,10116.0,CHEMBL618870,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma,7592,Rattus norvegicus,50597,,,Plasma,,N,1696,,,,1969.0,,1,10116.0,CHEMBL618871,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma was determined,7593,Rattus norvegicus,50597,,,Plasma,,N,1742,,,,1969.0,,1,10116.0,CHEMBL618872,Intermediate,
A,1,BAO_0000218,Half-life in rats was determined,7594,Rattus norvegicus,50597,,,,,N,17800,,,,,,1,10116.0,CHEMBL873816,Intermediate,
A,0,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,7595,,22224,,,,,U,12923,,,,,,1,,CHEMBL618873,Autocuration,
A,0,BAO_0000019,Area under curve after oral dose of 0.1 mg//kg,7596,,22224,,,,,U,11954,,,,,,1,,CHEMBL621602,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 0.3 mg/kg,7597,,22224,,,,,U,11954,,,,,,1,,CHEMBL621603,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 1 mg/kg,7598,,22224,,,,,U,11954,,,,,,1,,CHEMBL621604,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 10 mg/kg,7599,,22224,,,,,U,11954,,,,,,1,,CHEMBL621605,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 23.4 mg/kg,7600,,22224,,,,,U,11954,,,,,,1,,CHEMBL621606,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 3 mg/kg,7601,,22224,,,,,U,11954,,,,,,1,,CHEMBL621607,Autocuration,
A,0,BAO_0000218,Area under curve after oral dose of 3.87 mg/kg,7602,,22224,,,,,U,11954,,,,,,1,,CHEMBL621608,Autocuration,
A,0,BAO_0000019,Area under curve was determined,7603,,22224,,,,,U,5237,,,,,,1,,CHEMBL621609,Autocuration,
A,0,BAO_0000218,Area under curve at a dose of 10 mg/kg,7604,,22224,,,,,U,4026,,,,,,1,,CHEMBL621610,Autocuration,
A,1,BAO_0000218,Area under curve was determined; ND=No data,7605,Rattus norvegicus,50597,,,,,N,5237,,,,,,1,10116.0,CHEMBL621611,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7606,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL621612,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7607,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622308,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7608,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622309,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,7609,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622310,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7610,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622311,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,7611,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622312,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7612,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622931,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,7613,Rattus norvegicus,50597,,,,,N,14793,,,,,,1,10116.0,CHEMBL622932,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,7614,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622736,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,7615,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622737,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,7616,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622738,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,7617,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622739,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,7618,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622740,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,7619,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622741,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,7620,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622742,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,7621,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,,1,10116.0,CHEMBL622743,Intermediate,
A,1,BAO_0000218,AUC in mice,7622,Mus musculus,50594,,,Plasma,,N,11637,,,,1969.0,,1,10090.0,CHEMBL622744,Intermediate,
A,0,BAO_0000019,Area under curve was measured from the graph obtained from concentration Vs time,7623,,22224,,,,,U,11149,,,,,,1,,CHEMBL624134,Autocuration,
A,0,BAO_0000019,Area under curve value of compound per hour after oral administration,7624,,22224,,,,,U,10016,,,,,,1,,CHEMBL624135,Autocuration,
A,1,BAO_0000218,Area under curve was determined after oral administration in rats,7625,Rattus norvegicus,50597,,,,,N,17796,,,,,,1,10116.0,CHEMBL624136,Intermediate,
A,1,BAO_0000218,Area under curve was determined after oral administration in rats; No data,7626,Rattus norvegicus,50597,,,,,N,17796,,,,,,1,10116.0,CHEMBL624137,Intermediate,
A,1,BAO_0000218,Area under curve was determined after oral administration in rats;No data,7627,Rattus norvegicus,50597,,,,,N,17796,,,,,,1,10116.0,CHEMBL624320,Intermediate,
A,1,BAO_0000218,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,7628,Canis lupus familiaris,50588,,,,,N,12923,,,,,,1,9615.0,CHEMBL624321,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,7629,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624322,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.06 in rats,7630,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624323,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,7631,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624324,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,7632,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624325,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,7633,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624326,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,7634,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624327,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,7635,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL624328,Intermediate,
A,1,BAO_0000218,Area under curve was determined in Dogs after peroral administration,7636,Canis lupus familiaris,50588,,,,,N,14169,,,,,,1,9615.0,CHEMBL627848,Intermediate,
A,1,BAO_0000218,Area under curve was determined in Rats after peroral administration,7637,Rattus norvegicus,50597,,,,,N,14169,,,,,,1,10116.0,CHEMBL627849,Intermediate,
A,1,BAO_0000218,Area under curve was determined in carotid blood of rat when administered intradermally,7638,Rattus norvegicus,50597,,,,,N,14258,,,,,,1,10116.0,CHEMBL627850,Intermediate,
A,1,BAO_0000218,Area under curve was determined in portal blood of rat when administered intradermally,7639,Rattus norvegicus,50597,,,,,N,14258,,,,,,1,10116.0,CHEMBL627851,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7640,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627852,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7641,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627853,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),7642,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627854,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,7643,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627855,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),7644,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627856,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,7645,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL875339,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),7646,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL627857,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,7647,Rattus norvegicus,50597,,,Spleen,,N,11195,,,,2106.0,In vivo,1,10116.0,CHEMBL627858,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,7648,Rattus norvegicus,50597,,,Blood,,N,10130,,,,178.0,,1,10116.0,CHEMBL627859,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,7649,Rattus norvegicus,50597,,,Brain,,N,10130,,,,955.0,,1,10116.0,CHEMBL627860,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,7650,Rattus norvegicus,50597,,,Heart,,N,10130,,,,948.0,,1,10116.0,CHEMBL627019,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,7651,Rattus norvegicus,50597,,,Liver,,N,10130,,,,2107.0,,1,10116.0,CHEMBL627020,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,7652,Rattus norvegicus,50597,,,Lung,,N,10130,,,,2048.0,,1,10116.0,CHEMBL627021,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,7653,Rattus norvegicus,50597,,,Muscle tissue,,N,10130,,,,2385.0,,1,10116.0,CHEMBL627022,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,7654,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL627023,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,7655,Rattus norvegicus,50597,,,Spleen,,N,10130,,,,2106.0,,1,10116.0,CHEMBL627024,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,7656,Rattus norvegicus,50597,,,Thyroid gland,,N,10130,,,,2046.0,,1,10116.0,CHEMBL627025,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,7657,Rattus norvegicus,50597,,,Kidney,,N,10130,,,,2113.0,,1,10116.0,CHEMBL627026,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,7658,Rattus norvegicus,50597,,,Blood,,N,10130,,,,178.0,,1,10116.0,CHEMBL627027,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,7659,Rattus norvegicus,50597,,,Brain,,N,10130,,,,955.0,,1,10116.0,CHEMBL627028,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,7660,Rattus norvegicus,50597,,,Heart,,N,10130,,,,948.0,,1,10116.0,CHEMBL627029,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,7661,Rattus norvegicus,50597,,,Kidney,,N,10130,,,,2113.0,,1,10116.0,CHEMBL627030,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,7662,Rattus norvegicus,50597,,,Liver,,N,10130,,,,2107.0,,1,10116.0,CHEMBL627031,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,7663,Rattus norvegicus,50597,,,Lung,,N,10130,,,,2048.0,,1,10116.0,CHEMBL627032,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,7664,Rattus norvegicus,50597,,,Muscle tissue,,N,10130,,,,2385.0,,1,10116.0,CHEMBL627033,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,7665,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL627034,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,7666,Rattus norvegicus,50597,,,Spleen,,N,10130,,,,2106.0,,1,10116.0,CHEMBL627035,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,7667,Rattus norvegicus,50597,,,Thyroid gland,,N,10130,,,,2046.0,,1,10116.0,CHEMBL627036,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,7668,Rattus norvegicus,50597,,,Blood,,N,10130,,,,178.0,,1,10116.0,CHEMBL875340,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,7669,Rattus norvegicus,50597,,,Heart,,N,10130,,,,948.0,,1,10116.0,CHEMBL627037,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,7670,Rattus norvegicus,50597,,,Kidney,,N,10130,,,,2113.0,,1,10116.0,CHEMBL627038,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,7671,Rattus norvegicus,50597,,,Liver,,N,10130,,,,2107.0,,1,10116.0,CHEMBL627039,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,7672,Rattus norvegicus,50597,,,Muscle tissue,,N,10130,,,,2385.0,,1,10116.0,CHEMBL627040,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,7673,Rattus norvegicus,50597,,,Spleen,,N,10130,,,,2106.0,,1,10116.0,CHEMBL624663,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,7674,Rattus norvegicus,50597,,,Thyroid gland,,N,10130,,,,2046.0,,1,10116.0,CHEMBL625963,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,7675,Rattus norvegicus,50597,,,Brain,,N,10130,,,,955.0,,1,10116.0,CHEMBL876799,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,7676,Rattus norvegicus,50597,,,Lung,,N,10130,,,,2048.0,,1,10116.0,CHEMBL626133,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,7677,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL626134,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7678,Rattus norvegicus,50597,,,,,N,6295,,,,,,1,10116.0,CHEMBL626135,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,7679,Rattus norvegicus,50597,,,,,N,6296,,,,,,1,10116.0,CHEMBL626136,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,7680,Rattus norvegicus,50597,,,,,N,6296,,,,,,1,10116.0,CHEMBL626137,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7681,Rattus norvegicus,50597,,,,,N,6295,,,,,,1,10116.0,CHEMBL626138,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,7682,Rattus norvegicus,50597,,,,,N,6296,,,,,,1,10116.0,CHEMBL626139,Intermediate,
A,1,BAO_0000218,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7683,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL626140,Intermediate,
A,1,BAO_0000218,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,7684,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL626141,Intermediate,
A,1,BAO_0000218,C24h in rat p.o. at 20 mg/kg concentration,7685,Rattus norvegicus,50597,,,,,N,17686,,,,,,1,10116.0,CHEMBL626142,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7686,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL627930,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,7687,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL627931,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,7688,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL627932,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,7689,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL627933,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,7690,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL627934,Intermediate,
A,1,BAO_0000218,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,7691,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL627935,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,7692,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627936,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,7693,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627937,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,7694,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627938,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,7695,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627939,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,7696,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627940,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,7697,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627941,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7698,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL876800,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,7699,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627942,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,7700,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627943,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,7701,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627944,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,7702,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627945,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,7703,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628584,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 15 min,7704,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628585,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,7705,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628586,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 30 min,7706,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628587,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,7707,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628588,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,7708,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL628589,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,7709,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL625304,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,7710,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL625305,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,7711,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL625306,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,7712,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL625307,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,7713,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL625308,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,7714,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627740,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,7715,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627741,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7716,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627742,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,7717,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627743,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,7718,Rattus norvegicus,50597,,,Blood,,N,9866,,,,178.0,In vivo,1,10116.0,CHEMBL627744,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,7719,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627745,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,7720,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627746,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,7721,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627747,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,7722,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL876810,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,7723,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627748,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,7724,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627749,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7725,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL627750,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,7726,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618728,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,7727,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618729,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 15 min,7728,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618730,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,7729,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618731,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 30 min,7730,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618732,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,7731,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618733,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,7732,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618734,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,7733,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618735,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,7734,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL876602,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,7735,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618736,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,7736,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618737,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,7737,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618738,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,7738,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618739,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,7739,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618740,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7740,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618741,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,7741,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618742,Intermediate,
A,1,BAO_0000218,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,7742,Rattus norvegicus,50597,,,Bone,,N,9866,,,,10000001.0,In vivo,1,10116.0,CHEMBL618743,Intermediate,
A,1,BAO_0000218,Half-life from rat plasma at a single oral dose of 25 mg/kg,7743,Rattus norvegicus,50597,,,Plasma,,N,17752,,,,1969.0,In vivo,1,10116.0,CHEMBL618744,Intermediate,
A,1,BAO_0000218,Half-life in male rat,7744,Rattus norvegicus,50597,,,,,N,5610,,,,,,1,10116.0,CHEMBL618745,Intermediate,
A,1,BAO_0000218,Half-life in rat after peroral administration at 10 mg/kg concentration,7745,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL620479,Intermediate,
A,1,BAO_0000218,Half-life in rat after peroral administration at 5 mg/kg concentration,7746,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL620480,Intermediate,
A,1,BAO_0000218,Half-life in rat at a dose of 3 mg/kg,7747,Rattus norvegicus,50597,,,,,N,17771,,,,,In vivo,1,10116.0,CHEMBL620481,Intermediate,
A,1,BAO_0000218,Half-life was evaluated in rats,7748,Rattus norvegicus,50597,,,,,N,1974,,,,,,1,10116.0,CHEMBL620482,Intermediate,
A,1,BAO_0000218,Half-life was measured in rat,7749,Rattus norvegicus,50597,,,,,N,4239,,,,,,1,10116.0,CHEMBL876603,Intermediate,
A,1,BAO_0000218,Half-life period for the compound was determined in rats at 50 mg/kg dose,7750,Rattus norvegicus,50597,,,,,N,6681,,,,,In vivo,1,10116.0,CHEMBL620483,Intermediate,
A,1,BAO_0000218,Half-life period in rats after intravenous administration at 5 mg/kg,7751,Rattus norvegicus,50597,,,,,N,17752,,,,,In vivo,1,10116.0,CHEMBL620484,Intermediate,
A,1,BAO_0000218,Half-life period in rat at 10 mg/kg,7752,Rattus norvegicus,50597,,,,,N,6046,,,,,In vivo,1,10116.0,CHEMBL620485,Intermediate,
A,1,BAO_0000218,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",7753,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL620486,Intermediate,
A,1,BAO_0000218,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",7754,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL620487,Intermediate,
A,1,BAO_0000218,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",7755,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL620488,Intermediate,
A,1,BAO_0000218,Half-life time in rat the dose of 2 mg/kg,7756,Rattus norvegicus,50597,,,,,N,4727,,,,,In vivo,1,10116.0,CHEMBL620489,Intermediate,
A,1,BAO_0000218,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,7757,Rattus norvegicus,50597,,,,,N,1088,,,,,In vivo,1,10116.0,CHEMBL620490,Intermediate,
A,1,BAO_0000218,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,7758,Rattus norvegicus,50597,,,,,N,5610,,,,,In vivo,1,10116.0,CHEMBL620491,Intermediate,
A,1,BAO_0000218,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",7759,Rattus norvegicus,50597,,,Plasma,,N,3032,,,,1969.0,In vivo,1,10116.0,CHEMBL876604,Intermediate,
A,1,BAO_0000218,Oral half life was determined,7760,Rattus norvegicus,50597,,,,,N,5199,,,,,In vivo,1,10116.0,CHEMBL620492,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",7761,Rattus norvegicus,50597,,,,,N,14941,,,,,In vivo,1,10116.0,CHEMBL620493,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (t1/2) in rat,7762,Rattus norvegicus,50597,,,,,N,4408,,,,,In vivo,1,10116.0,CHEMBL620494,Intermediate,
A,1,BAO_0000218,Plasma elimination half-life was determined,7763,Rattus norvegicus,50597,,,Plasma,,N,2552,,,,1969.0,,1,10116.0,CHEMBL620495,Intermediate,
A,1,BAO_0000218,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7764,Rattus norvegicus,50597,,,Plasma,,N,5199,,,,1969.0,In vivo,1,10116.0,CHEMBL620496,Intermediate,
A,1,BAO_0000218,Plasma half life was observed after intravenous administration in rat,7765,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL620497,Intermediate,
A,1,BAO_0000218,Plasma half-life was determined,7766,Rattus norvegicus,50597,,,Plasma,,N,1465,,,,1969.0,,1,10116.0,CHEMBL620498,Intermediate,
A,1,BAO_0000218,Plasma half-life following oral administration in Fisher rats,7767,Rattus norvegicus,50597,,,Plasma,,N,1446,,,,1969.0,In vivo,1,10116.0,CHEMBL620499,Intermediate,
A,1,BAO_0000218,Plasma half-life in rat,7768,Rattus norvegicus,50597,,,Plasma,,N,6824,,,,1969.0,,1,10116.0,CHEMBL620500,Intermediate,
A,1,BAO_0000218,Plasmatic Half-life after intravenous administration to rat,7769,Rattus norvegicus,50597,,,Plasma,,N,17533,,,,1969.0,In vivo,1,10116.0,CHEMBL873809,Intermediate,
A,1,BAO_0000218,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,7770,Rattus norvegicus,50597,,,,,N,5979,,,,,In vivo,1,10116.0,CHEMBL620501,Intermediate,
A,1,BAO_0000218,Terminal half life after intravenous administration (1 mg/kg) in rat,7771,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL620502,Intermediate,
A,1,BAO_0000218,Terminal half life in Rat at a oral dose of 5 mg/kg,7772,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL620503,Intermediate,
A,1,BAO_0000218,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,7773,Rattus norvegicus,50597,,,,,N,2463,,,,,In vivo,1,10116.0,CHEMBL620504,Intermediate,
A,1,BAO_0000218,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,7774,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL876605,Intermediate,
A,1,BAO_0000218,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,7775,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL620505,Intermediate,
A,1,BAO_0000218,plasma half life was observed after intravenous administration in rat,7776,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL873811,Intermediate,
A,1,BAO_0000218,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,7777,Rattus norvegicus,50597,,,,,N,3598,,,,,In vivo,1,10116.0,CHEMBL624016,Expert,
A,1,BAO_0000218,Half life of compound determined in rat,7778,Rattus norvegicus,50597,,,,,N,4576,,,,,,1,10116.0,CHEMBL624017,Intermediate,
A,1,BAO_0000218,Mean residence time determined in rat,7779,Rattus norvegicus,50597,,,,,N,4576,,,,,,1,10116.0,CHEMBL624018,Intermediate,
A,1,BAO_0000218,Plasma half life determined in rat,7780,Rattus norvegicus,50597,,,,,N,4576,,,,,,1,10116.0,CHEMBL624019,Intermediate,
A,1,BAO_0000218,Compound was evaluated for Tmax in brain after intravenous administration in male rats,7781,Rattus norvegicus,50597,,,Brain,,N,4910,,,,955.0,In vivo,1,10116.0,CHEMBL624020,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum time period,7782,Rattus norvegicus,50597,,,,,N,4891,,,,,In vivo,1,10116.0,CHEMBL624201,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,7783,Rattus norvegicus,50597,,,,,N,429,,,,,In vivo,1,10116.0,CHEMBL872528,Intermediate,
A,1,BAO_0000218,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,7784,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624202,Intermediate,
A,1,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,7785,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624203,Intermediate,
A,1,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,7786,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624350,Intermediate,
A,1,BAO_0000218,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,7787,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL621320,Intermediate,
A,1,BAO_0000218,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,7788,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL621321,Intermediate,
A,1,BAO_0000218,Maximum time (Tmax) required to reach Cmax in rats,7789,Rattus norvegicus,50597,,,,,N,4026,,,,,,1,10116.0,CHEMBL621322,Intermediate,
A,1,BAO_0000218,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,7790,Rattus norvegicus,50597,,,,,N,4890,,,,,In vivo,1,10116.0,CHEMBL621323,Intermediate,
A,1,BAO_0000218,Maximum time of clearance of compound in rats after peroral administration,7791,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL621324,Intermediate,
A,1,BAO_0000218,Maximum time at the dose of 2 mg/kg in rat,7792,Rattus norvegicus,50597,,,,,N,4727,,,,,,1,10116.0,CHEMBL621325,Intermediate,
A,1,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,7793,Rattus norvegicus,50597,,,Plasma,,N,17651,,,,1969.0,In vivo,1,10116.0,CHEMBL875837,Intermediate,
A,1,BAO_0000218,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,7794,Rattus norvegicus,50597,,,Plasma,,N,17651,,,,1969.0,In vivo,1,10116.0,CHEMBL621326,Intermediate,
A,1,BAO_0000218,Tmax in Guinea pig (PO dose),7795,Rattus norvegicus,50597,,,,,N,14465,,,,,In vivo,1,10116.0,CHEMBL621327,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",7796,Rattus norvegicus,50597,,,,,N,14941,,,,,In vivo,1,10116.0,CHEMBL621328,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Tmax) in rat,7797,Rattus norvegicus,50597,,,,,N,5960,,,,,In vivo,1,10116.0,CHEMBL621329,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Tmax) was estimated,7798,Rattus norvegicus,50597,,,,,N,5022,,,,,In vivo,1,10116.0,CHEMBL621330,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Tmax) in rat,7799,Rattus norvegicus,50597,,,,,N,4408,,,,,In vivo,1,10116.0,CHEMBL621331,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,7800,Rattus norvegicus,50597,,,,,N,5983,,,,,In vivo,1,10116.0,CHEMBL621332,Intermediate,
A,1,BAO_0000218,T max in Rat at a oral dose of 5 mg/kg,7801,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL621333,Intermediate,
A,1,BAO_0000218,T max was determined at 10 mg/kg po dose in rats,7802,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL621334,Intermediate,
A,1,BAO_0000218,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),7803,Mus musculus,50594,,,,,N,15011,,,,,,1,10090.0,CHEMBL621335,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,7804,Canis lupus familiaris,50588,,,,,N,14180,,,,,,1,9615.0,CHEMBL621336,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,7805,Rattus norvegicus,50597,,,,,N,14180,,,,,,1,10116.0,CHEMBL621337,Intermediate,
A,1,BAO_0000218,Area under curve was measured after i.v. administration into Beagle dog.,7806,Canis lupus familiaris,50588,,,,,N,14599,,,,,,1,9615.0,CHEMBL621338,Intermediate,
A,1,BAO_0000218,Area under curve was measured after iv administration into Beagle dog,7807,Canis lupus familiaris,50588,,,,,N,14599,,,,,,1,9615.0,CHEMBL875838,Intermediate,
A,1,BAO_0000218,Area under curve was measured after po administration into Beagle dog,7808,Canis lupus familiaris,50588,,,,,N,14599,,,,,,1,9615.0,CHEMBL621339,Intermediate,
A,1,BAO_0000218,Area under curve was measured after po administration into Beagle dog.,7809,Canis lupus familiaris,50588,,,,,N,14599,,,,,,1,9615.0,CHEMBL621340,Intermediate,
A,0,BAO_0000218,Area under curve was measured at peroral dose of 3 mg/kg,7810,,22224,,,,,U,15675,,,,,,1,,CHEMBL621341,Autocuration,
A,0,BAO_0000019,Area under curve was measured by using concentration Vs time,7811,,22224,,,,,U,12706,,,,,,1,,CHEMBL621342,Autocuration,
A,0,BAO_0000019,Area under curve was measured by using concentration Vs time; not tested,7812,,22224,,,,,U,12706,,,,,,1,,CHEMBL621343,Autocuration,
A,1,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),7813,Mus musculus,50594,,,,,N,9750,,,,,,1,10090.0,CHEMBL621344,Intermediate,
A,1,BAO_0000218,Area under curve(AUC) was measured in mice after oral administration.,7814,Mus musculus,50594,,,,,N,9750,,,,,,1,10090.0,CHEMBL621345,Intermediate,
A,0,BAO_0000019,Area under curve(AUC) value of the compound,7815,,22224,,,,,U,14691,,,,,,1,,CHEMBL621346,Autocuration,
A,0,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,7816,,22224,,,,,U,14691,,,,,,1,,CHEMBL621347,Autocuration,
A,1,BAO_0000218,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,7817,Canis lupus familiaris,50588,,,,,N,14691,,,,,,1,9615.0,CHEMBL621348,Intermediate,
A,0,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood,7818,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL621349,Autocuration,
A,0,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,7819,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL621350,Autocuration,
A,0,BAO_0000019,Area under curve(carotid artery) was determined by the availability in blood; No data,7820,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL875839,Autocuration,
A,0,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood,7821,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL620211,Autocuration,
A,0,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; ND means no data,7822,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL620212,Autocuration,
A,0,BAO_0000019,Area under curve(portal vein) was determined by the availability in blood; No data,7823,,22224,,,Blood,,U,2939,,,,178.0,,1,,CHEMBL620213,Autocuration,
A,1,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7824,Macaca mulatta,50797,,,Plasma,,N,9552,,,,1969.0,,1,9544.0,CHEMBL620214,Intermediate,
A,1,BAO_0000218,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",7825,Macaca mulatta,50797,,,Plasma,,N,9552,,,,1969.0,,1,9544.0,CHEMBL620215,Intermediate,
A,1,BAO_0000218,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,7826,Macaca mulatta,50797,,,Plasma,,N,9552,,,,1969.0,,1,9544.0,CHEMBL620216,Intermediate,
A,1,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",7827,Canis lupus familiaris,50588,,,Plasma,,N,9552,,,,1969.0,,1,9615.0,CHEMBL620888,Intermediate,
A,1,BAO_0000218,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",7828,Canis lupus familiaris,50588,,,Plasma,,N,9552,,,,1969.0,,1,9615.0,CHEMBL620889,Intermediate,
A,0,BAO_0000019,Area under plasma concentration vs time curve observed in rats for 0-3 h,7829,,22224,,,Plasma,,U,9552,,,,1969.0,,1,,CHEMBL620890,Autocuration,
A,1,BAO_0000218,Area under plasma time curve determined in male rat,7830,Rattus norvegicus,50597,,,Plasma,,N,11911,,,,1969.0,,1,10116.0,CHEMBL620891,Intermediate,
A,0,BAO_0000019,Area under the MAP curve measured over 5 min.,7831,,22224,,,,,U,16618,,,,,,1,,CHEMBL620892,Autocuration,
A,1,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,7832,Mus musculus,50594,,,,,N,14387,,,,,,1,10090.0,CHEMBL621079,Intermediate,
A,1,BAO_0000218,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,7833,Mus musculus,50594,,,,,N,14387,,,,,,1,10090.0,CHEMBL621080,Intermediate,
A,1,BAO_0000218,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,7834,Canis lupus familiaris,50588,,,,,N,12836,,,,,,1,9615.0,CHEMBL621081,Intermediate,
A,1,BAO_0000218,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,7835,Cricetinae,100712,,,,,N,12836,,,,,,1,10026.0,CHEMBL621082,Intermediate,
A,1,BAO_0000218,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,7836,Rattus norvegicus,50597,,,,,N,12836,,,,,,1,10116.0,CHEMBL621083,Intermediate,
A,1,BAO_0000218,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,7837,Canis lupus familiaris,50588,,,,,N,14339,,,,,,1,9615.0,CHEMBL621084,Intermediate,
A,1,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,7838,Canis lupus familiaris,50588,,,,,N,14339,,,,,,1,9615.0,CHEMBL621085,Intermediate,
A,1,BAO_0000218,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,7839,Canis lupus familiaris,50588,,,,,N,14339,,,,,,1,9615.0,CHEMBL621086,Intermediate,
A,1,BAO_0000218,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),7840,Canis lupus familiaris,50588,,,,,N,10524,,,,,,1,9615.0,CHEMBL621087,Intermediate,
A,1,BAO_0000218,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),7841,Canis lupus familiaris,50588,,,,,N,9994,,,,,,1,9615.0,CHEMBL622607,Intermediate,
A,1,BAO_0000218,Serum AUC in marmosets (IV dose),7842,Canis lupus familiaris,50588,,,,,N,11325,,,,,,1,9615.0,CHEMBL622608,Intermediate,
A,0,BAO_0000019,Area under the curve after intravenous administration at a dose of 10 umol/kg,7843,,22224,,,,,U,12536,,,,,,1,,CHEMBL624481,Autocuration,
A,0,BAO_0000019,Area under the curve after intravenous administration at a dose of 2 umol/kg,7844,,22224,,,,,U,12536,,,,,,1,,CHEMBL624482,Autocuration,
A,0,BAO_0000019,Area under the curve after intravenous administration at a dose of 4 umol/kg,7845,,22224,,,,,U,12536,,,,,,1,,CHEMBL624483,Autocuration,
A,0,BAO_0000019,Area under the curve after intravenous administration at a dose of 40 umol/kg,7846,,22224,,,,,U,12536,,,,,,1,,CHEMBL624484,Autocuration,
A,0,BAO_0000019,Area under the curve after intravenous administration at a dose of 5 umol/kg,7847,,22224,,,,,U,12536,,,,,,1,,CHEMBL624485,Autocuration,
A,1,BAO_0000218,Area under the curve for fumarate salt was evaluated in F344 Rats.,7848,Rattus norvegicus,50597,,,,,N,15556,,,,,,1,10116.0,CHEMBL624486,Intermediate,
A,0,BAO_0000019,Area under the curve for the compound was calculated.,7849,,22224,,,,,U,2809,,,,,,1,,CHEMBL624487,Autocuration,
A,0,BAO_0000019,Area under the curve in concentration/ time,7850,,22224,,,,,U,9511,,,,,,1,,CHEMBL624488,Autocuration,
A,1,BAO_0000218,Area under the curve administered intraintestinal in rats.,7851,Rattus norvegicus,50597,,,,,N,12818,,,,,,1,10116.0,CHEMBL624489,Intermediate,
A,1,BAO_0000218,Area under the curve administered intravenously in rats.,7852,Rattus norvegicus,50597,,,,,N,12818,,,,,,1,10116.0,CHEMBL625184,Intermediate,
A,0,BAO_0000019,Area under the curve during intravenous administration,7853,,22224,,,,,U,15118,,,,,,1,,CHEMBL625185,Autocuration,
A,0,BAO_0000019,Area under the curve during intravenous administration; Not determined,7854,,22224,,,,,U,15118,,,,,,1,,CHEMBL875954,Autocuration,
A,0,BAO_0000019,Area under the curve during systemic administration,7855,,22224,,,,,U,15118,,,,,,1,,CHEMBL625186,Autocuration,
A,0,BAO_0000019,Area under the curve during systemic administration; Not determined,7856,,22224,,,,,U,15118,,,,,,1,,CHEMBL625187,Autocuration,
A,0,BAO_0000019,Area under the curve was calculated for the compound.,7857,,22224,,,,,U,2632,,,,,,1,,CHEMBL625188,Autocuration,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,7858,Canis lupus familiaris,50588,,,,,N,14346,,,,,,1,9615.0,CHEMBL625189,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,7859,Canis lupus familiaris,50588,,,,,N,14346,,,,,,1,9615.0,CHEMBL625190,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,7860,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL621733,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,7861,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL621734,Intermediate,
A,1,BAO_0000218,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,7862,Rattus norvegicus,50597,,,,,N,11149,,,,,,1,10116.0,CHEMBL621735,Intermediate,
A,1,BAO_0000218,Clearance of the drug was measured in the plasma of rat; No data,7863,Rattus norvegicus,50597,,,Plasma,,N,17796,,,,1969.0,,1,10116.0,CHEMBL621736,Intermediate,
A,1,BAO_0000218,The pharmacokinetic parameter plasma clearance in vivo in rats,7864,Rattus norvegicus,50597,,,Plasma,,N,5247,,,,1969.0,,1,10116.0,CHEMBL621737,Intermediate,
A,1,BAO_0000218,Plasma clearance at the dose of 2 mg/kg in rat,7865,Rattus norvegicus,50597,,,,,N,4727,,,,,,1,10116.0,CHEMBL621738,Intermediate,
A,1,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,7866,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL622806,Intermediate,
A,1,BAO_0000218,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,7867,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL623519,Intermediate,
A,1,BAO_0000218,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,7868,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL623520,Intermediate,
A,1,BAO_0000218,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,7869,Rattus norvegicus,50597,,,,,N,17065,,,,,In vivo,1,10116.0,CHEMBL623521,Intermediate,
A,1,BAO_0000218,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,7870,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL623522,Intermediate,
A,1,BAO_0000218,Clearance rate in rat,7871,Rattus norvegicus,50597,,,,,N,6672,,,,,In vivo,1,10116.0,CHEMBL623523,Intermediate,
A,1,BAO_0000218,Clearance rate in rat,7872,Rattus norvegicus,50597,,,,,N,6673,,,,,In vivo,1,10116.0,CHEMBL623690,Intermediate,
A,1,BAO_0000218,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,7873,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL623691,Intermediate,
A,1,BAO_0000218,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,7874,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL623692,Intermediate,
A,1,BAO_0000218,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,7875,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL623693,Intermediate,
A,1,BAO_0000218,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,7876,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL623694,Intermediate,
A,1,BAO_0000218,Clearance of compound after iv administration of 20 mg/kg dose in rat,7877,Rattus norvegicus,50597,,,,,N,4413,,,,,In vivo,1,10116.0,CHEMBL623695,Intermediate,
A,1,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,7878,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL623696,Intermediate,
A,1,BAO_0000218,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,7879,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL623697,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,7880,Macaca mulatta,22224,,,Plasma,,U,5005,,,,1969.0,In vivo,1,9544.0,CHEMBL623698,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma clearance rate in Sprague Dawley rats,7881,Rattus norvegicus,22224,,,Plasma,,U,5005,,,,1969.0,In vivo,1,10116.0,CHEMBL623699,Intermediate,
A,1,BAO_0000218,Mean (%CV) PK parameters for CL(mL/min/kg).,7882,Rattus norvegicus,50597,,,,,N,15765,,,,,In vivo,1,10116.0,CHEMBL623700,Intermediate,
A,1,BAO_0000218,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,7883,Rattus norvegicus,50597,,,,,N,3747,,,,,In vivo,1,10116.0,CHEMBL623701,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,7884,Rattus norvegicus,50597,,,Plasma,,N,16366,,,,1969.0,In vivo,1,10116.0,CHEMBL623702,Intermediate,
A,1,BAO_0000218,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,7885,Rattus norvegicus,50597,,,,,N,4199,,,,,In vivo,1,10116.0,CHEMBL623703,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat was determined,7886,Rattus norvegicus,50597,,,,,N,17267,,,,,In vivo,1,10116.0,CHEMBL623704,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,7887,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL623705,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after administration of 2 mg/kg iv,7888,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL623706,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined,7889,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL623707,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,7890,Rattus norvegicus,50597,,,,,N,5960,,,,,In vivo,1,10116.0,CHEMBL623708,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,7891,Rattus norvegicus,50597,,,,,N,5937,,,,,In vivo,1,10116.0,CHEMBL623709,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat by iv administration,7892,Rattus norvegicus,50597,,,,,N,5871,,,,,In vivo,1,10116.0,CHEMBL623710,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,7893,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL623711,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat p.o.,7894,Rattus norvegicus,50597,,,,,N,6504,,,,,In vivo,1,10116.0,CHEMBL623712,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats,7895,Rattus norvegicus,50597,,,,,N,6803,,,,,In vivo,1,10116.0,CHEMBL623713,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined; ND denotes no data,7896,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL623714,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined; ND denotes not determined,7897,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL623715,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,7898,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL623716,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,7899,Rattus norvegicus,50597,,,,,N,5199,,,,,In vivo,1,10116.0,CHEMBL622980,Intermediate,
A,1,BAO_0000218,Plasma administration to rats,7900,Rattus norvegicus,50597,,,,,N,16367,,,,,In vivo,1,10116.0,CHEMBL622981,Intermediate,
A,1,BAO_0000218,Plasma clearance of the compound in female Sprague-Dawley rats,7901,Rattus norvegicus,50597,,,,,N,6362,,,,,In vivo,1,10116.0,CHEMBL622982,Intermediate,
A,1,BAO_0000218,Plasma clearance was observed after intravenous administration in rat,7902,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL622983,Intermediate,
A,1,BAO_0000218,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,7903,Rattus norvegicus,50597,,,,,N,6215,,,,,In vivo,1,10116.0,CHEMBL622984,Intermediate,
A,1,BAO_0000218,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,7904,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL622985,Intermediate,
A,1,BAO_0000218,plasma clearance was observed after intravenous administration in rat,7905,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL623631,Intermediate,
A,1,BAO_0000218,In vivo CL/F determined,7906,Rattus norvegicus,50597,,,,,N,4723,,,,,In vivo,1,10116.0,CHEMBL623632,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,7907,Rattus norvegicus,50597,,,Plasma,,N,2792,,,,1969.0,In vivo,1,10116.0,CHEMBL623633,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,7908,Rattus norvegicus,50597,,,Plasma,,N,2792,,,,1969.0,In vivo,1,10116.0,CHEMBL623634,Intermediate,
A,1,BAO_0000218,Compound was tested for the lower blood clearance in rat,7909,Rattus norvegicus,50597,,,,,N,5213,,,,,In vivo,1,10116.0,CHEMBL623635,Intermediate,
A,1,BAO_0000218,Evaluated for the low clearance in rat (in vivo),7910,Rattus norvegicus,50597,,,,,N,4687,,,,,In vivo,1,10116.0,CHEMBL621195,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (CLb)of the compound was determined in rat,7911,Rattus norvegicus,50597,,,,,N,3371,,,,,In vivo,1,10116.0,CHEMBL621196,Intermediate,
A,1,BAO_0000218,Rapid clearance after intravenous administration in rat was determined,7912,Rattus norvegicus,50597,,,,,N,4690,,,,,In vivo,1,10116.0,CHEMBL875287,Intermediate,
A,1,BAO_0000218,Clearance measured in rat,7913,Rattus norvegicus,50597,,,,,N,5702,,,,,In vivo,1,10116.0,CHEMBL621197,Intermediate,
A,1,BAO_0000218,Compound was evaluated for plasma clearance in rat,7914,Rattus norvegicus,50597,,,Plasma,,N,740,,,,1969.0,In vivo,1,10116.0,CHEMBL621198,Intermediate,
A,1,BAO_0000218,Low plasma clearance was calculated in rat,7915,Rattus norvegicus,50597,,,Plasma,,N,4853,,,,1969.0,In vivo,1,10116.0,CHEMBL621199,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Clp) in rat,7916,Rattus norvegicus,50597,,,,,N,5789,,,,,In vivo,1,10116.0,CHEMBL621200,Intermediate,
A,1,BAO_0000218,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,7917,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL621201,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,7918,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL621202,Intermediate,
A,1,BAO_0000218,Plasma clearance after IV dosing at 0.5 mg/kg in rat,7919,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL621203,Intermediate,
A,1,BAO_0000218,Plasma clearance after IV dosing at 1 mg/kg in rat,7920,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL621204,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,7921,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621205,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,7922,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621206,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,7923,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621207,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,7924,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621208,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,7925,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621209,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,7926,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL876484,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7927,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621210,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,7928,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621211,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,7929,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621212,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 15 min,7930,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621213,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,7931,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621214,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 30 min,7932,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621215,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,7933,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621216,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,7934,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621217,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,7935,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621218,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,7936,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621219,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,7937,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621220,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,7938,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621221,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,7939,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621222,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,7940,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621223,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,7941,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL876485,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7942,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621224,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,7943,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621225,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,7944,Rattus norvegicus,50597,,,Heart,,N,9866,,,,948.0,In vivo,1,10116.0,CHEMBL621226,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,7945,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621227,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,7946,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621228,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,7947,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621229,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,7948,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621230,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,7949,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621231,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,7950,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621232,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7951,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621233,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,7952,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621234,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7953,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621235,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,7954,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621236,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,7955,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL621237,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,7956,Rattus norvegicus,50597,,,Kidney,,N,9866,,,,2113.0,In vivo,1,10116.0,CHEMBL876486,Intermediate,
A,1,BAO_0000218,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,7957,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL622436,Intermediate,
A,1,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,7958,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL622437,Intermediate,
A,1,BAO_0000218,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,7959,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL622438,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,7960,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622439,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,7961,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622440,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,7962,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622441,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,7963,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622442,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,7964,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622443,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,7965,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622444,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,7966,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622445,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,7967,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622446,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,7968,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622447,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,7969,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622448,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,7970,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622449,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,7971,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622450,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,7972,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622451,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 15 min,7973,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622452,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,7974,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622453,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 30 min,7975,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622454,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,7976,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL622455,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,7977,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL876024,Intermediate,
A,1,BAO_0000218,T max was determined at 3 mg/kg po dose in rats,7978,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL622456,Intermediate,
A,1,BAO_0000218,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",7979,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL622457,Intermediate,
A,1,BAO_0000218,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",7980,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL622458,Intermediate,
A,1,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,7981,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL622459,Intermediate,
A,1,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,7982,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL873343,Intermediate,
A,1,BAO_0000218,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,7983,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL622460,Intermediate,
A,1,BAO_0000218,Time for maximum plasma concentration determined in rat,7984,Rattus norvegicus,50597,,,Plasma,,N,4576,,,,1969.0,,1,10116.0,CHEMBL622461,Intermediate,
A,1,BAO_0000218,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,7985,Rattus norvegicus,50597,,,Plasma,,N,6681,,,,1969.0,In vivo,1,10116.0,CHEMBL622462,Intermediate,
A,1,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,7986,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622463,Intermediate,
A,1,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,7987,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622464,Intermediate,
A,1,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,7988,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622465,Intermediate,
A,1,BAO_0000218,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,7989,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622466,Intermediate,
A,1,BAO_0000218,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,7990,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622467,Intermediate,
A,1,BAO_0000218,Time of maximum plasma concentration in rat,7991,Rattus norvegicus,50597,,,Plasma,,N,6824,,,,1969.0,,1,10116.0,CHEMBL622468,Intermediate,
A,1,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",7992,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,,1,10116.0,CHEMBL876025,Intermediate,
A,1,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",7993,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,,1,10116.0,CHEMBL622469,Intermediate,
A,1,BAO_0000218,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",7994,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,,1,10116.0,CHEMBL622470,Intermediate,
A,1,BAO_0000218,Time required to reach maximum concentration (Cmax) after oral administration in rat,7995,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL622471,Intermediate,
A,1,BAO_0000218,Time required to reach maximum concentration in rat plasma,7996,Rattus norvegicus,50597,,,Plasma,,N,1742,,,,1969.0,,1,10116.0,CHEMBL622472,Intermediate,
A,1,BAO_0000218,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,7997,Rattus norvegicus,50597,,,Plasma,,N,2774,,,,1969.0,In vivo,1,10116.0,CHEMBL622473,Intermediate,
A,1,BAO_0000218,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,7998,Rattus norvegicus,50597,,,Plasma,,N,5199,,,,1969.0,In vivo,1,10116.0,CHEMBL624282,Intermediate,
A,1,BAO_0000218,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,7999,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL624283,Intermediate,
A,1,BAO_0000218,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8000,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL624284,Intermediate,
A,1,BAO_0000218,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8001,Rattus norvegicus,50597,,,Plasma,,N,1916,,,,1969.0,In vivo,1,10116.0,CHEMBL624285,Intermediate,
A,1,BAO_0000218,Time to reach Cmax after oral administration to rats,8002,Rattus norvegicus,50597,,,,,N,16367,,,,,In vivo,1,10116.0,CHEMBL624286,Intermediate,
A,1,BAO_0000218,Time to reach Cmax when a dose of 1 mg/kg is administered orally,8003,Rattus norvegicus,50597,,,,,N,16366,,,,,In vivo,1,10116.0,CHEMBL624287,Intermediate,
A,1,BAO_0000218,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,8004,Rattus norvegicus,50597,,,,,N,216,,,,,,1,10116.0,CHEMBL624288,Intermediate,
A,1,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,8005,Rattus norvegicus,50597,,,Plasma,,N,6410,,,,1969.0,In vivo,1,10116.0,CHEMBL624289,Intermediate,
A,1,BAO_0000218,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,8006,Rattus norvegicus,50597,,,Plasma,,N,6410,,,,1969.0,In vivo,1,10116.0,CHEMBL873344,Intermediate,
A,1,BAO_0000218,Tmax after peroral administration (10 mg/kg) was determined in rat,8007,Rattus norvegicus,50597,,,,,N,6215,,,,,In vivo,1,10116.0,CHEMBL619623,Intermediate,
A,1,BAO_0000218,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,8008,Rattus norvegicus,50597,,,,,N,3598,,,,,In vivo,1,10116.0,CHEMBL621399,Expert,
A,1,BAO_0000218,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,8009,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL621400,Intermediate,
A,1,BAO_0000218,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",8010,Rattus norvegicus,50597,,,,,N,17670,,,,,In vivo,1,10116.0,CHEMBL621401,Intermediate,
A,1,BAO_0000218,Tmax was determined,8011,Rattus norvegicus,50597,,,,,N,1465,,,,,,1,10116.0,CHEMBL621402,Intermediate,
A,1,BAO_0000218,Tmax was determined,8012,Rattus norvegicus,50597,,,,,N,2552,,,,,,1,10116.0,CHEMBL621403,Intermediate,
A,1,BAO_0000218,Tmax after oral administration in rat,8013,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL621121,Intermediate,
A,1,BAO_0000218,Tmax after peroral administration in rats at 2.4 uM/kg,8014,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL872525,Intermediate,
A,1,BAO_0000218,Tmax in male rat,8015,Rattus norvegicus,50597,,,,,N,5610,,,,,,1,10116.0,CHEMBL621122,Intermediate,
A,1,BAO_0000218,Tmax in rat at 10 mg/kg,8016,Rattus norvegicus,50597,,,,,N,6046,,,,,In vivo,1,10116.0,CHEMBL621123,Intermediate,
A,1,BAO_0000218,Tmax in rat by po administration at a dose of 40 mg/kg,8017,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL621124,Intermediate,
A,1,BAO_0000218,Tmax in rats,8018,Rattus norvegicus,50597,,,,,N,17596,,,,,,1,10116.0,CHEMBL621125,Intermediate,
A,1,BAO_0000218,Tmax was measured in rats after peroral administration at 5 mg/kg,8019,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL621126,Intermediate,
A,1,BAO_0000218,Tmax value after oral dose at a dose of 10 mg/kg in rats.,8020,Rattus norvegicus,50597,,,,,N,1908,,,,,In vivo,1,10116.0,CHEMBL621127,Intermediate,
A,1,BAO_0000218,Tmax value after administration of 20 mg/Kg oral dose in rat,8021,Rattus norvegicus,50597,,,,,N,2959,,,,,In vivo,1,10116.0,CHEMBL621128,Intermediate,
A,1,BAO_0000218,Tmax value at a dose of 10 mg/kg in male SD rats,8022,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL618263,Intermediate,
A,1,BAO_0000218,Tmax value at a dose of 100 mg/kg in male SD rats,8023,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL618264,Intermediate,
A,1,BAO_0000218,Tmax value at a dose of 50 mg/kg in male SD rats,8024,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL618265,Intermediate,
A,1,BAO_0000218,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8025,Rattus norvegicus,50597,,,Plasma,,N,4186,,,,1969.0,In vivo,1,10116.0,CHEMBL618266,Intermediate,
A,1,BAO_0000218,time required to reach maximum concentration (Cmax) after oral administration in rat,8026,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL618267,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),8027,Rattus norvegicus,50597,,,Urine,,N,429,,,,1088.0,,1,10116.0,CHEMBL618450,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),8028,Rattus norvegicus,50597,,,Urine,,N,429,,,,1088.0,,1,10116.0,CHEMBL618451,Intermediate,
A,1,BAO_0000218,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8029,Rattus norvegicus,50597,,,,,N,5546,,,,,,1,10116.0,CHEMBL618452,Intermediate,
A,1,BAO_0000218,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,8030,Rattus norvegicus,50597,,,Urine,,N,3173,,,,1088.0,,1,10116.0,CHEMBL618453,Intermediate,
A,1,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,8031,Rattus norvegicus,50597,,,Urine,,N,3173,,,,1088.0,,1,10116.0,CHEMBL618454,Intermediate,
A,1,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,8032,Rattus norvegicus,50597,,,Urine,,N,3173,,,,1088.0,,1,10116.0,CHEMBL618455,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,8033,Rattus norvegicus,50597,,,,,N,4257,,,,,In vivo,1,10116.0,CHEMBL618456,Intermediate,
A,1,BAO_0000218,Compound distribution in rat tissues was determined,8034,Rattus norvegicus,50597,,,,,N,6011,,,,,In vivo,1,10116.0,CHEMBL618457,Intermediate,
A,1,BAO_0000218,Volume of distribution was evaluated in rat,8035,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL618458,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,8036,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618459,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,8037,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL876733,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,8038,Canis lupus familiaris,50588,,,,,N,14346,,,,,,1,9615.0,CHEMBL618460,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,8039,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618461,Intermediate,
A,0,BAO_0000019,Area under the curve was determined after oral administration (300 uM/Kg),8040,,22224,,,,,U,15469,,,,,,1,,CHEMBL618462,Autocuration,
A,1,BAO_0000218,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,8041,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618463,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,8042,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618464,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,8043,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618465,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,8044,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618466,Intermediate,
A,1,BAO_0000218,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,8045,Rattus norvegicus,50597,,,,,N,14346,,,,,,1,10116.0,CHEMBL618467,Intermediate,
A,1,BAO_0000218,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,8046,Rattus norvegicus,50597,,,,,N,15372,,,,,,1,10116.0,CHEMBL618468,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,8047,Canis lupus familiaris,50588,,,Plasma,,N,12935,,,,1969.0,,1,9615.0,CHEMBL618469,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,8048,Canis lupus familiaris,50588,,,Plasma,,N,12935,,,,1969.0,,1,9615.0,CHEMBL618470,Intermediate,
A,0,BAO_0000218,Plasma drug AUC in rat (PO dose),8049,,22224,,,,,U,14813,,,,,,1,,CHEMBL618471,Autocuration,
A,1,BAO_0000218,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,8050,Mus musculus,50594,,,,,N,15792,,,,,,1,10090.0,CHEMBL618472,Intermediate,
A,0,BAO_0000218,Area under was determined at a dose of 30 mg/kg,8051,,22224,,,,,U,3579,,,,,,1,,CHEMBL618473,Autocuration,
A,1,BAO_0000218,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,8052,Mustela putorius furo,50506,,,,,N,12487,,,,,,1,9669.0,CHEMBL621699,Intermediate,
A,1,BAO_0000218,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,8053,Rattus norvegicus,50597,,,,,N,12487,,,,,,1,10116.0,CHEMBL621700,Intermediate,
A,1,BAO_0000218,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,8054,Rattus norvegicus,50597,,,,,N,12487,,,,,,1,10116.0,CHEMBL621701,Intermediate,
A,1,BAO_0000218,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,8055,Mustela putorius furo,50506,,,,,N,12487,,,,,,1,9669.0,CHEMBL621702,Intermediate,
A,1,BAO_0000218,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,8056,Canis lupus familiaris,50588,,,,,N,12487,,,,,,1,9615.0,CHEMBL621703,Intermediate,
A,1,BAO_0000218,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,8057,Canis lupus familiaris,50588,,,,,N,12487,,,,,,1,9615.0,CHEMBL621704,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",8058,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624259,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",8059,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624260,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",8060,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624430,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",8061,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624431,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",8062,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624432,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",8063,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624433,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",8064,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624434,Intermediate,
A,1,BAO_0000218,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",8065,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL624435,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,8066,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL618570,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8067,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL618571,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,8068,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL618572,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8069,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL618573,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,8070,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL619267,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8071,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL619431,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,8072,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL619432,Intermediate,
A,1,BAO_0000218,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),8073,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL619433,Intermediate,
A,0,BAO_0000218,AUC in mice after oral dose (50 mg/kg),8074,,22224,,,Plasma,,U,13298,,,,1969.0,,1,,CHEMBL619434,Autocuration,
A,1,BAO_0000218,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,8075,Mus musculus,50594,,,Serum,,N,12226,,,,1977.0,,1,10090.0,CHEMBL619435,Intermediate,
A,0,BAO_0000019,AUC (0-4 hr) ug/ml/h,8076,,22224,,,Plasma,,U,12634,,,,1969.0,,1,,CHEMBL619436,Autocuration,
A,1,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,8077,Rattus norvegicus,50597,,,,,N,14810,,,,,,1,10116.0,CHEMBL619437,Intermediate,
A,0,BAO_0000218,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,8078,,22224,,,,,U,13889,,,,,,1,,CHEMBL619438,Autocuration,
A,1,BAO_0000218,Compound was evaluated for Area under curve in mice,8079,Mus musculus,50594,,,,,N,10018,,,,,,1,10090.0,CHEMBL619439,Intermediate,
A,1,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8080,Rattus norvegicus,50597,,,,,N,8758,,,,,,1,10116.0,CHEMBL619440,Intermediate,
F,0,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8081,,22224,,,,,U,8758,,,,,,1,,CHEMBL619441,Autocuration,
A,1,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8082,Rattus norvegicus,50597,,,,,N,8758,,,,,,1,10116.0,CHEMBL619442,Intermediate,
A,0,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,8083,,22224,,,,,U,2249,,,,,,1,,CHEMBL875156,Autocuration,
A,0,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,8084,,22224,,,,,U,2249,,,,,,1,,CHEMBL619443,Autocuration,
A,0,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,8085,,22224,,,,,U,2249,,,,,,1,,CHEMBL619444,Autocuration,
A,0,BAO_0000019,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,8086,,22224,,,,,U,2249,,,,,,1,,CHEMBL623464,Autocuration,
A,1,BAO_0000218,Compound was evaluated for area under curve when administered through oral route in mouse,8087,Mus musculus,50594,,,,,N,15115,,,,,,1,10090.0,CHEMBL623465,Intermediate,
A,1,BAO_0000218,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,8088,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623466,Intermediate,
A,1,BAO_0000218,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,8089,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623467,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8090,Rattus norvegicus,50597,,,,,N,6249,,,,,In vivo,1,10116.0,CHEMBL623468,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,8091,Rattus norvegicus,50597,,,,,N,2463,,,,,In vivo,1,10116.0,CHEMBL622660,Intermediate,
A,1,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,8092,Rattus norvegicus,50597,,,,,N,4969,,,,,In vivo,1,10116.0,CHEMBL622661,Intermediate,
F,1,BAO_0000218,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,8093,Rattus norvegicus,50597,,,,,N,17720,,,,,In vivo,1,10116.0,CHEMBL622662,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (total body clearance) in rat,8094,Rattus norvegicus,50597,,,,,N,3457,,,,,In vivo,1,10116.0,CHEMBL622663,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,8095,Rattus norvegicus,50597,,,,,N,5983,,,,,In vivo,1,10116.0,CHEMBL622664,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8096,Rattus norvegicus,50597,,,,,N,6295,,,,,,1,10116.0,CHEMBL622665,Intermediate,
A,1,BAO_0000218,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,8097,Rattus norvegicus,50597,,,,,N,6296,,,,,,1,10116.0,CHEMBL622666,Intermediate,
A,1,BAO_0000218,Cl in rat i.v. at 2 mg/kg concentration,8098,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL621615,Intermediate,
A,1,BAO_0000218,Clearance of compound after intravenous administration in rats at 24 uM/kg,8099,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL621616,Intermediate,
A,1,BAO_0000218,Clearance was determined,8100,Rattus norvegicus,50597,,,,,N,5503,,,,,In vivo,1,10116.0,CHEMBL621617,Intermediate,
A,1,BAO_0000218,Clearance by intravenous administration of 3.4 mg/kg in rat,8101,Rattus norvegicus,50597,,,,,N,4368,,,,,In vivo,1,10116.0,CHEMBL621618,Intermediate,
A,1,BAO_0000218,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8102,Rattus norvegicus,50597,,,,,N,6005,,,,,In vivo,1,10116.0,CHEMBL621619,Intermediate,
A,1,BAO_0000218,Clearance rate after i.v. administration in rats,8103,Rattus norvegicus,50597,,,,,N,5031,,,,,In vivo,1,10116.0,CHEMBL621620,Intermediate,
A,1,BAO_0000218,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8104,Rattus norvegicus,50597,,,,,N,4890,,,,,In vivo,1,10116.0,CHEMBL621786,Intermediate,
A,1,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,8105,Rattus norvegicus,50597,,,,,N,5182,,,,,In vivo,1,10116.0,CHEMBL621787,Intermediate,
A,1,BAO_0000218,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,8106,Rattus norvegicus,50597,,,,,N,5979,,,,,In vivo,1,10116.0,CHEMBL621788,Intermediate,
A,1,BAO_0000218,Clearance (Cl) after oral administration in rat,8107,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL621789,Intermediate,
A,1,BAO_0000218,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,8108,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL621790,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma clearance in rat,8109,Rattus norvegicus,50597,,,Plasma,,N,4839,,,,1969.0,In vivo,1,10116.0,CHEMBL621791,Intermediate,
A,1,BAO_0000218,In vitro microsome metabolism clearance in rat was determined,8110,Rattus norvegicus,50597,,,,,N,5041,,,,,In vitro,1,10116.0,CHEMBL621792,Intermediate,Microsomes
A,1,BAO_0000218,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,8111,Rattus norvegicus,50597,,,,,N,5041,,,,,In vitro,1,10116.0,CHEMBL621793,Intermediate,Microsomes
A,1,BAO_0000218,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8112,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL621794,Intermediate,
A,1,BAO_0000218,In vivo plasma clearance was determined,8113,Rattus norvegicus,50597,,,Plasma,,N,5496,,,,1969.0,In vivo,1,10116.0,CHEMBL621795,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,8114,Rattus norvegicus,50597,,,,,N,5739,,,,,In vivo,1,10116.0,CHEMBL621796,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,8115,Rattus norvegicus,50597,,,Liver,Hepatocyte,N,5676,,401.0,,2107.0,In vivo,1,10116.0,CHEMBL621797,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Plasma clearance) was measured in rat,8116,Rattus norvegicus,50597,,,,,N,4239,,,,,In vivo,1,10116.0,CHEMBL621798,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (clearance) in rat i.v.,8117,Rattus norvegicus,50597,,,,,N,5676,,,,,In vivo,1,10116.0,CHEMBL621799,Intermediate,
A,1,BAO_0000218,"Plasma Clearance was evaluated in rats, iv",8118,Rattus norvegicus,50597,,,,,N,1918,,,,,In vivo,1,10116.0,CHEMBL621800,Intermediate,
A,1,BAO_0000218,Plasma clearance (in vivo) in rats was determined,8119,Rattus norvegicus,50597,,,,,N,17800,,,,,In vivo,1,10116.0,CHEMBL621801,Intermediate,
A,1,BAO_0000218,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,8120,Rattus norvegicus,50597,,,,,N,6056,,,,,In vivo,1,10116.0,CHEMBL621802,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined,8121,Rattus norvegicus,50597,,,,,N,5496,,,,,In vivo,1,10116.0,CHEMBL618596,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,8122,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL618597,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,8123,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL618598,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats,8124,Rattus norvegicus,50597,,,,,N,17752,,,,,In vivo,1,10116.0,CHEMBL618599,Intermediate,
A,1,BAO_0000218,Plasma clearance rate determined in rat,8125,Rattus norvegicus,50597,,,,,N,4576,,,,,In vivo,1,10116.0,CHEMBL618600,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined in rat,8126,Rattus norvegicus,50597,,,,,N,6011,,,,,In vivo,1,10116.0,CHEMBL618601,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined,8127,Rattus norvegicus,50597,,,,,N,5510,,,,,In vivo,1,10116.0,CHEMBL618602,Intermediate,
A,1,BAO_0000218,Plasma clearance value in rat,8128,Rattus norvegicus,50597,,,,,N,5948,,,,,In vivo,1,10116.0,CHEMBL618603,Intermediate,
A,1,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,8129,Rattus norvegicus,50597,,,Liver,,N,6125,,,,2107.0,Ex vivo,1,10116.0,CHEMBL618604,Intermediate,
A,1,BAO_0000218,Clearance in rat,8130,Rattus norvegicus,50597,,,,,N,4839,,,,,In vivo,1,10116.0,CHEMBL618605,Intermediate,
A,1,BAO_0000218,Total body clearance in rat i.v. at 2 mg/kg concentration,8131,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL618606,Intermediate,
A,1,BAO_0000218,Clearance of compound in rats after intravenous administration,8132,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL618607,Intermediate,
A,1,BAO_0000218,Clearance after iv administration to rats,8133,Rattus norvegicus,50597,,,,,N,3364,,,,,In vivo,1,10116.0,CHEMBL618608,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8134,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618609,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8135,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618610,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,8136,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618611,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8137,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618612,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8138,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618613,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8139,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL621076,Intermediate,
A,1,BAO_0000218,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8140,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL621077,Intermediate,
A,1,BAO_0000218,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",8141,Rattus norvegicus,50597,,,,,N,17670,,,,,In vivo,1,10116.0,CHEMBL621078,Intermediate,
A,1,BAO_0000218,Clearance in rat,8142,Rattus norvegicus,50597,,,,,N,5970,,,,,In vivo,1,10116.0,CHEMBL621251,Intermediate,
A,1,BAO_0000218,Clearance in rat after oral administration at 10 mg/kg,8143,Rattus norvegicus,50597,,,,,N,6495,,,,,In vivo,1,10116.0,CHEMBL621252,Intermediate,
A,1,BAO_0000218,Clearance in rat.,8144,Rattus norvegicus,50597,,,,,N,4590,,,,,In vivo,1,10116.0,CHEMBL621253,Intermediate,
A,1,BAO_0000218,Clearance rate following an oral dose of 20 mg/kg in rats,8145,Rattus norvegicus,50597,,,,,N,6193,,,,,In vivo,1,10116.0,CHEMBL621254,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,8146,Rattus norvegicus,50597,,,,,N,2832,,,,,In vivo,1,10116.0,CHEMBL621255,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,8147,Rattus norvegicus,50597,,,Plasma,,N,1052,,,,1969.0,In vivo,1,10116.0,CHEMBL621256,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,8148,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621257,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,8149,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621258,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,8150,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621259,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,8151,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621260,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,8152,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL876494,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,8153,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621261,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,8154,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621262,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,8155,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621263,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,8156,Rattus norvegicus,50597,,,Liver,,N,9866,,,,2107.0,In vivo,1,10116.0,CHEMBL621264,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,8157,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621265,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,8158,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621266,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,8159,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621267,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,8160,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621268,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,8161,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621269,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,8162,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621270,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,8163,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621271,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,8164,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621272,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,8165,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621273,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,8166,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621274,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,8167,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL876495,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,8168,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621275,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,8169,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621276,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,8170,Rattus norvegicus,50597,,,Muscle tissue,,N,9866,,,,2385.0,In vivo,1,10116.0,CHEMBL621277,Intermediate,
A,1,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,8171,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL621278,Intermediate,
A,1,BAO_0000218,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,8172,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL621279,Intermediate,
A,1,BAO_0000218,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),8173,Rattus norvegicus,50597,,,Intestine,,N,9866,,,,160.0,In vivo,1,10116.0,CHEMBL621280,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,8174,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621281,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,8175,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621282,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,8176,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621283,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,8177,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621284,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,8178,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621285,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,8179,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL621286,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,8180,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL623220,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,8181,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL623221,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,8182,Rattus norvegicus,50597,,,Spleen,,N,9866,,,,2106.0,In vivo,1,10116.0,CHEMBL876029,Intermediate,
A,1,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,8183,Rattus norvegicus,50597,,,Stomach,,N,9866,,,,945.0,In vivo,1,10116.0,CHEMBL623222,Intermediate,
A,1,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,8184,Rattus norvegicus,50597,,,Stomach,,N,9866,,,,945.0,In vivo,1,10116.0,CHEMBL623223,Intermediate,
A,1,BAO_0000218,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,8185,Rattus norvegicus,50597,,,Stomach,,N,9866,,,,945.0,In vivo,1,10116.0,CHEMBL621445,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8186,Rattus norvegicus,50597,,,Blood,,N,13950,,,,178.0,In vivo,1,10116.0,CHEMBL621446,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,8187,Rattus norvegicus,50597,,,Blood,,N,13950,,,,178.0,In vivo,1,10116.0,CHEMBL621447,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,8188,Rattus norvegicus,50597,,,Blood,,N,13950,,,,178.0,In vivo,1,10116.0,CHEMBL619681,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,8189,Rattus norvegicus,50597,,,Blood,,N,13950,,,,178.0,In vivo,1,10116.0,CHEMBL619682,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,8190,Rattus norvegicus,50597,,,Blood,,N,13950,,,,178.0,In vivo,1,10116.0,CHEMBL619683,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8191,Rattus norvegicus,50597,,,Brain,,N,13950,,,,955.0,In vivo,1,10116.0,CHEMBL619684,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,8192,Rattus norvegicus,50597,,,Brain,,N,13950,,,,955.0,In vivo,1,10116.0,CHEMBL619685,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,8193,Rattus norvegicus,50597,,,Brain,,N,13950,,,,955.0,In vivo,1,10116.0,CHEMBL619686,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,8194,Rattus norvegicus,50597,,,Brain,,N,13950,,,,955.0,In vivo,1,10116.0,CHEMBL619687,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,8195,Rattus norvegicus,50597,,,Brain,,N,13950,,,,955.0,In vivo,1,10116.0,CHEMBL619688,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8196,Rattus norvegicus,50597,,,Heart,,N,13950,,,,948.0,In vivo,1,10116.0,CHEMBL619689,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,8197,Rattus norvegicus,50597,,,Heart,,N,13950,,,,948.0,In vivo,1,10116.0,CHEMBL619690,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,8198,Rattus norvegicus,50597,,,Heart,,N,13950,,,,948.0,In vivo,1,10116.0,CHEMBL619691,Intermediate,
A,1,BAO_0000218,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,8199,Rattus norvegicus,50597,,,,,N,6062,,,,,In vivo,1,10116.0,CHEMBL619692,Intermediate,
A,1,BAO_0000218,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,8200,Rattus norvegicus,50597,,,,,N,3598,,,,,,1,10116.0,CHEMBL619693,Expert,
A,1,BAO_0000218,Vc value after IV dose at a dose of 5 mg/kg in rats.,8201,Rattus norvegicus,50597,,,,,N,1908,,,,,In vivo,1,10116.0,CHEMBL619694,Intermediate,
A,1,BAO_0000218,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,8202,Rattus norvegicus,50597,,,,,N,17596,,,,,In vivo,1,10116.0,CHEMBL619695,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic parameter volume of distribution,8203,Rattus norvegicus,50597,,,,,N,4891,,,,,In vivo,1,10116.0,CHEMBL619696,Intermediate,
A,1,BAO_0000218,Compound was evaluated for volume of distribution in rat,8204,Rattus norvegicus,50597,,,,,N,740,,,,,In vivo,1,10116.0,CHEMBL619697,Intermediate,
A,1,BAO_0000218,Steady state volume distribution was determined; steady state(ss),8205,Rattus norvegicus,50597,,,,,N,16366,,,,,In vivo,1,10116.0,CHEMBL619698,Intermediate,
A,1,BAO_0000218,Steady state volume of distribution after iv administration to rats,8206,Rattus norvegicus,50597,,,,,N,3364,,,,,In vivo,1,10116.0,CHEMBL619699,Intermediate,
A,1,BAO_0000218,Steady state volume of distribution dosing at 3 mg/kg iv,8207,Rattus norvegicus,50597,,,,,N,2552,,,,,In vivo,1,10116.0,CHEMBL619700,Intermediate,
A,1,BAO_0000218,The compound was evaluated for volume of distribution in rat,8208,Rattus norvegicus,50597,,,,,N,406,,,,,In vivo,1,10116.0,CHEMBL619701,Intermediate,
A,1,BAO_0000218,The compound was tested for volume of distribution in rat,8209,Rattus norvegicus,50597,,,,,N,12500,,,,,In vivo,1,10116.0,CHEMBL619702,Intermediate,
A,1,BAO_0000218,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,8210,Rattus norvegicus,50597,,,,,N,12500,,,,,In vivo,1,10116.0,CHEMBL620335,Intermediate,
A,1,BAO_0000218,Volume distribution (VD) after oral administration in rat,8211,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL620336,Intermediate,
A,1,BAO_0000218,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8212,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL620337,Intermediate,
A,1,BAO_0000218,Volume distribution in rat,8213,Rattus norvegicus,50597,,,,,N,1094,,,,,In vivo,1,10116.0,CHEMBL620520,Intermediate,
A,1,BAO_0000218,Volume distribution in rat,8214,Rattus norvegicus,50597,,,,,N,5833,,,,,In vivo,1,10116.0,CHEMBL620521,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after peroral administration at 10 mg/kg,8215,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL875825,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after peroral administration at 5 mg/kg,8216,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL620522,Intermediate,
A,1,BAO_0000218,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,8217,Rattus norvegicus,50597,,,,,N,6005,,,,,In vivo,1,10116.0,CHEMBL620523,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat.,8218,Rattus norvegicus,50597,,,,,N,1696,,,,,In vivo,1,10116.0,CHEMBL620524,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat,8219,Rattus norvegicus,50597,,,,,N,6672,,,,,In vivo,1,10116.0,CHEMBL620525,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat,8220,Rattus norvegicus,50597,,,,,N,6673,,,,,In vivo,1,10116.0,CHEMBL620526,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat by iv administration,8221,Rattus norvegicus,50597,,,,,N,5871,,,,,In vivo,1,10116.0,CHEMBL620527,Intermediate,
A,1,BAO_0000218,Volume of distribution in rats,8222,Rattus norvegicus,50597,,,,,N,6803,,,,,In vivo,1,10116.0,CHEMBL620528,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,8223,Rattus norvegicus,50597,,,,,N,5199,,,,,In vivo,1,10116.0,CHEMBL620529,Intermediate,
A,1,BAO_0000218,Volume distribution at the dose of 2 mg/kg in rat,8224,Rattus norvegicus,50597,,,,,N,4727,,,,,,1,10116.0,CHEMBL620530,Intermediate,
A,1,BAO_0000218,Steady state volume of distribution was determined,8225,Rattus norvegicus,50597,,,,,N,16367,,,,,In vivo,1,10116.0,CHEMBL620531,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,8226,Macaca mulatta,22224,,,,,U,5005,,,,,In vivo,1,9544.0,CHEMBL620532,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats,8227,Rattus norvegicus,22224,,,,,U,5005,,,,,In vivo,1,10116.0,CHEMBL620533,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,8228,Rattus norvegicus,22224,,,,,U,5005,,,,,In vivo,1,10116.0,CHEMBL620534,Intermediate,
A,1,BAO_0000218,Mean (%CV) PK parameters for Vdss(mL/kg).,8229,Rattus norvegicus,50597,,,,,N,15765,,,,,In vivo,1,10116.0,CHEMBL620535,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,8230,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL875826,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,8231,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL620536,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8232,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL620537,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,8233,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL618526,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,8234,Rattus norvegicus,50597,,,,,N,5739,,,,,In vivo,1,10116.0,CHEMBL618527,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Vdss) in rat,8235,Rattus norvegicus,50597,,,,,N,5789,,,,,In vivo,1,10116.0,CHEMBL618528,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (vdss) was measured in rat,8236,Rattus norvegicus,50597,,,,,N,4239,,,,,In vivo,1,10116.0,CHEMBL618529,Intermediate,
A,1,BAO_0000218,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,8237,Rattus norvegicus,50597,,,,,N,4709,,,,,In vivo,1,10116.0,CHEMBL618530,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat,8238,Rattus norvegicus,50597,,,,,N,6642,,,,,In vivo,1,10116.0,CHEMBL618531,Intermediate,
A,1,BAO_0000218,The pharmacokinetic parameter volume of distribution in vivo in rats,8239,Rattus norvegicus,50597,,,,,N,5247,,,,,In vivo,1,10116.0,CHEMBL618532,Intermediate,
F,1,BAO_0000218,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,8240,Rattus norvegicus,50597,,,,,N,17720,,,,,In vivo,1,10116.0,CHEMBL618533,Intermediate,
A,1,BAO_0000218,Vdss in rat i.v. at 2 mg/kg concentration,8241,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL618534,Intermediate,
A,1,BAO_0000218,Volume distribution after intravenous administration (1 mg/kg) in rat,8242,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL618535,Intermediate,
A,1,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,8243,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL618536,Intermediate,
A,1,BAO_0000218,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,8244,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL618537,Intermediate,
A,1,BAO_0000218,Volume distribution at a dose of 10 uM/kg in rat was determined,8245,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL618538,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8246,Rattus norvegicus,50597,,,,,N,4521,,,,,In vivo,1,10116.0,CHEMBL618539,Intermediate,
A,1,BAO_0000218,Volume distribution was calculated in rat,8247,Rattus norvegicus,50597,,,,,N,6057,,,,,In vivo,1,10116.0,CHEMBL618540,Intermediate,
A,1,BAO_0000218,Volume distribution was determined,8248,Rattus norvegicus,50597,,,,,N,5510,,,,,In vivo,1,10116.0,CHEMBL618541,Intermediate,
A,1,BAO_0000218,Volume of distribution after intravenous administration was evaluated in rat,8249,Rattus norvegicus,50597,,,,,N,2938,,,,,In vivo,1,10116.0,CHEMBL618542,Intermediate,
A,1,BAO_0000218,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8250,Rattus norvegicus,50597,,,,,N,6679,,,,,In vivo,1,10116.0,CHEMBL622544,Intermediate,
A,1,BAO_0000218,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",8251,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL622545,Intermediate,
A,1,BAO_0000218,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8252,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL622546,Intermediate,
A,1,BAO_0000218,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",8253,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL622547,Intermediate,
A,1,BAO_0000218,Volume of distribution in steady state was determined in rat,8254,Rattus norvegicus,50597,,,,,N,5145,,,,,In vivo,1,10116.0,CHEMBL622548,Intermediate,
A,1,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,8255,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL622549,Intermediate,
A,1,BAO_0000218,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8256,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL622550,Intermediate,
A,1,BAO_0000218,Compound was evaluated for area under curve when administered through oral route to mouse,8257,Mus musculus,50594,,,,,N,15115,,,,,,1,10090.0,CHEMBL622551,Intermediate,
A,1,BAO_0000218,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8258,Rattus norvegicus,50597,,,,,N,8758,,,,,,1,10116.0,CHEMBL622552,Intermediate,
A,1,BAO_0000218,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8259,Rattus norvegicus,50597,,,,,N,8758,,,,,,1,10116.0,CHEMBL622553,Intermediate,
F,0,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,8260,,22224,,,,,U,8267,,,,,In vivo,1,,CHEMBL622554,Autocuration,
A,1,BAO_0000218,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,8261,Canis lupus familiaris,50588,,,,,N,8267,,,,,,1,9615.0,CHEMBL622555,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,8262,Mus musculus,50594,,,,,N,14239,,,,,,1,10090.0,CHEMBL622556,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,8263,Mus musculus,50594,,,,,N,14239,,,,,,1,10090.0,CHEMBL622557,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,8264,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,,1,10090.0,CHEMBL622558,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,8265,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,,1,10090.0,CHEMBL622559,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,8266,Canis lupus familiaris,50588,,,,,N,10754,,,,,,1,9615.0,CHEMBL622560,Intermediate,
A,1,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,8267,Rattus norvegicus,50597,,,,,N,14681,,,,,,1,10116.0,CHEMBL622561,Intermediate,
A,1,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,8268,Rattus norvegicus,50597,,,,,N,14681,,,,,,1,10116.0,CHEMBL622562,Intermediate,
A,1,BAO_0000218,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,8269,Rattus norvegicus,50597,,,,,N,14681,,,,,,1,10116.0,CHEMBL622563,Intermediate,
A,0,BAO_0000019,Concentration of compound in Central nervous system,8270,,22224,,,,,U,13118,,,,,,1,,CHEMBL622564,Autocuration,
A,0,BAO_0000019,Concentration of compound in Central nervous system; Not detectable,8271,,22224,,,,,U,13118,,,,,,1,,CHEMBL622565,Autocuration,
A,1,BAO_0000218,"Concentration of diester in the blood, following oral administration in mice",8272,Mus musculus,50594,,,,,N,13318,,,,,,1,10090.0,CHEMBL622566,Intermediate,
A,1,BAO_0000218,"Concentration of monoester in the blood, following oral administration in mice",8273,Mus musculus,50594,,,,,N,13318,,,,,,1,10090.0,CHEMBL624515,Intermediate,
A,1,BAO_0000218,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,8274,Mus musculus,50594,,,,,N,13318,,,,,,1,10090.0,CHEMBL624516,Intermediate,
A,0,BAO_0000019,Evaluated for Pharmacokinetic property: Area under the curve,8275,,22224,,,,,U,15692,,,,,,1,,CHEMBL624517,Autocuration,
A,1,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,8276,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL624518,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,8277,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624519,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,8278,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624520,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,8279,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624521,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,8280,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624522,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,8281,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624523,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8282,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624409,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",8283,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624410,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8284,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL624411,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",8285,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL623531,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",8286,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL623532,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",8287,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL623533,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",8288,Macaca fascicularis,100710,,,,,N,14839,,,,,,1,9541.0,CHEMBL623534,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,8289,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623535,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,8290,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623536,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,8291,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623537,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,8292,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623538,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,8293,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623539,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,8294,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623540,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",8295,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623541,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",8296,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623542,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",8297,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623543,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",8298,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623544,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",8299,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623545,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",8300,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623546,Intermediate,
A,1,BAO_0000218,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,8301,Rattus norvegicus,50597,,,Plasma,,N,5408,,,,1969.0,In vivo,1,10116.0,CHEMBL623547,Intermediate,
A,1,BAO_0000218,High i.v. clearance in Dawley rats,8302,Rattus norvegicus,50597,,,,,N,6827,,,,,In vivo,1,10116.0,CHEMBL623548,Intermediate,
A,1,BAO_0000218,In vitro clearance in rat liver microsomes,8303,Rattus norvegicus,50597,,,Liver,,N,17538,,,,2107.0,In vitro,1,10116.0,CHEMBL623549,Intermediate,Microsomes
A,1,BAO_0000218,Intrinsic clearance in rat liver microsomes was determined,8304,Rattus norvegicus,50597,,,Liver,,N,6331,,,,2107.0,In vitro,1,10116.0,CHEMBL623550,Intermediate,Microsomes
A,1,BAO_0000218,Intrinsic clearance in rat hepatocytes was determined,8305,Rattus norvegicus,50597,,,Liver,Hepatocyte,N,5948,,401.0,,2107.0,In vitro,1,10116.0,CHEMBL875276,Intermediate,
A,1,BAO_0000218,Plasma Clearance was determined,8306,Rattus norvegicus,50597,,,,,N,4026,,,,,In vivo,1,10116.0,CHEMBL621872,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,8307,Rattus norvegicus,50597,,,,,N,6647,,,,,In vivo,1,10116.0,CHEMBL621873,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat.,8308,Rattus norvegicus,50597,,,,,N,1696,,,,,In vivo,1,10116.0,CHEMBL621874,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats,8309,Rattus norvegicus,50597,,,,,N,6597,,,,,In vivo,1,10116.0,CHEMBL621875,Intermediate,
A,1,BAO_0000218,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,8310,Rattus norvegicus,50597,,,,,N,347,,,,,In vivo,1,10116.0,CHEMBL621876,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,8311,Rattus norvegicus,50597,,,,,N,16423,,,,,In vivo,1,10116.0,CHEMBL621877,Intermediate,
A,1,BAO_0000218,Plasma clearance was measured in rat,8312,Rattus norvegicus,50597,,,,,N,2879,,,,,In vivo,1,10116.0,CHEMBL621878,Intermediate,
A,1,BAO_0000218,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8313,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL621879,Intermediate,
A,1,BAO_0000218,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",8314,Rattus norvegicus,50597,,,Plasma,,N,5328,,,,1969.0,In vivo,1,10116.0,CHEMBL621880,Intermediate,
A,1,BAO_0000218,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,8315,Rattus norvegicus,50597,,,,,N,5160,,,,,In vivo,1,10116.0,CHEMBL621881,Intermediate,
A,1,BAO_0000218,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8316,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL621882,Intermediate,
A,1,BAO_0000218,Total clearance at 1 mg/kg was determined in rat,8317,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL875283,Intermediate,
A,1,BAO_0000218,Total clearance at 10 mg/kg was determined in rat,8318,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL621883,Intermediate,
A,1,BAO_0000218,Clearance in rat,8319,Rattus norvegicus,50597,,,,,N,6596,,,,,In vivo,1,10116.0,CHEMBL621884,Intermediate,
A,1,BAO_0000218,Plasma clearance rate determined in rats,8320,Rattus norvegicus,50597,,,,,N,4796,,,,,In vivo,1,10116.0,CHEMBL621885,Intermediate,
A,1,BAO_0000218,Clearance of compound in rat was evaluated,8321,Rattus norvegicus,50597,,,,,N,6850,,,,,In vivo,1,10116.0,CHEMBL621886,Intermediate,
A,1,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,8322,Rattus norvegicus,50597,,,Plasma,,N,5932,,,,1969.0,In vivo,1,10116.0,CHEMBL621887,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (blood clearance) in rat,8323,Rattus norvegicus,50597,,,,,N,3371,,,,,In vivo,1,10116.0,CHEMBL621888,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8324,Rattus norvegicus,50597,,,,,N,2083,,,,,In vivo,1,10116.0,CHEMBL621889,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats,8325,Rattus norvegicus,50597,,,,,N,4942,,,,,In vivo,1,10116.0,CHEMBL621890,Intermediate,
A,1,BAO_0000218,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,8326,Rattus norvegicus,50597,,,Liver,,N,6838,,,,2107.0,In vitro,1,10116.0,CHEMBL621891,Intermediate,Microsomes
A,1,BAO_0000218,Clearance in Dawley rat,8327,Rattus norvegicus,50597,,,,,N,5353,,,,,In vivo,1,10116.0,CHEMBL621892,Intermediate,
A,1,BAO_0000218,Clearance rat,8328,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL621893,Intermediate,
A,1,BAO_0000218,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),8329,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL621894,Intermediate,
A,1,BAO_0000218,Clearance rat; Not determined,8330,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL621895,Intermediate,
A,1,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.,8331,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL875284,Intermediate,
A,1,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8332,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL618699,Intermediate,
A,1,BAO_0000218,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8333,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL618700,Intermediate,
A,1,BAO_0000218,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,8334,Rattus norvegicus,50597,,,,,N,6211,,,,,In vivo,1,10116.0,CHEMBL618701,Intermediate,
A,1,BAO_0000218,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",8335,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL876600,Intermediate,
A,1,BAO_0000218,Clearance of compound in rat after 1 mg/kg i.v. administration,8336,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL618702,Intermediate,
A,1,BAO_0000218,Compound was evaluated for Hepatic clearance in rat,8337,Rattus norvegicus,50597,,,,,N,3341,,,,,In vivo,1,10116.0,CHEMBL618703,Intermediate,
A,1,BAO_0000218,In vivo clearance after 5 mg/kg dose,8338,Rattus norvegicus,50597,,,,,N,4891,,,,,In vivo,1,10116.0,CHEMBL618704,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma clearance in rats,8339,Rattus norvegicus,50597,,,Plasma,,N,1094,,,,1969.0,In vivo,1,10116.0,CHEMBL618705,Intermediate,
A,1,BAO_0000218,Hepatic clearance after intravenous administration was evaluated in rat,8340,Rattus norvegicus,50597,,,,,N,2938,,,,,In vivo,1,10116.0,CHEMBL618706,Intermediate,
A,1,BAO_0000218,Lower clearance in rat (i.v.) at 0.5 mpk,8341,Rattus norvegicus,50597,,,,,N,17853,,,,,In vivo,1,10116.0,CHEMBL618707,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter expressed as plasma clearance in rat,8342,Rattus norvegicus,50597,,,Plasma,,N,6049,,,,1969.0,In vivo,1,10116.0,CHEMBL618708,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Clp) in rat,8343,Rattus norvegicus,50597,,,,,N,5789,,,,,In vivo,1,10116.0,CHEMBL618709,Intermediate,
A,1,BAO_0000218,Plasma clearance in Sprague-Dawley rats,8344,Rattus norvegicus,50597,,,,,N,4514,,,,,In vivo,1,10116.0,CHEMBL618710,Intermediate,
A,1,BAO_0000218,Plasma clearance (Clp) in rat,8345,Rattus norvegicus,50597,,,,,N,6448,,,,,In vivo,1,10116.0,CHEMBL618711,Intermediate,
A,1,BAO_0000218,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,8346,Rattus norvegicus,50597,,,,,N,6062,,,,,In vivo,1,10116.0,CHEMBL618712,Intermediate,
A,1,BAO_0000218,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,8347,Rattus norvegicus,50597,,,,,N,5710,,,,,In vivo,1,10116.0,CHEMBL618713,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration of 1 mg/kg in rat,8348,Rattus norvegicus,50597,,,,,N,4709,,,,,In vivo,1,10116.0,CHEMBL618714,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,8349,Rattus norvegicus,50597,,,,,N,4521,,,,,In vivo,1,10116.0,CHEMBL618715,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat was determined,8350,Rattus norvegicus,50597,,,,,N,1742,,,,,In vivo,1,10116.0,CHEMBL618716,Intermediate,
A,1,BAO_0000218,Plasma clearance measured in rat,8351,Rattus norvegicus,50597,,,,,N,6057,,,,,In vivo,1,10116.0,CHEMBL876601,Intermediate,
A,1,BAO_0000218,Plasma clearance was calculated in rat,8352,Rattus norvegicus,50597,,,,,N,6057,,,,,In vivo,1,10116.0,CHEMBL618717,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8353,Rattus norvegicus,50597,,,,,N,5145,,,,,In vivo,1,10116.0,CHEMBL618718,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8354,Rattus norvegicus,50597,,,,,N,5833,,,,,In vivo,1,10116.0,CHEMBL618719,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8355,Rattus norvegicus,50597,,,,,N,6453,,,,,In vivo,1,10116.0,CHEMBL618720,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8356,Rattus norvegicus,50597,,,,,N,6640,,,,,In vivo,1,10116.0,CHEMBL618721,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats,8357,Rattus norvegicus,50597,,,,,N,6305,,,,,In vivo,1,10116.0,CHEMBL621477,Intermediate,
A,1,BAO_0000218,Plasma clearance in rat,8358,Rattus norvegicus,50597,,,,,N,6642,,,,,In vivo,1,10116.0,CHEMBL621478,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated in rat,8359,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL621479,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated in rat; Not tested,8360,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL621480,Intermediate,
A,1,BAO_0000218,Plasma clearance rate was determined for the compound in rat,8361,Rattus norvegicus,50597,,,,,N,5144,,,,,In vivo,1,10116.0,CHEMBL621481,Intermediate,
A,1,BAO_0000218,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",8362,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL621482,Intermediate,
A,1,BAO_0000218,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",8363,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL621483,Intermediate,
A,1,BAO_0000218,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",8364,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL621484,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,8365,Rattus norvegicus,50597,,,Heart,,N,13950,,,,948.0,In vivo,1,10116.0,CHEMBL621485,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,8366,Rattus norvegicus,50597,,,Heart,,N,13950,,,,948.0,In vivo,1,10116.0,CHEMBL621486,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8367,Rattus norvegicus,50597,,,Intestine,,N,13950,,,,160.0,In vivo,1,10116.0,CHEMBL621487,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,8368,Rattus norvegicus,50597,,,Intestine,,N,13950,,,,160.0,In vivo,1,10116.0,CHEMBL621488,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,8369,Rattus norvegicus,50597,,,Intestine,,N,13950,,,,160.0,In vivo,1,10116.0,CHEMBL621489,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,8370,Rattus norvegicus,50597,,,Intestine,,N,13950,,,,160.0,In vivo,1,10116.0,CHEMBL621490,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,8371,Rattus norvegicus,50597,,,Intestine,,N,13950,,,,160.0,In vivo,1,10116.0,CHEMBL621491,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8372,Rattus norvegicus,50597,,,Kidney,,N,13950,,,,2113.0,In vivo,1,10116.0,CHEMBL621492,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,8373,Rattus norvegicus,50597,,,Kidney,,N,13950,,,,2113.0,In vivo,1,10116.0,CHEMBL621493,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,8374,Rattus norvegicus,50597,,,Kidney,,N,13950,,,,2113.0,In vivo,1,10116.0,CHEMBL621494,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,8375,Rattus norvegicus,50597,,,Kidney,,N,13950,,,,2113.0,In vivo,1,10116.0,CHEMBL621495,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,8376,Rattus norvegicus,50597,,,Kidney,,N,13950,,,,2113.0,In vivo,1,10116.0,CHEMBL621496,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8377,Rattus norvegicus,50597,,,Liver,,N,13950,,,,2107.0,In vivo,1,10116.0,CHEMBL621497,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,8378,Rattus norvegicus,50597,,,Liver,,N,13950,,,,2107.0,In vivo,1,10116.0,CHEMBL621498,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,8379,Rattus norvegicus,50597,,,Liver,,N,13950,,,,2107.0,In vivo,1,10116.0,CHEMBL621499,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,8380,Rattus norvegicus,50597,,,Liver,,N,13950,,,,2107.0,In vivo,1,10116.0,CHEMBL618634,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,8381,Rattus norvegicus,50597,,,Liver,,N,13950,,,,2107.0,In vivo,1,10116.0,CHEMBL618635,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8382,Rattus norvegicus,50597,,,Lung,,N,13950,,,,2048.0,In vivo,1,10116.0,CHEMBL618636,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,8383,Rattus norvegicus,50597,,,Lung,,N,13950,,,,2048.0,In vivo,1,10116.0,CHEMBL619737,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,8384,Rattus norvegicus,50597,,,Lung,,N,13950,,,,2048.0,In vivo,1,10116.0,CHEMBL619738,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,8385,Rattus norvegicus,50597,,,Lung,,N,13950,,,,2048.0,In vivo,1,10116.0,CHEMBL624329,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,8386,Rattus norvegicus,50597,,,Lung,,N,13950,,,,2048.0,In vivo,1,10116.0,CHEMBL624330,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8387,Rattus norvegicus,50597,,,Muscle tissue,,N,13950,,,,2385.0,In vivo,1,10116.0,CHEMBL624331,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,8388,Rattus norvegicus,50597,,,Muscle tissue,,N,13950,,,,2385.0,In vivo,1,10116.0,CHEMBL624332,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,8389,Rattus norvegicus,50597,,,Muscle tissue,,N,13950,,,,2385.0,In vivo,1,10116.0,CHEMBL624333,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,8390,Rattus norvegicus,50597,,,Muscle tissue,,N,13950,,,,2385.0,In vivo,1,10116.0,CHEMBL624334,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,8391,Rattus norvegicus,50597,,,Muscle tissue,,N,13950,,,,2385.0,In vivo,1,10116.0,CHEMBL624335,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8392,Rattus norvegicus,50597,,,Spleen,,N,13950,,,,2106.0,In vivo,1,10116.0,CHEMBL620016,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,8393,Rattus norvegicus,50597,,,Spleen,,N,13950,,,,2106.0,In vivo,1,10116.0,CHEMBL620169,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,8394,Rattus norvegicus,50597,,,Spleen,,N,13950,,,,2106.0,In vivo,1,10116.0,CHEMBL620170,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,8395,Rattus norvegicus,50597,,,Spleen,,N,13950,,,,2106.0,In vivo,1,10116.0,CHEMBL620171,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,8396,Rattus norvegicus,50597,,,Spleen,,N,13950,,,,2106.0,In vivo,1,10116.0,CHEMBL620172,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,8397,Rattus norvegicus,50597,,,Stomach,,N,13950,,,,945.0,In vivo,1,10116.0,CHEMBL620173,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,8398,Rattus norvegicus,50597,,,Stomach,,N,13950,,,,945.0,In vivo,1,10116.0,CHEMBL620174,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,8399,Rattus norvegicus,50597,,,Stomach,,N,13950,,,,945.0,In vivo,1,10116.0,CHEMBL620175,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,8400,Rattus norvegicus,50597,,,Stomach,,N,13950,,,,945.0,In vivo,1,10116.0,CHEMBL620176,Intermediate,
A,1,BAO_0000218,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,8401,Rattus norvegicus,50597,,,Stomach,,N,13950,,,,945.0,In vivo,1,10116.0,CHEMBL620177,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8402,Rattus norvegicus,50597,,,Cerebellum,,N,13950,,,,2037.0,,1,10116.0,CHEMBL620178,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8403,Rattus norvegicus,50597,,,Cerebellum,,N,13950,,,,2037.0,,1,10116.0,CHEMBL620179,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,8404,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620180,Intermediate,
A,1,BAO_0000218,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,8405,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL620181,Intermediate,
A,1,BAO_0000218,Volume of distribution of compound in rats after intravenous administration,8406,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL620182,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat,8407,Rattus norvegicus,50597,,,,,N,6453,,,,,In vivo,1,10116.0,CHEMBL620183,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,8408,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL620184,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,8409,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL620185,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,8410,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL620186,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined in Dawley rat,8411,Rattus norvegicus,50597,,,,,N,5353,,,,,In vivo,1,10116.0,CHEMBL620187,Intermediate,
A,1,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8412,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL620188,Intermediate,
A,1,BAO_0000218,Volume of distribution was reported in Sprague-Dawley rat,8413,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL620189,Intermediate,
A,1,BAO_0000218,Volumes of distribution in rat after peroral administration,8414,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL620190,Intermediate,
A,1,BAO_0000218,Volumes of distribution in rat after po administration,8415,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL620191,Intermediate,
A,1,BAO_0000218,Volumes of distribution in rat after po administration; Not determined,8416,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL620192,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,8417,Rattus norvegicus,50597,,,,,N,5676,,,,,In vivo,1,10116.0,CHEMBL620193,Intermediate,
A,1,BAO_0000218,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,8418,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL620194,Intermediate,
A,1,BAO_0000218,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",8419,Rattus norvegicus,50597,,,,,N,17670,,,,,In vivo,1,10116.0,CHEMBL876730,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after oral administration at 10 mg/kg,8420,Rattus norvegicus,50597,,,,,N,6495,,,,,In vivo,1,10116.0,CHEMBL620195,Intermediate,
A,1,BAO_0000218,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,8421,Rattus norvegicus,50597,,,,,N,5408,,,,,In vivo,1,10116.0,CHEMBL620196,Intermediate,
A,1,BAO_0000218,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,8422,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL620197,Intermediate,
A,1,BAO_0000218,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,8423,Rattus norvegicus,50597,,,,,N,6647,,,,,In vivo,1,10116.0,CHEMBL620198,Intermediate,
A,1,BAO_0000218,Volume of distribution in rats,8424,Rattus norvegicus,50597,,,,,N,6495,,,,,In vivo,1,10116.0,CHEMBL620199,Intermediate,
A,1,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,8425,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL620200,Intermediate,
A,1,BAO_0000218,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,8426,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL620201,Intermediate,
A,1,BAO_0000218,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8427,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL620202,Intermediate,
A,1,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8428,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL620203,Intermediate,
A,1,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,8429,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL620204,Intermediate,
A,1,BAO_0000218,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8430,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL620205,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Vss) in rat,8431,Rattus norvegicus,50597,,,,,N,5960,,,,,In vivo,1,10116.0,CHEMBL624664,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Volume) in rat i.v.,8432,Rattus norvegicus,50597,,,,,N,5676,,,,,In vivo,1,10116.0,CHEMBL624665,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Vss) in rat,8433,Rattus norvegicus,50597,,,,,N,5948,,,,,,1,10116.0,CHEMBL624666,Intermediate,
A,1,BAO_0000218,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,8434,Rattus norvegicus,50597,,,,,N,5979,,,,,In vivo,1,10116.0,CHEMBL624667,Intermediate,
A,1,BAO_0000218,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,8435,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL624668,Intermediate,
A,1,BAO_0000218,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,8436,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL624669,Intermediate,
A,1,BAO_0000218,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,8437,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL624670,Intermediate,
A,1,BAO_0000218,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,8438,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL624671,Intermediate,
A,1,BAO_0000218,Steady state volume distribution in rat,8439,Rattus norvegicus,50597,,,,,N,6448,,,,,In vivo,1,10116.0,CHEMBL624672,Intermediate,
A,1,BAO_0000218,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",8440,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL624673,Intermediate,
A,1,BAO_0000218,Steady state volume of distribution determined in rat,8441,Rattus norvegicus,50597,,,,,N,4576,,,,,In vivo,1,10116.0,CHEMBL624674,Intermediate,
A,1,BAO_0000218,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,8442,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL624675,Intermediate,
A,1,BAO_0000218,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,8443,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL621728,Intermediate,
A,1,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,8444,Rattus norvegicus,50597,,,,,N,5182,,,,,,1,10116.0,CHEMBL621729,Intermediate,
A,1,BAO_0000218,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,8445,Rattus norvegicus,50597,,,,,N,5182,,,,,,1,10116.0,CHEMBL621730,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,8446,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL621731,Intermediate,
A,1,BAO_0000218,Volume distribution in rat after administration of 2 mg/kg iv,8447,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL621732,Intermediate,
A,1,BAO_0000218,Volume in steady state distribution value was determined,8448,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL621908,Intermediate,
A,1,BAO_0000218,Volume in steady state distribution value was determined; ND denotes no data,8449,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL875347,Intermediate,
A,1,BAO_0000218,Volume in steady state distribution value was determined; ND denotes not determined,8450,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL621909,Intermediate,
A,1,BAO_0000218,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,8451,Rattus norvegicus,50597,,,,,N,17065,,,,,In vivo,1,10116.0,CHEMBL621910,Intermediate,
A,1,BAO_0000218,Volume of distribution at steady state was evaluated in rats,8452,Rattus norvegicus,50597,,,,,N,6597,,,,,In vivo,1,10116.0,CHEMBL621911,Intermediate,
A,1,BAO_0000218,Volume of distribution at steady state was observed after intravenous administration in rat,8453,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL621912,Intermediate,
A,1,BAO_0000218,Volume of distribution in steady state was determined in rat,8454,Rattus norvegicus,50597,,,,,N,6485,,,,,In vivo,1,10116.0,CHEMBL621913,Intermediate,
A,1,BAO_0000218,Volume of distribution in steady state was determined in rat,8455,Rattus norvegicus,50597,,,,,N,17655,,,,,In vivo,1,10116.0,CHEMBL621914,Intermediate,
A,1,BAO_0000218,Volume of distribution after i.v. administration,8456,Rattus norvegicus,50597,,,,,N,6616,,,,,In vivo,1,10116.0,CHEMBL621915,Intermediate,
A,1,BAO_0000218,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,8457,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL621916,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8458,Mus musculus,50594,,,Liver,,N,16438,,,,2107.0,In vivo,1,10090.0,CHEMBL621917,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8459,Mus musculus,50594,,,Liver,,N,16438,,,,2107.0,In vivo,1,10090.0,CHEMBL621918,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (oxidized form) in spleen tissue,8460,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL621919,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",8461,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL621920,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",8462,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL621921,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8463,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL622401,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",8464,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL875348,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",8465,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL622402,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,8466,Mus musculus,50594,,,Blood,,N,16438,,,,178.0,In vivo,1,10090.0,CHEMBL622403,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8467,Mus musculus,50594,,,Blood,,N,16438,,,,178.0,In vivo,1,10090.0,CHEMBL622404,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,8468,Mus musculus,50594,,,Brain,,N,16438,,,,955.0,In vivo,1,10090.0,CHEMBL622405,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8469,Mus musculus,50594,,,Brain,,N,16438,,,,955.0,In vivo,1,10090.0,CHEMBL622406,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8470,Mus musculus,50594,,,Brain,,N,16438,,,,955.0,In vivo,1,10090.0,CHEMBL622407,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,8471,Mus musculus,50594,,,Heart,,N,16438,,,,948.0,In vivo,1,10090.0,CHEMBL622408,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",8472,Mus musculus,50594,,,Heart,,N,16438,,,,948.0,In vivo,1,10090.0,CHEMBL622409,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8473,Mus musculus,50594,,,Heart,,N,16438,,,,948.0,In vivo,1,10090.0,CHEMBL622410,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,8474,Mus musculus,50594,,,Kidney,,N,16438,,,,2113.0,In vivo,1,10090.0,CHEMBL622411,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",8475,Mus musculus,50594,,,Kidney,,N,16438,,,,2113.0,In vivo,1,10090.0,CHEMBL627864,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8476,Mus musculus,50594,,,Kidney,,N,16438,,,,2113.0,In vivo,1,10090.0,CHEMBL627865,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,8477,Mus musculus,50594,,,Liver,,N,16438,,,,2107.0,In vivo,1,10090.0,CHEMBL627866,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8478,Mus musculus,50594,,,Liver,,N,16438,,,,2107.0,In vivo,1,10090.0,CHEMBL627751,Intermediate,
A,1,BAO_0000218,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,8479,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL627752,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",8480,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL627753,Intermediate,
A,1,BAO_0000218,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",8481,Mus musculus,50594,,,Spleen,,N,16438,,,,2106.0,In vivo,1,10090.0,CHEMBL627754,Intermediate,
A,1,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,8482,Mus musculus,50594,,,,,N,12467,,,,,,1,10090.0,CHEMBL627755,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),8483,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627756,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),8484,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627757,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),8485,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627758,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),8486,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627759,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),8487,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627760,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),8488,Mus musculus,50594,,,Brain,,N,17208,,,,955.0,In vivo,1,10090.0,CHEMBL627761,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),8489,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL876811,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),8490,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL627762,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),8491,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL627763,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),8492,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL627764,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),8493,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL627765,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),8494,Mus musculus,50594,,,Heart,,N,17208,,,,948.0,In vivo,1,10090.0,CHEMBL627766,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),8495,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL627767,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),8496,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL627768,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),8497,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL628422,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),8498,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL628423,Intermediate,
A,1,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,8499,Rattus norvegicus,50597,,,,,N,5089,,,,,In vivo,1,10116.0,CHEMBL628424,Intermediate,
A,1,BAO_0000218,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,8500,Rattus norvegicus,50597,,,,,N,5089,,,,,In vivo,1,10116.0,CHEMBL628425,Intermediate,
A,1,BAO_0000218,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,8501,Rattus norvegicus,50597,,,,,N,4257,,,,,In vivo,1,10116.0,CHEMBL628426,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,8502,Rattus norvegicus,50597,,,,,N,6679,,,,,In vivo,1,10116.0,CHEMBL628427,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,8503,Rattus norvegicus,50597,,,,,N,5546,,,,,In vivo,1,10116.0,CHEMBL626938,Intermediate,
A,1,BAO_0000218,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,8504,Rattus norvegicus,50597,,,,,N,6141,,,,,In vivo,1,10116.0,CHEMBL626939,Intermediate,
A,1,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,8505,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL626940,Intermediate,
A,1,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,8506,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL626941,Intermediate,
A,1,BAO_0000218,Plasma clearance was reported in Sprague-Dawley rat,8507,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL626942,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration (1 mg/kg) in rat,8508,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL876812,Intermediate,
A,1,BAO_0000218,Plasma clearance of compound in rats was evaluated,8509,Rattus norvegicus,50597,,,,,N,6848,,,,,In vivo,1,10116.0,CHEMBL626943,Intermediate,
A,1,BAO_0000218,Plasma clearance of compound in rats was evaluated; ND indicates not determined,8510,Rattus norvegicus,50597,,,,,N,6848,,,,,In vivo,1,10116.0,CHEMBL626944,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,8511,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL626945,Intermediate,
A,1,BAO_0000218,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,8512,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL626946,Intermediate,
A,1,BAO_0000218,Plasma clearance rate in Sprague-Dawley rats,8513,Rattus norvegicus,50597,,,,,N,4956,,,,,In vivo,1,10116.0,CHEMBL626856,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),8514,Rattus norvegicus,50597,,,,,N,5529,,,,,In vivo,1,10116.0,CHEMBL626857,Intermediate,
A,1,BAO_0000218,The compound was evaluated for plasma clearance in rat,8515,Rattus norvegicus,50597,,,Plasma,,N,406,,,,1969.0,In vivo,1,10116.0,CHEMBL626858,Intermediate,
A,1,BAO_0000218,Total plasma clearance in rat,8516,Rattus norvegicus,50597,,,Plasma,,N,17655,,,,1969.0,In vivo,1,10116.0,CHEMBL627018,Intermediate,
A,1,BAO_0000218,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,8517,Rattus norvegicus,50597,,,Blood,,N,3293,,,,178.0,In vivo,1,10116.0,CHEMBL625331,Intermediate,
A,1,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,8518,Rattus norvegicus,50597,,,Blood,,N,4075,,,,178.0,In vivo,1,10116.0,CHEMBL625332,Intermediate,
A,1,BAO_0000218,C max was determined at 10 mg/kg po dose in rats,8519,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL877590,Intermediate,
A,1,BAO_0000218,C max was determined at 3 mg/kg po dose in rats,8520,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL625333,Intermediate,
A,1,BAO_0000218,Cmax after repeated oral dose of compound at 1 mg/kg in rats,8521,Rattus norvegicus,50597,,,,,N,17594,,,,,In vivo,1,10116.0,CHEMBL625334,Intermediate,
A,1,BAO_0000218,Cmax after single intravenous bolus of 1 mg/kg in rats,8522,Rattus norvegicus,50597,,,,,N,17594,,,,,In vivo,1,10116.0,CHEMBL625335,Intermediate,
A,1,BAO_0000218,Cmax of compound at 5 mg/kg after po administration was determined in rat,8523,Rattus norvegicus,50597,,,,,N,4762,,,,,In vivo,1,10116.0,CHEMBL625336,Intermediate,
A,1,BAO_0000218,Cmax 24 hr after 10 mg/kg oral administration in rats,8524,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL625337,Intermediate,
A,1,BAO_0000218,Cmax 24 hr after 2 mg/kg oral administration in rats,8525,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL625338,Intermediate,
A,1,BAO_0000218,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,8526,Rattus norvegicus,50597,,,Plasma,,N,1466,,,,1969.0,In vivo,1,10116.0,CHEMBL625339,Intermediate,
A,1,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,8527,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL625340,Intermediate,
A,1,BAO_0000218,Cmax in rat after administration of 2 mg/kg iv,8528,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL625341,Intermediate,
A,1,BAO_0000218,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,8529,Rattus norvegicus,50597,,,,,N,3169,,,,,In vivo,1,10116.0,CHEMBL622687,Intermediate,
A,1,BAO_0000218,Cmax wa determined in rat plasma at 30 mg/kg after po administration,8530,Rattus norvegicus,50597,,,Plasma,,N,6515,,,,1969.0,In vivo,1,10116.0,CHEMBL622688,Intermediate,
A,1,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,8531,Rattus norvegicus,50597,,,Blood,,N,11149,,,,178.0,In vivo,1,10116.0,CHEMBL622689,Intermediate,
A,1,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,8532,Rattus norvegicus,50597,,,Blood,,N,11149,,,,178.0,In vivo,1,10116.0,CHEMBL620295,Intermediate,
A,1,BAO_0000218,Cmax after 10 mg/kg oral administration in rat,8533,Rattus norvegicus,50597,,,,,N,17858,,,,,In vivo,1,10116.0,CHEMBL620296,Intermediate,
A,1,BAO_0000218,Cmax after IV dosing at 0.5 mg/kg in rat; no data,8534,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL620297,Intermediate,
A,1,BAO_0000218,Cmax after IV dosing at 1 mg/kg in rat; no data,8535,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL620298,Intermediate,
A,1,BAO_0000218,Cmax after oral administration at 20 mpk in rats,8536,Rattus norvegicus,50597,,,,,N,4426,,,,,In vivo,1,10116.0,CHEMBL620299,Intermediate,
A,1,BAO_0000218,Cmax after oral administration at 20 mpk in rats; Not performed.,8537,Rattus norvegicus,50597,,,,,N,4426,,,,,In vivo,1,10116.0,CHEMBL620300,Intermediate,
A,1,BAO_0000218,Cmax after oral administration at 20 mpk in rats d; Not performed.,8538,Rattus norvegicus,50597,,,,,N,4426,,,,,In vivo,1,10116.0,CHEMBL620301,Intermediate,
A,1,BAO_0000218,Cmax after oral administration in rat,8539,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL620302,Intermediate,
A,1,BAO_0000218,Cmax after oral administration at a dose of 2 mg/kg in rat,8540,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL620303,Intermediate,
A,1,BAO_0000218,Cmax after oral administration at a dose of 4 mg/kg in rat,8541,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL620304,Intermediate,
A,1,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,8542,Rattus norvegicus,50597,,,,,N,6113,,,,,In vivo,1,10116.0,CHEMBL620305,Intermediate,
A,1,BAO_0000218,Cmax after peroral administration in rats at 2.4 uM/kg,8543,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL620306,Intermediate,
A,1,BAO_0000218,Cmax at the dose of 2 mg/Kg administered perorally in rats,8544,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL620307,Intermediate,
A,1,BAO_0000218,Cmax at the dose of 5 mg/Kg administered perorally in rats,8545,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL620308,Intermediate,
A,1,BAO_0000218,Cmax by administering at 20 mg/kg p.o. in rats,8546,Rattus norvegicus,50597,,,,,N,6402,,,,,In vivo,1,10116.0,CHEMBL620309,Intermediate,
A,1,BAO_0000218,Cmax in male rat,8547,Rattus norvegicus,50597,,,,,N,5610,,,,,In vivo,1,10116.0,CHEMBL620310,Intermediate,
A,1,BAO_0000218,Cmax in rat,8548,Rattus norvegicus,50597,,,,,N,5207,,,,,In vivo,1,10116.0,CHEMBL620311,Intermediate,
A,1,BAO_0000218,Cmax in rat,8549,Rattus norvegicus,50597,,,,,N,6011,,,,,In vivo,1,10116.0,CHEMBL620312,Intermediate,
A,1,BAO_0000218,Cmax in rat,8550,Rattus norvegicus,50597,,,,,N,6504,,,,,In vivo,1,10116.0,CHEMBL620313,Intermediate,
A,1,BAO_0000218,Cmax in rat at 10 mg/kg,8551,Rattus norvegicus,50597,,,,,N,6046,,,,,In vivo,1,10116.0,CHEMBL620314,Intermediate,
A,1,BAO_0000218,Cmax in rat at the dose of 1 mg/kg i.v.,8552,Rattus norvegicus,50597,,,,,N,6504,,,,,In vivo,1,10116.0,CHEMBL620315,Intermediate,
A,1,BAO_0000218,Cmax in rat by po administration at a dose of 40 mg/kg,8553,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL620316,Intermediate,
A,1,BAO_0000218,Cmax in rat p.o. at 20 mg/kg concentration,8554,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL620317,Intermediate,
A,1,BAO_0000218,Cmax in rats,8555,Rattus norvegicus,50597,,,,,N,5836,,,,,In vivo,1,10116.0,CHEMBL620318,Intermediate,
A,1,BAO_0000218,Cmax in rats,8556,Rattus norvegicus,50597,,,,,N,17596,,,,,In vivo,1,10116.0,CHEMBL620319,Intermediate,
A,1,BAO_0000218,Cmax was evaluated after 20 uM/kg of peroral administration,8557,Rattus norvegicus,50597,,,,,N,16423,,,,,In vivo,1,10116.0,CHEMBL620320,Intermediate,
A,1,BAO_0000218,Cmax was measured in rats after peroral administration at 3 mg/kg,8558,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL620321,Intermediate,
A,1,BAO_0000218,Cmax value after oral dose at a dose of 10 mg/kg in rats.,8559,Rattus norvegicus,50597,,,,,N,1908,,,,,In vivo,1,10116.0,CHEMBL620322,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,8560,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620323,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8561,Rattus norvegicus,50597,,,Frontal cortex,,N,13950,,,,1870.0,,1,10116.0,CHEMBL620324,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8562,Rattus norvegicus,50597,,,Frontal cortex,,N,13950,,,,1870.0,,1,10116.0,CHEMBL620325,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,8563,Rattus norvegicus,50597,,,Hippocampus,,N,13950,,,,10000000.0,,1,10116.0,CHEMBL620326,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,8564,Rattus norvegicus,50597,,,Hippocampus,,N,13950,,,,10000000.0,,1,10116.0,CHEMBL620327,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,8565,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620328,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,8566,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620329,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,8567,Rattus norvegicus,50597,,,Midbrain,,N,13950,,,,1891.0,,1,10116.0,CHEMBL620330,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,8568,Rattus norvegicus,50597,,,Midbrain,,N,13950,,,,1891.0,,1,10116.0,CHEMBL875286,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,8569,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620331,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,8570,Rattus norvegicus,50597,,,,,N,13950,,,,,,1,10116.0,CHEMBL620332,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,8571,Rattus norvegicus,50597,,,Striatum,,N,13950,,,,2435.0,,1,10116.0,CHEMBL620333,Intermediate,
A,1,BAO_0000218,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,8572,Rattus norvegicus,50597,,,Striatum,,N,13950,,,,2435.0,,1,10116.0,CHEMBL620334,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8573,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621015,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8574,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621016,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8575,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621191,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8576,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621192,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8577,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621193,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8578,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL621194,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8579,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL624204,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8580,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL624205,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8581,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624206,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8582,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624207,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8583,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624208,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8584,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624209,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8585,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624210,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8586,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624211,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8587,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624212,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8588,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624213,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8589,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL876611,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8590,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL624214,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8591,Rattus norvegicus,50597,,,Blood,,N,16434,,,,178.0,,1,10116.0,CHEMBL624215,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8592,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624216,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8593,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624217,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8594,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624218,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8595,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624219,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8596,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624220,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8597,Rattus norvegicus,50597,,,Blood,,N,16435,,,,178.0,,1,10116.0,CHEMBL624221,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8598,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL624222,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8599,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL624223,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8600,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL624224,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8601,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL624225,Intermediate,
A,1,BAO_0000218,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,8602,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL622420,Intermediate,
A,1,BAO_0000218,Volume of steady state distribution after i.v. administration in rats,8603,Rattus norvegicus,50597,,,,,N,5031,,,,,In vivo,1,10116.0,CHEMBL622421,Intermediate,
A,1,BAO_0000218,Vss after intravenous administration (5.0 mg/kg) was determined in rat,8604,Rattus norvegicus,50597,,,,,N,6215,,,,,In vivo,1,10116.0,CHEMBL622422,Intermediate,
A,1,BAO_0000218,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,8605,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL622423,Intermediate,
A,1,BAO_0000218,Vss was determined,8606,Rattus norvegicus,50597,,,,,N,17752,,,,,In vivo,1,10116.0,CHEMBL622424,Intermediate,
A,1,BAO_0000218,Vss in rat,8607,Rattus norvegicus,50597,,,,,N,6596,,,,,In vivo,1,10116.0,CHEMBL622425,Intermediate,
A,1,BAO_0000218,Vss was evaluated after 10 uM/kg of intra arterial administration,8608,Rattus norvegicus,50597,,,,,N,16423,,,,,In vivo,1,10116.0,CHEMBL876612,Intermediate,
A,1,BAO_0000218,volume of distribution at steady state was observed after intravenous administration in rat,8609,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL622426,Intermediate,
A,1,BAO_0000218,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,8610,Rattus norvegicus,50597,,,,,N,6062,,,,,In vivo,1,10116.0,CHEMBL622427,Intermediate,
A,1,BAO_0000218,Pharmacokinetic (PK) parameter Vz in rat,8611,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL622428,Intermediate,
A,1,BAO_0000218,Volume distribution in rats,8612,Rattus norvegicus,50597,,,,,N,4942,,,,,In vivo,1,10116.0,CHEMBL622429,Intermediate,
A,1,BAO_0000218,Volume of distribution in rat; No data,8613,Rattus norvegicus,50597,,,,,N,17796,,,,,In vivo,1,10116.0,CHEMBL622430,Intermediate,
A,1,BAO_0000218,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,8614,Rattus norvegicus,50597,,,,,N,4890,,,,,In vivo,1,10116.0,CHEMBL622431,Intermediate,
A,1,BAO_0000218,% absorption predicted from in vitro rat ileum transport studies,8615,Rattus norvegicus,50597,,,Ileum,,N,15765,,,,2116.0,,1,10116.0,CHEMBL622432,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,8616,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL622433,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,8617,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL622434,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,8618,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL622435,Intermediate,
A,1,BAO_0000218,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),8619,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618748,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,8620,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618749,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,8621,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618750,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,8622,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618751,Intermediate,
A,1,BAO_0000218,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,8623,Rattus norvegicus,50597,,,,,N,13569,,,,,In vivo,1,10116.0,CHEMBL618752,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,8624,Rattus norvegicus,50597,,,,,N,4576,,,,,In vivo,1,10116.0,CHEMBL618753,Intermediate,
A,1,BAO_0000218,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,8625,Rattus norvegicus,50597,,,Plasma,,N,750,,,,1969.0,In vivo,1,10116.0,CHEMBL618754,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,8626,Rattus norvegicus,50597,,,,,N,750,,,,,In vivo,1,10116.0,CHEMBL618755,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,8627,Rattus norvegicus,50597,,,,,N,4590,,,,,In vivo,1,10116.0,CHEMBL618756,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,8628,Rattus norvegicus,50597,,,,,N,1716,,,,,In vivo,1,10116.0,CHEMBL618757,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,8629,Rattus norvegicus,50597,,,,,N,1974,,,,,In vivo,1,10116.0,CHEMBL618758,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),8630,Rattus norvegicus,50597,,,,,N,4502,,,,,In vivo,1,10116.0,CHEMBL621088,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (cLogP) in rat,8631,Rattus norvegicus,50597,,,,,N,3371,,,,,,1,10116.0,CHEMBL621089,Intermediate,
F,1,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,8632,Rattus norvegicus,50597,,,Blood,,N,9099,,,,178.0,,1,10116.0,CHEMBL621090,Intermediate,
F,1,BAO_0000218,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,8633,Rattus norvegicus,50597,,,Blood,,N,9099,,,,178.0,,1,10116.0,CHEMBL621091,Intermediate,
A,1,BAO_0000218,Clearance in rat.,8634,Rattus norvegicus,50597,,,,,N,4590,,,,,In vivo,1,10116.0,CHEMBL876731,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its clearance when administered intravenously in rat,8635,Rattus norvegicus,50597,,,,,N,3184,,,,,In vivo,1,10116.0,CHEMBL621092,Intermediate,
A,1,BAO_0000218,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,8636,Rattus norvegicus,50597,,,,,N,16456,,,,,In vivo,1,10116.0,CHEMBL621093,Intermediate,
A,1,BAO_0000218,Blood: Brain distribution ratio is determined in rat,8637,Rattus norvegicus,50597,,,,,N,4199,,,,,,1,10116.0,CHEMBL621094,Intermediate,
A,1,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,8638,Rattus norvegicus,50597,,,,,N,4199,,,,,,1,10116.0,CHEMBL621095,Intermediate,
A,1,BAO_0000218,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,8639,Rattus norvegicus,50597,,,,,N,4199,,,,,,1,10116.0,CHEMBL621096,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8640,Rattus norvegicus,50597,,,Kidney,,N,8677,,,,2113.0,In vivo,1,10116.0,CHEMBL621097,Intermediate,
F,1,BAO_0000218,Percent dose excreted in 0-48 hours administered ip to male rat,8641,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL621098,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8642,Rattus norvegicus,50597,,,Cerebellum,,N,11977,,,,2037.0,,1,10116.0,CHEMBL621099,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8643,Rattus norvegicus,50597,,,Cerebellum,,N,11977,,,,2037.0,,1,10116.0,CHEMBL621100,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8644,Rattus norvegicus,50597,,,Cerebellum,,N,11977,,,,2037.0,,1,10116.0,CHEMBL621101,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8645,Rattus norvegicus,50597,,,Cerebellum,,N,11977,,,,2037.0,,1,10116.0,CHEMBL621102,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8646,Rattus norvegicus,50597,,,Cerebellum,,N,11977,,,,2037.0,,1,10116.0,CHEMBL876732,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8647,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621103,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8648,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621104,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8649,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621105,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8650,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621106,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8651,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621107,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8652,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621108,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8653,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL621109,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),8654,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL621110,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),8655,Mus musculus,50594,,,Kidney,,N,17208,,,,2113.0,In vivo,1,10090.0,CHEMBL621111,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),8656,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL622541,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),8657,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL622542,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),8658,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL622543,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),8659,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL624412,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),8660,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL624413,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),8661,Mus musculus,50594,,,Liver,,N,17208,,,,2107.0,In vivo,1,10090.0,CHEMBL624414,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),8662,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624415,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),8663,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624416,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),8664,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624417,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),8665,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624418,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),8666,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624419,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),8667,Mus musculus,50594,,,Lung,,N,17208,,,,2048.0,In vivo,1,10090.0,CHEMBL624420,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),8668,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL624421,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),8669,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL624422,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),8670,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL624423,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),8671,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL625123,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),8672,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL625124,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),8673,Mus musculus,50594,,,Muscle tissue,,N,17208,,,,2385.0,In vivo,1,10090.0,CHEMBL625125,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),8674,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL625126,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),8675,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL626947,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),8676,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL626948,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),8677,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL626949,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),8678,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL626950,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),8679,Mus musculus,50594,,,Zone of skin,,N,17208,,,,14.0,In vivo,1,10090.0,CHEMBL626951,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),8680,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626952,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),8681,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626953,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),8682,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626954,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),8683,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626955,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),8684,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626956,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),8685,Mus musculus,50594,,,Spleen,,N,17208,,,,2106.0,In vivo,1,10090.0,CHEMBL626957,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),8686,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL626958,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),8687,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL626959,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),8688,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL626960,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),8689,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL626961,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),8690,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL627589,Intermediate,
A,1,BAO_0000218,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),8691,Mus musculus,50594,,,Blood,,N,17208,,,,178.0,In vivo,1,10090.0,CHEMBL627590,Intermediate,
A,1,BAO_0000218,Time taken for EC90 was determined when tested in mouse,8692,Mus musculus,50594,,,,,N,3132,,,,,,1,10090.0,CHEMBL627591,Intermediate,
A,1,BAO_0000218,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,8693,Mus musculus,50594,,,,,N,3132,,,,,,1,10090.0,CHEMBL627592,Intermediate,
A,1,BAO_0000218,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),8694,Mus musculus,50594,,,,,N,16597,,,,,In vivo,1,10090.0,CHEMBL627593,Intermediate,
A,1,BAO_0000218,Half life in mice,8695,Mus musculus,50594,,,,,N,5727,,,,,,1,10090.0,CHEMBL627594,Intermediate,
A,1,BAO_0000218,Half life period in mouse after 10 mg/Kg dose,8696,Mus musculus,50594,,,,,N,5302,,,,,In vivo,1,10090.0,CHEMBL876813,Intermediate,
A,1,BAO_0000218,Half life period in mouse after 10 mg/kg dose,8697,Mus musculus,50594,,,,,N,5302,,,,,In vivo,1,10090.0,CHEMBL627595,Intermediate,
A,1,BAO_0000218,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,8698,Mus musculus,50594,,,,,N,6348,,,,,In vivo,1,10090.0,CHEMBL627596,Intermediate,
A,1,BAO_0000218,Cmax value at 5 mg/kg po was determined in rat,8699,Rattus norvegicus,50597,,,,,N,5964,,,,,In vivo,1,10116.0,CHEMBL627597,Intermediate,
A,1,BAO_0000218,Cmax value evaluated in rat,8700,Rattus norvegicus,50597,,,,,N,6078,,,,,In vivo,1,10116.0,CHEMBL627598,Intermediate,
A,1,BAO_0000218,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,8701,Rattus norvegicus,50597,,,Brain,,N,5206,,,,955.0,In vivo,1,10116.0,CHEMBL627599,Intermediate,
A,1,BAO_0000218,Cmax value after administration of 20 mg/Kg oral dose in rat,8702,Rattus norvegicus,50597,,,,,N,2959,,,,,In vivo,1,10116.0,CHEMBL627600,Intermediate,
A,1,BAO_0000218,Cmax value at 1 mg/kg po in rat,8703,Rattus norvegicus,50597,,,,,N,5964,,,,,In vivo,1,10116.0,CHEMBL627601,Intermediate,
A,1,BAO_0000218,Cmax value at 5 mg/kg po in rat,8704,Rattus norvegicus,50597,,,,,N,5964,,,,,In vivo,1,10116.0,CHEMBL627776,Intermediate,
A,1,BAO_0000218,Cmax value at a dose of 10 mg/kg in male SD rats,8705,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL627777,Intermediate,
A,1,BAO_0000218,Cmax value at a dose of 100 mg/kg in male SD rats,8706,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL627778,Intermediate,
A,1,BAO_0000218,Cmax value at a dose of 50 mg/kg in male SD rats,8707,Rattus norvegicus,50597,,,,,N,6757,,,,,In vivo,1,10116.0,CHEMBL627779,Intermediate,
A,1,BAO_0000218,Cmax value in rats at 10 mg/kg,8708,Rattus norvegicus,50597,,,,,N,17617,,,,,In vivo,1,10116.0,CHEMBL876814,Intermediate,
A,1,BAO_0000218,Cmax value was evaluated in rats at a dose of 20 mg/kg,8709,Rattus norvegicus,50597,,,,,N,1445,,,,,In vivo,1,10116.0,CHEMBL627780,Intermediate,
A,1,BAO_0000218,Cmax value was determined after peroral administration of 20 mg/kg in rat,8710,Rattus norvegicus,50597,,,,,N,6082,,,,,In vivo,1,10116.0,CHEMBL627781,Intermediate,
A,1,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,8711,Rattus norvegicus,50597,,,,,N,1446,,,,,In vivo,1,10116.0,CHEMBL627782,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,8712,Rattus norvegicus,50597,,,Plasma,,N,5407,,,,1969.0,In vivo,1,10116.0,CHEMBL627783,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,8713,Rattus norvegicus,50597,,,Plasma,,N,2690,,,,1969.0,In vivo,1,10116.0,CHEMBL627784,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,8714,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627785,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,8715,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627786,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,8716,Rattus norvegicus,50597,,,Plasma,,N,4891,,,,1969.0,In vivo,1,10116.0,CHEMBL627787,Intermediate,
A,1,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,8717,Rattus norvegicus,50597,,,Plasma,,N,2807,,,,1969.0,In vivo,1,10116.0,CHEMBL627788,Intermediate,
A,1,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,8718,Rattus norvegicus,50597,,,Plasma,,N,2807,,,,1969.0,In vivo,1,10116.0,CHEMBL626579,Intermediate,
A,1,BAO_0000218,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,8719,Rattus norvegicus,50597,,,Plasma,,N,2807,,,,1969.0,In vivo,1,10116.0,CHEMBL626580,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,8720,Rattus norvegicus,50597,,,,,N,3634,,,,,In vivo,1,10116.0,CHEMBL876815,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,8721,Rattus norvegicus,50597,,,Plasma,,N,1881,,,,1969.0,In vivo,1,10116.0,CHEMBL626581,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,8722,Rattus norvegicus,50597,,,Plasma,,N,1881,,,,1969.0,In vivo,1,10116.0,CHEMBL626582,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,8723,Rattus norvegicus,50597,,,,,N,429,,,,,In vivo,1,10116.0,CHEMBL626583,Intermediate,
A,1,BAO_0000218,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,8724,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL626205,Intermediate,
A,1,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,8725,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL626206,Intermediate,
A,1,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,8726,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL626207,Intermediate,
A,1,BAO_0000218,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,8727,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL623882,Intermediate,
A,1,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,8728,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL623883,Intermediate,
A,1,BAO_0000218,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,8729,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL623884,Intermediate,
A,1,BAO_0000218,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",8730,Rattus norvegicus,50597,,,Plasma,,N,3032,,,,1969.0,In vivo,1,10116.0,CHEMBL623885,Intermediate,
A,1,BAO_0000218,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,8731,Rattus norvegicus,50597,,,Plasma,,N,6295,,,,1969.0,In vivo,1,10116.0,CHEMBL623886,Intermediate,
A,1,BAO_0000218,Maximal concentration in rat was determined,8732,Rattus norvegicus,50597,,,,,N,6619,,,,,In vivo,1,10116.0,CHEMBL623887,Intermediate,
A,1,BAO_0000218,Maximal concentration after i.v. administration,8733,Rattus norvegicus,50597,,,,,N,6616,,,,,In vivo,1,10116.0,CHEMBL623888,Intermediate,
A,1,BAO_0000218,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,8734,Rattus norvegicus,50597,,,Plasma,,N,3249,,,,1969.0,In vivo,1,10116.0,CHEMBL623889,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in rat after oral administration at 50 mg/kg,8735,Rattus norvegicus,50597,,,Plasma,,N,17791,,,,1969.0,In vivo,1,10116.0,CHEMBL623890,Intermediate,
A,1,BAO_0000218,Cmax in rat plasma after oral dose (50 mg/Kg),8736,Rattus norvegicus,50597,,,Plasma,,N,17791,,,,1969.0,In vivo,1,10116.0,CHEMBL623891,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration was determined.,8737,Rattus norvegicus,50597,,,Plasma,,N,1360,,,,1969.0,In vivo,1,10116.0,CHEMBL623892,Intermediate,
A,1,BAO_0000218,Maximal plasma drug concentration was determined,8738,Rattus norvegicus,50597,,,Plasma,,N,2552,,,,1969.0,In vivo,1,10116.0,CHEMBL623893,Intermediate,
A,1,BAO_0000218,Maximal concentration in rats after peroral administration,8739,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL877616,Intermediate,
A,1,BAO_0000218,Maximum concentration in rat after 2 mg/kg peroral administration,8740,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL623894,Intermediate,
A,1,BAO_0000218,Maximum concentration in rat plasma after 5 mg/kg oral gavage,8741,Rattus norvegicus,50597,,,Plasma,,N,6567,,,,1969.0,In vivo,1,10116.0,CHEMBL623895,Intermediate,
A,1,BAO_0000218,Maximum concentration of compound in rat was evaluated.,8742,Rattus norvegicus,50597,,,,,N,3031,,,,,In vivo,1,10116.0,CHEMBL623896,Intermediate,
A,1,BAO_0000218,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,8743,Rattus norvegicus,50597,,,,,N,3436,,,,,In vivo,1,10116.0,CHEMBL623897,Intermediate,
A,1,BAO_0000218,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,8744,Rattus norvegicus,50597,,,,,N,3436,,,,,In vivo,1,10116.0,CHEMBL623898,Intermediate,
A,1,BAO_0000218,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,8745,Rattus norvegicus,50597,,,,,N,2083,,,,,In vivo,1,10116.0,CHEMBL623899,Intermediate,
A,1,BAO_0000218,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,8746,Rattus norvegicus,50597,,,,,N,3436,,,,,In vivo,1,10116.0,CHEMBL623900,Intermediate,
A,1,BAO_0000218,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,8747,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL623901,Intermediate,
A,1,BAO_0000218,Maximum concentration was evaluated in rats,8748,Rattus norvegicus,50597,,,,,N,1974,,,,,In vivo,1,10116.0,CHEMBL623902,Intermediate,
A,1,BAO_0000218,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,8749,Rattus norvegicus,50597,,,Cerebrospinal fluid,,N,3307,,,,1359.0,In vivo,1,10116.0,CHEMBL623903,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,8750,Rattus norvegicus,50597,,,Plasma,,N,3307,,,,1969.0,In vivo,1,10116.0,CHEMBL623904,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,8751,Rattus norvegicus,50597,,,Plasma,,N,1916,,,,1969.0,In vivo,1,10116.0,CHEMBL877617,Intermediate,
A,1,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,8752,Rattus norvegicus,50597,,,,,N,1500,,,,,In vivo,1,10116.0,CHEMBL623905,Intermediate,
A,1,BAO_0000218,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,8753,Rattus norvegicus,50597,,,,,N,1500,,,,,In vivo,1,10116.0,CHEMBL623906,Intermediate,
A,1,BAO_0000218,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,8754,Rattus norvegicus,50597,,,Plasma,,N,4186,,,,1969.0,In vivo,1,10116.0,CHEMBL623907,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8755,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623908,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,8756,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623909,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8757,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623910,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8758,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623911,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8759,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623912,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8760,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624616,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8761,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624617,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8762,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624618,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8763,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624619,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8764,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624794,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8765,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL624795,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8766,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623921,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8767,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623922,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8768,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623923,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8769,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623924,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8770,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623925,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8771,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623926,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8772,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623927,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8773,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623928,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8774,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623929,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8775,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623930,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8776,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL623931,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8777,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL622165,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8778,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621249,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8779,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621250,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8780,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621448,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8781,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621449,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8782,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621450,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8783,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL621451,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8784,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL621452,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8785,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL621453,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8786,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL621454,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8787,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL621455,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8788,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL621456,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8789,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625145,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8790,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL875847,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8791,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625146,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8792,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL625147,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8793,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL625148,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8794,Rattus norvegicus,50597,,,Brain,,N,16434,,,,955.0,,1,10116.0,CHEMBL625149,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8795,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625150,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8796,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625151,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8797,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625152,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8798,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625153,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8799,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625154,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8800,Rattus norvegicus,50597,,,Brain,,N,16435,,,,955.0,,1,10116.0,CHEMBL625155,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8801,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL625156,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8802,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL624354,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8803,Rattus norvegicus,50597,,,Hippocampus,,N,11977,,,,10000000.0,,1,10116.0,CHEMBL624355,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8804,Rattus norvegicus,50597,,,Hippocampus,,N,11977,,,,10000000.0,,1,10116.0,CHEMBL624356,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8805,Rattus norvegicus,50597,,,Hippocampus,,N,11977,,,,10000000.0,,1,10116.0,CHEMBL624357,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8806,Rattus norvegicus,50597,,,Hippocampus,,N,11977,,,,10000000.0,,1,10116.0,CHEMBL624358,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),8807,Rattus norvegicus,50597,,,Striatum,,N,11977,,,,2435.0,,1,10116.0,CHEMBL624359,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),8808,Rattus norvegicus,50597,,,Striatum,,N,11977,,,,2435.0,,1,10116.0,CHEMBL624360,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),8809,Rattus norvegicus,50597,,,Striatum,,N,11977,,,,2435.0,,1,10116.0,CHEMBL624361,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),8810,Rattus norvegicus,50597,,,Striatum,,N,11977,,,,2435.0,,1,10116.0,CHEMBL624362,Intermediate,
A,1,BAO_0000218,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),8811,Rattus norvegicus,50597,,,Striatum,,N,11977,,,,2435.0,,1,10116.0,CHEMBL624363,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8812,Rattus norvegicus,50597,,,Blood,,N,11977,,,,178.0,In vivo,1,10116.0,CHEMBL624364,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8813,Rattus norvegicus,50597,,,Blood,,N,11977,,,,178.0,In vivo,1,10116.0,CHEMBL624365,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8814,Rattus norvegicus,50597,,,Blood,,N,11977,,,,178.0,In vivo,1,10116.0,CHEMBL624366,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8815,Rattus norvegicus,50597,,,Blood,,N,11977,,,,178.0,In vivo,1,10116.0,CHEMBL624367,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8816,Rattus norvegicus,50597,,,Brain,,N,11977,,,,955.0,In vivo,1,10116.0,CHEMBL624368,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8817,Rattus norvegicus,50597,,,Brain,,N,11977,,,,955.0,In vivo,1,10116.0,CHEMBL624369,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8818,Rattus norvegicus,50597,,,Brain,,N,11977,,,,955.0,In vivo,1,10116.0,CHEMBL624370,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8819,Rattus norvegicus,50597,,,Brain,,N,11977,,,,955.0,In vivo,1,10116.0,CHEMBL625069,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8820,Rattus norvegicus,50597,,,Brain,,N,11977,,,,955.0,In vivo,1,10116.0,CHEMBL625070,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8821,Rattus norvegicus,50597,,,Heart,,N,11977,,,,948.0,In vivo,1,10116.0,CHEMBL626051,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8822,Rattus norvegicus,50597,,,Heart,,N,11977,,,,948.0,In vivo,1,10116.0,CHEMBL626052,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8823,Rattus norvegicus,50597,,,Heart,,N,11977,,,,948.0,In vivo,1,10116.0,CHEMBL626053,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8824,Rattus norvegicus,50597,,,Heart,,N,11977,,,,948.0,In vivo,1,10116.0,CHEMBL626054,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8825,Rattus norvegicus,50597,,,Heart,,N,11977,,,,948.0,In vivo,1,10116.0,CHEMBL626055,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8826,Rattus norvegicus,50597,,,Kidney,,N,11977,,,,2113.0,In vivo,1,10116.0,CHEMBL626056,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8827,Rattus norvegicus,50597,,,Kidney,,N,11977,,,,2113.0,In vivo,1,10116.0,CHEMBL626057,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8828,Rattus norvegicus,50597,,,Kidney,,N,11977,,,,2113.0,In vivo,1,10116.0,CHEMBL625193,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8829,Rattus norvegicus,50597,,,Kidney,,N,11977,,,,2113.0,In vivo,1,10116.0,CHEMBL625194,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8830,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL625195,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8831,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL625196,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8832,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL625197,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8833,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL625198,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8834,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL627929,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8835,Rattus norvegicus,50597,,,Lung,,N,11977,,,,2048.0,In vivo,1,10116.0,CHEMBL627074,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8836,Rattus norvegicus,50597,,,Lung,,N,11977,,,,2048.0,In vivo,1,10116.0,CHEMBL627075,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8837,Rattus norvegicus,50597,,,Lung,,N,11977,,,,2048.0,In vivo,1,10116.0,CHEMBL627076,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8838,Rattus norvegicus,50597,,,Lung,,N,11977,,,,2048.0,In vivo,1,10116.0,CHEMBL627077,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8839,Rattus norvegicus,50597,,,Lung,,N,11977,,,,2048.0,In vivo,1,10116.0,CHEMBL627078,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),8840,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL627079,Intermediate,
A,1,BAO_0000218,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,8841,Mus musculus,50594,,,,,N,4573,,,,,In vivo,1,10090.0,CHEMBL873824,Intermediate,
A,1,BAO_0000218,Half life in mouse plasma was determined at dose 25 mg/kg,8842,Mus musculus,50594,,,Plasma,,N,3132,,,,1969.0,In vivo,1,10090.0,CHEMBL627080,Intermediate,
A,1,BAO_0000218,Half life was determined,8843,Mus musculus,50594,,,,,N,17718,,,,,,1,10090.0,CHEMBL627081,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8844,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL627082,Intermediate,
A,1,BAO_0000218,Half-life in male mice after 1 mg/kg intravenous dose,8845,Mus musculus,50594,,,,,N,5961,,,,,In vivo,1,10090.0,CHEMBL627083,Intermediate,
A,1,BAO_0000218,Half life in mice plasma,8847,Mus musculus,50594,,,Plasma,,N,17731,,,,1969.0,,1,10090.0,CHEMBL627085,Intermediate,
A,1,BAO_0000218,Half life in mouse,8848,Mus musculus,50594,,,,,N,17592,,,,,,1,10090.0,CHEMBL627086,Intermediate,
A,1,BAO_0000218,Half life in mouse plasma at dose 25 mg/kg,8849,Mus musculus,50594,,,Plasma,,N,3132,,,,1969.0,In vivo,1,10090.0,CHEMBL627087,Intermediate,
A,1,BAO_0000218,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,8850,Mus musculus,50594,,,,,N,17729,,,,,In vivo,1,10090.0,CHEMBL627088,Intermediate,
A,1,BAO_0000218,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,8851,Mus musculus,50594,,,,,N,17729,,,,,In vivo,1,10090.0,CHEMBL627089,Intermediate,
A,1,BAO_0000218,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,8852,Mus musculus,50594,,,,,N,17729,,,,,In vivo,1,10090.0,CHEMBL627090,Intermediate,
A,1,BAO_0000218,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),8853,Mus musculus,50594,,,,,N,3277,,,,,In vivo,1,10090.0,CHEMBL627091,Intermediate,
A,1,BAO_0000218,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",8854,Mus musculus,50594,,,,,N,3760,,,,,In vivo,1,10090.0,CHEMBL627092,Intermediate,
A,1,BAO_0000218,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",8855,Mus musculus,50594,,,,,N,3760,,,,,In vivo,1,10090.0,CHEMBL876785,Intermediate,
A,1,BAO_0000218,Half-life by iv administration in mouse,8856,Mus musculus,50594,,,,,N,2862,,,,,In vivo,1,10090.0,CHEMBL627093,Intermediate,
A,1,BAO_0000218,Half-life by oral administration in mouse,8857,Mus musculus,50594,,,,,N,2862,,,,,In vivo,1,10090.0,CHEMBL627094,Intermediate,
A,1,BAO_0000218,Half-life in mice,8858,Mus musculus,50594,,,,,N,5980,,,,,,1,10090.0,CHEMBL627095,Intermediate,
A,1,BAO_0000218,Half-life using mouse brain homogenate,8859,Mus musculus,50594,,,Brain,,N,6159,,,,955.0,,1,10090.0,CHEMBL627096,Intermediate,
A,1,BAO_0000218,Half-life was measured in mice,8860,Mus musculus,50594,,,,,N,6254,,,,,,1,10090.0,CHEMBL627097,Intermediate,
A,1,BAO_0000218,Half-life was measured in mouse after an iv dose of 1 mg/kg,8861,Mus musculus,50594,,,,,N,6062,,,,,In vivo,1,10090.0,CHEMBL627098,Intermediate,
A,1,BAO_0000218,Half-life period was determined in mouse blood,8862,Mus musculus,50594,,,Blood,,N,1574,,,,178.0,,1,10090.0,CHEMBL627099,Intermediate,
A,1,BAO_0000218,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",8863,Mus musculus,50594,,,Brain,,N,56,,,,955.0,,1,10090.0,CHEMBL627100,Intermediate,
A,1,BAO_0000218,Plasma half life in mouse,8864,Mus musculus,50594,,,Plasma,,N,993,,,,1969.0,,1,10090.0,CHEMBL627101,Intermediate,
A,1,BAO_0000218,Stability of the peptide in the presence of mouse serum,8865,Mus musculus,50594,,,,,N,6652,,,,,,1,10090.0,CHEMBL627102,Intermediate,
A,1,BAO_0000218,Terminal half life of compound was determined in mouse,8866,Mus musculus,50594,,,,,N,17852,,,,,,1,10090.0,CHEMBL627103,Intermediate,
A,1,BAO_0000218,Terminal half life was evaluated in mice after intravenous administration,8867,Mus musculus,50594,,,,,N,2675,,,,,In vivo,1,10090.0,CHEMBL627104,Intermediate,
A,1,BAO_0000218,Terminal half life was evaluated in mice after oral administration,8868,Mus musculus,50594,,,,,N,2675,,,,,In vivo,1,10090.0,CHEMBL627105,Intermediate,
A,1,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,8869,Mus musculus,50594,,,,,N,499,,,,,,1,10090.0,CHEMBL876786,Intermediate,
A,1,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,8870,Mus musculus,50594,,,,,N,499,,,,,,1,10090.0,CHEMBL873825,Intermediate,
A,1,BAO_0000218,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,8871,Mus musculus,50594,,,,,N,499,,,,,,1,10090.0,CHEMBL627106,Intermediate,
A,1,BAO_0000218,half life period is evaluated by administering intravenously at 25 mg/kg in mice,8872,Mus musculus,50594,,,,,N,14239,,,,,In vivo,1,10090.0,CHEMBL626336,Intermediate,
A,1,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",8873,Mus musculus,50594,,,,,N,5506,,,,,In vivo,1,10090.0,CHEMBL877462,Intermediate,
A,1,BAO_0000218,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",8874,Mus musculus,50594,,,,,N,5506,,,,,In vivo,1,10090.0,CHEMBL626337,Intermediate,
A,1,BAO_0000218,Half life after intraperitoneal administration of 100 mg/kg in mice,8875,Mus musculus,50594,,,,,N,17734,,,,,,1,10090.0,CHEMBL626338,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,8876,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL626339,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,8877,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL626340,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,8878,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL625377,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,8879,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL625378,Intermediate,
A,1,BAO_0000218,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,8880,Mus musculus,50594,,,,,N,17728,,,,,In vivo,1,10090.0,CHEMBL625379,Intermediate,
A,0,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),8881,Sus scrofa,22224,,,,,U,14294,,,,,,1,9823.0,CHEMBL625380,Autocuration,Microsomes
A,0,BAO_0000251,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),8882,Sus scrofa,22224,,,,,U,14294,,,,,,1,9823.0,CHEMBL625381,Autocuration,Microsomes
A,0,BAO_0000019,Stability to porcine renal DHP-I,8883,Sus scrofa,22224,,,,,U,6056,,,,,,1,9823.0,CHEMBL625382,Autocuration,
A,0,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,8884,Sus scrofa,22224,,,,,U,1317,,,,,In vivo,1,9823.0,CHEMBL873828,Autocuration,
A,0,BAO_0000218,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,8885,Sus scrofa,22224,,,,,U,1317,,,,,In vivo,1,9823.0,CHEMBL625383,Autocuration,
A,0,BAO_0000019,Half-life of the parent prodrug in porcine esterase solution,8886,Sus scrofa,22224,,,,,U,5229,,,,,,1,9823.0,CHEMBL625384,Autocuration,
A,0,BAO_0000019,"First order rate constant, k was determined in in pig liver Esterase",8887,Sus scrofa,22224,,,,,U,4231,,,,,,1,9823.0,CHEMBL625385,Autocuration,
A,0,BAO_0000221,Half life of the in pig liver Esterase,8888,Sus scrofa,22224,,,Liver,,U,4231,,,,2107.0,,1,9823.0,CHEMBL625386,Autocuration,
A,0,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,8889,Sus scrofa,22224,,,Liver,,U,5318,,,,2107.0,,1,9823.0,CHEMBL623571,Autocuration,
A,0,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,8890,Sus scrofa,22224,,,Liver,,U,5318,,,,2107.0,,1,9823.0,CHEMBL623572,Autocuration,
A,0,BAO_0000221,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,8891,Sus scrofa,22224,,,Liver,,U,5318,,,,2107.0,,1,9823.0,CHEMBL623573,Autocuration,
A,0,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,8892,Sus scrofa,22224,,,Liver,,U,3305,,,,2107.0,,1,9823.0,CHEMBL623574,Autocuration,
A,0,BAO_0000221,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,8893,Sus scrofa,22224,,,Liver,,U,3305,,,,2107.0,,1,9823.0,CHEMBL623575,Autocuration,
A,0,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated.,8894,Sus scrofa,22224,,,Liver,,U,2842,,,,2107.0,,1,9823.0,CHEMBL623749,Autocuration,
A,0,BAO_0000221,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,8895,Sus scrofa,22224,,,Liver,,U,2842,,,,2107.0,,1,9823.0,CHEMBL623750,Autocuration,
A,0,BAO_0000221,Half-life in vitro in pig liver,8896,Sus scrofa,22224,,,Liver,,U,889,,,,2107.0,In vitro,1,9823.0,CHEMBL623751,Autocuration,
A,0,BAO_0000221,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,8897,Sus scrofa,22224,,,Liver,,U,1904,,,,2107.0,,1,9823.0,CHEMBL623752,Autocuration,
A,1,BAO_0000218,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,8898,Rattus norvegicus,50597,,,Plasma,,N,4186,,,,1969.0,In vivo,1,10116.0,CHEMBL623753,Intermediate,
A,1,BAO_0000218,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,8899,Rattus norvegicus,50597,,,Plasma,,N,2774,,,,1969.0,In vivo,1,10116.0,CHEMBL623754,Intermediate,
A,1,BAO_0000218,Maximum concentration in rat plasma was determined,8900,Rattus norvegicus,50597,,,Plasma,,N,1742,,,,1969.0,In vivo,1,10116.0,CHEMBL623755,Intermediate,
A,1,BAO_0000218,Maximum concentration in rats,8901,Rattus norvegicus,50597,,,,,N,3169,,,,,In vivo,1,10116.0,CHEMBL623756,Intermediate,
A,1,BAO_0000218,Maximum concentration in rats at 1-2 hours,8902,Rattus norvegicus,50597,,,,,N,3169,,,,,In vivo,1,10116.0,CHEMBL623757,Intermediate,
A,1,BAO_0000218,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,8903,Rattus norvegicus,50597,,,,,N,2081,,,,,In vivo,1,10116.0,CHEMBL623758,Intermediate,
A,1,BAO_0000218,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,8904,Rattus norvegicus,50597,,,Brain,,N,3307,,,,955.0,In vivo,1,10116.0,CHEMBL623759,Intermediate,
A,1,BAO_0000218,Maximum concentration at the dose of 2 mg/kg in rat,8905,Rattus norvegicus,50597,,,,,N,4727,,,,,In vivo,1,10116.0,CHEMBL623760,Intermediate,
A,1,BAO_0000218,Maximum concentration was evaluated in rats,8906,Rattus norvegicus,50597,,,,,N,6597,,,,,In vivo,1,10116.0,CHEMBL623761,Intermediate,
A,1,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,8907,Rattus norvegicus,50597,,,Plasma,,N,16365,,,,1969.0,In vivo,1,10116.0,CHEMBL623762,Intermediate,
A,1,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,8908,Rattus norvegicus,50597,,,Plasma,,N,16365,,,,1969.0,In vivo,1,10116.0,CHEMBL877594,Intermediate,
A,1,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,8909,Rattus norvegicus,50597,,,Plasma,,N,16365,,,,1969.0,In vivo,1,10116.0,CHEMBL623763,Intermediate,
A,1,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,8910,Rattus norvegicus,50597,,,Plasma,,N,16365,,,,1969.0,In vivo,1,10116.0,CHEMBL623764,Intermediate,
A,1,BAO_0000218,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,8911,Rattus norvegicus,50597,,,Plasma,,N,16365,,,,1969.0,In vivo,1,10116.0,CHEMBL623765,Intermediate,
A,1,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,8912,Rattus norvegicus,50597,,,Blood,,N,2591,,,,178.0,In vivo,1,10116.0,CHEMBL623766,Intermediate,
A,1,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,8913,Rattus norvegicus,50597,,,Blood,,N,2591,,,,178.0,In vivo,1,10116.0,CHEMBL623767,Intermediate,
A,1,BAO_0000218,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,8914,Rattus norvegicus,50597,,,Blood,,N,2591,,,,178.0,In vivo,1,10116.0,CHEMBL623768,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,8915,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623769,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,8916,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623770,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,8917,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623771,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,8918,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623772,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,8919,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623773,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,8920,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623774,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,8921,Rattus norvegicus,50597,,,Plasma,,N,5978,,,,1969.0,In vivo,1,10116.0,CHEMBL623775,Intermediate,
A,1,BAO_0000218,Cmax in rat (PO dose),8922,Rattus norvegicus,50597,,,,,N,14465,,,,,In vivo,1,10116.0,CHEMBL623776,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,8923,Rattus norvegicus,50597,,,Plasma,,N,4723,,,,1969.0,In vivo,1,10116.0,CHEMBL622191,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,8924,Rattus norvegicus,50597,,,Plasma,,N,4723,,,,1969.0,In vivo,1,10116.0,CHEMBL622192,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration determined in rat,8925,Rattus norvegicus,50597,,,Plasma,,N,4576,,,,1969.0,In vivo,1,10116.0,CHEMBL622193,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,8926,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL622194,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,8927,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL622195,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in rat,8928,Rattus norvegicus,50597,,,Plasma,,N,6824,,,,1969.0,In vivo,1,10116.0,CHEMBL622196,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,8929,Rattus norvegicus,50597,,,Plasma,,N,17065,,,,1969.0,In vivo,1,10116.0,CHEMBL622197,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,8930,Rattus norvegicus,50597,,,Plasma,,N,2932,,,,1969.0,In vivo,1,10116.0,CHEMBL622198,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,8931,Rattus norvegicus,50597,,,Plasma,,N,2932,,,,1969.0,In vivo,1,10116.0,CHEMBL622199,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration of compound was measured in rat,8932,Rattus norvegicus,50597,,,Plasma,,N,2879,,,,1969.0,In vivo,1,10116.0,CHEMBL622200,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration after 20 mg/kg oral administration in rat,8933,Rattus norvegicus,50597,,,Plasma,,N,2864,,,,1969.0,In vivo,1,10116.0,CHEMBL622201,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration after oral administration to rats,8934,Rattus norvegicus,50597,,,Plasma,,N,16367,,,,1969.0,In vivo,1,10116.0,CHEMBL623990,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,8935,Rattus norvegicus,50597,,,Plasma,,N,17717,,,,1969.0,In vivo,1,10116.0,CHEMBL623991,Intermediate,
A,1,BAO_0000218,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",8936,Rattus norvegicus,50597,,,Plasma,,N,17717,,,,1969.0,In vivo,1,10116.0,CHEMBL623992,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,8937,Rattus norvegicus,50597,,,Plasma,,N,17717,,,,1969.0,In vivo,1,10116.0,CHEMBL623993,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,8938,Rattus norvegicus,50597,,,Plasma,,N,17717,,,,1969.0,In vivo,1,10116.0,CHEMBL623994,Intermediate,
F,1,BAO_0000218,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,8939,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL623995,Intermediate,
F,1,BAO_0000218,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,8940,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL623996,Intermediate,
F,1,BAO_0000218,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,8941,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL623997,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration dosed orally in rats,8942,Rattus norvegicus,50597,,,Plasma,,N,4516,,,,1969.0,In vivo,1,10116.0,CHEMBL623998,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours,8943,Rattus norvegicus,50597,,,Plasma,,N,4516,,,,1969.0,In vivo,1,10116.0,CHEMBL623999,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,8944,Rattus norvegicus,50597,,,Plasma,,N,4516,,,,1969.0,In vivo,1,10116.0,CHEMBL624000,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,8945,Rattus norvegicus,50597,,,Plasma,,N,5199,,,,1969.0,In vivo,1,10116.0,CHEMBL624001,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in rat after po administration,8946,Rattus norvegicus,50597,,,Plasma,,N,17538,,,,1969.0,In vivo,1,10116.0,CHEMBL624002,Intermediate,
A,1,BAO_0000218,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",8947,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,In vivo,1,10116.0,CHEMBL624003,Intermediate,
A,1,BAO_0000218,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",8948,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,In vivo,1,10116.0,CHEMBL624004,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8949,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624005,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8950,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624006,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8951,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624007,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8952,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624008,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8953,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624009,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8954,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL874387,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8955,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624010,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,8956,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624011,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8957,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624012,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8958,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624013,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8959,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624736,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8960,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624737,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8961,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624738,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8962,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624739,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8963,Rattus norvegicus,50597,,,Heart,,N,16434,,,,948.0,,1,10116.0,CHEMBL624740,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8964,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624896,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,8965,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624897,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,8966,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624108,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,8967,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624109,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,8968,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624110,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,8969,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624111,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8970,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624112,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8971,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL624113,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8972,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL619709,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8973,Rattus norvegicus,50597,,,Heart,,N,16435,,,,948.0,,1,10116.0,CHEMBL619710,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,8974,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619711,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,8975,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619712,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,8976,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619713,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,8977,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619714,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,8978,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619715,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,8979,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619716,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,8980,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619717,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,8981,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619718,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,8982,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619719,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,8983,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL875329,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,8984,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619720,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,8985,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619721,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,8986,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619722,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,8987,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619723,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,8988,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619724,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,8989,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619725,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,8990,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619726,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,8991,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619727,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,8992,Rattus norvegicus,50597,,,Kidney,,N,16434,,,,2113.0,,1,10116.0,CHEMBL619728,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,8993,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL619729,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8994,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL619730,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),8995,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL619731,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),8996,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL619732,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),8997,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL619733,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),8998,Rattus norvegicus,50597,,,Muscle tissue,,N,11977,,,,2385.0,In vivo,1,10116.0,CHEMBL619734,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),8999,Rattus norvegicus,50597,,,Zone of skin,,N,11977,,,,14.0,In vivo,1,10116.0,CHEMBL619735,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9000,Rattus norvegicus,50597,,,Zone of skin,,N,11977,,,,14.0,In vivo,1,10116.0,CHEMBL875330,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9001,Rattus norvegicus,50597,,,Zone of skin,,N,11977,,,,14.0,In vivo,1,10116.0,CHEMBL628465,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9002,Rattus norvegicus,50597,,,Zone of skin,,N,11977,,,,14.0,In vivo,1,10116.0,CHEMBL628466,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9003,Rattus norvegicus,50597,,,Zone of skin,,N,11977,,,,14.0,In vivo,1,10116.0,CHEMBL628467,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9004,Rattus norvegicus,50597,,,Spleen,,N,11977,,,,2106.0,In vivo,1,10116.0,CHEMBL628468,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9005,Rattus norvegicus,50597,,,Spleen,,N,11977,,,,2106.0,In vivo,1,10116.0,CHEMBL628469,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9006,Rattus norvegicus,50597,,,Spleen,,N,11977,,,,2106.0,In vivo,1,10116.0,CHEMBL628470,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9007,Rattus norvegicus,50597,,,Spleen,,N,11977,,,,2106.0,In vivo,1,10116.0,CHEMBL628471,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9008,Rattus norvegicus,50597,,,Spleen,,N,11977,,,,2106.0,In vivo,1,10116.0,CHEMBL628472,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),9009,Rattus norvegicus,50597,,,Thyroid gland,,N,11977,,,,2046.0,In vivo,1,10116.0,CHEMBL625191,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9010,Rattus norvegicus,50597,,,Thyroid gland,,N,11977,,,,2046.0,In vivo,1,10116.0,CHEMBL625192,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),9011,Rattus norvegicus,50597,,,Thyroid gland,,N,11977,,,,2046.0,In vivo,1,10116.0,CHEMBL875337,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),9012,Rattus norvegicus,50597,,,Thyroid gland,,N,11977,,,,2046.0,In vivo,1,10116.0,CHEMBL626341,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),9013,Rattus norvegicus,50597,,,Thyroid gland,,N,11977,,,,2046.0,In vivo,1,10116.0,CHEMBL626342,Intermediate,
A,1,BAO_0000218,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),9014,Rattus norvegicus,50597,,,Liver,,N,11977,,,,2107.0,In vivo,1,10116.0,CHEMBL621943,Intermediate,
A,1,BAO_0000218,Half life in rats,9015,Rattus norvegicus,50597,,,,,N,3748,,,,,,1,10116.0,CHEMBL621944,Intermediate,
A,1,BAO_0000218,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,9016,Rattus norvegicus,50597,,,,,N,15765,,,,,,1,10116.0,CHEMBL621945,Intermediate,
A,1,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),9017,Rattus norvegicus,50597,,,,,N,4871,,,,,,1,10116.0,CHEMBL621946,Intermediate,
A,1,BAO_0000218,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,9018,Rattus norvegicus,50597,,,,,N,4871,,,,,,1,10116.0,CHEMBL621947,Intermediate,
A,1,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),9019,Rattus norvegicus,50597,,,,,N,4872,,,,,,1,10116.0,CHEMBL621948,Intermediate,
A,1,BAO_0000218,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,9020,Rattus norvegicus,50597,,,,,N,4872,,,,,,1,10116.0,CHEMBL621949,Intermediate,
A,1,BAO_0000218,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),9021,Rattus norvegicus,50597,,,,,N,5413,,,,,,1,10116.0,CHEMBL621950,Intermediate,
A,1,BAO_0000218,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,9022,Rattus norvegicus,50597,,,,,N,5413,,,,,,1,10116.0,CHEMBL621951,Intermediate,
A,1,BAO_0000218,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,9023,Rattus norvegicus,50597,,,Blood,,N,15272,,,,178.0,In vivo,1,10116.0,CHEMBL621952,Intermediate,
A,1,BAO_0000218,Stability (%) in rat liver microsomes,9024,Rattus norvegicus,50597,,,Liver,,N,4689,,,,2107.0,,1,10116.0,CHEMBL621953,Intermediate,
A,1,BAO_0000218,Area under curve was calculated after intravenous administration,9025,Rattus norvegicus,50597,,,,,N,6057,,,,,,1,10116.0,CHEMBL621954,Intermediate,
A,1,BAO_0000218,Area under the curve was calculated after iv administration in rat,9026,Rattus norvegicus,50597,,,,,N,6057,,,,,,1,10116.0,CHEMBL621955,Intermediate,
A,1,BAO_0000218,Area under the curve was calculated in rat after peroral administration,9027,Rattus norvegicus,50597,,,,,N,6057,,,,,,1,10116.0,CHEMBL621956,Intermediate,
A,1,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9028,Rattus norvegicus,50597,,,,,N,6211,,,,,,1,10116.0,CHEMBL621957,Intermediate,
A,1,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,9029,Rattus norvegicus,50597,,,,,N,5710,,,,,,1,10116.0,CHEMBL621958,Intermediate,
A,1,BAO_0000218,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,9030,Rattus norvegicus,50597,,,,,N,5710,,,,,,1,10116.0,CHEMBL621959,Intermediate,
A,1,BAO_0000218,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,9031,Rattus norvegicus,50597,,,,,N,17853,,,,,,1,10116.0,CHEMBL621960,Intermediate,
A,1,BAO_0000218,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,9032,Rattus norvegicus,50597,,,,,N,17853,,,,,,1,10116.0,CHEMBL621961,Intermediate,
A,1,BAO_0000218,p value of the compound,9033,Rattus norvegicus,50597,,,,,N,15765,,,,,,1,10116.0,CHEMBL621962,Intermediate,
F,1,BAO_0000218,p value of the compound,9034,Rattus norvegicus,50597,,,,,N,15765,,,,,,1,10116.0,CHEMBL876787,Intermediate,
A,1,BAO_0000218,p value of the compound,9035,Rattus norvegicus,50597,,,,,N,15765,,,,,,1,10116.0,CHEMBL621963,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9036,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL622637,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9037,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL622638,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9038,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL626561,Intermediate,
F,0,BAO_0000019,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),9039,Oryctolagus cuniculus,22224,,,,,U,7991,,,,,,1,9986.0,CHEMBL626562,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),9040,Oryctolagus cuniculus,22224,,,,,U,429,,,,,,1,9986.0,CHEMBL626563,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),9041,Oryctolagus cuniculus,22224,,,,,U,429,,,,,,1,9986.0,CHEMBL626564,Autocuration,
A,0,BAO_0000218,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9042,Oryctolagus cuniculus,22224,,,,,U,6253,,,,,In vivo,1,9986.0,CHEMBL626565,Autocuration,
A,0,BAO_0000218,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9043,Oryctolagus cuniculus,22224,,,,,U,6253,,,,,In vivo,1,9986.0,CHEMBL626566,Autocuration,
A,0,BAO_0000218,Clearance rate in rabbits,9044,Oryctolagus cuniculus,22224,,,,,U,3615,,,,,In vivo,1,9986.0,CHEMBL626567,Autocuration,
A,0,BAO_0000218,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9045,Oryctolagus cuniculus,22224,,,,,U,4059,,,,,In vivo,1,9986.0,CHEMBL626568,Autocuration,
A,0,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9046,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL626569,Autocuration,
A,0,BAO_0000218,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9047,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL626570,Autocuration,
A,0,BAO_0000218,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9048,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL626571,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,9049,Oryctolagus cuniculus,22224,,,,,U,429,,,,,In vivo,1,9986.0,CHEMBL626572,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,9050,Oryctolagus cuniculus,22224,,,Plasma,,U,4059,,,,1969.0,In vivo,1,9986.0,CHEMBL626573,Autocuration,
A,0,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9051,Oryctolagus cuniculus,22224,,,Liver,,U,9659,,,,2107.0,,1,9986.0,CHEMBL626574,Autocuration,Microsomes
A,0,BAO_0000251,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9052,Oryctolagus cuniculus,22224,,,Liver,,U,9659,,,,2107.0,,1,9986.0,CHEMBL626575,Autocuration,Microsomes
A,0,BAO_0000218,Dose at which bioavailability of intravenously administered compound was tested in rabbit,9053,Oryctolagus cuniculus,22224,,,,,U,3639,,,,,,1,9986.0,CHEMBL626576,Autocuration,
A,0,BAO_0000218,Dose at which bioavailability of perorally administered compound was tested in rabbit,9054,Oryctolagus cuniculus,22224,,,,,U,3639,,,,,,1,9986.0,CHEMBL626577,Autocuration,
A,0,BAO_0000218,The compound was tested for its bioavailability in rabbit (by oral dosage).,9055,Oryctolagus cuniculus,22224,,,,,U,3639,,,,,In vivo,1,9986.0,CHEMBL626578,Autocuration,
A,0,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9056,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL625263,Autocuration,
A,0,BAO_0000218,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9057,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL625264,Autocuration,
A,0,BAO_0000218,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9058,Oryctolagus cuniculus,22224,,,,,U,5124,,,,,In vivo,1,9986.0,CHEMBL625265,Autocuration,
A,0,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),9059,Oryctolagus cuniculus,22224,,,,,U,14294,,,,,,1,9986.0,CHEMBL625266,Autocuration,Microsomes
A,0,BAO_0000251,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),9060,Oryctolagus cuniculus,22224,,,,,U,14294,,,,,,1,9986.0,CHEMBL876796,Autocuration,Microsomes
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,9061,Oryctolagus cuniculus,22224,,,,,U,429,,,,,In vivo,1,9986.0,CHEMBL625267,Autocuration,
A,0,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,9062,Oryctolagus cuniculus,22224,,,Plasma,,U,5124,,,,1969.0,In vivo,1,9986.0,CHEMBL625268,Autocuration,
A,0,BAO_0000218,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,9063,Oryctolagus cuniculus,22224,,,Plasma,,U,5124,,,,1969.0,In vivo,1,9986.0,CHEMBL625269,Autocuration,
A,0,BAO_0000218,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,9064,Oryctolagus cuniculus,22224,,,Plasma,,U,5124,,,,1969.0,In vivo,1,9986.0,CHEMBL624689,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,9065,Oryctolagus cuniculus,22224,,,,,U,429,,,,,In vivo,1,9986.0,CHEMBL624690,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),9066,Oryctolagus cuniculus,22224,,,Urine,,U,429,,,,1088.0,,1,9986.0,CHEMBL624691,Autocuration,
A,0,BAO_0000218,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),9067,Oryctolagus cuniculus,22224,,,Urine,,U,429,,,,1088.0,,1,9986.0,CHEMBL624692,Autocuration,
A,0,BAO_0000218,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,9068,Oryctolagus cuniculus,22224,,,,,U,4059,,,,,In vivo,1,9986.0,CHEMBL624693,Autocuration,
A,0,BAO_0000218,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,9069,Oryctolagus cuniculus,22224,,,,,U,4137,,,,,In vivo,1,9986.0,CHEMBL624694,Autocuration,
A,0,BAO_0000221,In vitro Biological half-life in crude homogenate of rabbit renal cortex,9070,Oryctolagus cuniculus,22224,,,,,U,11672,,,,,In vitro,1,9986.0,CHEMBL877596,Autocuration,
A,0,BAO_0000019,Time within which only 10% of the drug was degraded,9071,Oryctolagus cuniculus,22224,,,,,U,12886,,,,,,1,9986.0,CHEMBL624695,Autocuration,
A,0,BAO_0000221,Half life period in rabbit liver homogenate,9072,Oryctolagus cuniculus,22224,,,Liver,,U,3853,,,,2107.0,,1,9986.0,CHEMBL624696,Autocuration,
A,0,BAO_0000019,Half life value in rabbits,9073,Oryctolagus cuniculus,22224,,,,,U,3615,,,,,,1,9986.0,CHEMBL624697,Autocuration,
A,0,BAO_0000218,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,9074,Oryctolagus cuniculus,22224,,,Blood,,U,6253,,,,178.0,In vivo,1,9986.0,CHEMBL624698,Autocuration,
A,0,BAO_0000218,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,9075,Oryctolagus cuniculus,22224,,,Blood,,U,6253,,,,178.0,In vivo,1,9986.0,CHEMBL624699,Autocuration,
A,0,BAO_0000218,Half-life period in rabbits following intravenous administration at 2 mg/kg,9076,Oryctolagus cuniculus,22224,,,,,U,6077,,,,,In vivo,1,9986.0,CHEMBL624700,Autocuration,
A,1,BAO_0000218,AUC 0-8 hr value in rats at 10 mg/kg,9077,Rattus norvegicus,50597,,,Plasma,,N,17617,,,,1969.0,,1,10116.0,CHEMBL622903,Intermediate,
A,1,BAO_0000218,AUC after administration at 2000 mg/kg/day in rats,9078,Rattus norvegicus,50597,,,Plasma,,N,17594,,,,1969.0,,1,10116.0,CHEMBL622904,Intermediate,
A,1,BAO_0000218,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,9079,Rattus norvegicus,50597,,,Plasma,,N,6149,,,,1969.0,,1,10116.0,CHEMBL622905,Intermediate,
A,1,BAO_0000218,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,9080,Rattus norvegicus,50597,,,Plasma,,N,17260,,,,1969.0,,1,10116.0,CHEMBL622906,Intermediate,
A,1,BAO_0000218,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,9081,Rattus norvegicus,50597,,,Plasma,,N,17260,,,,1969.0,,1,10116.0,CHEMBL622907,Intermediate,
A,1,BAO_0000218,AUC in rat after oral administration at 10.5 mg/kg dose,9082,Rattus norvegicus,50597,,,Plasma,,N,6644,,,,1969.0,,1,10116.0,CHEMBL622908,Intermediate,
A,1,BAO_0000218,AUC in rat after oral administration at 11.2 mg/kg dose,9083,Rattus norvegicus,50597,,,Plasma,,N,6644,,,,1969.0,,1,10116.0,CHEMBL622909,Intermediate,
A,1,BAO_0000218,AUC in rat after oral administration at 9.7 mg/kg dose,9084,Rattus norvegicus,50597,,,Plasma,,N,6644,,,,1969.0,,1,10116.0,CHEMBL622910,Intermediate,
A,1,BAO_0000218,AUC in rat brain after oral administration at 10 mg/kg,9085,Rattus norvegicus,50597,,,Brain,,N,6495,,,,955.0,,1,10116.0,CHEMBL622911,Intermediate,
A,1,BAO_0000218,AUC in rat p.o.,9086,Rattus norvegicus,50597,,,Plasma,,N,6504,,,,1969.0,,1,10116.0,CHEMBL622912,Intermediate,
A,1,BAO_0000218,AUC in rat p.o. at 20 mg/kg concentration,9087,Rattus norvegicus,50597,,,Plasma,,N,17686,,,,1969.0,,1,10116.0,CHEMBL622913,Intermediate,
A,1,BAO_0000218,AUC in rat plasma after oral administration at 10 mg/kg,9088,Rattus norvegicus,50597,,,Plasma,,N,6495,,,,1969.0,,1,10116.0,CHEMBL622914,Intermediate,
A,1,BAO_0000218,AUC in rats,9089,Rattus norvegicus,50597,,,Plasma,,N,216,,,,1969.0,,1,10116.0,CHEMBL622915,Intermediate,
A,1,BAO_0000218,AUC value after IV dose at a dose of 5 mg/kg in rats.,9090,Rattus norvegicus,50597,,,Plasma,,N,1908,,,,1969.0,,1,10116.0,CHEMBL622916,Intermediate,
A,1,BAO_0000218,AUC value after oral dose at a dose of 10 mg/kg in rats.,9091,Rattus norvegicus,50597,,,Plasma,,N,1908,,,,1969.0,,1,10116.0,CHEMBL622917,Intermediate,
A,1,BAO_0000218,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",9092,Rattus norvegicus,50597,,,Plasma,,N,6685,,,,1969.0,In vivo,1,10116.0,CHEMBL622918,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,9093,Rattus norvegicus,50597,,,Plasma,,N,216,,,,1969.0,In vivo,1,10116.0,CHEMBL622919,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was evaluated in rat,9094,Rattus norvegicus,50597,,,Plasma,,N,6049,,,,1969.0,In vivo,1,10116.0,CHEMBL622920,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9095,Rattus norvegicus,50597,,,Plasma,,N,2463,,,,1969.0,In vivo,1,10116.0,CHEMBL622921,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,9096,Rattus norvegicus,50597,,,Plasma,,N,6679,,,,1969.0,In vivo,1,10116.0,CHEMBL622922,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,9097,Rattus norvegicus,50597,,,Plasma,,N,6681,,,,1969.0,In vivo,1,10116.0,CHEMBL622923,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9098,Rattus norvegicus,50597,,,Plasma,,N,4890,,,,1969.0,In vivo,1,10116.0,CHEMBL877604,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,9099,Rattus norvegicus,50597,,,Plasma,,N,6410,,,,1969.0,In vivo,1,10116.0,CHEMBL622924,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,9100,Rattus norvegicus,50597,,,Plasma,,N,6410,,,,1969.0,In vivo,1,10116.0,CHEMBL622925,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,9101,Rattus norvegicus,50597,,,Plasma,,N,16366,,,,1969.0,In vivo,1,10116.0,CHEMBL622926,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,9102,Rattus norvegicus,50597,,,Plasma,,N,6227,,,,1969.0,In vivo,1,10116.0,CHEMBL623625,Intermediate,
A,1,BAO_0000218,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,9103,Rattus norvegicus,50597,,,Plasma,,N,3598,,,,1969.0,In vivo,1,10116.0,CHEMBL623626,Expert,
A,1,BAO_0000218,Maximum plasma drug concentration was determined,9104,Rattus norvegicus,50597,,,Plasma,,N,1465,,,,1969.0,In vivo,1,10116.0,CHEMBL623627,Intermediate,
A,1,BAO_0000218,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,9105,Rattus norvegicus,50597,,,,,N,4368,,,,,In vivo,1,10116.0,CHEMBL623628,Intermediate,
A,1,BAO_0000218,Mean peak plasma concentration was observed after intravenous administration in rat,9106,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL623629,Intermediate,
A,1,BAO_0000218,Mean peak plasma concentration was observed after oral administration in rat,9107,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL623630,Intermediate,
A,1,BAO_0000218,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,9108,Rattus norvegicus,50597,,,,,N,5355,,,,,In vivo,1,10116.0,CHEMBL623804,Intermediate,
A,1,BAO_0000218,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,9109,Rattus norvegicus,50597,,,,,N,5355,,,,,In vivo,1,10116.0,CHEMBL623805,Intermediate,
A,1,BAO_0000218,Peak oral plasma concentration was determined in rats by oral administration,9110,Rattus norvegicus,50597,,,Plasma,,N,1567,,,,1969.0,In vivo,1,10116.0,CHEMBL623806,Intermediate,
A,1,BAO_0000218,Peak plasma concentration (Cmax) was determined,9111,Rattus norvegicus,50597,,,Plasma,,N,4026,,,,1969.0,In vivo,1,10116.0,CHEMBL623807,Intermediate,
A,1,BAO_0000218,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,9112,Rattus norvegicus,50597,,,Plasma,,N,6193,,,,1969.0,In vivo,1,10116.0,CHEMBL623808,Intermediate,
A,1,BAO_0000218,Peak plasma concentration (Cmax) in rats,9113,Rattus norvegicus,50597,,,Plasma,,N,4026,,,,1969.0,In vivo,1,10116.0,CHEMBL623809,Intermediate,
A,1,BAO_0000218,Peak plasma concentration at 1 mg/kg peroral administration,9114,Rattus norvegicus,50597,,,Plasma,,N,6485,,,,1969.0,In vivo,1,10116.0,CHEMBL623810,Intermediate,
A,1,BAO_0000218,Peak plasma concentration in rat,9115,Rattus norvegicus,50597,,,Plasma,,N,17655,,,,1969.0,In vivo,1,10116.0,CHEMBL623811,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",9116,Rattus norvegicus,50597,,,Plasma,,N,14941,,,,1969.0,In vivo,1,10116.0,CHEMBL623812,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,9117,Rattus norvegicus,50597,,,,,N,5394,,,,,In vivo,1,10116.0,CHEMBL877605,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Cmax) in rat,9118,Rattus norvegicus,50597,,,,,N,4408,,,,,In vivo,1,10116.0,CHEMBL623813,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,9119,Rattus norvegicus,50597,,,,,N,5983,,,,,In vivo,1,10116.0,CHEMBL623814,Intermediate,
A,1,BAO_0000218,Cmax in rat after 3mg/kg oral dose,9120,Rattus norvegicus,50597,,,,,N,4878,,,,,In vivo,1,10116.0,CHEMBL623815,Intermediate,
A,1,BAO_0000218,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,9121,Rattus norvegicus,50597,,,,,N,5862,Sprague-Dawley,,,,In vivo,1,10116.0,CHEMBL623816,Intermediate,
A,1,BAO_0000218,Cmax in rats after 20 mg/kg oral dose,9122,Rattus norvegicus,50597,,,,,N,4517,,,,,In vivo,1,10116.0,CHEMBL623145,Intermediate,
A,1,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,9123,Rattus norvegicus,50597,,,Plasma,,N,5932,,,,1969.0,In vivo,1,10116.0,CHEMBL623146,Intermediate,
A,1,BAO_0000218,Plasma concentration after oral administration of 100 mg/kg to rats,9124,Rattus norvegicus,50597,,,Plasma,,N,5436,,,,1969.0,In vivo,1,10116.0,CHEMBL623147,Intermediate,
A,1,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9125,Rattus norvegicus,50597,,,Brain,,N,4910,,,,955.0,In vivo,1,10116.0,CHEMBL623042,Intermediate,
A,1,BAO_0000218,Tested for the Cmax in rat at 10 mg/kg per orally,9126,Rattus norvegicus,50597,,,,,N,4950,,,,,In vivo,1,10116.0,CHEMBL623043,Intermediate,
A,1,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",9127,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL623044,Intermediate,
A,1,BAO_0000218,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",9128,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL623045,Intermediate,
A,1,BAO_0000218,Bioavailability as oral Cmax in rats at 30 mins,9129,Rattus norvegicus,50597,,,,,N,3360,,,,,In vivo,1,10116.0,CHEMBL623046,Intermediate,
A,1,BAO_0000218,Bioavailability as oral Cmax in rats at 6hr,9130,Rattus norvegicus,50597,,,,,N,3360,,,,,In vivo,1,10116.0,CHEMBL623226,Intermediate,
A,1,BAO_0000218,The maximum concentration of compound was measured at the dose of 100 umol/kg,9131,Rattus norvegicus,50597,,,,,N,15022,,,,,In vivo,1,10116.0,CHEMBL623227,Intermediate,
A,1,BAO_0000218,The maximum concentration of compound was measured at the dose of 300 umol/kg,9132,Rattus norvegicus,50597,,,,,N,15022,,,,,In vivo,1,10116.0,CHEMBL623228,Intermediate,
A,1,BAO_0000218,The maximum concentration of compound was measured at the dose of 30 umol/kg,9133,Rattus norvegicus,50597,,,,,N,15022,,,,,In vivo,1,10116.0,CHEMBL623229,Intermediate,
A,1,BAO_0000218,The maximum plasma levels for the compounds were determined by LC-MS.,9134,Rattus norvegicus,50597,,,Plasma,,N,5160,,,,1969.0,In vivo,1,10116.0,CHEMBL623230,Intermediate,
A,1,BAO_0000218,mean peak plasma concentration was observed after intravenous administration in rat,9135,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL623231,Intermediate,
A,1,BAO_0000218,mean peak plasma concentration was observed after oral administration in rat,9136,Rattus norvegicus,50597,,,Plasma,,N,15662,,,,1969.0,In vivo,1,10116.0,CHEMBL623232,Intermediate,
A,1,BAO_0000218,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,9137,Rattus norvegicus,50597,,,,,N,4709,,,,,,1,10116.0,CHEMBL623233,Intermediate,
A,1,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,9138,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623234,Intermediate,
A,1,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 1 hr,9139,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623235,Intermediate,
A,1,BAO_0000218,Concentration in plasma (portal) following oral dose in rats at 2 hr,9140,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623236,Intermediate,
A,1,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,9141,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623237,Intermediate,
A,1,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 1 hr,9142,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623238,Intermediate,
A,1,BAO_0000218,Concentration in plasma (systemic) following oral dose in rats at 2 hr,9143,Rattus norvegicus,50597,,,,,N,3535,,,,,,1,10116.0,CHEMBL623239,Intermediate,
A,0,BAO_0000218,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,9144,Rattus norvegicus,22224,,,Plasma,,U,5005,,,,1969.0,In vivo,1,10116.0,CHEMBL623240,Intermediate,
A,1,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",9145,Rattus norvegicus,50597,,,Hypothalamus,,N,6326,,,,1898.0,,1,10116.0,CHEMBL623241,Intermediate,
A,1,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",9146,Rattus norvegicus,50597,,,Hypothalamus,,N,6326,,,,1898.0,,1,10116.0,CHEMBL623242,Intermediate,
A,1,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",9147,Rattus norvegicus,50597,,,,,N,6326,,,,,,1,10116.0,CHEMBL874394,Intermediate,
A,1,BAO_0000218,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",9148,Rattus norvegicus,50597,,,,,N,6326,,,,,,1,10116.0,CHEMBL623243,Intermediate,
A,1,BAO_0000218,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9149,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL623244,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9150,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL623245,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9151,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL623246,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9152,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL623247,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9153,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL623248,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9154,Rattus norvegicus,50597,,,Kidney,,N,16435,,,,2113.0,,1,10116.0,CHEMBL623249,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9155,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625072,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9156,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625073,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9157,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625074,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9158,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625075,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,9159,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625076,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9160,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625077,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9161,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625078,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9162,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL874395,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9163,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625079,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9164,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625080,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9165,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625081,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9166,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625082,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9167,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625083,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9168,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625084,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9169,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625085,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9170,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL625086,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9171,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625087,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9172,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL625088,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9173,Rattus norvegicus,50597,,,Liver,,N,16434,,,,2107.0,,1,10116.0,CHEMBL622205,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9174,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL622206,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9175,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL622207,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9176,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL622366,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9177,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL622367,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9178,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL875331,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9179,Rattus norvegicus,50597,,,Liver,,N,16435,,,,2107.0,,1,10116.0,CHEMBL622368,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9180,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622369,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9181,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622370,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9182,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622371,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9183,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622372,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9184,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622373,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9185,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622374,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9186,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622375,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9187,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622376,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9188,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622377,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9189,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622378,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9190,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622379,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9191,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622380,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9192,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622381,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9193,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622382,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,9194,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL622383,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9195,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL875332,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9196,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL622384,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9197,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL622385,Intermediate,
A,1,BAO_0000218,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),9198,Rattus norvegicus,50597,,,Stomach,,N,6175,,,,945.0,,1,10116.0,CHEMBL622386,Intermediate,
A,1,BAO_0000218,The compound was tested for the plasma binding in rat,9199,Rattus norvegicus,50597,,,,,N,10839,,,,,,1,10116.0,CHEMBL622387,Intermediate,
A,1,BAO_0000218,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",9200,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622388,Intermediate,
A,1,BAO_0000218,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",9201,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622389,Intermediate,
A,1,BAO_0000218,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",9202,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622390,Intermediate,
A,1,BAO_0000218,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),9203,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622391,Intermediate,
A,1,BAO_0000218,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),9204,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622392,Intermediate,
A,1,BAO_0000218,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),9205,Rattus norvegicus,50597,,,,,N,16459,,,,,,1,10116.0,CHEMBL622393,Intermediate,
A,1,BAO_0000218,Plasma level at 2 hr after administration of the compound,9206,Rattus norvegicus,50597,,,,,N,3278,,,,,,1,10116.0,CHEMBL622394,Intermediate,
A,1,BAO_0000218,plasma level at 2 hr after administration of the compound,9207,Rattus norvegicus,50597,,,,,N,3278,,,,,,1,10116.0,CHEMBL622395,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 1 min,9208,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL622396,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 10 min,9209,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624894,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 10 mins,9210,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624895,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 2 hr,9211,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624058,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 3 min,9212,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624059,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 3 mins,9213,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624060,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 5 min,9214,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624061,Intermediate,
A,1,BAO_0000218,Stability in rat serum measured as % recovery at 5 mins,9215,Rattus norvegicus,50597,,,Serum,,N,4684,,,,1977.0,,1,10116.0,CHEMBL624062,Intermediate,
A,1,BAO_0000218,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9216,Rattus norvegicus,50597,,,,,N,16456,,,,,In vivo,1,10116.0,CHEMBL624063,Intermediate,
A,1,BAO_0000218,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,9217,Rattus norvegicus,50597,,,,,N,16456,,,,,In vivo,1,10116.0,CHEMBL624064,Intermediate,
A,1,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,9218,Rattus norvegicus,50597,,,Plasma,,N,723,,,,1969.0,,1,10116.0,CHEMBL624065,Intermediate,
A,1,BAO_0000218,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,9219,Rattus norvegicus,50597,,,Plasma,,N,723,,,,1969.0,,1,10116.0,CHEMBL624066,Intermediate,
A,1,BAO_0000218,Half life tested in mature male rat at a dose of 30 mg/kg,9220,Rattus norvegicus,50597,,,,,N,5160,,,,,In vivo,1,10116.0,CHEMBL877490,Intermediate,
A,1,BAO_0000218,Half life after intravenous administration of 1 mg/kg in rat,9221,Rattus norvegicus,50597,,,,,N,4709,,,,,In vivo,1,10116.0,CHEMBL874442,Intermediate,
A,1,BAO_0000218,Half life period after administration (30 mg/kg) in rat,9222,Rattus norvegicus,50597,,,,,N,5633,,,,,In vivo,1,10116.0,CHEMBL626890,Intermediate,
A,1,BAO_0000218,Half life period in rat after 5 mg/Kg dose,9223,Rattus norvegicus,50597,,,,,N,5302,,,,,In vivo,1,10116.0,CHEMBL626891,Intermediate,
A,1,BAO_0000218,Half life period in rat after 5 mg/kg dose,9224,Rattus norvegicus,50597,,,,,N,5302,,,,,In vivo,1,10116.0,CHEMBL626892,Intermediate,
A,1,BAO_0000218,Half life period was determined,9225,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL626893,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rat,9226,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL626894,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rat; 0.5-1.0,9227,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL626895,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rat; 5.9-7.5,9228,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL626896,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma,9229,Rattus norvegicus,50597,,,Plasma,,N,14512,,,,1969.0,,1,10116.0,CHEMBL626897,Intermediate,
A,1,BAO_0000218,Half-life time in rat was determined,9230,Rattus norvegicus,50597,,,,,N,6230,,,,,,1,10116.0,CHEMBL626898,Intermediate,
A,1,BAO_0000218,Terminal half-life after iv administration to rats,9231,Rattus norvegicus,50597,,,,,N,3364,,,,,In vivo,1,10116.0,CHEMBL626899,Intermediate,
A,1,BAO_0000218,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,9232,Rattus norvegicus,50597,,,,,N,6874,,,,,In vivo,1,10116.0,CHEMBL626900,Intermediate,
A,1,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,9233,Rattus norvegicus,50597,,,,,N,857,,,,,,1,10116.0,CHEMBL626901,Intermediate,
A,1,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),9234,Rattus norvegicus,50597,,,,,N,858,,,,,In vivo,1,10116.0,CHEMBL626902,Intermediate,
A,1,BAO_0000218,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),9235,Rattus norvegicus,50597,,,,,N,858,,,,,In vivo,1,10116.0,CHEMBL626903,Intermediate,
A,1,BAO_0000218,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,9236,Rattus norvegicus,50597,,,,,N,5355,,,,,In vivo,1,10116.0,CHEMBL874443,Intermediate,
A,1,BAO_0000218,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,9237,Rattus norvegicus,50597,,,,,N,5355,,,,,In vivo,1,10116.0,CHEMBL626904,Intermediate,
A,1,BAO_0000218,Half life in rats,9238,Rattus norvegicus,50597,,,,,N,6305,,,,,,1,10116.0,CHEMBL626905,Intermediate,
A,1,BAO_0000218,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,9239,Rattus norvegicus,50597,,,Plasma,,N,13501,,,,1969.0,In vivo,1,10116.0,CHEMBL873830,Intermediate,
A,1,BAO_0000218,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,9240,Rattus norvegicus,50597,,,,,N,17594,,,,,In vivo,1,10116.0,CHEMBL626906,Intermediate,
A,1,BAO_0000218,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9241,Rattus norvegicus,50597,,,Plasma,,N,4186,,,,1969.0,In vivo,1,10116.0,CHEMBL631076,Intermediate,
A,1,BAO_0000218,Biological half-life was measured in plasma of rats,9242,Rattus norvegicus,50597,,,Plasma,,N,2932,,,,1969.0,,1,10116.0,CHEMBL631077,Intermediate,
A,1,BAO_0000218,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,9243,Rattus norvegicus,50597,,,,,N,17065,,,,,In vivo,1,10116.0,CHEMBL631078,Intermediate,
A,1,BAO_0000218,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,9244,Rattus norvegicus,50597,,,,,N,15765,,,,,In vivo,1,10116.0,CHEMBL631079,Intermediate,
A,1,BAO_0000218,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,9245,Rattus norvegicus,50597,,,,,N,2713,,,,,In vivo,1,10116.0,CHEMBL631080,Intermediate,
A,1,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,9246,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL631081,Intermediate,
A,1,BAO_0000218,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,9247,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL631239,Intermediate,
A,1,BAO_0000218,Compound was evaluated for plasma half life in rat,9248,Rattus norvegicus,50597,,,Plasma,,N,740,,,,1969.0,,1,10116.0,CHEMBL631240,Intermediate,
A,1,BAO_0000218,AUC value at a dose of 5 mg/kg (p.o.) in rats,9249,Rattus norvegicus,50597,,,Plasma,,N,6597,,,,1969.0,,1,10116.0,CHEMBL631241,Intermediate,
A,1,BAO_0000218,AUC value after administration of 20 mg/Kg oral dose in rat,9250,Rattus norvegicus,50597,,,Plasma,,N,2959,,,,1969.0,,1,10116.0,CHEMBL631242,Intermediate,
A,1,BAO_0000218,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,9251,Rattus norvegicus,50597,,,Plasma,,N,17594,,,,1969.0,,1,10116.0,CHEMBL631243,Intermediate,
A,1,BAO_0000218,AUC0-96 after administration at 50 mg/kg,9252,Rattus norvegicus,50597,,,Plasma,,N,17596,,,,1969.0,,1,10116.0,CHEMBL874444,Intermediate,
A,1,BAO_0000218,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,9253,Rattus norvegicus,50597,,,Plasma,,N,17594,,,,1969.0,,1,10116.0,CHEMBL631244,Intermediate,
A,1,BAO_0000218,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",9254,Rattus norvegicus,50597,,,,,N,3293,,,,,,1,10116.0,CHEMBL631245,Intermediate,
A,1,BAO_0000218,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,9255,Rattus norvegicus,50597,,,,,N,6757,,,,,,1,10116.0,CHEMBL627162,Intermediate,
A,1,BAO_0000218,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,9256,Rattus norvegicus,50597,,,,,N,6757,,,,,,1,10116.0,CHEMBL627163,Intermediate,
A,1,BAO_0000218,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,9257,Rattus norvegicus,50597,,,,,N,6757,,,,,,1,10116.0,CHEMBL627164,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,9258,Rattus norvegicus,50597,,,Kidney,,N,5979,,,,2113.0,,1,10116.0,CHEMBL627165,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,9259,Rattus norvegicus,50597,,,,,N,5979,,,,,,1,10116.0,CHEMBL627166,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,9260,Rattus norvegicus,50597,,,,,N,5979,,,,,,1,10116.0,CHEMBL627167,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) at a dose of 30 mg/kg in rats,9261,Rattus norvegicus,50597,,,,,N,4026,,,,,,1,10116.0,CHEMBL627822,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9262,Rattus norvegicus,50597,,,,,N,5355,,,,,,1,10116.0,CHEMBL627823,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,9263,Rattus norvegicus,50597,,,,,N,5355,,,,,,1,10116.0,CHEMBL627824,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,9264,Rattus norvegicus,50597,,,,,N,5355,,,,,,1,10116.0,CHEMBL627825,Intermediate,
A,1,BAO_0000218,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,9265,Rattus norvegicus,50597,,,,,N,5633,,,,,,1,10116.0,CHEMBL627826,Intermediate,
A,1,BAO_0000218,Area under curve (Pharmacokinetic property) was determined,9266,Rattus norvegicus,50597,,,,,N,1716,,,,,,1,10116.0,CHEMBL627827,Intermediate,
A,1,BAO_0000218,Area under curve (Pharmacokinetic property) of the compound; Not determined,9267,Rattus norvegicus,50597,,,,,N,1716,,,,,,1,10116.0,CHEMBL627828,Intermediate,
A,1,BAO_0000218,Area under curve after intravenous administration (1 mg/kg) in rat,9268,Rattus norvegicus,50597,,,,,N,4689,,,,,,1,10116.0,CHEMBL627829,Intermediate,
A,1,BAO_0000218,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,9269,Rattus norvegicus,50597,,,,,N,4527,,,,,,1,10116.0,CHEMBL627830,Intermediate,
A,1,BAO_0000218,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,9270,Rattus norvegicus,50597,,,,,N,4527,,,,,,1,10116.0,CHEMBL627831,Intermediate,
A,1,BAO_0000218,Area under curve in male SD rats was observed after oral administration in rat,9271,Rattus norvegicus,50597,,,,,N,15662,,,,,,1,10116.0,CHEMBL627832,Intermediate,
A,1,BAO_0000218,Area under curve of compound after iv administration of 20 mg/kg dose in rat,9272,Rattus norvegicus,50597,,,,,N,4413,,,,,,1,10116.0,CHEMBL627833,Intermediate,
A,1,BAO_0000218,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,9273,Rattus norvegicus,50597,,,,,N,3598,,,,,,1,10116.0,CHEMBL627834,Expert,
A,1,BAO_0000218,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,9274,Rattus norvegicus,50597,,,,,N,3598,,,,,,1,10116.0,CHEMBL628004,Expert,
A,1,BAO_0000218,Area under curve at 5 mg/kg po was determined in rat,9275,Rattus norvegicus,50597,,,,,N,5964,,,,,,1,10116.0,CHEMBL628005,Intermediate,
A,1,BAO_0000218,Area under curve in Rat at a oral dose of 5 mg/kg,9276,Rattus norvegicus,50597,,,,,N,4689,,,,,,1,10116.0,CHEMBL628006,Intermediate,
A,1,BAO_0000218,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,9277,Rattus norvegicus,50597,,,,,N,4186,,,,,,1,10116.0,CHEMBL628007,Intermediate,
A,1,BAO_0000218,Area under curve was determined,9278,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL625676,Intermediate,
A,1,BAO_0000218,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,9279,Rattus norvegicus,50597,,,,,N,17858,,,,,,1,10116.0,CHEMBL631309,Intermediate,
A,1,BAO_0000218,Area under curve after intravenous administration at 3 mg/kg,9280,Rattus norvegicus,50597,,,,,N,17804,,,,,,1,10116.0,CHEMBL631310,Intermediate,
A,1,BAO_0000218,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,9281,Rattus norvegicus,50597,,,,,N,6106,,,,,,1,10116.0,CHEMBL631311,Intermediate,
A,1,BAO_0000218,Area under curve at 4 hr in rat,9282,Rattus norvegicus,50597,,,,,N,5964,,,,,,1,10116.0,CHEMBL631312,Intermediate,
A,1,BAO_0000218,Area under curve at a dose of 30 mg/kg,9283,Rattus norvegicus,50597,,,,,N,4026,,,,,,1,10116.0,CHEMBL631313,Intermediate,
A,1,BAO_0000218,Area under curve at the dose of 2 mg/Kg administered perorally in rats,9284,Rattus norvegicus,50597,,,,,N,4756,,,,,,1,10116.0,CHEMBL631314,Intermediate,
A,1,BAO_0000218,Area under curve at the dose of 5 mg/Kg administered perorally in rats,9285,Rattus norvegicus,50597,,,,,N,4756,,,,,,1,10116.0,CHEMBL631315,Intermediate,
A,1,BAO_0000218,Area under curve for a 2-mpk po dose in SD rats,9286,Rattus norvegicus,50597,,,,,N,5862,,,,,,1,10116.0,CHEMBL631316,Intermediate,
A,1,BAO_0000218,Area under curve in SD rats,9287,Rattus norvegicus,50597,,,,,N,5862,,,,,,1,10116.0,CHEMBL631317,Intermediate,
A,1,BAO_0000218,Area under curve in rat after oral administration at 13 mg/kg dose,9288,Rattus norvegicus,50597,,,,,N,6644,,,,,,1,10116.0,CHEMBL874471,Intermediate,
A,1,BAO_0000218,Area under curve in rat by po administration at 0-24 hr,9289,Rattus norvegicus,50597,,,,,N,5871,,,,,,1,10116.0,CHEMBL631318,Intermediate,
A,1,BAO_0000218,Area under curve in rat plasma,9290,Rattus norvegicus,50597,,,Plasma,,N,5919,,,,1969.0,,1,10116.0,CHEMBL631319,Intermediate,
A,1,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,9291,Rattus norvegicus,50597,,,,,N,5939,,,,,,1,10116.0,CHEMBL631320,Intermediate,
A,1,BAO_0000218,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,9292,Rattus norvegicus,50597,,,,,N,5939,,,,,,1,10116.0,CHEMBL631321,Intermediate,
A,1,BAO_0000218,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,9293,Rattus norvegicus,50597,,,,,N,10,,,,,,1,10116.0,CHEMBL631322,Intermediate,
A,1,BAO_0000218,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,9294,Rattus norvegicus,50597,,,,,N,11149,,,,,,1,10116.0,CHEMBL631323,Intermediate,
A,1,BAO_0000218,Area under curve value in rat at a dose of 5 mg/kg,9295,Rattus norvegicus,50597,,,,,N,5302,,,,,,1,10116.0,CHEMBL631324,Intermediate,
A,1,BAO_0000218,Area under curve was determined after oral administration in rats,9296,Rattus norvegicus,50597,,,,,N,17796,,,,,,1,10116.0,CHEMBL631325,Intermediate,
A,1,BAO_0000218,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,9297,Rattus norvegicus,50597,,,,,N,4890,,,,,,1,10116.0,CHEMBL631326,Intermediate,
A,1,BAO_0000218,Area under curve was determined after peroral administration in rat,9298,Rattus norvegicus,50597,,,,,N,6011,,,,,,1,10116.0,CHEMBL631327,Intermediate,
A,1,BAO_0000218,Area under curve was determined at a dose 30 mpk administered orally.,9299,Rattus norvegicus,50597,,,,,N,5375,,,,,,1,10116.0,CHEMBL631328,Intermediate,
A,1,BAO_0000218,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,9300,Rattus norvegicus,50597,,,,,N,17764,,,,,,1,10116.0,CHEMBL631329,Intermediate,
A,1,BAO_0000218,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,9301,Rattus norvegicus,50597,,,,,N,4368,,,,,,1,10116.0,CHEMBL627217,Intermediate,
A,1,BAO_0000218,Area under curve was determined in male rat,9302,Rattus norvegicus,50597,,,,,N,5610,,,,,,1,10116.0,CHEMBL626352,Intermediate,
A,1,BAO_0000218,Area under curve was determined in rat after PO administration,9303,Rattus norvegicus,50597,,,,,N,5833,,,,,,1,10116.0,CHEMBL626353,Intermediate,
A,1,BAO_0000218,Area under curve was determined in rat after a 3 mg/kg of oral dose,9304,Rattus norvegicus,50597,,,,,N,4257,,,,,,1,10116.0,CHEMBL626354,Intermediate,
A,1,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,9305,Rattus norvegicus,50597,,,,,N,5937,,,,,,1,10116.0,CHEMBL626355,Intermediate,
A,1,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,9306,Rattus norvegicus,50597,,,,,N,5932,,,,,,1,10116.0,CHEMBL626356,Intermediate,
A,1,BAO_0000218,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,9307,Rattus norvegicus,50597,,,,,N,5932,,,,,,1,10116.0,CHEMBL626357,Intermediate,
A,1,BAO_0000218,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9308,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL626358,Intermediate,
A,1,BAO_0000218,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9309,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL626359,Intermediate,
A,1,BAO_0000218,Peak plasma concentration in rat at a dose of 3 mg/kg,9310,Rattus norvegicus,50597,,,Plasma,,N,17771,,,,1969.0,,1,10116.0,CHEMBL626360,Intermediate,
A,1,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated.,9311,Rattus norvegicus,50597,,,,,N,1628,,,,,,1,10116.0,CHEMBL626361,Intermediate,
A,1,BAO_0000218,Plasma concentration at 2 hr in rats was evaluated; Not available,9312,Rattus norvegicus,50597,,,,,N,1628,,,,,,1,10116.0,CHEMBL626362,Intermediate,
A,1,BAO_0000218,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,9313,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL626363,Intermediate,
A,1,BAO_0000218,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9314,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL626970,Intermediate,
A,1,BAO_0000218,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,9315,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL626971,Intermediate,
A,1,BAO_0000218,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9316,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,,1,10116.0,CHEMBL626972,Intermediate,
A,1,BAO_0000218,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,9317,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,,1,10116.0,CHEMBL626973,Intermediate,
A,1,BAO_0000218,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,9318,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,,1,10116.0,CHEMBL626974,Intermediate,
A,1,BAO_0000218,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,9319,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,,1,10116.0,CHEMBL874592,Intermediate,
A,1,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,9320,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626975,Intermediate,
A,1,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,9321,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626976,Intermediate,
A,1,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,9322,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626977,Intermediate,
A,1,BAO_0000218,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,9323,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626978,Intermediate,
A,1,BAO_0000218,PK study was carried to determine the relative absorption ranking in rat.,9324,Rattus norvegicus,50597,,,,,N,16427,,,,,,1,10116.0,CHEMBL626979,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,9325,Rattus norvegicus,50597,,,Plasma,,N,4689,,,,1969.0,In vivo,1,10116.0,CHEMBL626980,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",9326,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL626981,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",9327,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL626982,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",9328,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL626983,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",9329,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL622522,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",9330,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL622523,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",9331,Rattus norvegicus,50597,,,Blood,,N,11450,,,,178.0,,1,10116.0,CHEMBL622524,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",9332,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL622525,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",9333,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL622526,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",9334,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL619849,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",9335,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL619850,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",9336,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL623864,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",9337,Rattus norvegicus,50597,,,Brain,,N,11450,,,,955.0,,1,10116.0,CHEMBL623865,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",9338,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL623866,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",9339,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL623867,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",9340,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL877615,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",9341,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL623868,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",9342,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL623869,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",9343,Rattus norvegicus,50597,,,Heart,,N,11450,,,,948.0,,1,10116.0,CHEMBL623870,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9344,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL623871,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9345,Rattus norvegicus,50597,,,Lung,,N,16434,,,,2048.0,,1,10116.0,CHEMBL623872,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9346,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622129,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9347,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622130,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9348,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622131,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9349,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622132,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9350,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622133,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9351,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622134,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9352,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622135,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9353,Rattus norvegicus,50597,,,Lung,,N,16435,,,,2048.0,,1,10116.0,CHEMBL622136,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9354,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL622137,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9355,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL622138,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9356,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623017,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9357,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623018,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9358,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623019,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9359,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623020,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,9360,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623021,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,9361,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL623022,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9362,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL623023,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9363,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL623024,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9364,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL623025,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9365,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620545,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9366,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620546,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9367,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620547,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9368,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620548,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9369,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620549,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9370,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL620550,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9371,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL620551,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9372,Rattus norvegicus,50597,,,Muscle tissue,,N,16434,,,,2385.0,,1,10116.0,CHEMBL620552,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9373,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620553,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9374,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620554,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9375,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL875845,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9376,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620555,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9377,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620556,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9378,Rattus norvegicus,50597,,,Muscle tissue,,N,16435,,,,2385.0,,1,10116.0,CHEMBL620557,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9379,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL620558,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9380,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL620559,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9381,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622939,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9382,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622940,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9383,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622941,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9384,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622942,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9385,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622943,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9386,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622944,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9387,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622945,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9388,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622946,Intermediate,
A,1,BAO_0000218,Compound was evaluated for terminal half life in rat,9389,Rattus norvegicus,50597,,,,,N,3341,,,,,,1,10116.0,CHEMBL622947,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,9390,Rattus norvegicus,50597,,,Plasma,,N,3634,,,,1969.0,In vivo,1,10116.0,CHEMBL622948,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,9391,Rattus norvegicus,50597,,,Plasma,,N,3634,,,,1969.0,In vivo,1,10116.0,CHEMBL622949,Intermediate,
A,1,BAO_0000218,Compound was tested for its half life in rat,9392,Rattus norvegicus,50597,,,,,N,4839,,,,,,1,10116.0,CHEMBL622950,Intermediate,
A,0,BAO_0000218,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,9393,Macaca mulatta,22224,,,Plasma,,U,5005,,,,1969.0,In vivo,1,9544.0,CHEMBL622951,Intermediate,
A,0,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats,9394,Rattus norvegicus,22224,,,Plasma,,U,5005,,,,1969.0,,1,10116.0,CHEMBL622952,Intermediate,
A,0,BAO_0000366,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,9395,Rattus norvegicus,22224,,,Plasma,,U,5005,,,,1969.0,,1,10116.0,CHEMBL622953,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma half-life period in rat,9396,Rattus norvegicus,50597,,,Plasma,,N,1094,,,,1969.0,,1,10116.0,CHEMBL873818,Intermediate,
A,1,BAO_0000218,Elimination half life after i.v. administration of compound in rats,9397,Rattus norvegicus,50597,,,,,N,5031,,,,,In vivo,1,10116.0,CHEMBL622954,Intermediate,
A,1,BAO_0000218,Elimination half-life after IV dosing at 0.5 mg/kg in rat,9398,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL622955,Intermediate,
A,1,BAO_0000218,Elimination half-life after IV dosing at 1 mg/kg in rat,9399,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL875229,Intermediate,
A,1,BAO_0000218,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,9400,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL622956,Intermediate,
A,1,BAO_0000218,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,9401,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL622957,Intermediate,
A,1,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9402,Rattus norvegicus,50597,,,Brain,,N,5408,,,,955.0,In vivo,1,10116.0,CHEMBL622958,Intermediate,
A,1,BAO_0000218,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9403,Rattus norvegicus,50597,,,Plasma,,N,5408,,,,1969.0,In vivo,1,10116.0,CHEMBL622959,Intermediate,
A,1,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9404,Rattus norvegicus,50597,,,Brain,,N,5408,,,,955.0,In vivo,1,10116.0,CHEMBL622960,Intermediate,
A,1,BAO_0000218,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9405,Rattus norvegicus,50597,,,Plasma,,N,5408,,,,1969.0,In vivo,1,10116.0,CHEMBL622961,Intermediate,
A,1,BAO_0000218,Evaluated for the half life in rat (in vivo),9406,Rattus norvegicus,50597,,,,,N,4687,,,,,In vivo,1,10116.0,CHEMBL622962,Intermediate,
A,1,BAO_0000218,Hafl life in rat,9407,Rattus norvegicus,50597,,,,,N,6640,,,,,,1,10116.0,CHEMBL622963,Intermediate,
A,1,BAO_0000218,Hafl life rat,9408,Rattus norvegicus,50597,,,,,N,6640,,,,,,1,10116.0,CHEMBL622964,Intermediate,
A,1,BAO_0000218,Hafl life rat,9409,Rattus norvegicus,50597,,,,,N,6641,,,,,,1,10116.0,CHEMBL622965,Intermediate,
A,1,BAO_0000218,Hafl life rat; Not determined,9410,Rattus norvegicus,50597,,,,,N,6640,,,,,,1,10116.0,CHEMBL622966,Intermediate,
A,1,BAO_0000218,Hafl life rat; Not determined,9411,Rattus norvegicus,50597,,,,,N,6641,,,,,,1,10116.0,CHEMBL622967,Intermediate,
A,1,BAO_0000218,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9412,Rattus norvegicus,50597,,,Kidney,,N,17411,,,,2113.0,In vivo,1,10116.0,CHEMBL622968,Intermediate,
A,1,BAO_0000218,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9413,Rattus norvegicus,50597,,,Liver,,N,17411,,,,2107.0,In vivo,1,10116.0,CHEMBL622969,Intermediate,
A,1,BAO_0000218,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9414,Rattus norvegicus,50597,,,Lung,,N,17411,,,,2048.0,In vivo,1,10116.0,CHEMBL875327,Intermediate,
A,1,BAO_0000218,Half life in rat after 1 mg/kg i.v. administration,9415,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL628638,Intermediate,
A,1,BAO_0000218,Half life in rat after 2 mg/kg peroral administration,9416,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL628639,Intermediate,
A,1,BAO_0000218,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,9417,Rattus norvegicus,50597,,,,,N,17411,,,,,In vivo,1,10116.0,CHEMBL625840,Intermediate,
A,1,BAO_0000218,Half life of 10 mg/kg oral dose determined in rats,9418,Rattus norvegicus,50597,,,,,N,4722,,,,,In vivo,1,10116.0,CHEMBL625841,Intermediate,
A,1,BAO_0000218,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,9419,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL625842,Intermediate,
A,1,BAO_0000218,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,9420,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL625843,Intermediate,
A,1,BAO_0000218,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,9421,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL625844,Intermediate,
A,1,BAO_0000218,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,9422,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL873822,Intermediate,
A,1,BAO_0000218,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,9423,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL625845,Intermediate,
A,1,BAO_0000218,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,9424,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL627059,Intermediate,
A,1,BAO_0000218,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,9425,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL627060,Intermediate,
A,1,BAO_0000218,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,9426,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL627061,Intermediate,
A,1,BAO_0000218,Half life of compound at 5 mg/kg after po administration was determined in rat,9427,Rattus norvegicus,50597,,,,,N,4762,,,,,In vivo,1,10116.0,CHEMBL627709,Intermediate,
A,1,BAO_0000218,Half life of compound determined after intravenous administration to rat,9428,Rattus norvegicus,50597,,,,,N,5327,,,,,In vivo,1,10116.0,CHEMBL627710,Intermediate,
A,1,BAO_0000218,Half life of compound was determined in rat,9429,Rattus norvegicus,50597,,,,,N,4847,,,,,,1,10116.0,CHEMBL627711,Intermediate,
A,1,BAO_0000218,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,9430,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL627712,Intermediate,
A,1,BAO_0000218,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9431,Rattus norvegicus,50597,,,,,N,4723,,,,,In vivo,1,10116.0,CHEMBL627713,Intermediate,
A,1,BAO_0000218,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,9432,Rattus norvegicus,50597,,,,,N,4723,,,,,In vivo,1,10116.0,CHEMBL627714,Intermediate,
A,0,BAO_0000218,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,9433,Macaca fascicularis,22224,,,,,U,4256,,,,,In vivo,1,9541.0,CHEMBL627889,Intermediate,
A,0,BAO_0000218,Half life determined in rat by intravenous administration,9434,Rattus norvegicus,22224,,,,,U,4256,,,,,In vivo,1,10116.0,CHEMBL627890,Intermediate,
A,1,BAO_0000218,Half life determined in rats after iv administration,9435,Rattus norvegicus,50597,,,,,N,4722,,,,,In vivo,1,10116.0,CHEMBL627891,Intermediate,
A,1,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,9436,Rattus norvegicus,50597,,,Plasma,,N,6535,,,,1969.0,In vivo,1,10116.0,CHEMBL627892,Intermediate,
A,1,BAO_0000218,Half life in rat plasma after administration of 2 mg/kg iv,9437,Rattus norvegicus,50597,,,Plasma,,N,6535,,,,1969.0,In vivo,1,10116.0,CHEMBL627893,Intermediate,
A,1,BAO_0000218,Half life in rat plasma was determined,9438,Rattus norvegicus,50597,,,Plasma,,N,1435,,,,1969.0,,1,10116.0,CHEMBL627894,Intermediate,
A,1,BAO_0000218,Half life in rat plasma was determined; NA means not applicable,9439,Rattus norvegicus,50597,,,Plasma,,N,1435,,,,1969.0,,1,10116.0,CHEMBL627895,Intermediate,
A,1,BAO_0000218,Half life in rat was tested,9440,Rattus norvegicus,50597,,,,,N,5206,,,,,,1,10116.0,CHEMBL627896,Intermediate,
A,1,BAO_0000218,Half life measured in rat plasma,9441,Rattus norvegicus,50597,,,Plasma,,N,6080,,,,1969.0,,1,10116.0,CHEMBL627897,Intermediate,
A,1,BAO_0000218,Half life recorded in rats,9442,Rattus norvegicus,50597,,,,,N,4449,,,,,,1,10116.0,CHEMBL627898,Intermediate,
A,1,BAO_0000218,Half life was calculated,9443,Rattus norvegicus,50597,,,,,N,6057,,,,,,1,10116.0,CHEMBL627899,Intermediate,
A,1,BAO_0000218,Half life was calculated in rat,9444,Rattus norvegicus,50597,,,,,N,6057,,,,,,1,10116.0,CHEMBL873823,Intermediate,
A,1,BAO_0000218,Half life was determined,9445,Rattus norvegicus,50597,,,,,N,3747,,,,,,1,10116.0,CHEMBL627900,Intermediate,
A,1,BAO_0000218,Half life after 10 mg/kg oral administration in rat,9446,Rattus norvegicus,50597,,,,,N,17858,,,,,In vivo,1,10116.0,CHEMBL627901,Intermediate,
A,1,BAO_0000218,Half life after administering orally a dose of 10 mg/kg to a fasting rat,9447,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL627902,Intermediate,
A,1,BAO_0000218,Half life after administering orally a dose of 30 mg/kg,9448,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL627903,Intermediate,
A,1,BAO_0000218,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,9449,Rattus norvegicus,50597,,,,,N,5031,,,,,,1,10116.0,CHEMBL627904,Intermediate,
A,1,BAO_0000218,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,9450,Rattus norvegicus,50597,,,,,N,4722,,,,,,1,10116.0,CHEMBL627905,Intermediate,
A,1,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,9451,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL627906,Intermediate,
A,1,BAO_0000218,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,9452,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL627907,Intermediate,
A,1,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,9453,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL876783,Intermediate,
A,1,BAO_0000218,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,9454,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL627908,Intermediate,
A,1,BAO_0000218,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,9455,Rattus norvegicus,50597,,,,,N,17065,,,,,,1,10116.0,CHEMBL627909,Intermediate,
A,1,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,9456,Rattus norvegicus,50597,,,,,N,1353,,,,,,1,10116.0,CHEMBL627910,Intermediate,
A,1,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),9457,Rattus norvegicus,50597,,,,,N,1353,,,,,,1,10116.0,CHEMBL627911,Intermediate,
A,1,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),9458,Rattus norvegicus,50597,,,,,N,1353,,,,,,1,10116.0,CHEMBL627912,Intermediate,
A,1,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),9459,Rattus norvegicus,50597,,,,,N,1353,,,,,,1,10116.0,CHEMBL627913,Intermediate,
A,1,BAO_0000218,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),9460,Rattus norvegicus,50597,,,,,N,1353,,,,,,1,10116.0,CHEMBL627914,Intermediate,
A,1,BAO_0000218,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,9461,Rattus norvegicus,50597,,,,,N,16423,,,,,,1,10116.0,CHEMBL627915,Intermediate,
A,1,BAO_0000218,Area under the curve was evaluated after 20 uM/kg of peroral administration,9462,Rattus norvegicus,50597,,,,,N,16423,,,,,,1,10116.0,CHEMBL627916,Intermediate,
A,1,BAO_0000218,Area under the curve was measured in rat after an iv dose of 1 mg/kg,9463,Rattus norvegicus,50597,,,,,N,6062,,,,,,1,10116.0,CHEMBL627917,Intermediate,
A,1,BAO_0000218,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,9464,Rattus norvegicus,50597,,,,,N,6056,,,,,,1,10116.0,CHEMBL627918,Intermediate,
A,1,BAO_0000218,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,9465,Rattus norvegicus,50597,,,,,N,5182,,,,,,1,10116.0,CHEMBL627919,Intermediate,
A,1,BAO_0000218,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,9466,Rattus norvegicus,50597,,,,,N,6410,,,,,,1,10116.0,CHEMBL627920,Intermediate,
A,1,BAO_0000218,Area under the curve was evaluated at an oral dose of 30 mg/kg,9467,Rattus norvegicus,50597,,,,,N,6410,,,,,,1,10116.0,CHEMBL627921,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9468,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL627922,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9469,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL876784,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9470,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL627923,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9471,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL626208,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,9472,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL626209,Intermediate,
A,1,BAO_0000218,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,9473,Rattus norvegicus,50597,,,,,N,4723,,,,,,1,10116.0,CHEMBL626210,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,9474,Rattus norvegicus,50597,,,Plasma,,N,2463,,,,1969.0,,1,10116.0,CHEMBL627994,Intermediate,
A,1,BAO_0000218,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,9475,Rattus norvegicus,50597,,,,,N,4709,,,,,,1,10116.0,CHEMBL627995,Intermediate,
A,1,BAO_0000218,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,9476,Rattus norvegicus,50597,,,,,N,4075,,,,,,1,10116.0,CHEMBL627996,Intermediate,
A,1,BAO_0000218,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,9477,Rattus norvegicus,50597,,,,,N,5394,,,,,,1,10116.0,CHEMBL627997,Intermediate,
A,1,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,9478,Rattus norvegicus,50597,,,,,N,2661,,,,,,1,10116.0,CHEMBL627998,Intermediate,
A,1,BAO_0000218,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,9479,Rattus norvegicus,50597,,,,,N,2661,,,,,,1,10116.0,CHEMBL628640,Intermediate,
A,1,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,9480,Rattus norvegicus,50597,,,,,N,2661,,,,,,1,10116.0,CHEMBL628641,Intermediate,
A,1,BAO_0000218,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,9481,Rattus norvegicus,50597,,,,,N,2661,,,,,,1,10116.0,CHEMBL628642,Intermediate,
A,1,BAO_0000218,Compound was evaluated for area under the curve expressed as (h*ug/ml),9482,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL628643,Intermediate,
A,1,BAO_0000218,Compound was tested for area under curve in rat,9483,Rattus norvegicus,50597,,,,,N,2591,,,,,,1,10116.0,CHEMBL628644,Intermediate,
A,1,BAO_0000218,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,9484,Rattus norvegicus,50597,,,,,N,6567,,,,,,1,10116.0,CHEMBL628645,Intermediate,
A,1,BAO_0000218,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,9485,Rattus norvegicus,50597,,,,,N,6211,,,,,,1,10116.0,CHEMBL628646,Intermediate,
A,1,BAO_0000218,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),9486,Rattus norvegicus,50597,,,,,N,5529,,,,,,1,10116.0,CHEMBL628647,Intermediate,
A,1,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,9487,Rattus norvegicus,50597,,,,,N,5408,,,,,,1,10116.0,CHEMBL628648,Intermediate,
A,1,BAO_0000218,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,9488,Rattus norvegicus,50597,,,,,N,5408,,,,,,1,10116.0,CHEMBL625358,Intermediate,
A,1,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,9489,Rattus norvegicus,50597,,,,,N,5408,,,,,,1,10116.0,CHEMBL625359,Intermediate,
A,1,BAO_0000218,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,9490,Rattus norvegicus,50597,,,,,N,5408,,,,,,1,10116.0,CHEMBL625360,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),9491,Rattus norvegicus,50597,,,,,N,429,,,,,,1,10116.0,CHEMBL625361,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),9492,Rattus norvegicus,50597,,,,,N,429,,,,,,1,10116.0,CHEMBL625362,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),9493,Rattus norvegicus,50597,,,,,N,429,,,,,,1,10116.0,CHEMBL625363,Intermediate,
A,1,BAO_0000218,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9494,Rattus norvegicus,50597,,,,,N,4796,,,,,,1,10116.0,CHEMBL625364,Intermediate,
A,1,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,9495,Rattus norvegicus,50597,,,,,N,5974,,,,,,1,10116.0,CHEMBL625365,Intermediate,
A,1,BAO_0000218,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,9496,Rattus norvegicus,50597,,,,,N,5974,,,,,,1,10116.0,CHEMBL625366,Intermediate,
A,1,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,9497,Rattus norvegicus,50597,,,,,N,5974,,,,,,1,10116.0,CHEMBL625367,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",9498,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625368,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",9499,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625369,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",9500,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625370,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",9501,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625371,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",9502,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625372,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",9503,Rattus norvegicus,50597,,,Kidney,,N,11450,,,,2113.0,,1,10116.0,CHEMBL625373,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",9504,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL625374,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",9505,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL877593,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",9506,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL625375,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",9507,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL625376,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",9508,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL621973,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",9509,Rattus norvegicus,50597,,,Liver,,N,11450,,,,2107.0,,1,10116.0,CHEMBL621974,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",9510,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL621975,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",9511,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL622166,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",9512,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL622167,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",9513,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL622168,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",9514,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL622169,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",9515,Rattus norvegicus,50597,,,Lung,,N,11450,,,,2048.0,,1,10116.0,CHEMBL622170,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",9516,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622171,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",9517,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622172,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",9518,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622173,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",9519,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622174,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",9520,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622175,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",9521,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622176,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",9522,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622177,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",9523,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622178,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",9524,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622179,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",9525,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622180,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9526,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622181,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9527,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622182,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9528,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622183,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9529,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622184,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9530,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622185,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9531,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622186,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9532,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622187,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,9533,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL625002,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,9534,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622090,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9535,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622091,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9536,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622092,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9537,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622093,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9538,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622094,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9539,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622095,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9540,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622264,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9541,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL622265,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9542,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL622266,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9543,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL622267,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9544,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL622268,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9545,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL622269,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9546,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL625071,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9547,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL621621,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9548,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL621622,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9549,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621623,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9550,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621624,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9551,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621625,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9552,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621626,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9553,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621627,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9554,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621628,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9555,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL875328,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9556,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621629,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9557,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL621630,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9558,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL621631,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9559,Rattus norvegicus,50597,,,Spleen,,N,16434,,,,2106.0,,1,10116.0,CHEMBL621632,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9560,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621633,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9561,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621634,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9562,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621635,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9563,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621636,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9564,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621637,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9565,Rattus norvegicus,50597,,,Spleen,,N,16435,,,,2106.0,,1,10116.0,CHEMBL621638,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9566,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL618883,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,9567,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL618884,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9568,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL628627,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9569,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL628628,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,9570,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL628629,Intermediate,
A,1,BAO_0000218,Half life after administering orally a dose of 3 mg/kg,9571,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL628630,Intermediate,
A,1,BAO_0000218,Half life after administering orally a dose of 3 mg/kg to a fasting rat,9572,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL628631,Intermediate,
A,1,BAO_0000218,Half life after administering intravenously a dose of 1 mg/kg,9573,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL628632,Intermediate,
A,1,BAO_0000218,Half life after oral dosing in rats,9574,Rattus norvegicus,50597,,,,,N,526,,,,,In vivo,1,10116.0,CHEMBL628633,Intermediate,
A,1,BAO_0000218,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,9575,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL628634,Intermediate,
A,1,BAO_0000218,Half life by intravenous administration of 3.4 mg/kg in rat,9576,Rattus norvegicus,50597,,,,,N,4368,,,,,In vivo,1,10116.0,CHEMBL627789,Intermediate,
A,1,BAO_0000218,Half life in rat,9577,Rattus norvegicus,50597,,,,,N,3371,,,,,,1,10116.0,CHEMBL627790,Intermediate,
A,1,BAO_0000218,Half life in rat,9578,Rattus norvegicus,50597,,,,,N,6448,,,,,,1,10116.0,CHEMBL627791,Intermediate,
A,1,BAO_0000218,Half life in rat,9579,Rattus norvegicus,50597,,,,,N,6453,,,,,,1,10116.0,CHEMBL627792,Intermediate,
A,1,BAO_0000218,Half life in rat after intravenous administration of the compound,9580,Rattus norvegicus,50597,,,,,N,4353,,,,,In vivo,1,10116.0,CHEMBL627793,Intermediate,
A,1,BAO_0000218,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,9581,Rattus norvegicus,50597,,,Plasma,,N,4353,,,,1969.0,In vivo,1,10116.0,CHEMBL627794,Intermediate,
A,1,BAO_0000218,Half life in rat after po administration of the compound,9582,Rattus norvegicus,50597,,,,,N,4353,,,,,In vivo,1,10116.0,CHEMBL627795,Intermediate,
A,1,BAO_0000218,Half life in rat after po administration of the compound; ND means Not determined,9583,Rattus norvegicus,50597,,,,,N,4353,,,,,In vivo,1,10116.0,CHEMBL627796,Intermediate,
A,1,BAO_0000218,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,9584,Rattus norvegicus,50597,,,Plasma,,N,4353,,,,1969.0,In vivo,1,10116.0,CHEMBL875335,Intermediate,
A,1,BAO_0000218,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,9585,Rattus norvegicus,50597,,,Plasma,,N,4353,,,,1969.0,In vivo,1,10116.0,CHEMBL627797,Intermediate,
A,1,BAO_0000218,Half life in rat i.v.,9586,Rattus norvegicus,50597,,,,,N,5789,,,,,In vivo,1,10116.0,CHEMBL627798,Intermediate,
A,1,BAO_0000218,Half life in rat i.v. at 2 mg/kg concentration,9587,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL627799,Intermediate,
A,1,BAO_0000218,Half life in rats,9588,Rattus norvegicus,50597,,,,,N,6495,,,,,,1,10116.0,CHEMBL627800,Intermediate,
A,1,BAO_0000218,Half life in rats after intravenous administration,9589,Rattus norvegicus,50597,,,,,N,484,,,,,In vivo,1,10116.0,CHEMBL627801,Intermediate,
A,1,BAO_0000218,Half life in rats at the dose of 1.0 mpk by i.v. administration,9590,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL627802,Intermediate,
A,1,BAO_0000218,Half life in rat,9591,Rattus norvegicus,50597,,,,,N,6642,,,,,,1,10116.0,CHEMBL627803,Expert,
A,1,BAO_0000218,Half life was evaluated after intravenous administration to rats,9592,Rattus norvegicus,50597,,,,,N,16367,,,,,In vivo,1,10116.0,CHEMBL873820,Intermediate,
A,1,BAO_0000218,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),9593,Rattus norvegicus,50597,,,,,N,1369,,,,,,1,10116.0,CHEMBL627804,Intermediate,
A,1,BAO_0000218,Half life was evaluated in rat,9594,Rattus norvegicus,50597,,,,,N,5472,,,,,,1,10116.0,CHEMBL627805,Intermediate,
A,1,BAO_0000218,Half life was evaluated in rat,9595,Rattus norvegicus,50597,,,,,N,6049,,,,,,1,10116.0,CHEMBL627806,Intermediate,
A,1,BAO_0000218,Half life was evaluated in rat; Not tested,9596,Rattus norvegicus,50597,,,,,N,5472,,,,,,1,10116.0,CHEMBL627107,Intermediate,
A,1,BAO_0000218,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,9597,Rattus norvegicus,50597,,,,,N,16366,,,,,In vivo,1,10116.0,CHEMBL627108,Intermediate,
A,1,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,9598,Rattus norvegicus,50597,,,,,N,11149,,,,,In vivo,1,10116.0,CHEMBL627109,Intermediate,
A,1,BAO_0000218,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,9599,Rattus norvegicus,50597,,,Blood,,N,11149,,,,178.0,In vivo,1,10116.0,CHEMBL627110,Intermediate,
A,0,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,9600,Primates,22224,,,,,U,2891,,,,,In vivo,1,9443.0,CHEMBL627111,Intermediate,
A,0,BAO_0000218,Half life was measured in monkey at dose of 10 mg/kg by po administration,9601,Primates,22224,,,,,U,2891,,,,,In vivo,1,9443.0,CHEMBL627112,Intermediate,
A,0,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by iv administration,9602,Rattus norvegicus,22224,,,,,U,2891,,,,,In vivo,1,10116.0,CHEMBL627113,Intermediate,
A,0,BAO_0000218,Half life was measured in rat at dose of 30 mg/kg by po administration,9603,Rattus norvegicus,22224,,,,,U,2891,,,,,In vivo,1,10116.0,CHEMBL627114,Intermediate,
A,1,BAO_0000218,Half life (t1/2) was determined,9604,Rattus norvegicus,50597,,,,,N,4026,,,,,,1,10116.0,CHEMBL627115,Intermediate,
A,1,BAO_0000218,Half life period at a dose of 10 uM/kg in rat was determined,9605,Rattus norvegicus,50597,,,,,N,4527,,,,,,1,10116.0,CHEMBL627116,Intermediate,
A,1,BAO_0000218,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,9606,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL627117,Intermediate,
A,1,BAO_0000218,Half life period was determined,9607,Rattus norvegicus,50597,,,,,N,5503,,,,,,1,10116.0,CHEMBL627118,Intermediate,
A,1,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats,9608,Rattus norvegicus,50597,,,,,N,4426,,,,,In vivo,1,10116.0,CHEMBL627119,Intermediate,
A,1,BAO_0000218,Half life period after intravenous administration at 20 mpk in rats; Not performed.,9609,Rattus norvegicus,50597,,,,,N,4426,,,,,In vivo,1,10116.0,CHEMBL627120,Intermediate,
A,1,BAO_0000218,Half life period after intravenous administration in rat,9610,Rattus norvegicus,50597,,,,,N,6109,,,,,In vivo,1,10116.0,CHEMBL626922,Intermediate,
A,1,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,9611,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL626923,Intermediate,
A,1,BAO_0000218,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,9612,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL626924,Intermediate,
A,1,BAO_0000218,Half life period in 80% rat plasma at 37 degree Centigrade,9613,Rattus norvegicus,50597,,,Plasma,,N,4755,,,,1969.0,,1,10116.0,CHEMBL626925,Intermediate,
A,1,BAO_0000218,Half life period in SD rats,9614,Rattus norvegicus,50597,,,,,N,5862,,,,,,1,10116.0,CHEMBL626926,Intermediate,
A,1,BAO_0000218,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),9615,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626927,Intermediate,
A,1,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),9616,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626928,Intermediate,
A,1,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9617,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626929,Intermediate,
A,1,BAO_0000218,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9618,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626930,Intermediate,
A,1,BAO_0000218,Half life period in rat,9619,Rattus norvegicus,50597,,,,,N,5960,,,,,,1,10116.0,CHEMBL626931,Intermediate,
A,1,BAO_0000218,Half life period in rat,9620,Rattus norvegicus,50597,,,,,N,6103,,,,,,1,10116.0,CHEMBL626932,Intermediate,
A,1,BAO_0000218,Half life period in rat,9621,Rattus norvegicus,50597,,,,,N,6317,,,,,,1,10116.0,CHEMBL626933,Intermediate,
A,1,BAO_0000218,Half life period in rat after oral administration at 10.5 mg/kg dose,9622,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL873826,Intermediate,
A,1,BAO_0000218,Half life period in rat after oral administration at 11.2 mg/kg dose,9623,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL626934,Intermediate,
A,1,BAO_0000218,Half life period in rat after oral administration at 13 mg/kg dose,9624,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL626935,Intermediate,
A,1,BAO_0000218,Half life period in rat after oral administration at 9.7 mg/kg dose,9625,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL626936,Intermediate,
A,1,BAO_0000218,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,9626,Rattus norvegicus,50597,,,,,N,5974,,,,,,1,10116.0,CHEMBL626937,Intermediate,
A,1,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9627,Rattus norvegicus,50597,,,,,N,6295,,,,,,1,10116.0,CHEMBL625906,Intermediate,
A,1,BAO_0000218,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,9628,Rattus norvegicus,50597,,,,,N,6296,,,,,,1,10116.0,CHEMBL625907,Intermediate,
A,1,BAO_0000218,PK study was carried to determine AUC (area under curve) value in rat,9629,Rattus norvegicus,50597,,,,,N,16427,,,,,,1,10116.0,CHEMBL625908,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC after intravenous administration to rats,9630,Rattus norvegicus,50597,,,,,N,16367,,,,,,1,10116.0,CHEMBL625909,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC after oral administration to rats,9631,Rattus norvegicus,50597,,,,,N,16367,,,,,,1,10116.0,CHEMBL625910,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,9632,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL625911,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,9633,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL625912,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,9634,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL626538,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,9635,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL876794,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,9636,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL626539,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,9637,Rattus norvegicus,50597,,,,,N,16365,,,,,,1,10116.0,CHEMBL626540,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,9638,Rattus norvegicus,50597,,,,,N,5394,,,,,,1,10116.0,CHEMBL626541,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,9639,Rattus norvegicus,50597,,,,,N,5394,,,,,,1,10116.0,CHEMBL626542,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,9640,Rattus norvegicus,50597,,,,,N,2792,,,,,,1,10116.0,CHEMBL626543,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,9641,Rattus norvegicus,50597,,,,,N,2792,,,,,,1,10116.0,CHEMBL626544,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,9642,Rattus norvegicus,50597,,,,,N,2792,,,,,,1,10116.0,CHEMBL626545,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,9643,Rattus norvegicus,50597,,,,,N,2792,,,,,,1,10116.0,CHEMBL626546,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under curve was reported,9644,Rattus norvegicus,50597,,,,,N,5334,,,,,,1,10116.0,CHEMBL626547,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (AUC) in rat,9645,Rattus norvegicus,50597,,,,,N,4408,,,,,,1,10116.0,CHEMBL626548,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,9646,Rattus norvegicus,50597,,,,,N,5983,,,,,,1,10116.0,CHEMBL626549,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,9647,Rattus norvegicus,50597,,,,,N,4397,,,,,,1,10116.0,CHEMBL626550,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,9648,Rattus norvegicus,50597,,,,,N,4397,,,,,,1,10116.0,CHEMBL626551,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property was determined,9649,Rattus norvegicus,50597,,,,,N,5491,,,,,,1,10116.0,CHEMBL623777,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,9650,Rattus norvegicus,50597,,,,,N,5491,,,,,,1,10116.0,CHEMBL623778,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,9651,Rattus norvegicus,50597,,,,,N,5491,,,,,,1,10116.0,CHEMBL623779,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,9652,Rattus norvegicus,50597,,,Plasma,,N,4199,,,,1969.0,,1,10116.0,CHEMBL623780,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,9653,Rattus norvegicus,50597,,,Plasma,,N,4199,,,,1969.0,,1,10116.0,CHEMBL622015,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,9654,Rattus norvegicus,50597,,,Plasma,,N,4199,,,,1969.0,,1,10116.0,CHEMBL622016,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",9655,Rattus norvegicus,50597,,,,,N,5173,,,,,,1,10116.0,CHEMBL622017,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",9656,Rattus norvegicus,50597,,,,,N,5173,,,,,,1,10116.0,CHEMBL622018,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",9657,Rattus norvegicus,50597,,,,,N,5173,,,,,,1,10116.0,CHEMBL622019,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",9658,Rattus norvegicus,50597,,,,,N,5173,,,,,,1,10116.0,CHEMBL622020,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,9659,Rattus norvegicus,50597,,,,,N,16366,,,,,,1,10116.0,CHEMBL622021,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,9660,Rattus norvegicus,50597,,,,,N,16366,,,,,,1,10116.0,CHEMBL622022,Intermediate,
A,1,BAO_0000218,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,9661,Rattus norvegicus,50597,,,,,N,5327,,,,,,1,10116.0,CHEMBL622023,Intermediate,
A,1,BAO_0000218,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,9662,Rattus norvegicus,50597,,,,,N,6681,,,,,,1,10116.0,CHEMBL622024,Intermediate,
A,1,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),9663,Rattus norvegicus,50597,,,,,N,12873,,,,,,1,10116.0,CHEMBL622693,Intermediate,
A,1,BAO_0000218,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),9664,Rattus norvegicus,50597,,,,,N,12873,,,,,,1,10116.0,CHEMBL622694,Intermediate,
A,1,BAO_0000218,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",9665,Rattus norvegicus,50597,,,,,N,6685,,,,,,1,10116.0,CHEMBL622695,Intermediate,
A,1,BAO_0000218,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",9666,Rattus norvegicus,50597,,,,,N,6685,,,,,,1,10116.0,CHEMBL622696,Intermediate,
A,1,BAO_0000218,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",9667,Rattus norvegicus,50597,,,,,N,6685,,,,,,1,10116.0,CHEMBL622697,Intermediate,
A,1,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",9668,Rattus norvegicus,50597,,,,,N,6619,,,,,,1,10116.0,CHEMBL622874,Intermediate,
A,1,BAO_0000218,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",9669,Rattus norvegicus,50597,,,,,N,6619,,,,,,1,10116.0,CHEMBL622875,Intermediate,
A,1,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,9670,Rattus norvegicus,50597,,,,,N,10363,,,,,,1,10116.0,CHEMBL622876,Intermediate,
A,1,BAO_0000218,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,9671,Rattus norvegicus,50597,,,,,N,4796,,,,,,1,10116.0,CHEMBL622877,Intermediate,
A,1,BAO_0000218,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,9672,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL622878,Intermediate,
A,1,BAO_0000218,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,9673,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,,1,10116.0,CHEMBL622879,Intermediate,
A,1,BAO_0000218,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,9674,Rattus norvegicus,50597,,,,,N,4839,,,,,,1,10116.0,CHEMBL877602,Intermediate,
A,1,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",9675,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL622880,Intermediate,
A,1,BAO_0000218,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",9676,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL622881,Intermediate,
A,1,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",9677,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL622882,Intermediate,
A,1,BAO_0000218,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",9678,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL622883,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",9679,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622884,Intermediate,
A,1,BAO_0000218,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",9680,Rattus norvegicus,50597,,,Thyroid gland,,N,11450,,,,2046.0,,1,10116.0,CHEMBL622885,Intermediate,
A,1,BAO_0000218,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,9681,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL622886,Intermediate,
A,1,BAO_0000218,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,9682,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL622887,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,9683,Rattus norvegicus,50597,,,Urine,,N,8151,,,,1088.0,,1,10116.0,CHEMBL622888,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9684,Rattus norvegicus,50597,,,Blood,,N,8677,,,,178.0,In vivo,1,10116.0,CHEMBL622889,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9685,Rattus norvegicus,50597,,,Blood,,N,8677,,,,178.0,In vivo,1,10116.0,CHEMBL622890,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9686,Rattus norvegicus,50597,,,Blood,,N,8677,,,,178.0,In vivo,1,10116.0,CHEMBL622891,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9687,Rattus norvegicus,50597,,,Blood,,N,8677,,,,178.0,In vivo,1,10116.0,CHEMBL877603,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9688,Rattus norvegicus,50597,,,Brain,,N,8677,,,,955.0,In vivo,1,10116.0,CHEMBL622892,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9689,Rattus norvegicus,50597,,,Brain,,N,8677,,,,955.0,In vivo,1,10116.0,CHEMBL622893,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9690,Rattus norvegicus,50597,,,Brain,,N,8677,,,,955.0,In vivo,1,10116.0,CHEMBL622894,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9691,Rattus norvegicus,50597,,,Brain,,N,8677,,,,955.0,In vivo,1,10116.0,CHEMBL622895,Intermediate,
A,1,BAO_0000218,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,9692,Rattus norvegicus,50597,,,Brain,,N,8677,,,,955.0,In vivo,1,10116.0,CHEMBL622896,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9693,Rattus norvegicus,50597,,,Heart,,N,8677,,,,948.0,In vivo,1,10116.0,CHEMBL622897,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9694,Rattus norvegicus,50597,,,Heart,,N,8677,,,,948.0,In vivo,1,10116.0,CHEMBL622898,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9695,Rattus norvegicus,50597,,,Heart,,N,8677,,,,948.0,In vivo,1,10116.0,CHEMBL622899,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9696,Rattus norvegicus,50597,,,Kidney,,N,8677,,,,2113.0,In vivo,1,10116.0,CHEMBL622900,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9697,Rattus norvegicus,50597,,,Kidney,,N,8677,,,,2113.0,In vivo,1,10116.0,CHEMBL624114,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9698,Rattus norvegicus,50597,,,Kidney,,N,8677,,,,2113.0,In vivo,1,10116.0,CHEMBL624115,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9699,Rattus norvegicus,50597,,,Kidney,,N,8677,,,,2113.0,In vivo,1,10116.0,CHEMBL624116,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9700,Rattus norvegicus,50597,,,Liver,,N,8677,,,,2107.0,In vivo,1,10116.0,CHEMBL624117,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9701,Rattus norvegicus,50597,,,Liver,,N,8677,,,,2107.0,In vivo,1,10116.0,CHEMBL624118,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9702,Rattus norvegicus,50597,,,Liver,,N,8677,,,,2107.0,In vivo,1,10116.0,CHEMBL624119,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9703,Rattus norvegicus,50597,,,Liver,,N,8677,,,,2107.0,In vivo,1,10116.0,CHEMBL624120,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9704,Rattus norvegicus,50597,,,Lung,,N,8677,,,,2048.0,In vivo,1,10116.0,CHEMBL624121,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9705,Rattus norvegicus,50597,,,Lung,,N,8677,,,,2048.0,In vivo,1,10116.0,CHEMBL624122,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9706,Rattus norvegicus,50597,,,Lung,,N,8677,,,,2048.0,In vivo,1,10116.0,CHEMBL624123,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9707,Rattus norvegicus,50597,,,Lung,,N,8677,,,,2048.0,In vivo,1,10116.0,CHEMBL624124,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9708,Rattus norvegicus,50597,,,Muscle tissue,,N,8677,,,,2385.0,In vivo,1,10116.0,CHEMBL624125,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9709,Rattus norvegicus,50597,,,Muscle tissue,,N,8677,,,,2385.0,In vivo,1,10116.0,CHEMBL624126,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9710,Rattus norvegicus,50597,,,Muscle tissue,,N,8677,,,,2385.0,In vivo,1,10116.0,CHEMBL624127,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9711,Rattus norvegicus,50597,,,Muscle tissue,,N,8677,,,,2385.0,In vivo,1,10116.0,CHEMBL624128,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9712,Rattus norvegicus,50597,,,Zone of skin,,N,8677,,,,14.0,In vivo,1,10116.0,CHEMBL624129,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9713,Rattus norvegicus,50597,,,Zone of skin,,N,8677,,,,14.0,In vivo,1,10116.0,CHEMBL624130,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9714,Rattus norvegicus,50597,,,Zone of skin,,N,8677,,,,14.0,In vivo,1,10116.0,CHEMBL622340,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9715,Rattus norvegicus,50597,,,Zone of skin,,N,8677,,,,14.0,In vivo,1,10116.0,CHEMBL622341,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9716,Rattus norvegicus,50597,,,Intestine,,N,8677,,,,160.0,In vivo,1,10116.0,CHEMBL622342,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9717,Rattus norvegicus,50597,,,Intestine,,N,8677,,,,160.0,In vivo,1,10116.0,CHEMBL622343,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9718,Rattus norvegicus,50597,,,Intestine,,N,8677,,,,160.0,In vivo,1,10116.0,CHEMBL622344,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9719,Rattus norvegicus,50597,,,Intestine,,N,8677,,,,160.0,In vivo,1,10116.0,CHEMBL622345,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9720,Rattus norvegicus,50597,,,Spleen,,N,8677,,,,2106.0,In vivo,1,10116.0,CHEMBL622346,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9721,Rattus norvegicus,50597,,,Spleen,,N,8677,,,,2106.0,In vivo,1,10116.0,CHEMBL622347,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9722,Rattus norvegicus,50597,,,Spleen,,N,8677,,,,2106.0,In vivo,1,10116.0,CHEMBL622348,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9723,Rattus norvegicus,50597,,,Spleen,,N,8677,,,,2106.0,In vivo,1,10116.0,CHEMBL622349,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,9724,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622350,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,9725,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622351,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,9726,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622352,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,9727,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622353,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,9728,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622354,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,9729,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622355,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,9730,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622356,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,9731,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622357,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,9732,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622358,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,9733,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL622359,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,9734,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL874393,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9735,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622872,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9736,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL622873,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9737,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL623047,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9738,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623048,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9739,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623049,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9740,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623050,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9741,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623051,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9742,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL623052,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9743,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL626343,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,9744,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626344,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,9745,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626345,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,9746,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626346,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,9747,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626347,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,9748,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626348,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,9749,Rattus norvegicus,50597,,,,,N,16434,,,,,,1,10116.0,CHEMBL626349,Intermediate,
F,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,9750,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL626350,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,9751,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL626351,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,9752,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL627650,Intermediate,
F,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,9753,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL627651,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,9754,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL627652,Intermediate,
A,1,BAO_0000218,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,9755,Rattus norvegicus,50597,,,,,N,16435,,,,,,1,10116.0,CHEMBL627653,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,9756,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627654,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,9757,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627835,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,9758,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627836,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,9759,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627837,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,9760,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627838,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,9761,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL875338,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,9762,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627839,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,9763,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627840,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,9764,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627841,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,9765,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627842,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,9766,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627843,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,9767,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627844,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,9768,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL627845,Intermediate,
A,1,BAO_0000218,Half life period in rat by iv administration at a dose of 3 mg/kg,9769,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL627846,Intermediate,
A,1,BAO_0000218,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),9770,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL627847,Intermediate,
A,1,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),9771,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL873821,Intermediate,
A,1,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9772,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626079,Intermediate,
A,1,BAO_0000218,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,9773,Rattus norvegicus,50597,,,Plasma,,N,1515,,,,1969.0,,1,10116.0,CHEMBL626080,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rat plasma,9774,Rattus norvegicus,50597,,,Plasma,,N,5491,,,,1969.0,,1,10116.0,CHEMBL626081,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rat plasma; Not tested,9775,Rattus norvegicus,50597,,,Plasma,,N,5491,,,,1969.0,,1,10116.0,CHEMBL875344,Intermediate,
A,1,BAO_0000218,Half life period was evaluated in rats,9776,Rattus norvegicus,50597,,,,,N,1918,,,,,,1,10116.0,CHEMBL626082,Intermediate,
A,1,BAO_0000218,"Half life period was evaluated in rats, iv",9777,Rattus norvegicus,50597,,,,,N,1918,,,,,In vivo,1,10116.0,CHEMBL626250,Intermediate,
A,1,BAO_0000218,Half life period after intravenous administration at 5 mg/kg in rat,9778,Rattus norvegicus,50597,,,,,N,6113,,,,,In vivo,1,10116.0,CHEMBL626251,Intermediate,
A,1,BAO_0000218,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,9779,Rattus norvegicus,50597,,,,,N,5546,,,,,In vivo,1,10116.0,CHEMBL626252,Intermediate,
A,1,BAO_0000218,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,9780,Rattus norvegicus,50597,,,,,N,5553,,,,,In vivo,1,10116.0,CHEMBL626253,Intermediate,
A,1,BAO_0000218,Half life stability of compound was evaluated in rat plasma,9781,Rattus norvegicus,50597,,,Plasma,,N,4188,,,,1969.0,,1,10116.0,CHEMBL626254,Intermediate,
A,1,BAO_0000218,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,9782,Rattus norvegicus,50597,,,,,N,6215,,,,,In vivo,1,10116.0,CHEMBL626255,Intermediate,
A,1,BAO_0000218,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,9783,Rattus norvegicus,50597,,,,,N,6141,,,,,In vivo,1,10116.0,CHEMBL626256,Intermediate,
A,1,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,9784,Rattus norvegicus,50597,,,,,N,5182,,,,,In vivo,1,10116.0,CHEMBL626257,Intermediate,
A,1,BAO_0000218,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,9785,Rattus norvegicus,50597,,,,,N,5182,,,,,In vivo,1,10116.0,CHEMBL626258,Intermediate,
A,1,BAO_0000218,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,9786,Rattus norvegicus,50597,,,,,N,5710,,,,,In vivo,1,10116.0,CHEMBL626259,Intermediate,
A,1,BAO_0000218,Half in rat i.v.,9787,Rattus norvegicus,50597,,,,,N,5789,,,,,In vivo,1,10116.0,CHEMBL626260,Intermediate,
A,1,BAO_0000218,Half period in rat after intravenous administration,9788,Rattus norvegicus,50597,,,,,N,6011,,,,,In vivo,1,10116.0,CHEMBL875345,Intermediate,
A,1,BAO_0000218,Half-life after repeated oral dose of compound at 1 mg/kg in rats,9789,Rattus norvegicus,50597,,,,,N,17594,,,,,In vivo,1,10116.0,CHEMBL626261,Intermediate,
A,1,BAO_0000218,Half-life measured in in vitro Cathepsin B assay in rat liver,9790,Rattus norvegicus,50597,,,Liver,,N,12357,,,,2107.0,In vitro,1,10116.0,CHEMBL626262,Intermediate,
A,1,BAO_0000218,Half-life of compound was determined in rats,9791,Rattus norvegicus,50597,,,,,N,5210,,,,,,1,10116.0,CHEMBL626263,Intermediate,
A,1,BAO_0000218,Half-life at 10 mg/kg in rat upon intravenous administration,9792,Rattus norvegicus,50597,,,,,N,17596,,,,,In vivo,1,10116.0,CHEMBL625270,Intermediate,
A,1,BAO_0000218,Half-life determined in rat,9793,Rattus norvegicus,50597,,,,,N,6672,,,,,,1,10116.0,CHEMBL625271,Intermediate,
A,1,BAO_0000218,Half-life determined in rat,9794,Rattus norvegicus,50597,,,,,N,6673,,,,,,1,10116.0,CHEMBL625272,Intermediate,
A,1,BAO_0000218,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,9795,Rattus norvegicus,50597,,,Brain,,N,4910,,,,955.0,In vivo,1,10116.0,CHEMBL625273,Intermediate,
A,1,BAO_0000218,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",9796,Rattus norvegicus,50597,,,Plasma,,N,3741,,,,1969.0,,1,10116.0,CHEMBL625274,Intermediate,
A,1,BAO_0000218,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,9797,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL625275,Intermediate,
A,1,BAO_0000218,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,9798,Rattus norvegicus,50597,,,Plasma,,N,4910,,,,1969.0,In vivo,1,10116.0,CHEMBL625276,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma,9799,Rattus norvegicus,50597,,,Plasma,,N,17537,,,,1969.0,,1,10116.0,CHEMBL625277,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma was determined,9800,Rattus norvegicus,50597,,,Plasma,,N,4965,,,,1969.0,,1,10116.0,CHEMBL625278,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma; Not tested,9801,Rattus norvegicus,50597,,,Plasma,,N,17537,,,,1969.0,,1,10116.0,CHEMBL625279,Intermediate,
A,1,BAO_0000218,Half-life in rat serum,9802,Rattus norvegicus,50597,,,Serum,,N,6124,,,,1977.0,,1,10116.0,CHEMBL625280,Intermediate,
A,1,BAO_0000218,Half-life in rat serum; na is not available,9803,Rattus norvegicus,50597,,,Serum,,N,6124,,,,1977.0,,1,10116.0,CHEMBL876797,Intermediate,
A,1,BAO_0000218,Half-life was calculated in rat,9804,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL625281,Intermediate,
A,1,BAO_0000218,Half-life was calculated in rat plasma,9805,Rattus norvegicus,50597,,,Plasma,,N,17668,,,,1969.0,,1,10116.0,CHEMBL873827,Intermediate,
A,1,BAO_0000218,Half-life was determined,9806,Rattus norvegicus,50597,,,,,N,3185,,,,,,1,10116.0,CHEMBL625282,Intermediate,
A,1,BAO_0000218,Half-life was determined,9807,Rattus norvegicus,50597,,,,,N,4883,,,,,,1,10116.0,CHEMBL625283,Intermediate,
A,1,BAO_0000218,Half-life after administration of 20 mg/Kg oral dose in rat,9808,Rattus norvegicus,50597,,,,,N,2959,,,,,In vivo,1,10116.0,CHEMBL625284,Intermediate,
A,1,BAO_0000218,Half-life after administration of 3.2 mg/kg intravenously in male rat,9809,Rattus norvegicus,50597,,,,,N,4029,,,,,In vivo,1,10116.0,CHEMBL625285,Intermediate,
A,1,BAO_0000218,Half-life after intravenous administration in female rat,9810,Rattus norvegicus,50597,,,,,N,4029,,,,,In vivo,1,10116.0,CHEMBL625286,Intermediate,
A,1,BAO_0000218,Half-life after intravenous administration in male rat,9811,Rattus norvegicus,50597,,,,,N,4029,,,,,In vivo,1,10116.0,CHEMBL625287,Intermediate,
A,1,BAO_0000218,Half-life after intravenous dose in rat,9812,Rattus norvegicus,50597,,,,,N,6180,,,,,In vivo,1,10116.0,CHEMBL625288,Intermediate,
A,1,BAO_0000218,Half-life in a rat liver homogenate preparation,9813,Rattus norvegicus,50597,,,Liver,,N,1557,,,,2107.0,,1,10116.0,CHEMBL625289,Intermediate,
A,1,BAO_0000218,Half-life in plasma of rat,9814,Rattus norvegicus,50597,,,Plasma,,N,12500,,,,1969.0,,1,10116.0,CHEMBL625290,Intermediate,
A,1,BAO_0000218,Half-life in plasma of rat at dose of 3-10 mgkg,9815,Rattus norvegicus,50597,,,Plasma,,N,12500,,,,1969.0,,1,10116.0,CHEMBL876798,Intermediate,
A,1,BAO_0000218,Half-life in rat,9816,Rattus norvegicus,50597,,,,,N,5064,,,,,,1,10116.0,CHEMBL625291,Intermediate,
A,1,BAO_0000218,Half-life in rat,9817,Rattus norvegicus,50597,,,,,N,5145,,,,,,1,10116.0,CHEMBL625292,Intermediate,
A,1,BAO_0000218,Half-life in rat,9818,Rattus norvegicus,50597,,,,,N,5147,,,,,,1,10116.0,CHEMBL625293,Intermediate,
A,1,BAO_0000218,Half-life in rat,9819,Rattus norvegicus,50597,,,,,N,5833,,,,,,1,10116.0,CHEMBL622832,Intermediate,
A,1,BAO_0000218,Half-life in rat,9820,Rattus norvegicus,50597,,,,,N,6596,,,,,,1,10116.0,CHEMBL622833,Intermediate,
A,1,BAO_0000218,Half-life in rat,9821,Rattus norvegicus,50597,,,,,N,17655,,,,,,1,10116.0,CHEMBL622834,Intermediate,
A,1,BAO_0000218,Half-life in rat after oral administration at 10 mg/kg,9822,Rattus norvegicus,50597,,,,,N,6495,,,,,In vivo,1,10116.0,CHEMBL622835,Intermediate,
A,1,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg,9823,Rattus norvegicus,50597,,,,,N,17538,,,,,In vivo,1,10116.0,CHEMBL622836,Intermediate,
A,1,BAO_0000218,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,9824,Rattus norvegicus,50597,,,,,N,17538,,,,,In vivo,1,10116.0,CHEMBL622837,Intermediate,
A,1,BAO_0000218,Half-life in rat at 3 mg/kg dose administered intravenously,9825,Rattus norvegicus,50597,,,,,N,10,,,,,In vivo,1,10116.0,CHEMBL622838,Intermediate,
A,1,BAO_0000218,Half-life in rat brain homogenate,9826,Rattus norvegicus,50597,,,Brain,,N,17669,,,,955.0,,1,10116.0,CHEMBL622839,Intermediate,
A,1,BAO_0000218,Half-life in rat plasma,9827,Rattus norvegicus,50597,,,Plasma,,N,17065,,,,1969.0,,1,10116.0,CHEMBL622840,Intermediate,
A,1,BAO_0000218,Half-life in rats,9828,Rattus norvegicus,50597,,,,,N,4333,,,,,,1,10116.0,CHEMBL622841,Intermediate,
A,1,BAO_0000218,Half-life in Dawley rats,9829,Rattus norvegicus,50597,,,,,N,6827,,,,,,1,10116.0,CHEMBL622842,Intermediate,
A,1,BAO_0000218,Half-life in vitro in rat plasma,9830,Rattus norvegicus,50597,,,Plasma,,N,889,,,,1969.0,In vitro,1,10116.0,CHEMBL622843,Intermediate,
A,1,BAO_0000218,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,9831,Rattus norvegicus,50597,,,Plasma,,N,889,,,,1969.0,In vitro,1,10116.0,CHEMBL622844,Intermediate,
A,1,BAO_0000218,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",9832,Rattus norvegicus,50597,,,,,N,3747,,,,,,1,10116.0,CHEMBL622845,Intermediate,
A,1,BAO_0000218,The area under the curve of compound was measured at the dose of 100 umol/kg,9833,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL622846,Intermediate,
A,1,BAO_0000218,The area under the curve of compound was measured at the dose of 300 umol/kg,9834,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL622847,Intermediate,
A,1,BAO_0000218,The area under the curve of compound was measured at the dose of 30 umol/kg,9835,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL622848,Intermediate,
A,1,BAO_0000218,Bioavailability as oral AUC in rats,9836,Rattus norvegicus,50597,,,,,N,3360,,,,,In vivo,1,10116.0,CHEMBL622849,Intermediate,
A,1,BAO_0000218,The plasma concentration versus time curve (AUC) was determined,9837,Rattus norvegicus,50597,,,Plasma,,N,5334,,,,1969.0,,1,10116.0,CHEMBL622850,Intermediate,
A,1,BAO_0000218,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9838,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL876807,Intermediate,
A,1,BAO_0000218,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9839,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL622851,Intermediate,
A,1,BAO_0000218,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9840,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL622852,Intermediate,
A,1,BAO_0000218,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,9841,Rattus norvegicus,50597,,,,,N,6570,,,,,,1,10116.0,CHEMBL622853,Intermediate,
A,1,BAO_0000218,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,9842,Rattus norvegicus,50597,,,,,N,6570,,,,,,1,10116.0,CHEMBL622854,Intermediate,
A,1,BAO_0000218,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,9843,Rattus norvegicus,50597,,,,,N,17411,,,,,,1,10116.0,CHEMBL622855,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",9844,Rattus norvegicus,50597,,,Plasma,,N,14941,,,,1969.0,,1,10116.0,CHEMBL622856,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",9845,Rattus norvegicus,50597,,,Plasma,,N,14941,,,,1969.0,,1,10116.0,CHEMBL622857,Intermediate,
A,1,BAO_0000218,AUC in rat after po administration at a dose of 10 mg/kg,9846,Rattus norvegicus,50597,,,Plasma,,N,17538,,,,1969.0,,1,10116.0,CHEMBL622858,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,9847,Rattus norvegicus,50597,,,Plasma,,N,17752,,,,1969.0,,1,10116.0,CHEMBL622859,Intermediate,
A,1,BAO_0000218,Area under curve value 24 hr after 10 mg/kg iv administration in rats,9848,Rattus norvegicus,50597,,,,,N,17509,,,,,,1,10116.0,CHEMBL622860,Intermediate,
A,1,BAO_0000218,Area under curve value 24 hr after 10 mg/kg oral administration in rats,9849,Rattus norvegicus,50597,,,,,N,17509,,,,,,1,10116.0,CHEMBL622861,Intermediate,
A,1,BAO_0000218,Area under curve value 24 hr after 2 mg/kg iv administration in rats,9850,Rattus norvegicus,50597,,,,,N,17509,,,,,,1,10116.0,CHEMBL622862,Intermediate,
A,1,BAO_0000218,Area under curve value 24 hr after 2 mg/kg oral administration in rats,9851,Rattus norvegicus,50597,,,,,N,17509,,,,,,1,10116.0,CHEMBL622863,Intermediate,
A,1,BAO_0000218,Area under curve value 6 hr after po administration in rat,9852,Rattus norvegicus,50597,,,,,N,17509,,,,,,1,10116.0,CHEMBL623817,Intermediate,
A,1,BAO_0000218,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,9853,Rattus norvegicus,50597,,,,,N,17717,,,,,,1,10116.0,CHEMBL623818,Intermediate,
A,1,BAO_0000218,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",9854,Rattus norvegicus,50597,,,,,N,17717,,,,,,1,10116.0,CHEMBL623819,Intermediate,
A,1,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,9855,Rattus norvegicus,50597,,,,,N,17717,,,,,,1,10116.0,CHEMBL623820,Intermediate,
A,1,BAO_0000218,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,9856,Rattus norvegicus,50597,,,,,N,17717,,,,,,1,10116.0,CHEMBL623821,Intermediate,
A,1,BAO_0000218,AUC normalized for dose (AUCN) in rat,9857,Rattus norvegicus,50597,,,Plasma,,N,6642,,,,1969.0,,1,10116.0,CHEMBL623822,Intermediate,
A,1,BAO_0000218,Area under curve in rat after p.o. administration,9858,Rattus norvegicus,50597,,,,,N,6640,,,,,,1,10116.0,CHEMBL623823,Intermediate,
A,1,BAO_0000218,Area under curve in rat after p.o. administration,9859,Rattus norvegicus,50597,,,,,N,6641,,,,,,1,10116.0,CHEMBL623824,Intermediate,
A,1,BAO_0000218,Area under curve in rat after p.o. administration; Not determined,9860,Rattus norvegicus,50597,,,,,N,6641,,,,,,1,10116.0,CHEMBL623825,Intermediate,
A,1,BAO_0000218,Area under curve in rat after peroral administration,9861,Rattus norvegicus,50597,,,,,N,6641,,,,,,1,10116.0,CHEMBL622070,Intermediate,
A,1,BAO_0000218,Area under curve (carotid artery) value of the compound,9862,Rattus norvegicus,50597,,,,,N,3603,,,,,,1,10116.0,CHEMBL622071,Intermediate,
A,1,BAO_0000218,Bioavailability expressed as the area under curve of rat carotid artery,9863,Rattus norvegicus,50597,,,,,N,3550,,,,,,1,10116.0,CHEMBL622072,Intermediate,
A,1,BAO_0000218,Area under curve in male SD rats was observed after intravenous administration in rat,9864,Rattus norvegicus,50597,,,,,N,15662,,,,,,1,10116.0,CHEMBL622073,Intermediate,
A,1,BAO_0000218,Area under curve of the compound was determined,9865,Rattus norvegicus,50597,,,,,N,17720,,,,,,1,10116.0,CHEMBL622074,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,9866,Rattus norvegicus,50597,,,,,N,5407,,,,,,1,10116.0,CHEMBL622075,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,9867,Rattus norvegicus,50597,,,Plasma,,N,17752,,,,1969.0,,1,10116.0,CHEMBL622076,Intermediate,
A,1,BAO_0000218,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,9868,Rattus norvegicus,50597,,,Plasma,,N,17752,,,,1969.0,,1,10116.0,CHEMBL622077,Intermediate,
A,1,BAO_0000218,Area under curve (portal vein) value of the compound,9869,Rattus norvegicus,50597,,,,,N,3603,,,,,,1,10116.0,CHEMBL622078,Intermediate,
A,1,BAO_0000218,Bioavailability expressed as the area under curve of rat portal vein,9870,Rattus norvegicus,50597,,,,,N,3550,,,,,,1,10116.0,CHEMBL622079,Intermediate,
A,1,BAO_0000218,Area Under plasma concentration time curve in rat upon peroral administration,9871,Rattus norvegicus,50597,,,Plasma,,N,17655,,,,1969.0,,1,10116.0,CHEMBL622080,Intermediate,
A,1,BAO_0000218,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,9872,Rattus norvegicus,50597,,,,,N,17582,,,,,,1,10116.0,CHEMBL877612,Intermediate,
A,1,BAO_0000218,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,9873,Rattus norvegicus,50597,,,,,N,17582,,,,,,1,10116.0,CHEMBL622081,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats,9874,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622082,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats after iv administration,9875,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622083,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 30-80,9876,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622084,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 50-60,9877,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622085,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats; no data,9878,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622086,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats; peptide,9879,Rattus norvegicus,50597,,,,,N,17791,,,,,,1,10116.0,CHEMBL622087,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",9880,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL622088,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",9881,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL622089,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",9882,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL623685,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",9883,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL623686,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9884,Rattus norvegicus,50597,,,Stomach,,N,8677,,,,945.0,In vivo,1,10116.0,CHEMBL623687,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9885,Rattus norvegicus,50597,,,Stomach,,N,8677,,,,945.0,In vivo,1,10116.0,CHEMBL623688,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9886,Rattus norvegicus,50597,,,Stomach,,N,8677,,,,945.0,In vivo,1,10116.0,CHEMBL623689,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9887,Rattus norvegicus,50597,,,Stomach,,N,8677,,,,945.0,In vivo,1,10116.0,CHEMBL622485,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9888,Rattus norvegicus,50597,,,Thyroid gland,,N,8677,,,,2046.0,In vivo,1,10116.0,CHEMBL622486,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9889,Rattus norvegicus,50597,,,Thyroid gland,,N,8677,,,,2046.0,In vivo,1,10116.0,CHEMBL877613,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9890,Rattus norvegicus,50597,,,Thyroid gland,,N,8677,,,,2046.0,In vivo,1,10116.0,CHEMBL622487,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9891,Rattus norvegicus,50597,,,Thyroid gland,,N,8677,,,,2046.0,In vivo,1,10116.0,CHEMBL622488,Intermediate,
A,1,BAO_0000218,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",9892,Rattus norvegicus,50597,,,Heart,,N,8677,,,,948.0,In vivo,1,10116.0,CHEMBL622489,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9893,Rattus norvegicus,50597,,,Urine,,N,6899,,,,1088.0,,1,10116.0,CHEMBL622490,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9894,Rattus norvegicus,50597,,,Urine,,N,6899,,,,1088.0,,1,10116.0,CHEMBL622491,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,9895,Rattus norvegicus,50597,,,Liver,,N,6899,,,,2107.0,,1,10116.0,CHEMBL622492,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9896,Rattus norvegicus,50597,,,Urine,,N,6899,,,,1088.0,,1,10116.0,CHEMBL622493,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,9897,Rattus norvegicus,50597,,,Urine,,N,6899,,,,1088.0,,1,10116.0,CHEMBL622494,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",9898,Rattus norvegicus,50597,,,Muscle tissue,,N,8677,,,,2385.0,,1,10116.0,CHEMBL622495,Intermediate,
A,1,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,9899,Rattus norvegicus,50597,,,,,N,6899,,,,,,1,10116.0,CHEMBL622496,Intermediate,
A,1,BAO_0000218,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,9900,Rattus norvegicus,50597,,,Urine,,N,6899,,,,1088.0,,1,10116.0,CHEMBL622497,Intermediate,
A,1,BAO_0000218,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,9901,Rattus norvegicus,50597,,,,,N,2189,,,,,,1,10116.0,CHEMBL622498,Intermediate,
A,1,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,9902,Rattus norvegicus,50597,,,Urine,,N,2189,,,,1088.0,,1,10116.0,CHEMBL624918,Intermediate,
A,1,BAO_0000218,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,9903,Rattus norvegicus,50597,,,Urine,,N,2189,,,,1088.0,,1,10116.0,CHEMBL624919,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration,9904,Rattus norvegicus,50597,,,Blood,,N,10839,,,,178.0,In vivo,1,10116.0,CHEMBL624920,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat blood after 5 min of administration.,9905,Rattus norvegicus,50597,,,Blood,,N,10839,,,,178.0,In vivo,1,10116.0,CHEMBL624921,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat brain after 5 min of administration,9906,Rattus norvegicus,50597,,,Brain,,N,10839,,,,955.0,In vivo,1,10116.0,CHEMBL624922,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration,9907,Rattus norvegicus,50597,,,Heart,,N,10839,,,,948.0,In vivo,1,10116.0,CHEMBL624923,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat heart after 5 min of administration.,9908,Rattus norvegicus,50597,,,Heart,,N,10839,,,,948.0,In vivo,1,10116.0,CHEMBL624924,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration,9909,Rattus norvegicus,50597,,,Kidney,,N,10839,,,,2113.0,In vivo,1,10116.0,CHEMBL624925,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat kidney after 5 min of administration.,9910,Rattus norvegicus,50597,,,Kidney,,N,10839,,,,2113.0,In vivo,1,10116.0,CHEMBL624926,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration,9911,Rattus norvegicus,50597,,,Liver,,N,10839,,,,2107.0,In vivo,1,10116.0,CHEMBL624927,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat liver after 5 min of administration.,9912,Rattus norvegicus,50597,,,Liver,,N,10839,,,,2107.0,In vivo,1,10116.0,CHEMBL874402,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration,9913,Rattus norvegicus,50597,,,Lung,,N,10839,,,,2048.0,In vivo,1,10116.0,CHEMBL624928,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat lung after 5 min of administration.,9914,Rattus norvegicus,50597,,,Lung,,N,10839,,,,2048.0,In vivo,1,10116.0,CHEMBL624929,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,9915,Rattus norvegicus,50597,,,Muscle tissue,,N,10839,,,,2385.0,In vivo,1,10116.0,CHEMBL624930,Intermediate,
A,1,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,9916,Rattus norvegicus,50597,,,Muscle tissue,,N,10839,,,,2385.0,In vivo,1,10116.0,CHEMBL624931,Intermediate,
A,1,BAO_0000218,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9917,Rattus norvegicus,50597,,,Heart,,N,4043,,,,948.0,,1,10116.0,CHEMBL624932,Intermediate,
A,1,BAO_0000218,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9918,Rattus norvegicus,50597,,,Heart,,N,4043,,,,948.0,,1,10116.0,CHEMBL624933,Intermediate,
A,1,BAO_0000218,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9919,Rattus norvegicus,50597,,,Liver,,N,4043,,,,2107.0,,1,10116.0,CHEMBL624934,Intermediate,
A,1,BAO_0000218,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9920,Rattus norvegicus,50597,,,Liver,,N,4043,,,,2107.0,,1,10116.0,CHEMBL624935,Intermediate,
A,1,BAO_0000218,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9921,Rattus norvegicus,50597,,,,,N,4043,,,,,,1,10116.0,CHEMBL624936,Intermediate,
A,1,BAO_0000218,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9922,Rattus norvegicus,50597,,,,,N,4043,,,,,,1,10116.0,CHEMBL624937,Intermediate,
A,1,BAO_0000218,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9923,Rattus norvegicus,50597,,,Spleen,,N,4043,,,,2106.0,,1,10116.0,CHEMBL624938,Intermediate,
A,1,BAO_0000218,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9924,Rattus norvegicus,50597,,,Spleen,,N,4043,,,,2106.0,,1,10116.0,CHEMBL624939,Intermediate,
A,1,BAO_0000218,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9925,Rattus norvegicus,50597,,,,,N,4043,,,,,,1,10116.0,CHEMBL624940,Intermediate,
A,1,BAO_0000218,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,9926,Rattus norvegicus,50597,,,,,N,4043,,,,,,1,10116.0,CHEMBL874403,Intermediate,
A,1,BAO_0000218,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,9927,Rattus norvegicus,50597,,,,,N,1446,,,,,,1,10116.0,CHEMBL624941,Intermediate,
A,1,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat,9928,Rattus norvegicus,50597,,,Urine,,N,9971,,,,1088.0,,1,10116.0,CHEMBL624942,Intermediate,
A,1,BAO_0000218,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,9929,Rattus norvegicus,50597,,,Urine,,N,9971,,,,1088.0,,1,10116.0,CHEMBL624943,Intermediate,
A,1,BAO_0000218,% Bioavailability after 1 day of the drug administration in rats,9930,Rattus norvegicus,50597,,,,,N,5765,,,,,In vivo,1,10116.0,CHEMBL624944,Intermediate,
A,1,BAO_0000218,% Bioavailability after 4 day of the drug administration in rats,9931,Rattus norvegicus,50597,,,,,N,5765,,,,,In vivo,1,10116.0,CHEMBL624945,Intermediate,
A,1,BAO_0000218,Absolute bioavailability was evaluated in rat,9932,Rattus norvegicus,50597,,,,,N,4257,,,,,In vivo,1,10116.0,CHEMBL624946,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,9933,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624947,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,9934,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624948,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,9935,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624949,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,9936,Rattus norvegicus,50597,,,Kidney,,N,13091,,,,2113.0,,1,10116.0,CHEMBL622025,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,9937,Rattus norvegicus,50597,,,Kidney,,N,13091,,,,2113.0,,1,10116.0,CHEMBL622026,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,9938,Rattus norvegicus,50597,,,Kidney,,N,13091,,,,2113.0,,1,10116.0,CHEMBL622027,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,9939,Rattus norvegicus,50597,,,Kidney,,N,13091,,,,2113.0,,1,10116.0,CHEMBL622028,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,9940,Rattus norvegicus,50597,,,Liver,,N,13091,,,,2107.0,,1,10116.0,CHEMBL622029,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,9941,Rattus norvegicus,50597,,,Liver,,N,13091,,,,2107.0,,1,10116.0,CHEMBL622208,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,9942,Rattus norvegicus,50597,,,Liver,,N,13091,,,,2107.0,,1,10116.0,CHEMBL622209,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,9943,Rattus norvegicus,50597,,,Liver,,N,13091,,,,2107.0,,1,10116.0,CHEMBL622210,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,9944,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL622211,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,9945,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL622212,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,9946,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL622213,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,9947,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL874404,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,9948,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL620452,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,9949,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL620453,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,9950,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL620454,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,9951,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL624067,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,9952,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624068,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,9953,Rattus norvegicus,50597,,,Female gonad,,N,13091,,,,992.0,,1,10116.0,CHEMBL624069,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,9954,Rattus norvegicus,50597,,,Female gonad,,N,13091,,,,992.0,,1,10116.0,CHEMBL624070,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,9955,Rattus norvegicus,50597,,,Female gonad,,N,13091,,,,992.0,,1,10116.0,CHEMBL624071,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,9956,Rattus norvegicus,50597,,,Uterus,,N,13091,,,,995.0,,1,10116.0,CHEMBL624072,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,9957,Rattus norvegicus,50597,,,Uterus,,N,13091,,,,995.0,,1,10116.0,CHEMBL624073,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,9958,Rattus norvegicus,50597,,,Uterus,,N,13091,,,,995.0,,1,10116.0,CHEMBL624788,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,9959,Rattus norvegicus,50597,,,Uterus,,N,13091,,,,995.0,,1,10116.0,CHEMBL624789,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,9960,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624790,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,9961,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624791,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,9962,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624792,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,9963,Rattus norvegicus,50597,,,,,N,13091,,,,,,1,10116.0,CHEMBL624793,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,9964,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL877491,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,9965,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL624957,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,9966,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL624958,Intermediate,
A,1,BAO_0000218,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,9967,Rattus norvegicus,50597,,,Muscle tissue,,N,13091,,,,2385.0,,1,10116.0,CHEMBL624959,Intermediate,
A,1,BAO_0000218,Dissociation constant was determined,9968,Rattus norvegicus,50597,,,,,N,11977,,,,,,1,10116.0,CHEMBL624960,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",9969,Rattus norvegicus,50597,,,,,N,14941,,,,,,1,10116.0,CHEMBL624961,Intermediate,
A,1,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",9970,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL624962,Intermediate,
A,1,BAO_0000218,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",9971,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL624963,Intermediate,
A,1,BAO_0000218,Observed rate constant in 80% rat plasma at 37 degree Centigrade,9972,Rattus norvegicus,50597,,,,,N,4755,,,,,,1,10116.0,CHEMBL624964,Intermediate,
A,1,BAO_0000218,LogP value was evaluated in the in situ rat gut perfusion assay,9973,Rattus norvegicus,50597,,,,,N,589,,,,,,1,10116.0,CHEMBL624965,Intermediate,
A,1,BAO_0000218,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,9974,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL624966,Intermediate,
A,1,BAO_0000218,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,9975,Rattus norvegicus,50597,,,,,N,5031,,,,,In vivo,1,10116.0,CHEMBL624967,Intermediate,
A,1,BAO_0000218,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,9976,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL624968,Intermediate,
A,1,BAO_0000218,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,9977,Rattus norvegicus,50597,,,,,N,17720,,,,,,1,10116.0,CHEMBL624969,Intermediate,
F,1,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,9978,Rattus norvegicus,50597,,,,,N,2862,,,,,,1,10116.0,CHEMBL624970,Expert,
A,1,BAO_0000218,Half-life was evaluated after 10 uM/kg of intra arterial administration,9979,Rattus norvegicus,50597,,,,,N,16423,,,,,,1,10116.0,CHEMBL624971,Intermediate,
A,1,BAO_0000218,Half-life was evaluated after 20 uM/kg of peroral administration,9980,Rattus norvegicus,50597,,,,,N,16423,,,,,In vivo,1,10116.0,CHEMBL624972,Intermediate,
A,1,BAO_0000218,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,9981,Rattus norvegicus,50597,,,,,N,6005,,,,,In vivo,1,10116.0,CHEMBL624973,Intermediate,
A,1,BAO_0000218,Half-life was evaluated in plasma of rat,9982,Rattus norvegicus,50597,,,Plasma,,N,2938,,,,1969.0,,1,10116.0,CHEMBL624974,Intermediate,
A,1,BAO_0000218,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,9983,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL624975,Intermediate,
A,1,BAO_0000218,Half-life was evaluated in rats at an oral dose of 30 mg/kg,9984,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL877492,Intermediate,
A,1,BAO_0000218,Half-life was measured in rat after an iv dose of 1 mg/kg,9985,Rattus norvegicus,50597,,,,,N,6062,,,,,In vivo,1,10116.0,CHEMBL624976,Intermediate,
A,1,BAO_0000218,Half-life period of compound in rats after peroral administration,9986,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL624977,Intermediate,
A,1,BAO_0000218,Half-life period of compound was measured in rat plasma.,9987,Rattus norvegicus,50597,,,Plasma,,N,3136,,,,1969.0,,1,10116.0,CHEMBL626848,Intermediate,
A,1,BAO_0000218,Half-life period of compound was measured in rat plasma; ND is not determined,9988,Rattus norvegicus,50597,,,Plasma,,N,3136,,,,1969.0,,1,10116.0,CHEMBL626849,Intermediate,
A,1,BAO_0000218,Half-life period of compound was measured in rat plasma; not determined,9989,Rattus norvegicus,50597,,,Plasma,,N,3136,,,,1969.0,,1,10116.0,CHEMBL626850,Intermediate,
A,1,BAO_0000218,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,9990,Rattus norvegicus,50597,,,,,N,4521,,,,,In vivo,1,10116.0,CHEMBL626851,Intermediate,
A,1,BAO_0000218,Half-life period in rat by iv administration,9991,Rattus norvegicus,50597,,,,,N,5871,,,,,In vivo,1,10116.0,CHEMBL626852,Intermediate,
A,1,BAO_0000218,Half-life period in rats following intravenous administration at 2 mg/kg,9992,Rattus norvegicus,50597,,,,,N,6077,,,,,In vivo,1,10116.0,CHEMBL626853,Intermediate,
A,1,BAO_0000218,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,9993,Rattus norvegicus,50597,,,,,N,6679,,,,,In vivo,1,10116.0,CHEMBL626854,Intermediate,
A,1,BAO_0000218,Half-life period was determined for the compound in rat,9994,Rattus norvegicus,50597,,,,,N,5144,,,,,,1,10116.0,CHEMBL627486,Intermediate,
A,1,BAO_0000218,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",9995,Rattus norvegicus,50597,,,,,N,4498,,,,,In vivo,1,10116.0,CHEMBL627487,Intermediate,
A,1,BAO_0000218,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",9996,Rattus norvegicus,50597,,,,,N,4498,,,,,In vivo,1,10116.0,CHEMBL627488,Intermediate,
A,1,BAO_0000218,Half-life value after IV dose at a dose of 5 mg/kg in rats.,9997,Rattus norvegicus,50597,,,,,N,1908,,,,,In vivo,1,10116.0,CHEMBL627489,Intermediate,
A,1,BAO_0000218,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,9998,Rattus norvegicus,50597,,,,,N,6211,,,,,In vivo,1,10116.0,CHEMBL627490,Intermediate,
A,1,BAO_0000218,Half-life was determined in rat after intravenous administration (0.5 mg/kg),9999,Rattus norvegicus,50597,,,,,N,5529,,,,,In vivo,1,10116.0,CHEMBL873829,Intermediate,
A,1,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.,10000,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL627655,Intermediate,
A,1,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,10001,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL625994,Intermediate,
A,1,BAO_0000218,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,10002,Rattus norvegicus,50597,,,,,N,6444,,,,,In vivo,1,10116.0,CHEMBL625995,Intermediate,
A,1,BAO_0000218,Half-life in rat,10003,Rattus norvegicus,50597,,,,,N,5207,,,,,,1,10116.0,CHEMBL625996,Intermediate,
A,1,BAO_0000218,In vitro half life in rat plasma,10004,Rattus norvegicus,50597,,,Plasma,,N,530,,,,1969.0,In vitro,1,10116.0,CHEMBL625850,Intermediate,
A,1,BAO_0000218,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",10005,Rattus norvegicus,50597,,,Plasma,,N,1116,,,,1969.0,In vitro,1,10116.0,CHEMBL625851,Intermediate,
A,1,BAO_0000218,In vitro half life in rat,10006,Rattus norvegicus,50597,,,,,N,3219,,,,,In vitro,1,10116.0,CHEMBL625852,Intermediate,
A,1,BAO_0000218,In vivo half life period after intravenous administration in rat,10007,Rattus norvegicus,50597,,,,,N,6109,,,,,In vivo,1,10116.0,CHEMBL625853,Intermediate,
A,1,BAO_0000218,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,10008,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL625854,Intermediate,
A,1,BAO_0000218,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,10009,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL874450,Intermediate,
A,1,BAO_0000218,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10010,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL625855,Intermediate,
A,1,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10011,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL625856,Intermediate,
A,1,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10012,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL625857,Intermediate,
A,1,BAO_0000218,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10013,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL873831,Intermediate,
A,1,BAO_0000218,Longer half-life in rat (i.v.) at 0.5 mpk,10014,Rattus norvegicus,50597,,,,,N,17853,,,,,In vivo,1,10116.0,CHEMBL625858,Intermediate,
A,1,BAO_0000218,Longer half-life in rat (p.o.) at 2.0 mpk,10015,Rattus norvegicus,50597,,,,,N,17853,,,,,In vivo,1,10116.0,CHEMBL625859,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (half life) in rat,10016,Rattus norvegicus,50597,,,,,N,3457,,,,,,1,10116.0,CHEMBL625860,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,10017,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL625861,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,10018,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL625862,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,10019,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL625863,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,10020,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL625864,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,10021,Rattus norvegicus,50597,,,,,N,5739,,,,,In vivo,1,10116.0,CHEMBL625865,Intermediate,
A,1,BAO_0000218,Pharmacokinetic half time was determined intravenously in rats.,10022,Rattus norvegicus,50597,,,,,N,15765,,,,,In vivo,1,10116.0,CHEMBL625866,Intermediate,
A,1,BAO_0000218,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,10023,Rattus norvegicus,50597,,,Plasma,,N,6567,,,,1969.0,In vivo,1,10116.0,CHEMBL625867,Intermediate,
A,1,BAO_0000218,Plasma half life of hydrolysis of the compound,10024,Rattus norvegicus,50597,,,Plasma,,N,2448,,,,1969.0,,1,10116.0,CHEMBL625868,Intermediate,
A,1,BAO_0000218,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,10025,Rattus norvegicus,50597,,,Plasma,,N,5423,,,,1969.0,In vivo,1,10116.0,CHEMBL625869,Intermediate,
A,1,BAO_0000218,Plasma half life period was calculated in rat,10026,Rattus norvegicus,50597,,,Plasma,,N,4853,,,,1969.0,,1,10116.0,CHEMBL874451,Intermediate,
A,1,BAO_0000218,Plasma half-life in Sprague-Dawley rats,10027,Rattus norvegicus,50597,,,Plasma,,N,4514,,,,1969.0,,1,10116.0,CHEMBL625870,Intermediate,
A,1,BAO_0000218,Plasma half-life in Sprague-Dawley rats; Not determined,10028,Rattus norvegicus,50597,,,Plasma,,N,4514,,,,1969.0,,1,10116.0,CHEMBL625871,Intermediate,
A,1,BAO_0000218,Plasma half-life in rats,10029,Rattus norvegicus,50597,,,Plasma,,N,1500,,,,1969.0,,1,10116.0,CHEMBL625872,Intermediate,
A,1,BAO_0000218,Plasma half-life in rats; <MQL,10030,Rattus norvegicus,50597,,,Plasma,,N,1500,,,,1969.0,,1,10116.0,CHEMBL625873,Intermediate,
A,1,BAO_0000218,Plasma half-life period (0-8 h) was determined,10031,Rattus norvegicus,50597,,,Plasma,,N,5334,,,,1969.0,,1,10116.0,CHEMBL625874,Intermediate,
A,1,BAO_0000218,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,10032,Rattus norvegicus,50597,,,Plasma,,N,5334,,,,1969.0,,1,10116.0,CHEMBL625875,Intermediate,
A,1,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,10033,Rattus norvegicus,50597,,,Plasma,,N,5334,,,,1969.0,In vivo,1,10116.0,CHEMBL625876,Intermediate,
A,1,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,10034,Rattus norvegicus,50597,,,Plasma,,N,5334,,,,1969.0,In vivo,1,10116.0,CHEMBL631258,Intermediate,
A,1,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,10035,Rattus norvegicus,50597,,,Plasma,,N,4956,,,,1969.0,,1,10116.0,CHEMBL631259,Intermediate,
A,1,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,10036,Rattus norvegicus,50597,,,Plasma,,N,4956,,,,1969.0,,1,10116.0,CHEMBL631260,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",10037,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL631261,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",10038,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL631262,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",10039,Rattus norvegicus,50597,,,Blood,,N,7768,,,,178.0,,1,10116.0,CHEMBL631263,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",10040,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631264,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",10041,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631265,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",10042,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631266,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",10043,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631267,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",10044,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631268,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",10045,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631269,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",10046,Rattus norvegicus,50597,,,,,N,7768,,,,,,1,10116.0,CHEMBL631270,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10047,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL631271,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",10048,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL631272,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",10049,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL631273,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",10050,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL631274,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",10051,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL631275,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",10052,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL626984,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",10053,Rattus norvegicus,50597,,,Heart,,N,7768,,,,948.0,,1,10116.0,CHEMBL626985,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",10054,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626986,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",10055,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626987,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",10056,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626988,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",10057,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626989,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",10058,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626990,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",10059,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626991,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",10060,Rattus norvegicus,50597,,,Liver,,N,7768,,,,2107.0,,1,10116.0,CHEMBL626992,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",10061,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626993,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",10062,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL874593,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",10063,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626994,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",10064,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626995,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",10065,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626190,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",10066,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626191,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",10067,Rattus norvegicus,50597,,,Lung,,N,7768,,,,2048.0,,1,10116.0,CHEMBL626364,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",10068,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626365,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",10069,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626366,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",10070,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626367,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",10071,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626368,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",10072,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626369,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",10073,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626370,Intermediate,
A,1,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",10074,Rattus norvegicus,50597,,,,,N,4498,,,,,In vivo,1,10116.0,CHEMBL626371,Intermediate,
A,1,BAO_0000218,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",10075,Rattus norvegicus,50597,,,,,N,4498,,,,,In vivo,1,10116.0,CHEMBL626372,Intermediate,
A,1,BAO_0000218,Bioavailability after a dose of 10 mg/kg p.o.,10076,Rattus norvegicus,50597,,,,,N,3603,,,,,In vivo,1,10116.0,CHEMBL626373,Intermediate,
A,1,BAO_0000218,Bioavailability after peroral administration (10 mg/kg) was determined in rat,10077,Rattus norvegicus,50597,,,,,N,6215,,,,,In vivo,1,10116.0,CHEMBL626374,Intermediate,
A,1,BAO_0000218,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,10078,Rattus norvegicus,50597,,,,,N,5710,,,,,In vivo,1,10116.0,CHEMBL626375,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),10079,Rattus norvegicus,50597,,,,,N,5710,,,,,In vivo,1,10116.0,CHEMBL626376,Intermediate,
A,1,BAO_0000218,Bioavailability in rat po was determined,10080,Rattus norvegicus,50597,,,,,N,5676,,,,,In vivo,1,10116.0,CHEMBL626377,Intermediate,
A,1,BAO_0000218,Bioavailability of compound at 10 mg/kg in rat after oral administration,10081,Rattus norvegicus,50597,,,,,N,17667,,,,,In vivo,1,10116.0,CHEMBL626378,Intermediate,
A,1,BAO_0000218,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,10082,Rattus norvegicus,50597,,,,,N,17667,,,,,In vivo,1,10116.0,CHEMBL626379,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10083,Rattus norvegicus,50597,,,,,N,6848,,,,,In vivo,1,10116.0,CHEMBL626380,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10084,Rattus norvegicus,50597,,,,,N,6848,,,,,In vivo,1,10116.0,CHEMBL626381,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10085,Rattus norvegicus,50597,,,,,N,17267,,,,,In vivo,1,10116.0,CHEMBL626382,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (female),10086,Rattus norvegicus,50597,,,,,N,6362,,,,,In vivo,1,10116.0,CHEMBL626383,Intermediate,
A,1,BAO_0000218,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,10087,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL874652,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),10088,Rattus norvegicus,50597,,,,,N,17671,,,,,In vivo,1,10116.0,CHEMBL626384,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,10089,Rattus norvegicus,50597,,,,,N,4333,,,,,In vivo,1,10116.0,CHEMBL626385,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at an oral dose of 2 mg/kg,10090,Rattus norvegicus,50597,,,,,N,6077,,,,,In vivo,1,10116.0,CHEMBL626386,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10091,Rattus norvegicus,50597,,,,,N,3278,,,,,In vivo,1,10116.0,CHEMBL626387,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10092,Rattus norvegicus,50597,,,,,N,5964,,,,,In vivo,1,10116.0,CHEMBL626388,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10093,Rattus norvegicus,50597,,,,,N,4884,,,,,In vivo,1,10116.0,CHEMBL626389,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10094,Rattus norvegicus,50597,,,,,N,4905,,,,,In vivo,1,10116.0,CHEMBL626390,Intermediate,
A,1,BAO_0000218,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,10095,Rattus norvegicus,50597,,,,,N,4884,,,,,In vivo,1,10116.0,CHEMBL626391,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10096,Rattus norvegicus,50597,,,,,N,6850,,,,,In vivo,1,10116.0,CHEMBL626392,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10097,Rattus norvegicus,50597,,,,,N,2864,,,,,In vivo,1,10116.0,CHEMBL626393,Intermediate,
A,1,BAO_0000218,Bioavailability was determined in rat,10098,Rattus norvegicus,50597,,,,,N,5780,,,,,In vivo,1,10116.0,CHEMBL623026,Intermediate,
A,1,BAO_0000218,Bioavailability,10099,Rattus norvegicus,50597,,,,,N,1465,,,,,In vivo,1,10116.0,CHEMBL623027,Intermediate,
A,1,BAO_0000218,Bioavailability,10100,Rattus norvegicus,50597,,,,,N,5199,,,,,In vivo,1,10116.0,CHEMBL623028,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after 1 day dosing,10101,Rattus norvegicus,50597,,,,,N,5765,,,,,In vivo,1,10116.0,CHEMBL623029,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after 4 day dosing,10102,Rattus norvegicus,50597,,,,,N,5765,,,,,In vivo,1,10116.0,CHEMBL623030,Intermediate,
A,1,BAO_0000218,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,10103,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623031,Intermediate,
A,1,BAO_0000218,Bioavailability after IV dosing at 1 mg/kg in rat; no data,10104,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623032,Intermediate,
A,1,BAO_0000218,Bioavailability after oral administration at a dose of 2 mg/kg in rat,10105,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623033,Intermediate,
A,1,BAO_0000218,Bioavailability after oral administration at a dose of 4 mg/kg in rat,10106,Rattus norvegicus,50597,,,,,N,6518,,,,,In vivo,1,10116.0,CHEMBL623034,Intermediate,
A,1,BAO_0000218,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,10107,Rattus norvegicus,50597,,,,,N,2083,,,,,In vivo,1,10116.0,CHEMBL623035,Intermediate,
A,1,BAO_0000218,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,10108,Rattus norvegicus,50597,,,,,N,17260,,,,,In vivo,1,10116.0,CHEMBL623036,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10109,Rattus norvegicus,50597,,,,,N,4956,,,,,In vivo,1,10116.0,CHEMBL623037,Intermediate,
A,1,BAO_0000218,Bioavailability by intravenous administration of 3.4 mg/kg in rat,10110,Rattus norvegicus,50597,,,,,N,4368,,,,,In vivo,1,10116.0,CHEMBL623038,Intermediate,
A,1,BAO_0000218,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,10111,Rattus norvegicus,50597,,,Plasma,,N,17752,,,,1969.0,In vivo,1,10116.0,CHEMBL874385,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Fisher) (fasted),10112,Rattus norvegicus,50597,,,,,N,1446,,,,,In vivo,1,10116.0,CHEMBL623039,Intermediate,
A,0,BAO_0000218,Bioavailability in monkey after po administration of 10 mg/kg dose,10113,Primates,22224,,,,,U,2891,,,,,In vivo,1,9443.0,CHEMBL623040,Intermediate,
A,0,BAO_0000218,Oral bioavailability in monkey (dose 10 mg/kg),10114,Primates,22224,,,,,U,2891,,,,,In vivo,1,9443.0,CHEMBL623041,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10115,Rattus norvegicus,50597,,,,,N,6672,,,,,In vivo,1,10116.0,CHEMBL623741,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10116,Rattus norvegicus,50597,,,,,N,6673,,,,,In vivo,1,10116.0,CHEMBL623742,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10117,Rattus norvegicus,50597,,,,,N,17655,,,,,In vivo,1,10116.0,CHEMBL623743,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10118,Rattus norvegicus,50597,,,,,N,17796,,,,,In vivo,1,10116.0,CHEMBL623744,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 2.0 mg/kg p.o.),10119,Rattus norvegicus,50597,,,,,N,17853,,,,,In vivo,1,10116.0,CHEMBL623745,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),10120,Rattus norvegicus,50597,,,,,N,4521,,,,,In vivo,1,10116.0,CHEMBL623746,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg p.o.),10121,Rattus norvegicus,50597,,,,,N,4940,,,,,In vivo,1,10116.0,CHEMBL623747,Intermediate,
A,0,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,10122,Rattus norvegicus,22224,,,,,U,2891,,,,,In vivo,1,10116.0,CHEMBL623748,Intermediate,
A,0,BAO_0000218,Bioavailability in rat after po administration of 30 mg/kg dose,10123,Rattus norvegicus,22224,,,,,U,2891,,,,,In vivo,1,10116.0,CHEMBL623916,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,10124,Rattus norvegicus,50597,,,,,N,4521,,,,,In vivo,1,10116.0,CHEMBL623917,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 2 mg/kg i.v.),10125,Rattus norvegicus,50597,,,,,N,17686,,,,,In vivo,1,10116.0,CHEMBL623918,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10126,Rattus norvegicus,50597,,,,,N,17796,,,,,In vivo,1,10116.0,CHEMBL874386,Intermediate,
A,1,BAO_0000218,Bioavailability in rat; Only traces detected in rat plasma,10127,Rattus norvegicus,50597,,,Plasma,,N,17796,,,,1969.0,In vivo,1,10116.0,CHEMBL623919,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10128,Rattus norvegicus,50597,,,,,N,5064,,,,,In vivo,1,10116.0,CHEMBL623920,Intermediate,
A,1,BAO_0000218,Bioavailability upon oral administration of compound,10129,Rattus norvegicus,50597,,,,,N,5147,,,,,In vivo,1,10116.0,CHEMBL623148,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),10130,Rattus norvegicus,50597,,,,,N,1916,,,,,In vivo,1,10116.0,CHEMBL623149,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10131,Rattus norvegicus,50597,,,,,N,6049,,,,,In vivo,1,10116.0,CHEMBL623150,Intermediate,
A,1,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",10132,Rattus norvegicus,50597,,,,,N,1445,,,,,In vivo,1,10116.0,CHEMBL623151,Intermediate,
A,1,BAO_0000218,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",10133,Rattus norvegicus,50597,,,,,N,1445,,,,,In vivo,1,10116.0,CHEMBL623152,Intermediate,
F,1,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,10134,Rattus norvegicus,50597,,,,,N,2862,,,,,,1,10116.0,CHEMBL623153,Expert,
F,1,BAO_0000218,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,10135,Rattus norvegicus,50597,,,,,N,2862,,,,,,1,10116.0,CHEMBL623154,Expert,
A,1,BAO_0000218,In vitro and metabolic stability was determined,10136,Rattus norvegicus,50597,,,,,N,4194,,,,,,1,10116.0,CHEMBL623155,Intermediate,
A,1,BAO_0000218,In vitro metabolic stability in rat hepatocytes,10137,Rattus norvegicus,50597,,,,,N,4194,,,,,,1,10116.0,CHEMBL623156,Intermediate,
A,1,BAO_0000218,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,10138,Rattus norvegicus,50597,,,,,N,5486,,,,,,1,10116.0,CHEMBL623157,Intermediate,
A,1,BAO_0000218,Metabolic rate for compound was observed in rat hepatocytes,10139,Rattus norvegicus,50597,,,Liver,Hepatocyte,N,17582,,401.0,,2107.0,In vitro,1,10116.0,CHEMBL623158,Intermediate,
A,1,BAO_0000218,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,10140,Rattus norvegicus,50597,,,,,N,5600,,,,,,1,10116.0,CHEMBL623159,Intermediate,
A,1,BAO_0000218,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),10141,Rattus norvegicus,50597,,,,,N,14294,,,,,,1,10116.0,CHEMBL874390,Intermediate,
A,1,BAO_0000218,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),10142,Rattus norvegicus,50597,,,,,N,14294,,,,,,1,10116.0,CHEMBL623160,Intermediate,
A,1,BAO_0000218,Metabolism of compound in rat S9 microsomes; Trace,10143,Rattus norvegicus,50597,,,,,N,14294,,,,,,1,10116.0,CHEMBL623161,Intermediate,
A,1,BAO_0000218,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,10144,Rattus norvegicus,50597,,,,,N,17847,,,,,,1,10116.0,CHEMBL623162,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,10145,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623163,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,10146,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623164,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,10147,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623165,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,10148,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623166,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,10149,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624983,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,10150,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624984,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,10151,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624985,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,10152,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622970,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,10153,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622971,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,10154,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622972,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,10155,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622973,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,10156,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622974,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,10157,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622975,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,10158,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622976,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,10159,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622977,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10160,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624351,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,10161,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624352,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10162,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL624353,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,10163,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622397,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,10164,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622398,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,10165,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622399,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,10166,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL622400,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,10167,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628428,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,10168,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628590,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10169,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628591,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,10170,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628592,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10171,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628593,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,10172,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL875333,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10173,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628594,Intermediate,
A,1,BAO_0000218,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,10174,Rattus norvegicus,50597,,,Plasma,,N,4969,,,,1969.0,,1,10116.0,CHEMBL628595,Intermediate,
A,1,BAO_0000218,Stability in rat plasma was determined,10175,Rattus norvegicus,50597,,,Plasma,,N,6737,,,,1969.0,,1,10116.0,CHEMBL628596,Intermediate,
A,1,BAO_0000218,Stability in rat plasma was determined; ND= no data,10176,Rattus norvegicus,50597,,,Plasma,,N,6737,,,,1969.0,,1,10116.0,CHEMBL628597,Intermediate,
A,1,BAO_0000218,Tested for plasma half life period in rat (0-8 hr),10177,Rattus norvegicus,50597,,,Plasma,,N,5089,,,,1969.0,,1,10116.0,CHEMBL628598,Intermediate,
A,1,BAO_0000218,Tested for plasma half life period in rat (0-8 hr); Not determined,10178,Rattus norvegicus,50597,,,Plasma,,N,5089,,,,1969.0,,1,10116.0,CHEMBL628599,Intermediate,
A,1,BAO_0000218,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,10179,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL628600,Intermediate,
A,1,BAO_0000218,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,10180,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL628601,Intermediate,
A,1,BAO_0000218,Tested for the half life in rat,10181,Rattus norvegicus,50597,,,,,N,4950,,,,,,1,10116.0,CHEMBL628602,Intermediate,
A,1,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,10182,Rattus norvegicus,50597,,,,,N,2412,,,,,In vitro,1,10116.0,CHEMBL628603,Intermediate,
A,1,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,10183,Rattus norvegicus,50597,,,,,N,2412,,,,,In vitro,1,10116.0,CHEMBL628604,Intermediate,
A,1,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,10184,Rattus norvegicus,50597,,,,,N,2412,,,,,In vitro,1,10116.0,CHEMBL628605,Intermediate,
A,1,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,10185,Rattus norvegicus,50597,,,,,N,2412,,,,,In vitro,1,10116.0,CHEMBL628606,Intermediate,
A,1,BAO_0000218,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,10186,Rattus norvegicus,50597,,,,,N,2412,,,,,In vitro,1,10116.0,CHEMBL628607,Intermediate,
A,1,BAO_0000218,The biological half life the compound was measured at the dose of 100 umol/kg,10187,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL628608,Intermediate,
A,1,BAO_0000218,The biological half life the compound was measured at the dose of 30 umol/kg,10188,Rattus norvegicus,50597,,,,,N,15022,,,,,,1,10116.0,CHEMBL628609,Intermediate,
A,1,BAO_0000218,The compound was evaluated for plasma half life period in rat,10189,Rattus norvegicus,50597,,,Plasma,,N,406,,,,1969.0,,1,10116.0,CHEMBL628610,Intermediate,
A,1,BAO_0000218,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",10190,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL873819,Intermediate,
A,1,BAO_0000218,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",10191,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL628611,Intermediate,
A,1,BAO_0000218,The pharmacokinetic parameter half-life period in vivo in rats,10192,Rattus norvegicus,50597,,,,,N,5247,,,,,In vivo,1,10116.0,CHEMBL628612,Intermediate,
A,1,BAO_0000218,"The pharmacokinetic property, Half-life was determined",10193,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL628613,Intermediate,
A,1,BAO_0000218,"The pharmacokinetic property, Half-life in rat in vivo",10194,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL628614,Intermediate,
A,1,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes no data",10195,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL628615,Intermediate,
A,1,BAO_0000218,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",10196,Rattus norvegicus,50597,,,,,N,5041,,,,,In vivo,1,10116.0,CHEMBL628616,Intermediate,
A,1,BAO_0000218,The plasma half life period in rats,10197,Rattus norvegicus,50597,,,Plasma,,N,3918,,,,1969.0,,1,10116.0,CHEMBL627924,Intermediate,
A,1,BAO_0000218,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,10198,Rattus norvegicus,50597,,,Liver,,N,2906,,,,2107.0,,1,10116.0,CHEMBL627925,Intermediate,
A,1,BAO_0000218,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,10199,Rattus norvegicus,50597,,,,,N,6467,,,,,In vivo,1,10116.0,CHEMBL627926,Intermediate,
A,1,BAO_0000218,t1/2 (apparent elimination)of the compound was determined,10200,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL627927,Intermediate,
A,1,BAO_0000218,t1/2 value in rat,10201,Rattus norvegicus,50597,,,,,N,3788,,,,,,1,10116.0,CHEMBL627928,Intermediate,
A,1,BAO_0000218,Half life in rat,10202,Rattus norvegicus,50597,,,,,N,17796,,,,,,1,10116.0,CHEMBL627539,Intermediate,
A,1,BAO_0000218,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",10203,Rattus norvegicus,50597,,,Plasma,,N,12873,,,,1969.0,In vivo,1,10116.0,CHEMBL876790,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,10204,Rattus norvegicus,50597,,,,,N,5983,,,,,In vivo,1,10116.0,CHEMBL858186,Intermediate,
A,1,BAO_0000218,Half-life period in fasted rats,10205,Rattus norvegicus,50597,,,,,N,15765,,,,,,1,10116.0,CHEMBL627540,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,10206,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627541,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,10207,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627715,Intermediate,
A,1,BAO_0000218,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,10208,Rattus norvegicus,50597,,,,,N,429,,,,,In vivo,1,10116.0,CHEMBL627716,Intermediate,
A,1,BAO_0000218,Maximum time required to achieve Cmax was determined in rat,10209,Rattus norvegicus,50597,,,,,N,17655,,,,,,1,10116.0,CHEMBL627717,Intermediate,
A,1,BAO_0000218,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,10210,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL627718,Intermediate,
A,1,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,10211,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL627719,Intermediate,
A,1,BAO_0000218,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,10212,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL627720,Intermediate,
A,1,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,10213,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL627721,Intermediate,
A,1,BAO_0000218,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,10214,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL627722,Intermediate,
A,1,BAO_0000218,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10215,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL627723,Intermediate,
A,1,BAO_0000218,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10216,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL626058,Intermediate,
A,1,BAO_0000218,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10217,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL626059,Intermediate,
A,1,BAO_0000218,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10218,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL626060,Intermediate,
A,1,BAO_0000218,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,10219,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL626061,Intermediate,
A,1,BAO_0000218,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,10220,Rattus norvegicus,50597,,,,,N,4723,,,,,In vivo,1,10116.0,CHEMBL876791,Intermediate,
A,1,BAO_0000218,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,10221,Rattus norvegicus,50597,,,,,N,4723,,,,,In vivo,1,10116.0,CHEMBL626062,Intermediate,
A,1,BAO_0000218,Tmax at the dose of 2 mg/Kg administered perorally in rats,10222,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL626063,Intermediate,
A,1,BAO_0000218,Tmax at the dose of 5 mg/Kg administered perorally in rats,10223,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL626064,Intermediate,
A,1,BAO_0000218,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,10224,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL626065,Intermediate,
A,1,BAO_0000218,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,10225,Rattus norvegicus,50597,,,Plasma,,N,17720,,,,1969.0,In vivo,1,10116.0,CHEMBL626066,Intermediate,
A,1,BAO_0000218,tmax upon peroral administration of 10.0 mg/Kg dose in rat,10226,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL626067,Intermediate,
F,1,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,10227,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626068,Intermediate,
F,1,BAO_0000218,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,10228,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626069,Intermediate,
F,1,BAO_0000218,Percent total excretion of 3-methoxyacetaminophen glucuronide,10229,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626070,Intermediate,
F,1,BAO_0000218,Percent total excretion of N-methoxyacetaminophen glucuronide,10230,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626071,Intermediate,
F,1,BAO_0000218,Percent total excretion of N-methoxyacetaminophen sulfate,10231,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626072,Intermediate,
F,1,BAO_0000218,Percent total excretion of acetaminophen,10232,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626073,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",10233,Rattus norvegicus,50597,,,Thyroid gland,,N,7768,,,,2046.0,,1,10116.0,CHEMBL626741,Intermediate,
A,1,BAO_0000218,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",10234,Rattus norvegicus,50597,,,,,N,17655,,,,,,1,10116.0,CHEMBL626742,Intermediate,
A,1,BAO_0000218,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,10235,Rattus norvegicus,50597,,,,,N,17735,,,,,,1,10116.0,CHEMBL626743,Intermediate,
A,1,BAO_0000218,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,10236,Rattus norvegicus,50597,,,,,N,5960,,,,,,1,10116.0,CHEMBL876792,Intermediate,
A,1,BAO_0000218,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,10237,Rattus norvegicus,50597,,,,,N,17735,,,,,,1,10116.0,CHEMBL626744,Intermediate,
A,1,BAO_0000218,Compound was tested for antidiuretic activity in rats,10238,Rattus norvegicus,50597,,,,,N,7116,,,,,,1,10116.0,CHEMBL626745,Intermediate,
A,1,BAO_0000218,AUC in rat after 3mg/kg oral dose,10239,Rattus norvegicus,50597,,,Plasma,,N,4878,,,,1969.0,In vivo,1,10116.0,CHEMBL626746,Intermediate,
A,1,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,10240,Rattus norvegicus,50597,,,,,N,5939,,,,,,1,10116.0,CHEMBL626747,Intermediate,
A,1,BAO_0000218,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,10241,Rattus norvegicus,50597,,,,,N,5939,,,,,,1,10116.0,CHEMBL626748,Intermediate,
A,1,BAO_0000218,Bioavailability administered orally at a dose of 10 mg/kg to rats,10242,Rattus norvegicus,50597,,,,,N,16367,,,,,,1,10116.0,CHEMBL626749,Intermediate,
A,1,BAO_0000218,Oral Bioavailability was determined,10243,Rattus norvegicus,50597,,,,,N,16366,,,,,,1,10116.0,CHEMBL626750,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10244,Rattus norvegicus,50597,,,,,N,4426,,,,,,1,10116.0,CHEMBL626751,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat; Not performed.,10245,Rattus norvegicus,50597,,,,,N,4426,,,,,,1,10116.0,CHEMBL626913,Intermediate,
A,1,BAO_0000218,Bioavailability,10246,Rattus norvegicus,50597,,,,,N,5041,,,,,,1,10116.0,CHEMBL626914,Intermediate,
A,1,BAO_0000218,Bioavailability was determined; ND denotes no data,10247,Rattus norvegicus,50597,,,,,N,5041,,,,,,1,10116.0,CHEMBL626915,Intermediate,
A,1,BAO_0000218,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,10248,Rattus norvegicus,50597,,,,,N,1500,,,,,,1,10116.0,CHEMBL626916,Intermediate,
A,1,BAO_0000218,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,10249,Rattus norvegicus,50597,,,,,N,1500,,,,,,1,10116.0,CHEMBL626917,Intermediate,
A,1,BAO_0000218,Binding towards rat plasma protein at 10 uM,10250,Rattus norvegicus,50597,,,,,N,17409,,,,,,1,10116.0,CHEMBL626918,Intermediate,
A,1,BAO_0000218,Binding towards rat plasma protein at 100 uM,10251,Rattus norvegicus,50597,,,,,N,17409,,,,,,1,10116.0,CHEMBL626919,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),10252,Rattus norvegicus,50597,,,,,N,2959,,,,,In vivo,1,10116.0,CHEMBL626920,Intermediate,
A,1,BAO_0000218,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,10253,Rattus norvegicus,50597,,,,,N,13501,,,,,In vivo,1,10116.0,CHEMBL621976,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after 5 mg/kg oral gavage,10254,Rattus norvegicus,50597,,,,,N,6567,,,,,In vivo,1,10116.0,CHEMBL877599,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10255,Rattus norvegicus,50597,,,,,N,6571,,,,,In vivo,1,10116.0,CHEMBL621977,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 1 mg/kg i.v.),10256,Rattus norvegicus,50597,,,,,N,6715,,,,,In vivo,1,10116.0,CHEMBL621978,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 3 mg/kg p.o.),10257,Rattus norvegicus,50597,,,,,N,6715,,,,,In vivo,1,10116.0,CHEMBL621979,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10258,Rattus norvegicus,50597,,,,,N,2932,,,,,In vivo,1,10116.0,CHEMBL621980,Intermediate,
A,1,BAO_0000218,Bioavailability of the compound in rats after administration of 30 mg/kg,10259,Rattus norvegicus,50597,,,,,N,4171,,,,,In vivo,1,10116.0,CHEMBL621981,Intermediate,
A,1,BAO_0000218,Bioavailability after administration of 10 mg/kg in rats,10260,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL621982,Intermediate,
A,1,BAO_0000218,Bioavailability after administration of 2 mg/kg in rats,10261,Rattus norvegicus,50597,,,,,N,17509,,,,,In vivo,1,10116.0,CHEMBL882953,Intermediate,
A,1,BAO_0000218,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,10262,Rattus norvegicus,50597,,,,,N,4527,,,,,In vivo,1,10116.0,CHEMBL621983,Intermediate,
A,1,BAO_0000218,Bioavailability in dogs was determined; high,10263,Rattus norvegicus,50597,,,,,N,4026,,,,,In vivo,1,10116.0,CHEMBL621984,Intermediate,
A,1,BAO_0000218,Bioavailability in monkey after intravenous administration at 1 mpk,10264,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL621985,Intermediate,
A,1,BAO_0000218,Bioavailability in monkey after peroral administration at 10 mpk,10265,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL621986,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after intravenous administration at 1 mpk,10266,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL621987,Intermediate,
F,1,BAO_0000218,Bioavailability in rat after intravenous administration at 2 mpk,10267,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL877600,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after peroral administration at 30 mpk,10268,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL621988,Intermediate,
F,1,BAO_0000218,Bioavailability in rat after peroral administration at at 100 mpk,10269,Rattus norvegicus,50597,,,,,N,6659,,,,,In vivo,1,10116.0,CHEMBL621989,Intermediate,
A,1,BAO_0000218,Bioavailability in rats was evaluated,10270,Rattus norvegicus,50597,,,,,N,6597,,,,,In vivo,1,10116.0,CHEMBL621990,Intermediate,
A,1,BAO_0000218,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,10271,Rattus norvegicus,50597,,,,,N,1202,,,,,In vivo,1,10116.0,CHEMBL621991,Intermediate,
A,1,BAO_0000218,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,10272,Rattus norvegicus,50597,,,,,N,1202,,,,,In vivo,1,10116.0,CHEMBL621992,Intermediate,
A,1,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,10273,Rattus norvegicus,50597,,,,,N,1202,,,,,In vivo,1,10116.0,CHEMBL621993,Intermediate,
A,1,BAO_0000218,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,10274,Rattus norvegicus,50597,,,,,N,1202,,,,,In vivo,1,10116.0,CHEMBL621994,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10275,Rattus norvegicus,50597,,,,,N,5207,,,,,In vivo,1,10116.0,CHEMBL621995,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10276,Rattus norvegicus,50597,,,,,N,5970,,,,,In vivo,1,10116.0,CHEMBL621996,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),10277,Rattus norvegicus,50597,,,,,N,17538,,,,,In vivo,1,10116.0,CHEMBL621997,Intermediate,
A,1,BAO_0000218,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,10278,Rattus norvegicus,50597,,,,,N,17538,,,,,In vivo,1,10116.0,CHEMBL621998,Intermediate,
A,1,BAO_0000218,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,10279,Rattus norvegicus,50597,,,,,N,1466,,,,,In vivo,1,10116.0,CHEMBL621999,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10280,Rattus norvegicus,50597,,,,,N,2879,,,,,In vivo,1,10116.0,CHEMBL622000,Intermediate,
A,1,BAO_0000218,Bioavailability was measured in rat after oral administration; 2-4,10281,Rattus norvegicus,50597,,,,,N,2879,,,,,In vivo,1,10116.0,CHEMBL622001,Intermediate,
A,1,BAO_0000218,Bioavailability was measured in rat after oral administration; 3-7,10282,Rattus norvegicus,50597,,,,,N,2879,,,,,In vivo,1,10116.0,CHEMBL622002,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (intraduodenal administration),10283,Rattus norvegicus,50597,,,,,N,3777,,,,,In vivo,1,10116.0,CHEMBL622003,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (intraduodenal administration),10284,Rattus norvegicus,50597,,,,,N,3777,,,,,In vivo,1,10116.0,CHEMBL877601,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10285,Rattus norvegicus,50597,,,,,N,3777,,,,,In vivo,1,10116.0,CHEMBL624871,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10286,Rattus norvegicus,50597,,,,,N,3777,,,,,In vivo,1,10116.0,CHEMBL622004,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),10287,Rattus norvegicus,50597,,,,,N,5423,,,,,In vivo,1,10116.0,CHEMBL882954,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,10288,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622005,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,10289,Rattus norvegicus,50597,,,,,N,16365,,,,,In vivo,1,10116.0,CHEMBL622006,Intermediate,
A,1,BAO_0000218,Bioavailability was measured in rat,10290,Rattus norvegicus,50597,,,,,N,4239,,,,,In vivo,1,10116.0,CHEMBL622007,Intermediate,
A,1,BAO_0000218,Bioavailability was reported,10291,Rattus norvegicus,50597,,,,,N,5438,,,,,In vivo,1,10116.0,CHEMBL622008,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10292,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL622009,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10293,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL622010,Intermediate,
A,1,BAO_0000218,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,10294,Rattus norvegicus,50597,,,,,N,4199,,,,,In vivo,1,10116.0,CHEMBL622011,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),10295,Rattus norvegicus,50597,,,,,N,4199,,,,,In vivo,1,10116.0,CHEMBL622012,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),10296,Rattus norvegicus,50597,,,,,N,4199,,,,,In vivo,1,10116.0,CHEMBL622013,Intermediate,
A,1,BAO_0000218,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,10297,Rattus norvegicus,50597,,,,,N,4890,,,,,In vivo,1,10116.0,CHEMBL622014,Intermediate,
A,1,BAO_0000218,Bioavailability was determined at 3 mg/kg po dose in rats,10298,Rattus norvegicus,50597,,,,,N,2792,,,,,In vivo,1,10116.0,CHEMBL624749,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),10299,Rattus norvegicus,50597,,,,,N,5529,,,,,In vivo,1,10116.0,CHEMBL624750,Intermediate,
A,1,BAO_0000218,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",10300,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL624751,Intermediate,
A,1,BAO_0000218,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",10301,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL624752,Intermediate,
A,1,BAO_0000218,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",10302,Rattus norvegicus,50597,,,,,N,6685,,,,,In vivo,1,10116.0,CHEMBL624753,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,10303,Rattus norvegicus,50597,,,,,N,6005,,,,,In vivo,1,10116.0,CHEMBL624754,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10304,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL624755,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10305,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL624756,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10306,Rattus norvegicus,50597,,,,,N,6103,,,,,In vivo,1,10116.0,CHEMBL624757,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,10307,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL624758,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,10308,Rattus norvegicus,50597,,,,,N,6410,,,,,In vivo,1,10116.0,CHEMBL622270,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (Sprague-Dawley),10309,Rattus norvegicus,50597,,,,,N,5353,,,,,In vivo,1,10116.0,CHEMBL622271,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at the dose of 2 mg/kg,10310,Rattus norvegicus,50597,,,,,N,4727,,,,,In vivo,1,10116.0,CHEMBL622272,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10311,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL622273,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (cannulated) (dose 2 mg/kg),10312,Rattus norvegicus,50597,,,,,N,5809,,,,,In vivo,1,10116.0,CHEMBL622274,Intermediate,
A,1,BAO_0000218,Bioavailability value of compound in rats was determined after peroral administration,10313,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL622275,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),10314,Rattus norvegicus,50597,,,,,N,3634,,,,,In vivo,1,10116.0,CHEMBL622276,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10315,Rattus norvegicus,50597,,,,,N,3341,,,,,In vivo,1,10116.0,CHEMBL622277,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),10316,Rattus norvegicus,50597,,,,,N,2690,,,,,In vivo,1,10116.0,CHEMBL622278,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10317,Rattus norvegicus,50597,,,,,N,3184,,,,,In vivo,1,10116.0,CHEMBL622279,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10318,Rattus norvegicus,50597,,,,,N,740,,,,,In vivo,1,10116.0,CHEMBL622280,Intermediate,
A,1,BAO_0000218,Compound was evaluated for oral bioavailability in rats; 15-27 %,10319,Rattus norvegicus,50597,,,,,N,1806,,,,,In vivo,1,10116.0,CHEMBL624083,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,10320,Rattus norvegicus,50597,,,,,N,4891,,,,,In vivo,1,10116.0,CHEMBL624084,Intermediate,
A,1,BAO_0000218,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),10321,Rattus norvegicus,50597,,,,,N,3634,,,,,In vivo,1,10116.0,CHEMBL624085,Intermediate,
A,1,BAO_0000218,Compound was tested for bioavailability in rats,10322,Rattus norvegicus,50597,,,,,N,64,,,,,In vivo,1,10116.0,CHEMBL624086,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10323,Rattus norvegicus,50597,,,,,N,4839,,,,,In vivo,1,10116.0,CHEMBL624087,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10324,Rattus norvegicus,50597,,,,,N,1094,,,,,In vivo,1,10116.0,CHEMBL624088,Intermediate,
A,0,BAO_0000218,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,10325,Macaca mulatta,22224,,,,,U,5005,,,,,In vivo,1,9544.0,CHEMBL624089,Intermediate,
A,0,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),10326,Rattus norvegicus,22224,,,,,U,5005,,,,,In vivo,1,10116.0,CHEMBL624090,Intermediate,
A,1,BAO_0000218,Evaluated for the bioavailability in rat (in vivo),10327,Rattus norvegicus,50597,,,,,N,4687,,,,,In vivo,1,10116.0,CHEMBL624091,Intermediate,
A,1,BAO_0000218,F value of compound in rats was determined after peroral administration,10328,Rattus norvegicus,50597,,,,,N,17804,,,,,In vivo,1,10116.0,CHEMBL624092,Intermediate,
A,1,BAO_0000218,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,10329,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624093,Intermediate,
A,1,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,10330,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624094,Intermediate,
A,1,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,10331,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624095,Intermediate,
A,1,BAO_0000218,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,10332,Rattus norvegicus,50597,,,,,N,5974,,,,,In vivo,1,10116.0,CHEMBL624096,Intermediate,
A,1,BAO_0000218,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",10333,Rattus norvegicus,50597,,,,,N,1088,,,,,In vivo,1,10116.0,CHEMBL624097,Intermediate,
A,1,BAO_0000218,Maximum fall in carotid flow in rat,10334,Rattus norvegicus,50597,,,,,N,1742,,,,,In vivo,1,10116.0,CHEMBL624098,Intermediate,
A,1,BAO_0000218,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,10335,Rattus norvegicus,50597,,,,,N,4689,,,,,In vivo,1,10116.0,CHEMBL874392,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg),10336,Rattus norvegicus,50597,,,,,N,2463,,,,,In vivo,1,10116.0,CHEMBL624099,Intermediate,
A,1,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,10337,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL624100,Intermediate,
A,1,BAO_0000218,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,10338,Rattus norvegicus,50597,,,,,N,5654,,,,,In vivo,1,10116.0,CHEMBL624101,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (male Wistar),10339,Rattus norvegicus,50597,,,,,N,6874,,,,,In vivo,1,10116.0,CHEMBL624102,Intermediate,
A,1,BAO_0000218,Oral bioavailability after administration (30 mg/kg) in rat; good,10340,Rattus norvegicus,50597,,,,,N,5633,,,,,In vivo,1,10116.0,CHEMBL624103,Intermediate,
A,1,BAO_0000218,Oral bioavailability at the dose of 2 mg/kg in rat,10341,Rattus norvegicus,50597,,,,,N,5496,,,,,In vivo,1,10116.0,CHEMBL624104,Intermediate,
A,1,BAO_0000218,Oral bioavailability determined in rats,10342,Rattus norvegicus,50597,,,,,N,2358,,,,,In vivo,1,10116.0,CHEMBL624105,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),10343,Rattus norvegicus,50597,,,,,N,16456,,,,,In vivo,1,10116.0,CHEMBL624106,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),10344,Rattus norvegicus,50597,,,,,N,5302,,,,,In vivo,1,10116.0,CHEMBL624107,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose single 10 mg/kg),10345,Rattus norvegicus,50597,,,,,N,5302,,,,,In vivo,1,10116.0,CHEMBL623943,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 5 mg/kg,10346,Rattus norvegicus,50597,,,,,N,5302,,,,,In vivo,1,10116.0,CHEMBL623944,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,10347,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623945,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,10348,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623946,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,10349,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623947,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,10350,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623948,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,10351,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623949,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,10352,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623950,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,10353,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL874398,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,10354,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623951,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,10355,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623952,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,10356,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623953,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,10357,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623954,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,10358,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623955,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,10359,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL623956,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,10360,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627807,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,10361,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627808,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,10362,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627809,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,10363,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627810,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",10364,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627811,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",10365,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627812,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",10366,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627813,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",10367,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627814,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",10368,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL875336,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",10369,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627815,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",10370,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627816,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",10371,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627817,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",10372,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627818,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",10373,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627819,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",10374,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627820,Intermediate,
A,1,BAO_0000218,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",10375,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL627821,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,10376,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL628464,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,10377,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626239,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,10378,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626240,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,10379,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626241,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,10380,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626242,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,10381,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626243,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,10382,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626244,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,10383,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626907,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,10384,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626908,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,10385,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626909,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,10386,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL626910,Intermediate,
F,1,BAO_0000218,Percent total excretion of acetaminophen cysteine conjugate,10387,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL875342,Intermediate,
F,1,BAO_0000218,Percent total excretion of acetaminophen glucuronide,10388,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626911,Intermediate,
F,1,BAO_0000218,Percent total excretion of acetaminophen sulfate,10389,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL626912,Intermediate,
F,1,BAO_0000218,Percent total excretion of acetaminophen-mercapturic acid,10390,Rattus norvegicus,50597,,,,,N,7449,,,,,,1,10116.0,CHEMBL627065,Intermediate,
A,1,BAO_0000218,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,10391,Rattus norvegicus,50597,,,Urine,,N,3172,,,,1088.0,,1,10116.0,CHEMBL627066,Intermediate,
A,1,BAO_0000218,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,10392,Rattus norvegicus,50597,,,,,N,16456,,,,,In vivo,1,10116.0,CHEMBL627067,Intermediate,
A,0,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration,10393,ratrat,22224,,,Muscle tissue,,U,10839,,,,2385.0,In vivo,1,8656.0,CHEMBL627068,Autocuration,
A,0,BAO_0000218,Biodistribution of compound in rat muscle after 5 min of administration.,10394,ratrat,22224,,,Muscle tissue,,U,10839,,,,2385.0,In vivo,1,8656.0,CHEMBL627069,Autocuration,
A,0,BAO_0000218,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10395,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL627070,Autocuration,
A,0,BAO_0000218,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10396,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL627071,Autocuration,
A,0,BAO_0000218,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10397,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL627072,Autocuration,
A,0,BAO_0000218,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10398,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL627073,Autocuration,
A,0,BAO_0000218,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10399,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL625387,Autocuration,
A,0,BAO_0000218,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10400,Ovis aries,22224,,,,,U,5334,,,,,In vivo,1,9940.0,CHEMBL625388,Autocuration,
A,0,BAO_0000218,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),10401,Ovis aries,22224,,,Plasma,,U,5334,,,,1969.0,In vivo,1,9940.0,CHEMBL625389,Autocuration,
A,0,BAO_0000218,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),10402,Ovis aries,22224,,,Plasma,,U,5334,,,,1969.0,In vivo,1,9940.0,CHEMBL875343,Autocuration,
A,1,BAO_0000218,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),10403,Serpentes,50497,,,,,N,1735,,,,,,1,8570.0,CHEMBL876795,Intermediate,
A,1,BAO_0000218,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,10404,Serpentes,50497,,,,,N,1469,,,,,,1,8570.0,CHEMBL626552,Intermediate,
A,1,BAO_0000218,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,10405,Serpentes,50497,,,,,N,1336,,,,,,1,8570.0,CHEMBL626553,Intermediate,
A,0,BAO_0000366,The human biological plasma half life of the compound,10406,Homo sapiens,22224,,,Plasma,,U,12403,,,,1969.0,,1,9606.0,CHEMBL626554,Autocuration,
A,1,BAO_0000218,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,10407,Rattus norvegicus,50597,,,Urine,,N,8151,,,,1088.0,,1,10116.0,CHEMBL626555,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,10408,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL626556,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,10409,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL626557,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,10410,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL626558,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,10411,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL626559,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,10412,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL626560,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,10413,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL876803,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,10414,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627964,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,10415,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627965,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,10416,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627966,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,10417,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627967,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,10418,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627968,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,10419,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627969,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,10420,Rattus norvegicus,50597,,,,,N,8004,,,,,,1,10116.0,CHEMBL627970,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,10421,Rattus norvegicus,50597,,,Blood,,N,8004,,,,178.0,,1,10116.0,CHEMBL627971,Intermediate,
A,1,BAO_0000218,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,10422,Rattus norvegicus,50597,,,Blood,,N,8004,,,,178.0,,1,10116.0,CHEMBL627972,Intermediate,
B,9,BAO_0000357,Dissociation constant against binding to human cyclophilin A,10423,Homo sapiens,180,,,,,D,15917,,,,,,1,9606.0,CHEMBL856029,Expert,
B,8,BAO_0000019,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,10424,Bos taurus,11591,,,,,H,12396,,,,,,1,9913.0,CHEMBL627973,Expert,
A,0,BAO_0000019,-Log C was determined by performing the electroshock minimum test,10425,,22224,,,,,U,7065,,,,,,1,,CHEMBL627974,Autocuration,
A,0,BAO_0000019,-Log C was determined by performing the foot shock test,10426,,22224,,,,,U,7065,,,,,,1,,CHEMBL627975,Autocuration,
A,0,BAO_0000019,-Log C was determined by performing the incl screen test,10427,,22224,,,,,U,7065,,,,,,1,,CHEMBL627976,Autocuration,
A,0,BAO_0000019,-Log C was determined by performing the maximum electroshock test,10428,,22224,,,,,U,7065,,,,,,1,,CHEMBL627977,Autocuration,
A,0,BAO_0000019,-Log C was determined by performing the pentylenetetrazole test,10429,,22224,,,,,U,7065,,,,,,1,,CHEMBL627978,Autocuration,
A,0,BAO_0000019,Tested for experimental arotinoid inhibitory dose,10430,,22224,,,,,U,12415,,,,,,1,,CHEMBL627979,Autocuration,
A,0,BAO_0000019,Negative log transformed activity,10431,,22224,,,,,U,10256,,,,,,1,,CHEMBL876804,Autocuration,
A,0,BAO_0000019,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",10432,,22224,,,,,U,7991,,,,,,1,,CHEMBL627980,Autocuration,
A,1,BAO_0000218,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,10433,Cavia porcellus,50512,,,,,N,14342,,,,,,1,10141.0,CHEMBL627981,Intermediate,
A,1,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,10434,Cavia porcellus,50512,,,,,N,14342,,,,,,1,10141.0,CHEMBL627982,Intermediate,
A,1,BAO_0000218,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,10435,Cavia porcellus,50512,,,,,N,14342,,,,,,1,10141.0,CHEMBL627983,Intermediate,
A,1,BAO_0000218,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,10436,Cavia porcellus,50512,,,Ileum,,N,14342,,,,2116.0,,1,10141.0,CHEMBL627984,Intermediate,
P,0,BAO_0000100,Solubility in water was determined; values expressed as -log,10437,,22229,,,,,U,6047,,,,,,1,,CHEMBL627985,Autocuration,
A,0,BAO_0000019,Ratio of Kcat to that of Km was determined,10438,,22224,,,,,U,17269,,,,,,1,,CHEMBL627986,Autocuration,
A,0,BAO_0000019,Observed first order rate constant,10439,,22224,,,,,U,10026,,,,,,1,,CHEMBL627987,Autocuration,
A,0,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,10440,,22224,,,,,U,14583,,,,,,1,,CHEMBL627988,Autocuration,
A,1,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,10441,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627989,Intermediate,
A,1,BAO_0000218,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,10442,Rattus norvegicus,50597,,,,,N,2661,,,,,In vivo,1,10116.0,CHEMBL627990,Intermediate,
A,1,BAO_0000218,Oral Bioavailability after administration of 10 mg/kg in male rat,10443,Rattus norvegicus,50597,,,,,N,4029,,,,,In vivo,1,10116.0,CHEMBL876805,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),10444,Rattus norvegicus,50597,,,,,N,17735,,,,,In vivo,1,10116.0,CHEMBL627991,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10445,Rattus norvegicus,50597,,,,,N,4576,,,,,In vivo,1,10116.0,CHEMBL627992,Intermediate,
A,1,BAO_0000218,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,10446,Rattus norvegicus,50597,,,,,N,17582,,,,,In vivo,1,10116.0,CHEMBL627993,Intermediate,
A,1,BAO_0000218,Oral bioavailability at 1 mg/kg was determined in rat,10447,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL622817,Intermediate,
A,1,BAO_0000218,Oral bioavailability at 10 mg/kg was determined in rat,10448,Rattus norvegicus,50597,,,,,N,17651,,,,,In vivo,1,10116.0,CHEMBL622818,Intermediate,
A,1,BAO_0000218,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",10449,Rattus norvegicus,50597,,,,,N,17670,,,,,In vivo,1,10116.0,CHEMBL622819,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10450,Rattus norvegicus,50597,,,,,N,5045,,,,,In vivo,1,10116.0,CHEMBL872267,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10451,Rattus norvegicus,50597,,,,,N,1696,,,,,In vivo,1,10116.0,CHEMBL622820,Intermediate,
A,1,BAO_0000218,Oral bioavailability after intravenous administration in rats at 24 uM/kg,10452,Rattus norvegicus,50597,,,,,N,17764,,,,,In vivo,1,10116.0,CHEMBL622821,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10453,Rattus norvegicus,50597,,,,,N,6448,,,,,In vivo,1,10116.0,CHEMBL622822,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10454,Rattus norvegicus,50597,,,,,N,6596,,,,,In vivo,1,10116.0,CHEMBL622823,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10455,Rattus norvegicus,50597,,,,,N,17547,,,,,In vivo,1,10116.0,CHEMBL622824,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat at a dose of 3 mg/kg,10456,Rattus norvegicus,50597,,,,,N,17771,,,,,In vivo,1,10116.0,CHEMBL622825,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after oral administration at 10 mg/kg,10457,Rattus norvegicus,50597,,,,,N,6495,,,,,In vivo,1,10116.0,CHEMBL622901,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10458,Rattus norvegicus,50597,,,,,N,4558,,,,,In vivo,1,10116.0,CHEMBL622902,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10459,Rattus norvegicus,50597,,,,,N,17596,,,,,In vivo,1,10116.0,CHEMBL621844,Intermediate,
A,1,BAO_0000218,Oral bioavailability in Dawley rats,10460,Rattus norvegicus,50597,,,,,N,6827,,,,,In vivo,1,10116.0,CHEMBL621845,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10461,Rattus norvegicus,50597,,,,,N,4026,,,,,In vivo,1,10116.0,CHEMBL621846,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 30 mg/kg),10462,Rattus norvegicus,50597,,,,,N,10,,,,,In vivo,1,10116.0,CHEMBL621847,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10463,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL877609,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),10464,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL621848,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10465,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL621849,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),10466,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL622030,Intermediate,
A,1,BAO_0000218,Percent oral bioavailability determined in rats,10467,Rattus norvegicus,50597,,,,,N,4796,,,,,In vivo,1,10116.0,CHEMBL622031,Intermediate,
A,1,BAO_0000218,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,10468,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL622032,Intermediate,
A,1,BAO_0000218,The compound was evaluated for bioavailability in rats; 32-51,10469,Rattus norvegicus,50597,,,,,N,2137,,,,,In vivo,1,10116.0,CHEMBL622033,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 20 mg/kg p.o.),10470,Rattus norvegicus,50597,,,,,N,2959,,,,,In vivo,1,10116.0,CHEMBL622034,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10471,Rattus norvegicus,50597,,,,,N,1361,,,,,In vivo,1,10116.0,CHEMBL622035,Intermediate,
A,1,BAO_0000218,Bioavailability percent in rat at the dose of 2 mg/kg,10472,Rattus norvegicus,50597,,,,,N,4727,,,,,In vivo,1,10116.0,CHEMBL882966,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated after 20 uM/kg of peroral administration,10473,Rattus norvegicus,50597,,,,,N,16423,,,,,In vivo,1,10116.0,CHEMBL622036,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10474,Rattus norvegicus,50597,,,,,N,5206,,,,,In vivo,1,10116.0,CHEMBL622037,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10475,Rattus norvegicus,50597,,,,,N,6448,,,,,In vivo,1,10116.0,CHEMBL622038,Intermediate,
A,1,BAO_0000218,Bioavailability in rats,10476,Rattus norvegicus,50597,,,,,N,17723,,,,,In vivo,1,10116.0,CHEMBL622039,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,10477,Rattus norvegicus,50597,,,Blood,,N,17738,,,,178.0,In vivo,1,10116.0,CHEMBL622040,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,10478,Rattus norvegicus,50597,,,Blood,,N,17738,,,,178.0,In vivo,1,10116.0,CHEMBL622041,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,10479,Rattus norvegicus,50597,,,Blood,,N,17738,,,,178.0,In vivo,1,10116.0,CHEMBL622042,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,10480,Rattus norvegicus,50597,,,Blood,,N,17738,,,,178.0,In vivo,1,10116.0,CHEMBL622043,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,10481,Rattus norvegicus,50597,,,Blood,,N,17738,,,,178.0,In vivo,1,10116.0,CHEMBL622044,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,10482,Rattus norvegicus,50597,,,Bone,,N,17738,,,,10000001.0,In vivo,1,10116.0,CHEMBL622045,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,10483,Rattus norvegicus,50597,,,Bone,,N,17738,,,,10000001.0,In vivo,1,10116.0,CHEMBL622046,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,10484,Rattus norvegicus,50597,,,Bone,,N,17738,,,,10000001.0,In vivo,1,10116.0,CHEMBL622047,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,10485,Rattus norvegicus,50597,,,Bone,,N,17738,,,,10000001.0,In vivo,1,10116.0,CHEMBL877610,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,10486,Rattus norvegicus,50597,,,Brain,,N,17738,,,,955.0,In vivo,1,10116.0,CHEMBL622048,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,10487,Rattus norvegicus,50597,,,Brain,,N,17738,,,,955.0,In vivo,1,10116.0,CHEMBL622049,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,10488,Rattus norvegicus,50597,,,Brain,,N,17738,,,,955.0,In vivo,1,10116.0,CHEMBL622050,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,10489,Rattus norvegicus,50597,,,Brain,,N,17738,,,,955.0,In vivo,1,10116.0,CHEMBL622051,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,10490,Rattus norvegicus,50597,,,,,N,17738,,,,,In vivo,1,10116.0,CHEMBL622052,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,10491,Rattus norvegicus,50597,,,,,N,17738,,,,,In vivo,1,10116.0,CHEMBL622053,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,10492,Rattus norvegicus,50597,,,,,N,17738,,,,,In vivo,1,10116.0,CHEMBL622054,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,10493,Rattus norvegicus,50597,,,,,N,17738,,,,,In vivo,1,10116.0,CHEMBL622055,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rats was determined; High,10494,Rattus norvegicus,50597,,,,,N,5237,,,,,In vivo,1,10116.0,CHEMBL622056,Intermediate,
A,1,BAO_0000218,Oral bioavailability in the rat was determined,10495,Rattus norvegicus,50597,,,,,N,5503,,,,,In vivo,1,10116.0,CHEMBL622057,Intermediate,
A,1,BAO_0000218,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,10496,Rattus norvegicus,50597,,,,,N,15765,,,,,In vivo,1,10116.0,CHEMBL628008,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),10497,Rattus norvegicus,50597,,,,,N,15660,,,,,In vivo,1,10116.0,CHEMBL622058,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,10498,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL622059,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,10499,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL622060,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,10500,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL622061,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,10501,Rattus norvegicus,50597,,,,,N,5978,,,,,In vivo,1,10116.0,CHEMBL622062,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,10502,Rattus norvegicus,50597,,,,,N,5656,,,,,In vivo,1,10116.0,CHEMBL622063,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,10503,Rattus norvegicus,50597,,,,,N,3598,,,,,In vivo,1,10116.0,CHEMBL877611,Expert,
A,1,BAO_0000218,Oral bioavailability of compound in Sprague Dawley rats,10504,Rattus norvegicus,50597,,,,,N,4216,,,,,In vivo,1,10116.0,CHEMBL622064,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound in rat,10505,Rattus norvegicus,50597,,,,,N,17839,,,,,In vivo,1,10116.0,CHEMBL622065,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 2 mg/kg),10506,Rattus norvegicus,50597,,,,,N,6570,,,,,In vivo,1,10116.0,CHEMBL622066,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound in rat was determined,10507,Rattus norvegicus,50597,,,,,N,5334,,,,,In vivo,1,10116.0,CHEMBL622067,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound in rats,10508,Rattus norvegicus,50597,,,,,N,6886,,,,,In vivo,1,10116.0,CHEMBL622068,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound was determined in rats,10509,Rattus norvegicus,50597,,,,,N,5210,,,,,In vivo,1,10116.0,CHEMBL622069,Intermediate,
A,1,BAO_0000218,Oral bioavailability at a dose of 30 mg/kg in rats,10510,Rattus norvegicus,50597,,,,,N,4170,,,,,In vivo,1,10116.0,CHEMBL624796,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),10511,Rattus norvegicus,50597,,,,,N,6028,,,,,In vivo,1,10116.0,CHEMBL624797,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),10512,Rattus norvegicus,50597,,,,,N,6028,,,,,In vivo,1,10116.0,CHEMBL623053,Intermediate,
A,1,BAO_0000218,Oral bioavailability evaluated in rat,10513,Rattus norvegicus,50597,,,,,N,6078,,,,,In vivo,1,10116.0,CHEMBL623054,Intermediate,
A,1,BAO_0000218,Oral bioavailability in fasted rat,10514,Rattus norvegicus,50597,,,,,N,6168,,,,,In vivo,1,10116.0,CHEMBL623055,Intermediate,
A,1,BAO_0000218,Oral bioavailability in fed rat,10515,Rattus norvegicus,50597,,,,,N,6168,,,,,In vivo,1,10116.0,CHEMBL623056,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (mature male) (dose 30 mg/kg),10516,Rattus norvegicus,50597,,,,,N,5160,,,,,In vivo,1,10116.0,CHEMBL623057,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10517,Rattus norvegicus,50597,,,,,N,6057,,,,,In vivo,1,10116.0,CHEMBL623058,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),10518,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL623059,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after administration of 10 mg/kg po,10519,Rattus norvegicus,50597,,,,,N,6535,,,,,In vivo,1,10116.0,CHEMBL623060,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10520,Rattus norvegicus,50597,,,,,N,4194,,,,,In vivo,1,10116.0,CHEMBL623061,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10521,Rattus norvegicus,50597,,,,,N,6230,,,,,In vivo,1,10116.0,CHEMBL623062,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10522,Rattus norvegicus,50597,,,,,N,6619,,,,,In vivo,1,10116.0,CHEMBL623063,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10523,Rattus norvegicus,50597,,,,,N,17607,,,,,In vivo,1,10116.0,CHEMBL623064,Intermediate,
A,1,BAO_0000218,Oral bioavailability in ratrs,10524,Rattus norvegicus,50597,,,,,N,4942,,,,,In vivo,1,10116.0,CHEMBL623065,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10525,Rattus norvegicus,50597,,,,,N,4942,,,,,In vivo,1,10116.0,CHEMBL623066,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10526,Rattus norvegicus,50597,,,,,N,6646,,,,,In vivo,1,10116.0,CHEMBL623067,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rats was determined; High,10527,Rattus norvegicus,50597,,,,,N,5237,,,,,In vivo,1,10116.0,CHEMBL623068,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10528,Rattus norvegicus,50597,,,,,N,6646,,,,,In vivo,1,10116.0,CHEMBL623069,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10529,Rattus norvegicus,50597,,,,,N,4449,,,,,In vivo,1,10116.0,CHEMBL623070,Intermediate,
A,1,BAO_0000218,Oral bioavailability was calculated in rat,10530,Rattus norvegicus,50597,,,,,N,6057,,,,,In vivo,1,10116.0,CHEMBL623071,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10531,Rattus norvegicus,50597,,,,,N,2552,,,,,In vivo,1,10116.0,CHEMBL623072,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10532,Rattus norvegicus,50597,,,,,N,5496,,,,,In vivo,1,10116.0,CHEMBL623073,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10533,Rattus norvegicus,50597,,,,,N,6484,,,,,In vivo,1,10116.0,CHEMBL623074,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10534,Rattus norvegicus,50597,,,,,N,6485,,,,,In vivo,1,10116.0,CHEMBL623075,Intermediate,
A,1,BAO_0000218,Oral bioavailability after i.v. administration,10535,Rattus norvegicus,50597,,,,,N,6616,,,,,In vivo,1,10116.0,CHEMBL623076,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10536,Rattus norvegicus,50597,,,,,N,4969,,,,,In vivo,1,10116.0,CHEMBL623077,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),10537,Rattus norvegicus,50597,,,,,N,5862,,,,,In vivo,1,10116.0,CHEMBL623078,Intermediate,
A,1,BAO_0000218,Oral bioavailability in Sprague-Dawley rats,10538,Rattus norvegicus,50597,,,,,N,4514,,,,,In vivo,1,10116.0,CHEMBL623079,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10539,Rattus norvegicus,50597,,,,,N,4514,,,,,In vivo,1,10116.0,CHEMBL623080,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10540,Rattus norvegicus,50597,,,,,N,4514,,,,,In vivo,1,10116.0,CHEMBL623081,Intermediate,
A,1,BAO_0000218,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,10541,Rattus norvegicus,50597,,,,,N,5546,,,,,In vivo,1,10116.0,CHEMBL623082,Intermediate,
A,1,BAO_0000218,Oral bioavailability in fasted rat,10542,Rattus norvegicus,50597,,,,,N,6168,,,,,In vivo,1,10116.0,CHEMBL874400,Intermediate,
A,1,BAO_0000218,Oral bioavailability in fed rat,10543,Rattus norvegicus,50597,,,,,N,6168,,,,,In vivo,1,10116.0,CHEMBL623083,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10544,Rattus norvegicus,50597,,,,,N,3624,,,,,In vivo,1,10116.0,CHEMBL623084,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10545,Rattus norvegicus,50597,,,,,N,5213,,,,,In vivo,1,10116.0,CHEMBL623085,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10546,Rattus norvegicus,50597,,,,,N,5496,,,,,In vivo,1,10116.0,CHEMBL623086,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10547,Rattus norvegicus,50597,,,,,N,5553,,,,,In vivo,1,10116.0,CHEMBL623087,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10548,Rattus norvegicus,50597,,,,,N,5833,,,,,In vivo,1,10116.0,CHEMBL623088,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10549,Rattus norvegicus,50597,,,,,N,5836,,,,,In vivo,1,10116.0,CHEMBL623089,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10550,Rattus norvegicus,50597,,,,,N,5865,,,,,In vivo,1,10116.0,CHEMBL623090,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10551,Rattus norvegicus,50597,,,,,N,5960,,,,,In vivo,1,10116.0,CHEMBL623091,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10552,Rattus norvegicus,50597,,,,,N,6249,,,,,In vivo,1,10116.0,CHEMBL623092,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10553,Rattus norvegicus,50597,,,,,N,6448,,,,,In vivo,1,10116.0,CHEMBL623093,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10554,Rattus norvegicus,50597,,,,,N,6453,,,,,In vivo,1,10116.0,CHEMBL874401,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10555,Rattus norvegicus,50597,,,,,N,6640,,,,,In vivo,1,10116.0,CHEMBL623094,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10556,Rattus norvegicus,50597,,,,,N,17607,,,,,In vivo,1,10116.0,CHEMBL623095,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after peroral administration at 10 mg/kg,10557,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL623096,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after peroral administration at 5 mg/kg,10558,Rattus norvegicus,50597,,,,,N,5939,,,,,In vivo,1,10116.0,CHEMBL624913,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),10559,Rattus norvegicus,50597,,,,,N,6281,,,,,In vivo,1,10116.0,CHEMBL624914,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,10560,Rattus norvegicus,50597,,,,,N,5874,,,,,In vivo,1,10116.0,CHEMBL624915,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat; Not measured,10561,Rattus norvegicus,50597,,,,,N,5213,,,,,In vivo,1,10116.0,CHEMBL624916,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10562,Rattus norvegicus,50597,,,,,N,4964,,,,,In vivo,1,10116.0,CHEMBL624917,Intermediate,
A,1,BAO_0000218,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,10563,Rattus norvegicus,50597,,,,,N,11020,,,,,,1,10116.0,CHEMBL625157,Intermediate,
A,1,BAO_0000218,In vitro metabolic potential in rat liver microsomes,10564,Rattus norvegicus,50597,,,Liver,,N,6251,,,,2107.0,,1,10116.0,CHEMBL625158,Intermediate,
A,1,BAO_0000218,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",10565,Rattus norvegicus,50597,,,,,N,1568,,,,,In vivo,1,10116.0,CHEMBL625159,Intermediate,
A,1,BAO_0000218,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",10566,Rattus norvegicus,50597,,,,,N,3032,,,,,In vivo,1,10116.0,CHEMBL625160,Intermediate,
A,1,BAO_0000218,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,10567,Rattus norvegicus,50597,,,,,N,3748,,,,,In vivo,1,10116.0,CHEMBL625161,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10568,Rattus norvegicus,50597,,,,,N,401,,,,,In vivo,1,10116.0,CHEMBL625162,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10569,Rattus norvegicus,50597,,,,,N,6512,,,,,In vivo,1,10116.0,CHEMBL625163,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rats at 10 mg/kg,10570,Rattus norvegicus,50597,,,,,N,17617,,,,,In vivo,1,10116.0,CHEMBL625164,Intermediate,
A,1,BAO_0000218,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,10571,Rattus norvegicus,50597,,,,,N,6679,,,,,In vivo,1,10116.0,CHEMBL625165,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10572,Rattus norvegicus,50597,,,,,N,6742,,,,,In vivo,1,10116.0,CHEMBL625166,Intermediate,
A,1,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,10573,Rattus norvegicus,50597,,,,,N,589,,,,,,1,10116.0,CHEMBL625167,Intermediate,
A,1,BAO_0000218,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,10574,Rattus norvegicus,50597,,,,,N,589,,,,,,1,10116.0,CHEMBL625168,Intermediate,
A,1,BAO_0000218,Plasma clearance of the compound,10575,Rattus norvegicus,50597,,,,,N,3185,,,,,In vivo,1,10116.0,CHEMBL625169,Intermediate,
A,1,BAO_0000218,Plasma clearance at 10 mg/kg in rat upon intravenous administration,10576,Rattus norvegicus,50597,,,,,N,17596,,,,,In vivo,1,10116.0,CHEMBL626264,Intermediate,
A,1,BAO_0000218,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,10577,Rattus norvegicus,50597,,,,,N,2713,,,,,In vivo,1,10116.0,CHEMBL626265,Intermediate,
A,1,BAO_0000218,The compound was tested for plasma clearance in rat,10578,Rattus norvegicus,50597,,,Plasma,,N,12500,,,,1969.0,In vivo,1,10116.0,CHEMBL626266,Intermediate,
A,1,BAO_0000218,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,10579,Rattus norvegicus,50597,,,Plasma,,N,12500,,,,1969.0,In vivo,1,10116.0,CHEMBL626267,Intermediate,
A,1,BAO_0000218,Plasma concentration upon oral administration of 1 mg/Kg in rats,10580,Rattus norvegicus,50597,,,,,N,2713,,,,,,1,10116.0,CHEMBL626268,Intermediate,
A,1,BAO_0000218,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,10581,Rattus norvegicus,50597,,,,,N,1446,,,,,,1,10116.0,CHEMBL626269,Intermediate,
A,1,BAO_0000218,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,10582,Rattus norvegicus,50597,,,,,N,6227,,,,,,1,10116.0,CHEMBL626270,Intermediate,
A,1,BAO_0000218,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,10583,Rattus norvegicus,50597,,,,,N,4709,,,,,,1,10116.0,CHEMBL626271,Intermediate,
A,1,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",10584,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626272,Intermediate,
A,1,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10585,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626273,Intermediate,
A,1,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",10586,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL875346,Intermediate,
A,1,BAO_0000218,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",10587,Rattus norvegicus,50597,,,,,N,5510,,,,,,1,10116.0,CHEMBL626274,Intermediate,
A,1,BAO_0000218,Compound was tested for protein binding in rat plasma,10588,Rattus norvegicus,50597,,,,,N,4514,,,,,,1,10116.0,CHEMBL626275,Intermediate,
A,1,BAO_0000218,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,10589,Rattus norvegicus,50597,,,,,N,2713,,,,,,1,10116.0,CHEMBL624646,Intermediate,
A,1,BAO_0000218,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,10590,Rattus norvegicus,50597,,,,,N,2713,,,,,,1,10116.0,CHEMBL624647,Intermediate,
A,1,BAO_0000218,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,10591,Rattus norvegicus,50597,,,Liver,,N,5340,,,,2107.0,,1,10116.0,CHEMBL624648,Intermediate,
A,1,BAO_0000218,Area under curve ratio was determined (po/iv) in rat,10592,Rattus norvegicus,50597,,,,,N,12058,,,,,,1,10116.0,CHEMBL624649,Intermediate,
A,1,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,10593,Rattus norvegicus,50597,,,,,N,11195,,,,,,1,10116.0,CHEMBL624650,Intermediate,
A,1,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,10594,Rattus norvegicus,50597,,,,,N,11195,,,,,,1,10116.0,CHEMBL624651,Intermediate,
A,1,BAO_0000218,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,10595,Rattus norvegicus,50597,,,,,N,11195,,,,,,1,10116.0,CHEMBL624652,Intermediate,
A,1,BAO_0000218,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,10596,Rattus norvegicus,50597,,,,,N,6495,,,,,,1,10116.0,CHEMBL624653,Intermediate,
A,1,BAO_0000218,Ratio of AUCbrain to AUCplasma,10597,Rattus norvegicus,50597,,,,,N,6078,,,,,,1,10116.0,CHEMBL624654,Intermediate,
A,1,BAO_0000218,Ratio of brain to plasma,10598,Rattus norvegicus,50597,,,,,N,5656,,,,,,1,10116.0,CHEMBL624655,Intermediate,
A,1,BAO_0000218,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,10599,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL624656,Intermediate,
A,1,BAO_0000218,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10600,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL624657,Intermediate,
A,1,BAO_0000218,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,10601,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL624658,Intermediate,
A,1,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10602,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL624659,Intermediate,
A,1,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10603,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL624660,Intermediate,
A,1,BAO_0000218,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10604,Rattus norvegicus,50597,,,,,N,10130,,,,,,1,10116.0,CHEMBL624661,Intermediate,
A,1,BAO_0000218,Steady state brain :blood ratio was determined,10605,Rattus norvegicus,50597,,,,,N,5213,,,,,,1,10116.0,CHEMBL624662,Intermediate,
A,1,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,10606,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL625199,Intermediate,
A,1,BAO_0000218,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10607,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL625200,Intermediate,
A,1,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,10608,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL625201,Intermediate,
A,1,BAO_0000218,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,10609,Rattus norvegicus,50597,,,,,N,4910,,,,,,1,10116.0,CHEMBL625202,Intermediate,
A,1,BAO_0000218,Percentage recovery after 3h incubation with rat hapatocytes was determined,10610,Rattus norvegicus,50597,,,,,N,2083,,,,,,1,10116.0,CHEMBL625203,Intermediate,
A,1,BAO_0000218,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,10611,Rattus norvegicus,50597,,,,,N,2082,,,,,,1,10116.0,CHEMBL625204,Intermediate,
A,1,BAO_0000218,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,10612,Rattus norvegicus,50597,,,,,N,2082,,,,,,1,10116.0,CHEMBL625205,Intermediate,
A,1,BAO_0000218,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,10613,Rattus norvegicus,50597,,,,,N,6351,,,,,,1,10116.0,CHEMBL625206,Intermediate,
A,0,BAO_0000019,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",10614,,22224,,,,,U,14583,,,,,,1,,CHEMBL625207,Autocuration,
A,0,BAO_0000019,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,10615,,22224,,,,,U,14583,,,,,,1,,CHEMBL625208,Autocuration,
A,1,BAO_0000218,In vivo absorption in Caco-2 cell line monolayers was determined,10616,Homo sapiens,50587,,,,Caco-2,N,4608,,495.0,,,,1,9606.0,CHEMBL625209,Intermediate,
P,0,BAO_0000100,Calculated partition coefficient (clogP),10617,,22229,,,,,U,13668,,,,,,1,,CHEMBL625210,Autocuration,
A,1,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rat,10618,Rattus norvegicus,50597,,,,,N,5669,,,,,,1,10116.0,CHEMBL625211,Intermediate,
A,1,BAO_0000218,Area under curve was determine after peroral administration at 10 mpk in Rhesus,10619,Macaca mulatta,50797,,,,,N,5669,,,,,,1,9544.0,CHEMBL625212,Intermediate,
A,1,BAO_0000218,Area under curve was determine after peroral administration at 160 mpk in Rat,10620,Rattus norvegicus,50597,,,,,N,5669,,,,,,1,10116.0,CHEMBL625213,Intermediate,
A,1,BAO_0000218,Area under curve was determine after peroral administration at 20 mpk in Rat,10621,Rattus norvegicus,50597,,,,,N,5669,,,,,,1,10116.0,CHEMBL625214,Intermediate,
A,1,BAO_0000218,Area under curve was determine after peroral administration at 50 mpk in Rat,10622,Rattus norvegicus,50597,,,,,N,5669,,,,,,1,10116.0,CHEMBL874542,Intermediate,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (AlogP),10623,,22229,,,,,U,6472,,,,,,1,,CHEMBL625215,Autocuration,
A,0,BAO_0000019,Activated partial thromboplastin time measured,10624,,22224,,,,,U,15106,,,,,,1,,CHEMBL625216,Autocuration,
P,0,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),10625,,22224,,,,,U,15207,,,,,,1,,CHEMBL625217,Autocuration,
P,0,BAO_0000100,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),10626,,22224,,,,,U,15207,,,,,,1,,CHEMBL625218,Autocuration,
A,1,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,10627,Canis lupus familiaris,50588,,,Plasma,,N,13941,,,,1969.0,,1,9615.0,CHEMBL622864,Intermediate,
A,1,BAO_0000218,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,10628,Rattus norvegicus,50597,,,Plasma,,N,13941,,,,1969.0,,1,10116.0,CHEMBL622865,Intermediate,
A,1,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,10629,Rattus norvegicus,50597,,,Plasma,,N,13941,,,,1969.0,,1,10116.0,CHEMBL622866,Intermediate,
A,1,BAO_0000218,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,10630,Canis lupus familiaris,50588,,,Plasma,,N,13941,,,,1969.0,,1,9615.0,CHEMBL622867,Intermediate,
A,1,BAO_0000218,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,10631,Cavia porcellus,50512,,,Plasma,,N,15240,,,,1969.0,,1,10141.0,CHEMBL876808,Intermediate,
A,0,BAO_0000019,AUC in brain,10632,,22224,,,Brain,,U,10655,,,,955.0,,1,,CHEMBL627725,Autocuration,
A,0,BAO_0000019,AUC in serum,10633,,22224,,,Serum,,U,10655,,,,1977.0,,1,,CHEMBL627726,Autocuration,
A,0,BAO_0000019,AUC was determined,10634,,22224,,,Plasma,,U,6504,,,,1969.0,,1,,CHEMBL627727,Autocuration,
A,0,BAO_0000019,AUC of the compound.,10635,,22224,,,Plasma,,U,10615,,,,1969.0,,1,,CHEMBL627728,Autocuration,
A,0,BAO_0000019,AUC value (0-4 hr),10636,,22224,,,Plasma,,U,10353,,,,1969.0,,1,,CHEMBL627729,Autocuration,
A,0,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",10637,,22224,,,Plasma,,U,14907,,,,1969.0,,1,,CHEMBL627730,Autocuration,
A,0,BAO_0000019,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,10638,,22224,,,Plasma,,U,14907,,,,1969.0,,1,,CHEMBL627731,Autocuration,
A,0,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",10639,,22224,,,Plasma,,U,14907,,,,1969.0,,1,,CHEMBL627732,Autocuration,
A,0,BAO_0000019,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",10640,,22224,,,Plasma,,U,14907,,,,1969.0,,1,,CHEMBL627733,Autocuration,
A,1,BAO_0000218,AUC(area under curve) was determined after intravenous administration in rats,10641,Rattus norvegicus,50597,,,Plasma,,N,16359,,,,1969.0,,1,10116.0,CHEMBL627734,Intermediate,
A,1,BAO_0000218,AUC(area under curve) was determined after oral administration in rats,10642,Rattus norvegicus,50597,,,Plasma,,N,16359,,,,1969.0,,1,10116.0,CHEMBL627735,Intermediate,
A,1,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,10643,Cavia porcellus,50512,,,Plasma,,N,15240,,,,1969.0,,1,10141.0,CHEMBL627736,Intermediate,
A,1,BAO_0000218,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,10644,Rattus norvegicus,50597,,,Plasma,,N,15240,,,,1969.0,,1,10116.0,CHEMBL876809,Intermediate,
A,0,BAO_0000019,Area Under Curve after oral dosing of 100 uM/Kg,10645,,22224,,,,,U,15469,,,,,,1,,CHEMBL627737,Autocuration,
A,0,BAO_0000019,Area Under Curve after oral dosing of 30 uM/Kg,10646,,22224,,,,,U,15469,,,,,,1,,CHEMBL627738,Autocuration,
A,0,BAO_0000019,Area Under Curve was measured by ploting the graph between concentration verses time,10647,,22224,,,,,U,13520,,,,,,1,,CHEMBL627739,Autocuration,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,10648,Canis lupus familiaris,50588,,,,,N,17025,,,,,,1,9615.0,CHEMBL626143,Intermediate,
A,0,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,10649,Simiiformes,22224,,,,,U,17025,,,,,,1,314293.0,CHEMBL626144,Autocuration,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,10650,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,,1,9986.0,CHEMBL626145,Intermediate,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,10651,Rattus norvegicus,50597,,,,,N,17025,,,,,,1,10116.0,CHEMBL626146,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,10652,Rattus norvegicus,50597,,,Blood,,N,12032,,,,178.0,,1,10116.0,CHEMBL626147,Intermediate,
A,0,BAO_0000019,Area under curve (AUC) was determined,10653,,22224,,,,,U,10291,,,,,,1,,CHEMBL626148,Autocuration,
A,0,BAO_0000218,Area under curve (AUC) following ip administration at 1 mg/kg,10654,,22224,,,,,U,5767,,,,,,1,,CHEMBL626149,Autocuration,
A,0,BAO_0000019,Area under curve (AUC) was determined; ND is Not determined,10655,,22224,,,,,U,1434,,,,,,1,,CHEMBL626150,Autocuration,
A,1,BAO_0000218,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,10656,Canis lupus familiaris,50588,,,,,N,14925,,,,,,1,9615.0,CHEMBL626151,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,10657,Canis lupus familiaris,50588,,,,,N,14925,,,,,,1,9615.0,CHEMBL626152,Intermediate,
A,1,BAO_0000218,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,10658,Canis lupus familiaris,50588,,,,,N,14925,,,,,,1,9615.0,CHEMBL626153,Intermediate,
A,0,BAO_0000019,Area under curve (AUR) was determined,10659,,22224,,,,,U,1434,,,,,,1,,CHEMBL626154,Autocuration,
A,0,BAO_0000019,Area under curve at 1 uM/dg administered intravenously,10660,,22224,,,,,U,11883,,,,,,1,,CHEMBL626155,Autocuration,
A,0,BAO_0000019,Area under curve at 10 uM/dg administered perorally,10661,,22224,,,,,U,11883,,,,,,1,,CHEMBL626156,Autocuration,
A,0,BAO_0000019,Area under curve at 2 uM/dg administered intravenously,10662,,22224,,,,,U,11883,,,,,,1,,CHEMBL626157,Autocuration,
A,0,BAO_0000019,Area under curve at 20 uM/dg administered perorally,10663,,22224,,,,,U,11883,,,,,,1,,CHEMBL626158,Autocuration,
A,1,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in dog,10664,Canis lupus familiaris,50588,,,,,N,15233,,,,,,1,9615.0,CHEMBL626159,Intermediate,
A,1,BAO_0000218,Area under curve at a peroral dose of 3 mg/kg in rat,10665,Rattus norvegicus,50597,,,,,N,15233,,,,,,1,10116.0,CHEMBL626160,Intermediate,
A,1,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in dog,10666,Canis lupus familiaris,50588,,,,,N,15233,,,,,,1,9615.0,CHEMBL626161,Intermediate,
A,1,BAO_0000218,Area under curve at an iv dose of 1 mg/kg in rat,10667,Rattus norvegicus,50597,,,,,N,15233,,,,,,1,10116.0,CHEMBL626162,Intermediate,
A,0,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,10668,,22224,,,,,U,12978,,,,,,1,,CHEMBL626163,Autocuration,
A,0,BAO_0000019,Area under curve gives the effective duration for the angiotensin II antagonist effect.,10669,,22224,,,,,U,12978,,,,,,1,,CHEMBL626164,Autocuration,
A,1,BAO_0000218,Area under curve measured as conc vs time after intravenous administration to mice.,10670,Mus musculus,50594,,,,,N,11355,,,,,,1,10090.0,CHEMBL626165,Intermediate,
A,1,BAO_0000218,Area under curve measured as conc vs time after peroral administration to mice.,10671,Mus musculus,50594,,,,,N,11355,,,,,,1,10090.0,CHEMBL626166,Intermediate,
A,1,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,10672,Canis lupus familiaris,50588,,,,,N,12923,,,,,,1,9615.0,CHEMBL626167,Intermediate,
A,1,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,10673,Canis lupus familiaris,50588,,,,,N,12923,,,,,,1,9615.0,CHEMBL626168,Intermediate,
A,1,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,10674,Canis lupus familiaris,50588,,,,,N,12923,,,,,,1,9615.0,CHEMBL877463,Intermediate,
A,1,BAO_0000218,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,10675,Canis lupus familiaris,50588,,,,,N,12923,,,,,,1,9615.0,CHEMBL626169,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,10676,Rattus norvegicus,50597,,,Heart,,N,17738,,,,948.0,In vivo,1,10116.0,CHEMBL626170,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,10677,Rattus norvegicus,50597,,,Heart,,N,17738,,,,948.0,In vivo,1,10116.0,CHEMBL626171,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,10678,Rattus norvegicus,50597,,,Heart,,N,17738,,,,948.0,In vivo,1,10116.0,CHEMBL626172,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,10679,Rattus norvegicus,50597,,,Heart,,N,17738,,,,948.0,In vivo,1,10116.0,CHEMBL626173,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,10680,Rattus norvegicus,50597,,,Kidney,,N,17738,,,,2113.0,In vivo,1,10116.0,CHEMBL626174,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,10681,Rattus norvegicus,50597,,,Kidney,,N,17738,,,,2113.0,In vivo,1,10116.0,CHEMBL626175,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,10682,Rattus norvegicus,50597,,,Kidney,,N,17738,,,,2113.0,In vivo,1,10116.0,CHEMBL626176,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,10683,Rattus norvegicus,50597,,,Kidney,,N,17738,,,,2113.0,In vivo,1,10116.0,CHEMBL626177,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,10684,Rattus norvegicus,50597,,,Kidney,,N,17738,,,,2113.0,In vivo,1,10116.0,CHEMBL622499,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,10685,Rattus norvegicus,50597,,,Liver,,N,17738,,,,2107.0,In vivo,1,10116.0,CHEMBL622500,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,10686,Rattus norvegicus,50597,,,Liver,,N,17738,,,,2107.0,In vivo,1,10116.0,CHEMBL622501,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,10687,Rattus norvegicus,50597,,,Liver,,N,17738,,,,2107.0,In vivo,1,10116.0,CHEMBL622502,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,10688,Rattus norvegicus,50597,,,Liver,,N,17738,,,,2107.0,In vivo,1,10116.0,CHEMBL622503,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,10689,Rattus norvegicus,50597,,,Liver,,N,17738,,,,2107.0,In vivo,1,10116.0,CHEMBL877614,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,10690,Rattus norvegicus,50597,,,Lung,,N,17738,,,,2048.0,In vivo,1,10116.0,CHEMBL624839,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,10691,Rattus norvegicus,50597,,,Lung,,N,17738,,,,2048.0,In vivo,1,10116.0,CHEMBL624840,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,10692,Rattus norvegicus,50597,,,Lung,,N,17738,,,,2048.0,In vivo,1,10116.0,CHEMBL624841,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,10693,Rattus norvegicus,50597,,,Lung,,N,17738,,,,2048.0,In vivo,1,10116.0,CHEMBL624842,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,10694,Rattus norvegicus,50597,,,Muscle tissue,,N,17738,,,,2385.0,In vivo,1,10116.0,CHEMBL624843,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,10695,Rattus norvegicus,50597,,,Muscle tissue,,N,17738,,,,2385.0,In vivo,1,10116.0,CHEMBL624844,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,10696,Rattus norvegicus,50597,,,Muscle tissue,,N,17738,,,,2385.0,In vivo,1,10116.0,CHEMBL624845,Intermediate,
A,1,BAO_0000218,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,10697,Rattus norvegicus,50597,,,Muscle tissue,,N,17738,,,,2385.0,In vivo,1,10116.0,CHEMBL621904,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,10698,Rattus norvegicus,50597,,,Blood,,N,11195,,,,178.0,In vivo,1,10116.0,CHEMBL621905,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,10699,Rattus norvegicus,50597,,,Blood,,N,11195,,,,178.0,In vivo,1,10116.0,CHEMBL874382,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,10700,Rattus norvegicus,50597,,,Blood,,N,11195,,,,178.0,In vivo,1,10116.0,CHEMBL621906,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,10701,Rattus norvegicus,50597,,,Brain,,N,11195,,,,955.0,In vivo,1,10116.0,CHEMBL621907,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,10702,Rattus norvegicus,50597,,,Brain,,N,11195,,,,955.0,In vivo,1,10116.0,CHEMBL622096,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,10703,Rattus norvegicus,50597,,,Brain,,N,11195,,,,955.0,In vivo,1,10116.0,CHEMBL622097,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,10704,Rattus norvegicus,50597,,,Heart,,N,11195,,,,948.0,In vivo,1,10116.0,CHEMBL622098,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,10705,Rattus norvegicus,50597,,,Heart,,N,11195,,,,948.0,In vivo,1,10116.0,CHEMBL622099,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,10706,Rattus norvegicus,50597,,,Heart,,N,11195,,,,948.0,In vivo,1,10116.0,CHEMBL622100,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,10707,Rattus norvegicus,50597,,,Kidney,,N,11195,,,,2113.0,In vivo,1,10116.0,CHEMBL622101,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,10708,Rattus norvegicus,50597,,,Kidney,,N,11195,,,,2113.0,In vivo,1,10116.0,CHEMBL622102,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,10709,Rattus norvegicus,50597,,,Kidney,,N,11195,,,,2113.0,In vivo,1,10116.0,CHEMBL622103,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,10710,Rattus norvegicus,50597,,,Liver,,N,11195,,,,2107.0,In vivo,1,10116.0,CHEMBL622104,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,10711,Rattus norvegicus,50597,,,Liver,,N,11195,,,,2107.0,In vivo,1,10116.0,CHEMBL622105,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,10712,Rattus norvegicus,50597,,,Liver,,N,11195,,,,2107.0,In vivo,1,10116.0,CHEMBL622106,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,10713,Rattus norvegicus,50597,,,Lung,,N,11195,,,,2048.0,In vivo,1,10116.0,CHEMBL622107,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,10714,Rattus norvegicus,50597,,,Lung,,N,11195,,,,2048.0,In vivo,1,10116.0,CHEMBL622108,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,10715,Rattus norvegicus,50597,,,Lung,,N,11195,,,,2048.0,In vivo,1,10116.0,CHEMBL622109,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,10716,Rattus norvegicus,50597,,,Muscle tissue,,N,11195,,,,2385.0,In vivo,1,10116.0,CHEMBL622110,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,10717,Rattus norvegicus,50597,,,Muscle tissue,,N,11195,,,,2385.0,In vivo,1,10116.0,CHEMBL622111,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,10718,Rattus norvegicus,50597,,,Muscle tissue,,N,11195,,,,2385.0,In vivo,1,10116.0,CHEMBL874383,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,10719,Rattus norvegicus,50597,,,Zone of skin,,N,11195,,,,14.0,In vivo,1,10116.0,CHEMBL622112,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,10720,Rattus norvegicus,50597,,,Zone of skin,,N,11195,,,,14.0,In vivo,1,10116.0,CHEMBL622113,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,10721,Rattus norvegicus,50597,,,Zone of skin,,N,11195,,,,14.0,In vivo,1,10116.0,CHEMBL622114,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,10722,Rattus norvegicus,50597,,,Spleen,,N,11195,,,,2106.0,In vivo,1,10116.0,CHEMBL622115,Intermediate,
A,1,BAO_0000218,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,10723,Rattus norvegicus,50597,,,Spleen,,N,11195,,,,2106.0,In vivo,1,10116.0,CHEMBL622116,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10724,Rattus norvegicus,50597,,,,,N,6193,,,,,In vivo,1,10116.0,CHEMBL622117,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10725,Rattus norvegicus,50597,,,,,N,6803,,,,,In vivo,1,10116.0,CHEMBL622118,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rats at 6 mg/kg,10726,Rattus norvegicus,50597,,,,,N,6647,,,,,In vivo,1,10116.0,CHEMBL622119,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 6 mg/kg),10727,Rattus norvegicus,50597,,,,,N,6647,,,,,In vivo,1,10116.0,CHEMBL622120,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rats at 6 mg/kg dose; Not tested,10728,Rattus norvegicus,50597,,,,,N,6647,,,,,In vivo,1,10116.0,CHEMBL622121,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10729,Rattus norvegicus,50597,,,,,N,6640,,,,,In vivo,1,10116.0,CHEMBL622122,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10730,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL622123,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10731,Rattus norvegicus,50597,,,,,N,6641,,,,,In vivo,1,10116.0,CHEMBL622124,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10732,Rattus norvegicus,50597,,,,,N,6642,,,,,In vivo,1,10116.0,CHEMBL622125,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10733,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL622126,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10734,Rattus norvegicus,50597,,,,,N,6141,,,,,In vivo,1,10116.0,CHEMBL620455,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10735,Rattus norvegicus,50597,,,,,N,4390,,,,,In vivo,1,10116.0,CHEMBL620456,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10736,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL620457,Intermediate,
A,1,BAO_0000218,Oral bioavailability was evaluated; Not tested,10737,Rattus norvegicus,50597,,,,,N,5472,,,,,In vivo,1,10116.0,CHEMBL620458,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10738,Rattus norvegicus,50597,,,,,N,5438,,,,,In vivo,1,10116.0,CHEMBL620459,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat by oral dosing,10739,Rattus norvegicus,50597,,,,,N,4883,,,,,In vivo,1,10116.0,CHEMBL620460,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg p.o.),10740,Rattus norvegicus,50597,,,,,N,1908,,,,,In vivo,1,10116.0,CHEMBL620461,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),10741,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620462,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10742,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620463,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),10743,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620464,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),10744,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620465,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),10745,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620466,Intermediate,
A,1,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,10746,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620467,Intermediate,
A,1,BAO_0000218,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,10747,Rattus norvegicus,50597,,,,,N,4853,,,,,In vivo,1,10116.0,CHEMBL620468,Intermediate,
A,1,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,10748,Rattus norvegicus,50597,,,,,N,12873,,,,,In vivo,1,10116.0,CHEMBL620469,Intermediate,
A,1,BAO_0000218,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,10749,Rattus norvegicus,50597,,,,,N,12873,,,,,In vivo,1,10116.0,CHEMBL620470,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10750,Rattus norvegicus,50597,,,,,N,3169,,,,,In vivo,1,10116.0,CHEMBL620471,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10751,Rattus norvegicus,50597,,,,,N,6305,,,,,In vivo,1,10116.0,CHEMBL620472,Intermediate,
A,1,BAO_0000218,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,10752,Rattus norvegicus,50597,,,,,N,4762,,,,,In vivo,1,10116.0,CHEMBL620473,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10753,Rattus norvegicus,50597,,,,,N,17847,,,,,In vivo,1,10116.0,CHEMBL620474,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),10754,Rattus norvegicus,50597,,,,,N,6211,,,,,In vivo,1,10116.0,CHEMBL620475,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10755,Rattus norvegicus,50597,,,,,N,6011,,,,,In vivo,1,10116.0,CHEMBL620476,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10756,Rattus norvegicus,50597,,,,,N,6317,,,,,In vivo,1,10116.0,CHEMBL620477,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,10757,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL620478,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,10758,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL618768,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after oral administration at 13 mg/kg dose,10759,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL618769,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,10760,Rattus norvegicus,50597,,,,,N,6644,,,,,In vivo,1,10116.0,CHEMBL618770,Intermediate,
A,1,BAO_0000218,Oral bioavailability (dose 20 mg/kg p.o.),10761,Rattus norvegicus,50597,,,,,N,6113,,,,,In vivo,1,10116.0,CHEMBL618771,Intermediate,
A,1,BAO_0000218,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,10762,Rattus norvegicus,50597,,,,,N,5937,,,,,In vivo,1,10116.0,CHEMBL618772,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat at 10 mg/kg of the compound,10763,Rattus norvegicus,50597,,,,,N,5711,,,,,In vivo,1,10116.0,CHEMBL618773,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,10764,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL875842,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 3 mg/kg i.v.),10765,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL618774,Intermediate,
A,1,BAO_0000218,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,10766,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL618775,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 60 mg/kg p.o.),10767,Rattus norvegicus,50597,,,,,N,17717,,,,,In vivo,1,10116.0,CHEMBL618776,Intermediate,
A,1,BAO_0000218,Percent bioavailability (F) in rats after iv administration,10768,Rattus norvegicus,50597,,,,,N,4722,,,,,In vivo,1,10116.0,CHEMBL618777,Intermediate,
A,1,BAO_0000218,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,10769,Rattus norvegicus,50597,,,,,N,4722,,,,,In vivo,1,10116.0,CHEMBL618778,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 5 uM/kg p.o.),10770,Rattus norvegicus,50597,,,,,N,4353,,,,,In vivo,1,10116.0,CHEMBL618779,Intermediate,
A,1,BAO_0000218,Oral bioavailability,10771,Rattus norvegicus,50597,,,,,N,15662,,,,,In vivo,1,10116.0,CHEMBL618780,Intermediate,
A,1,BAO_0000218,Bioavailability in rat (dose 2 mg/kg p.o.),10772,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL618781,Intermediate,
A,1,BAO_0000218,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,10773,Rattus norvegicus,50597,,,,,N,4756,,,,,In vivo,1,10116.0,CHEMBL618782,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg),10774,Rattus norvegicus,50597,,,,,N,3436,,,,,In vivo,1,10116.0,CHEMBL618783,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10775,Rattus norvegicus,50597,,,,,N,17800,,,,,In vivo,1,10116.0,CHEMBL618784,Intermediate,
A,1,BAO_0000218,Percent oral bioavailability evaluated in rat,10776,Rattus norvegicus,50597,,,,,N,15762,,,,,In vivo,1,10116.0,CHEMBL618785,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10777,Rattus norvegicus,50597,,,,,N,5089,,,,,In vivo,1,10116.0,CHEMBL618786,Intermediate,
A,1,BAO_0000218,Percent oral bioavailability in rat; Not determined,10778,Rattus norvegicus,50597,,,,,N,5089,,,,,In vivo,1,10116.0,CHEMBL618787,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat,10779,Rattus norvegicus,50597,,,,,N,3185,,,,,In vivo,1,10116.0,CHEMBL618788,Intermediate,
A,1,BAO_0000218,Bioavailability in rat,10780,Rattus norvegicus,50597,,,,,N,5145,,,,,In vivo,1,10116.0,CHEMBL618789,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),10781,Rattus norvegicus,50597,,,,,N,3457,,,,,In vivo,1,10116.0,CHEMBL618790,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),10782,Rattus norvegicus,50597,,,,,N,3457,,,,,In vivo,1,10116.0,CHEMBL618791,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,10783,Rattus norvegicus,50597,,,,,N,5983,,,,,In vivo,1,10116.0,CHEMBL875843,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat (dose 20 mg/kg p.o.),10784,Rattus norvegicus,50597,,,,,N,5739,,,,,In vivo,1,10116.0,CHEMBL618792,Intermediate,
A,1,BAO_0000218,Cmax at a dose of 30 mg/kg in rat,10785,Rattus norvegicus,50597,,,,,N,3579,,,,,In vivo,1,10116.0,CHEMBL623395,Intermediate,
A,0,BAO_0000218,Cmax in monkeys at a dose of 1 mg/kg,10786,Simiiformes,22224,,,,,U,17788,,,,,In vivo,1,314293.0,CHEMBL623396,Autocuration,
A,1,BAO_0000218,Cmax in rat,10787,Rattus norvegicus,50597,,,,,N,14956,,,,,In vivo,1,10116.0,CHEMBL623397,Intermediate,
A,1,BAO_0000218,Cmax in rats at a dose of 1 mg/kg,10788,Rattus norvegicus,50597,,,,,N,17788,,,,,In vivo,1,10116.0,CHEMBL623398,Intermediate,
A,1,BAO_0000218,Cmax was measured in mice after an oral dose of 50 mg/kg.,10789,Mus musculus,50594,,,,,N,9750,,,,,In vivo,1,10090.0,CHEMBL623399,Intermediate,
A,0,BAO_0000218,"Cmax value at a dose of 12.7 uM/kg, po",10790,,22224,,,,,U,12767,,,,,In vivo,1,,CHEMBL623400,Autocuration,
A,0,BAO_0000218,"Cmax value at a dose of 6.3 uM/kg, iv",10791,,22224,,,,,U,12767,,,,,In vivo,1,,CHEMBL623401,Autocuration,
A,0,BAO_0000218,"Cmax value at a dose of 7.1 uM/kg, iv",10792,,22224,,,,,U,12767,,,,,In vivo,1,,CHEMBL623402,Autocuration,
A,0,BAO_0000218,Cmax value of compound was determined after 1 hr,10793,,22224,,,,,U,12703,,,,,In vivo,1,,CHEMBL623403,Autocuration,
A,0,BAO_0000218,Cmax value of the compound,10794,,22224,,,,,U,15778,,,,,In vivo,1,,CHEMBL623404,Autocuration,
A,1,BAO_0000218,Cmax value administered intraintestinal in rats.,10795,Rattus norvegicus,50597,,,,,N,12818,,,,,In vivo,1,10116.0,CHEMBL625997,Intermediate,
A,1,BAO_0000218,Cmax value administered perorally was determined in rat; Not determined,10796,Rattus norvegicus,50597,,,,,N,14964,,,,,In vivo,1,10116.0,CHEMBL625998,Intermediate,
A,0,BAO_0000218,Cmax value at the dose of 2.3 mg/kg,10797,,22224,,,,,U,15808,,,,,In vivo,1,,CHEMBL625999,Autocuration,
A,0,BAO_0000218,Cmax value at the dose of 5 mg/kg,10798,,22224,,,,,U,15808,,,,,In vivo,1,,CHEMBL626000,Autocuration,
A,0,BAO_0000218,Cmax value in the period of 8 hr after dosing. ,10799,,22224,,,,,U,15778,,,,,In vivo,1,,CHEMBL626001,Autocuration,
A,0,BAO_0000218,Cmax value at a oral dose of 20 mg/kg; Not tested,10800,,22224,,,,,U,3715,,,,,In vivo,1,,CHEMBL626002,Autocuration,
A,0,BAO_0000218,Cmax value at a oral dose of 20 mg/kg,10801,,22224,,,,,U,3715,,,,,In vivo,1,,CHEMBL626003,Autocuration,
A,1,BAO_0000218,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,10802,Rattus norvegicus,50597,,,,,N,1446,,,,,In vivo,1,10116.0,CHEMBL626004,Intermediate,
A,1,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,10803,Cavia porcellus,50512,,,,,N,15240,,,,,In vivo,1,10141.0,CHEMBL626005,Intermediate,
A,1,BAO_0000218,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,10804,Rattus norvegicus,50597,,,,,N,15240,,,,,In vivo,1,10116.0,CHEMBL626006,Intermediate,
A,1,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,10805,Rattus norvegicus,50597,,,Plasma,,N,14810,,,,1969.0,In vivo,1,10116.0,CHEMBL626007,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,10806,Mus musculus,50594,,,Plasma,,N,14239,,,,1969.0,In vivo,1,10090.0,CHEMBL626008,Intermediate,
A,1,BAO_0000218,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,10807,Canis lupus familiaris,50588,,,Liver,,N,12555,,,,2107.0,In vivo,1,9615.0,CHEMBL626009,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,10808,Canis lupus familiaris,50588,,,,,N,10754,,,,,In vivo,1,9615.0,CHEMBL626010,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10809,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,In vivo,1,10090.0,CHEMBL626011,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10810,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,In vivo,1,10090.0,CHEMBL626012,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10811,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,In vivo,1,10090.0,CHEMBL626013,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10812,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,In vivo,1,10090.0,CHEMBL626014,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10813,Mus musculus,50594,,,Blood,,N,10754,,,,178.0,In vivo,1,10090.0,CHEMBL877496,Intermediate,
F,1,BAO_0000218,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,10814,Canis lupus familiaris,50588,,,,,N,14600,,,,,In vivo,1,9615.0,CHEMBL626015,Intermediate,
F,1,BAO_0000218,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,10815,Canis lupus familiaris,50588,,,,,N,14600,,,,,In vivo,1,9615.0,CHEMBL626016,Intermediate,
F,1,BAO_0000218,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,10816,Canis lupus familiaris,50588,,,,,N,14600,,,,,In vivo,1,9615.0,CHEMBL626017,Intermediate,
A,1,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,10817,Canis lupus familiaris,50588,,,Plasma,,N,13543,,,,1969.0,In vivo,1,9615.0,CHEMBL626018,Intermediate,
A,1,BAO_0000218,Bioavailability as maximal plasma concentration in dogs,10818,Canis lupus familiaris,50588,,,Plasma,,N,13543,,,,1969.0,In vivo,1,9615.0,CHEMBL626692,Intermediate,
A,1,BAO_0000218,Bioavailability as maximal plasma concentration in rats,10819,Rattus norvegicus,50597,,,Plasma,,N,13543,,,,1969.0,In vivo,1,10116.0,CHEMBL626693,Intermediate,
A,0,BAO_0000218,Bioavailability as maximal plasma concentration in rats,10820,Rattus norvegicus,22224,,,Plasma,,U,13543,,,,1969.0,In vivo,1,10116.0,CHEMBL626694,Autocuration,
A,1,BAO_0000218,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10821,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626695,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10822,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626696,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10823,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626697,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,10824,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626859,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10825,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626860,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,10826,Canis lupus familiaris,50588,,,Blood,,N,14600,,,,178.0,In vivo,1,9615.0,CHEMBL626861,Intermediate,
A,1,BAO_0000218,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,10827,Rattus norvegicus,50597,,,,,N,14681,,,,,In vivo,1,10116.0,CHEMBL626296,Intermediate,
A,0,BAO_0000218,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,10828,,22224,,,,,U,15905,,,,,In vivo,1,,CHEMBL626297,Autocuration,
A,0,BAO_0000218,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,10829,,22224,,,Plasma,,U,15905,,,,1969.0,In vivo,1,,CHEMBL626298,Autocuration,
A,1,BAO_0000218,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",10830,Rattus norvegicus,50597,,,Plasma,,N,13304,,,,1969.0,In vivo,1,10116.0,CHEMBL626299,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,10831,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,In vivo,1,10116.0,CHEMBL626300,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,10832,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,In vivo,1,10116.0,CHEMBL626301,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,10833,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,In vivo,1,10116.0,CHEMBL626962,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,10834,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,In vivo,1,10116.0,CHEMBL626963,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,10835,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,In vivo,1,10116.0,CHEMBL626964,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,10836,Macaca fascicularis,100710,,,Plasma,,N,14839,,,,1969.0,In vivo,1,9541.0,CHEMBL626965,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10837,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL626966,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10838,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL626967,Intermediate,
A,1,BAO_0000218,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,10839,Macaca fascicularis,100710,,,Plasma,,N,14839,,,,1969.0,In vivo,1,9541.0,CHEMBL626968,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,10840,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL626969,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,10841,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL627126,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,10842,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631276,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,10843,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631277,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,10844,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631278,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,10845,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL874457,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,10846,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631279,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,10847,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631280,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,10848,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631281,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,10849,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631968,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,10850,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631969,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,10851,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631970,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,10852,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631971,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,10853,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL631972,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,10854,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL630435,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,10855,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL630436,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,10856,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL630437,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,10857,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL630438,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,10858,Rattus norvegicus,50597,,,Heart,,N,8418,,,,948.0,,1,10116.0,CHEMBL630439,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,10859,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL630440,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,10860,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL630441,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,10861,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL630442,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,10862,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL625234,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,10863,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL625235,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,10864,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL625236,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,10865,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL625237,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,10866,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626125,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,10867,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626126,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,10868,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626127,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,10869,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626128,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,10870,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626129,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,10871,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626130,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,10872,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626131,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,10873,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626132,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,10874,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626752,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,10875,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626753,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,10876,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626754,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,10877,Rattus norvegicus,50597,,,Kidney,,N,8418,,,,2113.0,,1,10116.0,CHEMBL626755,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,10878,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL626756,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,10879,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL626757,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,10880,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL626758,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,10881,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL626759,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,10882,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL626760,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),10883,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626394,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,10884,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626395,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),10885,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626396,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),10886,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626397,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),10887,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626398,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),10888,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL626399,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,10889,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL874653,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10890,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626400,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),10891,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626401,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),10892,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626402,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),10893,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626403,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),10894,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626404,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,10895,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL626405,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10896,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625529,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),10897,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625530,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),10898,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625531,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),10899,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625532,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),10900,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625533,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,10901,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL875474,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10902,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625534,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),10903,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625535,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),10904,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625536,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),10905,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625537,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),10906,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625538,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,10907,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625539,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10908,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625540,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),10909,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625541,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),10910,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625542,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),10911,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625543,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),10912,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625544,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,10913,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625545,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),10914,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625546,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,10915,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625547,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),10916,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625548,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),10917,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625549,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),10918,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625550,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),10919,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625551,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),10920,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL875475,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),10921,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625552,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),10922,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625553,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),10923,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625554,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),10924,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625555,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),10925,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL625556,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,10926,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624986,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),10927,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624987,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),10928,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624988,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,10929,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624989,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,10930,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624990,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,10931,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL874391,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,10932,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624991,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,10933,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624992,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,10934,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624993,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,10935,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624994,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,10936,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624995,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,10937,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624996,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,10938,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624997,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,10939,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624998,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,10940,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624999,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,10941,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL882955,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,10942,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625000,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,10943,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625001,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,10944,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625089,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,10945,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625090,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,10946,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625091,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,10947,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625092,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,10948,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625093,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,10949,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625094,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,10950,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL625095,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its bioavailability in the dogs,10951,Canis lupus familiaris,50588,,,,,N,2249,,,,,In vivo,1,9615.0,CHEMBL625096,Intermediate,
A,1,BAO_0000218,Compound was evaluated for its bioavailability in the rats,10952,Rattus norvegicus,50597,,,,,N,2249,,,,,In vivo,1,10116.0,CHEMBL625097,Intermediate,
A,0,BAO_0000218,Compound was evaluated for oral bioavailability,10953,,22224,,,,,U,17515,,,,,In vivo,1,,CHEMBL882956,Autocuration,
A,1,BAO_0000218,Compound was evaluated for percentage of Oral bioavailability in rats,10954,Rattus norvegicus,50597,,,,,N,14541,,,,,In vivo,1,10116.0,CHEMBL625098,Intermediate,
A,0,BAO_0000218,Bioavailability in guinea pig,10955,Cavia porcellus,22224,,,,,U,12797,,,,,In vivo,1,10141.0,CHEMBL625099,Autocuration,
A,1,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,10956,Rattus norvegicus,50597,,,,,N,12797,,,,,In vivo,1,10116.0,CHEMBL625100,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the oral bioavailability in dog,10957,Canis lupus familiaris,50588,,,,,N,12797,,,,,In vivo,1,9615.0,CHEMBL625101,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the oral bioavailability in rat,10958,Rattus norvegicus,50597,,,,,N,12797,,,,,In vivo,1,10116.0,CHEMBL874396,Intermediate,
F,0,BAO_0000218,Bioavailability in dog (dosed i.v.),10959,Canis lupus familiaris,22224,,,,,U,11727,,,,,In vivo,1,9615.0,CHEMBL625102,Autocuration,
A,1,BAO_0000218,Compound was tested for in vivo bioavailability in dog,10960,Canis lupus familiaris,50588,,,,,N,13249,,,,,In vivo,1,9615.0,CHEMBL625103,Intermediate,
A,1,BAO_0000218,Compound was tested for in vivo bioavailability in hamsters,10961,Cricetinae,100712,,,,,N,13249,,,,,In vivo,1,10026.0,CHEMBL625104,Intermediate,
A,0,BAO_0000218,Compound was tested for in vivo bioavailability in monkey,10962,Simiiformes,22224,,,,,U,13249,,,,,In vivo,1,314293.0,CHEMBL625105,Autocuration,
A,1,BAO_0000218,Compound was tested for in vivo bioavailability in rat,10963,Rattus norvegicus,50597,,,,,N,13249,,,,,In vivo,1,10116.0,CHEMBL625106,Intermediate,
A,0,BAO_0000218,Oral bioavailability in mouse,10964,Mus musculus,22224,,,,,U,9552,,,,,In vivo,1,10090.0,CHEMBL625107,Autocuration,
A,1,BAO_0000218,Compound was tested for percent of oral bioavailability in mice; 56-74,10965,Mus musculus,50594,,,,,N,9552,,,,,In vivo,1,10090.0,CHEMBL625108,Intermediate,
A,0,BAO_0000218,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),10966,Mus musculus,22224,,,,,U,14839,,,,,In vivo,1,10090.0,CHEMBL625109,Autocuration,
A,0,BAO_0000218,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),10967,Macaca fascicularis,22224,,,,,U,14839,,,,,In vivo,1,9541.0,CHEMBL625110,Autocuration,
A,0,BAO_0000218,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),10968,Macaca fascicularis,22224,,,,,U,14839,,,,,In vivo,1,9541.0,CHEMBL625111,Autocuration,
A,1,BAO_0000218,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),10969,Mus musculus,50594,,,,,N,14839,,,,,In vivo,1,10090.0,CHEMBL625112,Intermediate,
A,1,BAO_0000218,Oral bioavailability in nude mice,10970,Mus musculus,50594,,,,,N,14839,,,,,In vivo,1,10090.0,CHEMBL875334,Intermediate,
A,0,BAO_0000218,Bioavailability in monkey (i.d. dosing),10971,Primates,22224,,,,,U,11219,,,,,In vivo,1,9443.0,CHEMBL628617,Autocuration,
A,0,BAO_0000218,Bioavailability in rat,10972,Rattus norvegicus,22224,,,,,U,9552,,,,,In vivo,1,10116.0,CHEMBL628618,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,10973,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL628619,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,10974,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL628620,Autocuration,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10975,Macaca fascicularis,100710,,,,,N,14839,,,,,In vivo,1,9541.0,CHEMBL628621,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10976,Macaca fascicularis,100710,,,,,N,14839,,,,,In vivo,1,9541.0,CHEMBL628622,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",10977,Macaca fascicularis,100710,,,,,N,14839,,,,,In vivo,1,9541.0,CHEMBL628623,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,10978,Macaca fascicularis,100710,,,Plasma,,N,14839,,,,1969.0,In vivo,1,9541.0,CHEMBL628624,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10979,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL628625,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,10980,Macaca fascicularis,100710,,,Plasma,,N,14839,,,,1969.0,In vivo,1,9541.0,CHEMBL628626,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10981,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL627041,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10982,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL627042,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,10983,Mus musculus,50594,,,Plasma,,N,14839,,,,1969.0,In vivo,1,10090.0,CHEMBL627043,Intermediate,
A,0,BAO_0000218,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,10984,,22224,,,Plasma,,U,13932,,,,1969.0,In vivo,1,,CHEMBL627044,Autocuration,
A,1,BAO_0000218,Cmax in mouse plasma,10985,Mus musculus,50594,,,Plasma,,N,11637,,,,1969.0,In vivo,1,10090.0,CHEMBL627045,Intermediate,
A,0,BAO_0000218,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,10986,,22224,,,Plasma,,U,11637,,,,1969.0,In vivo,1,,CHEMBL627046,Autocuration,
A,1,BAO_0000218,Maximal plasma concentration in rat,10987,Rattus norvegicus,50597,,,Plasma,,N,13960,,,,1969.0,In vivo,1,10116.0,CHEMBL627047,Intermediate,
A,1,BAO_0000218,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,10988,Rattus norvegicus,50597,,,Plasma,,N,15905,,,,1969.0,In vivo,1,10116.0,CHEMBL627048,Intermediate,
A,1,BAO_0000218,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,10989,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627049,Intermediate,
A,1,BAO_0000218,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,10990,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627050,Intermediate,
A,1,BAO_0000218,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,10991,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627051,Intermediate,
A,1,BAO_0000218,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,10992,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627052,Intermediate,
A,1,BAO_0000218,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,10993,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627053,Intermediate,
A,1,BAO_0000218,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,10994,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL627054,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10995,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL627055,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10996,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL627056,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),10997,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL627057,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,10998,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL627058,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,10999,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL626211,Intermediate,
A,0,BAO_0000218,Maximum Concentration of the compound.,11000,,22224,,,,,U,10291,,,,,In vivo,1,,CHEMBL626212,Autocuration,
A,1,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog,11001,Canis lupus familiaris,50588,,,,,N,14599,,,,,In vivo,1,9615.0,CHEMBL626213,Intermediate,
A,1,BAO_0000218,Maximum Concentration was measured after iv administration into Beagle dog.,11002,Canis lupus familiaris,50588,,,,,N,14599,,,,,In vivo,1,9615.0,CHEMBL626214,Intermediate,
A,1,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog,11003,Canis lupus familiaris,50588,,,,,N,14599,,,,,In vivo,1,9615.0,CHEMBL626215,Intermediate,
A,1,BAO_0000218,Maximum Concentration was measured after po administration into Beagle dog.,11004,Canis lupus familiaris,50588,,,,,N,14599,,,,,In vivo,1,9615.0,CHEMBL626216,Intermediate,
A,0,BAO_0000218,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,11005,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626217,Autocuration,
A,0,BAO_0000218,Maximum blood level reached after an iv dose of 12.2 uM/kg,11006,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626218,Autocuration,
A,0,BAO_0000218,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,11007,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626219,Autocuration,
A,0,BAO_0000218,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,11008,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626220,Autocuration,
A,0,BAO_0000218,Maximum blood level reached after an oral dose of 5.0 mg/kg,11009,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626221,Autocuration,
A,0,BAO_0000218,Maximum blood level reached at dose of 10.6 uM/kg orally,11010,,22224,,,Blood,,U,12767,,,,178.0,In vivo,1,,CHEMBL626222,Autocuration,
A,1,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,11011,Cavia porcellus,50512,,,,,N,14706,,,,,In vivo,1,10141.0,CHEMBL626223,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,11012,Cavia porcellus,50512,,,,,N,14706,,,,,In vivo,1,10141.0,CHEMBL626224,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,11013,Rattus norvegicus,50597,,,Brain,,N,14793,,,,955.0,In vivo,1,10116.0,CHEMBL626225,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,11014,Rattus norvegicus,50597,,,Brain,,N,14793,,,,955.0,In vivo,1,10116.0,CHEMBL626226,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,11015,Rattus norvegicus,50597,,,Brain,,N,14793,,,,955.0,In vivo,1,10116.0,CHEMBL626227,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,11016,Rattus norvegicus,50597,,,Brain,,N,14793,,,,955.0,In vivo,1,10116.0,CHEMBL626228,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,11017,Rattus norvegicus,50597,,,,,N,14793,,,,,In vivo,1,10116.0,CHEMBL626229,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,11018,Rattus norvegicus,50597,,,,,N,14793,,,,,In vivo,1,10116.0,CHEMBL626921,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,11019,Rattus norvegicus,50597,,,,,N,14793,,,,,In vivo,1,10116.0,CHEMBL876793,Intermediate,
A,1,BAO_0000218,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,11020,Rattus norvegicus,50597,,,,,N,14793,,,,,In vivo,1,10116.0,CHEMBL625309,Intermediate,
A,1,BAO_0000218,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),11021,Bacillus subtilis,50278,,,,,N,10524,,,,,In vivo,1,1423.0,CHEMBL625310,Intermediate,
A,0,BAO_0000218,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,11022,Simiiformes,22224,,,,,U,11871,,,,,In vivo,1,314293.0,CHEMBL625311,Autocuration,
A,1,BAO_0000218,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,11023,Rattus norvegicus,50597,,,,,N,11871,,,,,In vivo,1,10116.0,CHEMBL625312,Intermediate,
A,0,BAO_0000218,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,11024,,22224,,,,,U,3437,,,,,In vivo,1,,CHEMBL625313,Autocuration,
A,1,BAO_0000218,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,11025,Mus musculus,50594,,,,,N,12038,,,,,In vivo,1,10090.0,CHEMBL625314,Intermediate,
A,1,BAO_0000218,Maximum concentration in male rats after iv administration of 20 mg/kg,11026,Rattus norvegicus,50597,,,,,N,12038,,,,,In vivo,1,10116.0,CHEMBL625315,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,11027,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625316,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,11028,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625317,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,11029,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625318,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,11030,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625319,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,11031,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625320,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,11032,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625321,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,11033,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625322,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,11034,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL876801,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,11035,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625323,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,11036,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625324,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,11037,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625325,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,11038,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625326,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,11039,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625327,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,11040,Rattus norvegicus,50597,,,Liver,,N,8418,,,,2107.0,,1,10116.0,CHEMBL625328,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,11041,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL625329,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,11042,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL625330,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,11043,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627774,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,11044,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627775,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,11045,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627949,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,11046,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627950,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,11047,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627951,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,11048,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627952,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,11049,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627953,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,11050,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627954,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,11051,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627955,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,11052,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627956,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,11053,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL876802,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,11054,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627957,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,11055,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627958,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,11056,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627959,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,11057,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627960,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,11058,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627961,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,11059,Rattus norvegicus,50597,,,Lung,,N,8418,,,,2048.0,,1,10116.0,CHEMBL627962,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11060,Rattus norvegicus,50597,,,,,N,9796,,,,,,1,10116.0,CHEMBL627963,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11061,Rattus norvegicus,50597,,,,,N,9796,,,,,,1,10116.0,CHEMBL624759,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11062,Rattus norvegicus,50597,,,,,N,9796,,,,,,1,10116.0,CHEMBL624760,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11063,Rattus norvegicus,50597,,,,,N,9796,,,,,,1,10116.0,CHEMBL624761,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11064,Rattus norvegicus,50597,,,,,N,9796,,,,,,1,10116.0,CHEMBL877607,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11065,Rattus norvegicus,50597,,,Liver,,N,9796,,,,2107.0,,1,10116.0,CHEMBL624762,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11066,Rattus norvegicus,50597,,,Liver,,N,9796,,,,2107.0,,1,10116.0,CHEMBL624763,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11067,Rattus norvegicus,50597,,,Liver,,N,9796,,,,2107.0,,1,10116.0,CHEMBL624764,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11068,Rattus norvegicus,50597,,,Liver,,N,9796,,,,2107.0,,1,10116.0,CHEMBL624765,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11069,Rattus norvegicus,50597,,,Liver,,N,9796,,,,2107.0,,1,10116.0,CHEMBL624766,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11070,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624767,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,11071,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624768,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11072,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624769,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11073,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624770,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11074,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624771,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11075,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624772,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,11076,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624773,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11077,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624774,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),11078,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624775,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),11079,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624776,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),11080,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624777,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),11081,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624778,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,11082,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624779,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),11083,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624780,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),11084,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624781,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11085,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL877608,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),11086,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624782,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),11087,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624783,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,11088,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624784,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11089,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624785,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),11090,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624786,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),11091,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL624787,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),11092,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL628676,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,11093,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL621842,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11094,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL621843,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),11095,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL623873,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),11096,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL623874,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),11097,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL623875,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),11098,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL623876,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,11099,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623877,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),11100,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623878,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,11101,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623879,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),11102,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623880,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),11103,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623881,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),11104,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623957,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),11105,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623958,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),11106,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623959,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),11107,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623960,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),11108,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623961,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),11109,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL623962,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),11110,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624676,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),11111,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624677,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,11112,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624678,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),11113,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624679,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),11114,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624680,Intermediate,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,11115,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL624849,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,11116,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL624850,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,11117,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL874399,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,11118,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL624851,Autocuration,
A,0,BAO_0000218,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,11119,,22224,,,,,U,11732,,,,,In vivo,1,,CHEMBL624852,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rat (dose 10 mg/kg),11120,Rattus norvegicus,22224,,,,,U,13359,,,,,In vivo,1,10116.0,CHEMBL624853,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley),11121,Rattus norvegicus,22224,,,,,U,16618,,,,,In vivo,1,10116.0,CHEMBL624854,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rat,11122,Rattus norvegicus,22224,,,,,U,13960,,,,,In vivo,1,10116.0,CHEMBL624855,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rats was determined in vivo,11123,Rattus norvegicus,22224,,,,,U,13917,,,,,In vivo,1,10116.0,CHEMBL624856,Autocuration,
A,0,BAO_0000218,Oral bioavailability in dog,11124,Canis lupus familiaris,22224,,,,,U,14266,,,,,In vivo,1,9615.0,CHEMBL882957,Autocuration,
A,0,BAO_0000218,Oral bioavailability of compound in monkey,11125,Simiiformes,22224,,,,,U,12359,,,,,In vivo,1,314293.0,CHEMBL624857,Autocuration,
A,1,BAO_0000218,Oral bioavailability of compound in rat,11126,Rattus norvegicus,50597,,,,,N,12359,,,,,In vivo,1,10116.0,CHEMBL622202,Intermediate,
A,0,BAO_0000218,Bioavailability in rat of PMEA prodrug,11127,Rattus norvegicus,22224,,,,,U,12359,,,,,In vivo,1,10116.0,CHEMBL622203,Autocuration,
A,1,BAO_0000218,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,11128,Rattus norvegicus,50597,,,,,N,12359,,,,,In vivo,1,10116.0,CHEMBL625522,Intermediate,
A,0,BAO_0000218,Serum conc at 3 hours following 25 mg/kg dose,11129,Macaca mulatta,22224,,,,,U,10791,,,,,In vivo,1,9544.0,CHEMBL622868,Autocuration,
A,0,BAO_0000218,Urine conc 0-5 hours following 25 mg/kg dose,11130,Macaca mulatta,22224,,,Urine,,U,10791,,,,1088.0,In vivo,1,9544.0,CHEMBL622869,Autocuration,
A,0,BAO_0000218,Urine conc 0-24 hours following 25 mg/kg dose,11131,Macaca mulatta,22224,,,Urine,,U,10791,,,,1088.0,In vivo,1,9544.0,CHEMBL622870,Autocuration,
A,0,BAO_0000218,Oral bioavailability in African green monkeys; 20-25,11132,Chlorocebus aethiops,22224,,,,,U,138,,,,,In vivo,1,9534.0,CHEMBL622871,Autocuration,
A,1,BAO_0000218,Oral bioavailability in cynomolgus monkey.,11133,Macaca fascicularis,100710,,,,,N,14521,,,,,In vivo,1,9541.0,CHEMBL620560,Intermediate,
A,0,BAO_0000218,Oral bioavailability in dog,11134,Canis lupus familiaris,22224,,,,,U,13953,,,,,In vivo,1,9615.0,CHEMBL620561,Autocuration,
A,1,BAO_0000218,Oral bioavailability in dog at 10 mg/kg oral dose,11135,Canis lupus familiaris,50588,,,,,N,12836,,,,,In vivo,1,9615.0,CHEMBL620562,Intermediate,
A,1,BAO_0000218,Oral bioavailability in hamster at 10 mg/kg oral dose,11136,Cricetinae,100712,,,,,N,12836,,,,,In vivo,1,10026.0,CHEMBL620563,Intermediate,
A,1,BAO_0000218,Oral bioavailability in rat at 10 mg/kg oral dose,11137,Rattus norvegicus,50597,,,,,N,12836,,,,,In vivo,1,10116.0,CHEMBL620564,Intermediate,
A,0,BAO_0000218,Oral bioavailability in rat,11138,Rattus norvegicus,22224,,,,,U,14521,,,,,In vivo,1,10116.0,CHEMBL872265,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rat,11139,Rattus norvegicus,22224,,,,,U,13953,,,,,In vivo,1,10116.0,CHEMBL620565,Autocuration,
A,0,BAO_0000218,Oral bioavailability,11140,Eutheria,22224,,,,,U,6799,,,,,In vivo,1,9347.0,CHEMBL620566,Autocuration,
A,0,BAO_0000218,Oral bioavailability was determined; range 49-102%,11141,,22224,,,,,U,11311,,,,,In vivo,1,,CHEMBL620567,Autocuration,
A,1,BAO_0000218,Oral bioavailability was determined in dogs,11142,Canis lupus familiaris,50588,,,,,N,4013,,,,,In vivo,1,9615.0,CHEMBL620568,Intermediate,
A,0,BAO_0000218,Oral bioavailability in rat,11143,Rattus norvegicus,22224,,,,,U,4013,,,,,In vivo,1,10116.0,CHEMBL620569,Autocuration,
A,0,BAO_0000218,Oral bioavailability,11144,Eutheria,22224,,,,,U,17591,,,,,In vivo,1,9347.0,CHEMBL620570,Autocuration,
A,0,BAO_0000218,Oral bioavailability was determined; Not orally available,11145,,22224,,,,,U,17591,,,,,In vivo,1,,CHEMBL620571,Autocuration,
A,1,BAO_0000218,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),11146,Mus musculus,50594,,,,,N,15011,,,,,In vivo,1,10090.0,CHEMBL620572,Intermediate,
A,0,BAO_0000218,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),11147,Mus musculus,22224,,,,,U,15011,,,,,In vivo,1,10090.0,CHEMBL620573,Autocuration,
A,0,BAO_0000218,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,11148,Mus musculus,22224,,,,,U,15011,,,,,In vivo,1,10090.0,CHEMBL620574,Autocuration,
A,0,BAO_0000218,Oral bioavailability in Rhesus monkey,11149,Macaca mulatta,22224,,,,,U,9552,,,,,In vivo,1,9544.0,CHEMBL620575,Autocuration,
A,0,BAO_0000218,Oral bioavailability in dog (female mongrel),11150,Canis lupus familiaris,22224,,,,,U,9552,,,,,In vivo,1,9615.0,CHEMBL620576,Autocuration,
A,0,BAO_0000218,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,11151,,22224,,,,,U,3639,,,,,In vivo,1,,CHEMBL875846,Autocuration,
A,0,BAO_0000218,Oral bioavailability in dog,11152,Canis lupus familiaris,22224,,,,,U,13397,,,,,In vivo,1,9615.0,CHEMBL620577,Autocuration,
A,0,BAO_0000218,Percentage Bioavailability was evaluated.,11153,,22224,,,,,U,3031,,,,,In vivo,1,,CHEMBL620578,Autocuration,
A,0,BAO_0000218,Bioavailability in rat administered i.d.,11154,Rattus norvegicus,22224,,,,,U,12818,,,,,In vivo,1,10116.0,CHEMBL620579,Autocuration,
A,0,BAO_0000218,Bioavailability,11155,Eutheria,22224,,,,,U,4847,,,,,In vivo,1,9347.0,CHEMBL621248,Autocuration,
A,0,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,11156,Canis lupus familiaris,22224,,,,,U,12421,,,,,In vivo,1,9615.0,CHEMBL625390,Autocuration,
A,0,BAO_0000218,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",11157,Rattus norvegicus,22224,,,,,U,11966,,,,,In vivo,1,10116.0,CHEMBL625391,Autocuration,
A,0,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),11158,Primates,22224,,,,,U,11218,,,,,In vivo,1,9443.0,CHEMBL872266,Autocuration,
A,0,BAO_0000218,Oral bioavailability in rat (Sprague-Dawley) (male),11159,Rattus norvegicus,22224,,,,,U,13129,,,,,In vivo,1,10116.0,CHEMBL625392,Autocuration,
A,1,BAO_0000218,The oral bioavailability was measured on rats after oral administration,11160,Rattus norvegicus,50597,,,,,N,12350,,,,,In vivo,1,10116.0,CHEMBL625393,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11161,Rattus norvegicus,50597,,,,,N,2231,,,,,In vivo,1,10116.0,CHEMBL625394,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11162,Macaca mulatta,50797,,,,,N,2231,,,,,In vivo,1,9544.0,CHEMBL625395,Intermediate,
A,0,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),11163,Rattus norvegicus,22224,,,,,U,12187,,,,,In vivo,1,10116.0,CHEMBL625396,Autocuration,
A,0,BAO_0000218,Bioavailability in dog (male Beagle) i.v. administration,11164,Canis lupus familiaris,22224,,,,,U,12421,,,,,In vivo,1,9615.0,CHEMBL625397,Autocuration,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11165,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL625398,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11166,Mus musculus,50594,,,Blood,,N,13256,,,,178.0,In vivo,1,10090.0,CHEMBL625399,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11167,Mus musculus,50594,,,Cerebellum,,N,13256,,,,2037.0,In vivo,1,10090.0,CHEMBL626074,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11168,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL626075,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,11169,Rattus norvegicus,50597,,,Plasma,,N,2231,,,,1969.0,In vivo,1,10116.0,CHEMBL626076,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,11170,Macaca mulatta,50797,,,Plasma,,N,2231,,,,1969.0,In vivo,1,9544.0,CHEMBL626077,Intermediate,
A,1,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),11171,Rattus norvegicus,50597,,,Blood,,N,12178,,,,178.0,In vivo,1,10116.0,CHEMBL626078,Intermediate,
A,0,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),11172,,22224,,,Blood,,U,12178,,,,178.0,In vivo,1,,CHEMBL625846,Autocuration,
A,0,BAO_0000218,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),11173,,22224,,,Blood,,U,12178,,,,178.0,In vivo,1,,CHEMBL625847,Autocuration,
A,1,BAO_0000218,Maximum concentration observed in rats at an oral dose of 50 mg/kg,11174,Rattus norvegicus,50597,,,,,N,15633,,,,,In vivo,1,10116.0,CHEMBL625848,Expert,
A,1,BAO_0000218,Maximum concentration of compound in plasma administered orally to rats,11175,Rattus norvegicus,50597,,,Plasma,,N,14258,,,,1969.0,In vivo,1,10116.0,CHEMBL625849,Intermediate,
A,1,BAO_0000218,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",11176,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL626023,Intermediate,
A,1,BAO_0000218,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",11177,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL626024,Intermediate,
A,1,BAO_0000218,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",11178,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL626025,Intermediate,
A,0,BAO_0000218,Maximum concentration after 10 mg/kg by oral administration,11179,,22224,,,,,U,5566,,,,,In vivo,1,,CHEMBL626026,Autocuration,
A,0,BAO_0000218,Maximum concentration at a dose of 1.5 mg/kg,11180,,22224,,,,,U,16935,,,,,In vivo,1,,CHEMBL626027,Autocuration,
A,0,BAO_0000218,Maximum concentration at a dose of 2.0 mg/kg,11181,,22224,,,,,U,16935,,,,,In vivo,1,,CHEMBL626028,Autocuration,
A,1,BAO_0000218,Maximum concentration in dog plasma,11182,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL626029,Intermediate,
A,0,BAO_0000218,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,11183,,22224,,,Plasma,,U,12536,,,,1969.0,In vivo,1,,CHEMBL626030,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,11184,,22224,,,Plasma,,U,12536,,,,1969.0,In vivo,1,,CHEMBL626031,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,11185,,22224,,,Plasma,,U,12536,,,,1969.0,In vivo,1,,CHEMBL626032,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,11186,,22224,,,Plasma,,U,12536,,,,1969.0,In vivo,1,,CHEMBL626033,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,11187,,22224,,,Plasma,,U,12536,,,,1969.0,In vivo,1,,CHEMBL626034,Autocuration,
A,1,BAO_0000218,Maximum concentration in plasma after oral administration in dog (25 mg/kg),11188,Canis lupus familiaris,50588,,,Plasma,,N,9994,,,,1969.0,In vivo,1,9615.0,CHEMBL626035,Intermediate,
A,0,BAO_0000218,Maximum concentration in plasma at Tmax,11189,,22224,,,Plasma,,U,1434,,,,1969.0,In vivo,1,,CHEMBL626036,Autocuration,
A,1,BAO_0000218,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,11190,Canis lupus familiaris,50588,,,Plasma,,N,12836,,,,1969.0,In vivo,1,9615.0,CHEMBL626037,Expert,
A,1,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,11191,Cricetinae,100712,,,Plasma,,N,12836,,,,1969.0,In vivo,1,10026.0,CHEMBL626038,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,11192,Rattus norvegicus,50597,,,Plasma,,N,12836,,,,1969.0,In vivo,1,10116.0,CHEMBL626039,Intermediate,
A,1,BAO_0000218,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,11193,Rattus norvegicus,50597,,,Plasma,,N,12545,,,,1969.0,In vivo,1,10116.0,CHEMBL626040,Intermediate,
A,1,BAO_0000218,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,11194,Oryctolagus cuniculus,50592,,,Plasma,,N,13856,,,,1969.0,In vivo,1,9986.0,CHEMBL626041,Intermediate,
A,0,BAO_0000218,Maximum concentration was calculated,11195,,22224,,,,,U,3550,,,,,In vivo,1,,CHEMBL626042,Autocuration,
A,0,BAO_0000218,Maximum concentration was calculated.,11196,,22224,,,,,U,2632,,,,,In vivo,1,,CHEMBL626043,Autocuration,
A,0,BAO_0000218,Maximum concentration at a peroral dose of 10 mg/kg,11197,,22224,,,,,U,5566,,,,,In vivo,1,,CHEMBL626044,Autocuration,
A,0,BAO_0000218,Maximum concentration of the drug at 10 uM/dg administered perorally,11198,,22224,,,,,U,11883,,,,,In vivo,1,,CHEMBL626045,Autocuration,
A,0,BAO_0000218,Maximum concentration of the drug at 2 uM/dg administered intravenously,11199,,22224,,,,,U,11883,,,,,In vivo,1,,CHEMBL626046,Autocuration,
A,1,BAO_0000218,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",11200,Canis lupus familiaris,50588,,,Plasma,,N,14122,,,,1969.0,In vivo,1,9615.0,CHEMBL626047,Intermediate,
A,1,BAO_0000218,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",11201,Cricetinae,100712,,,Plasma,,N,14122,,,,1969.0,In vivo,1,10026.0,CHEMBL626048,Intermediate,
A,1,BAO_0000218,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",11202,Rattus norvegicus,50597,,,Plasma,,N,14122,,,,1969.0,In vivo,1,10116.0,CHEMBL626049,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,11203,Rattus norvegicus,50597,,,Plasma,,N,12542,,,,1969.0,In vivo,1,10116.0,CHEMBL626050,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,11204,Canis lupus familiaris,50588,,,Plasma,,N,12542,,,,1969.0,In vivo,1,9615.0,CHEMBL874541,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,11205,Cricetinae,100712,,,Plasma,,N,12542,,,,1969.0,In vivo,1,10026.0,CHEMBL622826,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,11206,Cricetinae,100712,,,Plasma,,N,12542,,,,1969.0,In vivo,1,10026.0,CHEMBL622827,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,11207,Rattus norvegicus,50597,,,Plasma,,N,12542,,,,1969.0,In vivo,1,10116.0,CHEMBL622828,Intermediate,
A,1,BAO_0000218,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,11208,Rattus norvegicus,50597,,,Plasma,,N,14080,,,,1969.0,In vivo,1,10116.0,CHEMBL622829,Intermediate,
A,1,BAO_0000218,Maximum concentration reached following intravenous administration in male rat,11209,Rattus norvegicus,50597,,,,,N,11911,,,,,In vivo,1,10116.0,CHEMBL876806,Intermediate,
A,1,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,11210,Canis lupus familiaris,50588,,,,,N,13204,,,,,In vivo,1,9615.0,CHEMBL622830,Intermediate,
A,1,BAO_0000218,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,11211,Rattus norvegicus,50597,,,,,N,13204,,,,,In vivo,1,10116.0,CHEMBL622831,Intermediate,
A,1,BAO_0000218,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,11212,Canis lupus familiaris,50588,,,,,N,14346,,,,,In vivo,1,9615.0,CHEMBL626794,Intermediate,
A,1,BAO_0000218,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,11213,Rattus norvegicus,50597,,,,,N,14346,,,,,In vivo,1,10116.0,CHEMBL626795,Intermediate,
A,1,BAO_0000218,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,11214,Rattus norvegicus,50597,,,,,N,14346,,,,,In vivo,1,10116.0,CHEMBL626796,Intermediate,
A,1,BAO_0000218,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,11215,Rattus norvegicus,50597,,,,,N,14346,,,,,In vivo,1,10116.0,CHEMBL626797,Intermediate,
A,1,BAO_0000218,Maximum drug concentration is determined after oral dosing in rats.,11216,Rattus norvegicus,50597,,,,,N,14127,,,,,In vivo,1,10116.0,CHEMBL626798,Intermediate,
A,1,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fasted dogs,11217,Canis lupus familiaris,50588,,,,,N,14339,,,,,In vivo,1,9615.0,CHEMBL626799,Intermediate,
A,1,BAO_0000218,Maximum observed concentration in oral (5 mg/kg) fed dogs,11218,Canis lupus familiaris,50588,,,,,N,14339,,,,,In vivo,1,9615.0,CHEMBL626800,Intermediate,
A,0,BAO_0000218,Maximum plasma concentration,11219,,22224,,,Plasma,,U,13494,,,,1969.0,In vivo,1,,CHEMBL626801,Autocuration,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,11220,Rattus norvegicus,50597,,,Plasma,,N,14925,,,,1969.0,In vivo,1,10116.0,CHEMBL876816,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,11221,Rattus norvegicus,50597,,,Plasma,,N,14474,,,,1969.0,In vivo,1,10116.0,CHEMBL626802,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,11222,Canis lupus familiaris,50588,,,Plasma,,N,14474,,,,1969.0,In vivo,1,9615.0,CHEMBL626803,Intermediate,
A,0,BAO_0000218,Maximum plasma concentration following oral administration of 30 umol/kg,11223,,22224,,,Plasma,,U,13917,,,,1969.0,In vivo,1,,CHEMBL626804,Autocuration,
A,1,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,11224,Rattus norvegicus,50597,,,Plasma,,N,9796,,,,1969.0,,1,10116.0,CHEMBL626805,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11225,Rattus norvegicus,50597,,,Plasma,,N,9796,,,,1969.0,,1,10116.0,CHEMBL626309,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11226,Rattus norvegicus,50597,,,Plasma,,N,9796,,,,1969.0,,1,10116.0,CHEMBL626310,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11227,Rattus norvegicus,50597,,,Plasma,,N,9796,,,,1969.0,,1,10116.0,CHEMBL626311,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11228,Rattus norvegicus,50597,,,Plasma,,N,9796,,,,1969.0,,1,10116.0,CHEMBL626312,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,11229,Rattus norvegicus,50597,,,Uterus,,N,9796,,,,995.0,,1,10116.0,CHEMBL626313,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,11230,Rattus norvegicus,50597,,,Uterus,,N,9796,,,,995.0,,1,10116.0,CHEMBL626314,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,11231,Rattus norvegicus,50597,,,Uterus,,N,9796,,,,995.0,,1,10116.0,CHEMBL626315,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,11232,Rattus norvegicus,50597,,,Uterus,,N,9796,,,,995.0,,1,10116.0,CHEMBL626316,Intermediate,
A,1,BAO_0000218,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,11233,Rattus norvegicus,50597,,,Uterus,,N,9796,,,,995.0,,1,10116.0,CHEMBL626317,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),11234,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626318,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),11235,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626319,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),11236,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626320,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),11237,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL875053,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),11238,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626321,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),11239,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626322,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),11240,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626323,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),11241,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626324,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),11242,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626325,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),11243,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626326,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),11244,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626327,Intermediate,
A,1,BAO_0000218,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),11245,Rattus norvegicus,50597,,,,,N,8363,,,,,,1,10116.0,CHEMBL626328,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",11246,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626329,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",11247,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626330,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",11248,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626331,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",11249,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626332,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",11250,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626333,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",11251,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626334,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",11252,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL626335,Intermediate,
A,1,BAO_0000218,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",11253,Rattus norvegicus,50597,,,Blood,,N,8684,,,,178.0,,1,10116.0,CHEMBL624798,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",11254,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624799,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",11255,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624800,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",11256,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624801,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",11257,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624802,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",11258,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624803,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",11259,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624804,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",11260,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624805,Intermediate,
A,1,BAO_0000218,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",11261,Rattus norvegicus,50597,,,Brain,,N,8684,,,,955.0,,1,10116.0,CHEMBL624806,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",11262,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624807,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",11263,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624808,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",11264,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624809,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",11265,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624810,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",11266,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL877618,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",11267,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624811,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",11268,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624812,Intermediate,
A,1,BAO_0000218,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",11269,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624813,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",11270,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624814,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",11271,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624815,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",11272,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624816,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",11273,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624817,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),11274,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624818,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,11275,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624819,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),11276,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624820,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),11277,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624821,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),11278,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624822,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),11279,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624823,Intermediate,
A,1,BAO_0000218,Observed diffusion coefficient in organic solvent for Escherichia coli,11280,Escherichia coli,50212,,,,,N,15599,,,,,,1,562.0,CHEMBL624824,Intermediate,
A,1,BAO_0000218,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11281,Rattus norvegicus,50597,,,Blood,,N,9614,,,,178.0,,1,10116.0,CHEMBL624825,Intermediate,
A,1,BAO_0000218,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11282,Rattus norvegicus,50597,,,Blood,,N,9614,,,,178.0,,1,10116.0,CHEMBL624826,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11283,Rattus norvegicus,50597,,,Cardiac atrium,,N,9614,,,,2081.0,,1,10116.0,CHEMBL876817,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11284,Rattus norvegicus,50597,,,Cardiac atrium,,N,9614,,,,2081.0,,1,10116.0,CHEMBL624827,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11285,Rattus norvegicus,50597,,,,,N,9614,,,,,,1,10116.0,CHEMBL624828,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11286,Rattus norvegicus,50597,,,,,N,9614,,,,,,1,10116.0,CHEMBL624829,Intermediate,
A,1,BAO_0000218,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11287,Rattus norvegicus,50597,,,Liver,,N,9614,,,,2107.0,,1,10116.0,CHEMBL624830,Intermediate,
A,1,BAO_0000218,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11288,Rattus norvegicus,50597,,,Liver,,N,9614,,,,2107.0,,1,10116.0,CHEMBL624831,Intermediate,
A,1,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11289,Rattus norvegicus,50597,,,Cardiac atrium,,N,9614,,,,2081.0,,1,10116.0,CHEMBL624832,Intermediate,
A,1,BAO_0000218,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11290,Rattus norvegicus,50597,,,Cardiac atrium,,N,9614,,,,2081.0,,1,10116.0,CHEMBL624833,Intermediate,
A,1,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11291,Rattus norvegicus,50597,,,,,N,9614,,,,,,1,10116.0,CHEMBL624834,Intermediate,
A,1,BAO_0000218,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11292,Rattus norvegicus,50597,,,,,N,9614,,,,,,1,10116.0,CHEMBL624835,Intermediate,
A,1,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",11293,Rattus norvegicus,50597,,,Spleen,,N,9614,,,,2106.0,,1,10116.0,CHEMBL624836,Intermediate,
A,1,BAO_0000218,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",11294,Rattus norvegicus,50597,,,Spleen,,N,9614,,,,2106.0,,1,10116.0,CHEMBL624837,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,11295,Rattus norvegicus,50597,,,Blood,,N,9071,,,,178.0,,1,10116.0,CHEMBL624838,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,11296,Rattus norvegicus,50597,,,Blood,,N,9071,,,,178.0,,1,10116.0,CHEMBL622188,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,11297,Rattus norvegicus,50597,,,Heart,,N,9071,,,,948.0,,1,10116.0,CHEMBL622189,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,11298,Rattus norvegicus,50597,,,Heart,,N,9071,,,,948.0,,1,10116.0,CHEMBL622190,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,11299,Rattus norvegicus,50597,,,Heart,,N,9071,,,,948.0,,1,10116.0,CHEMBL625170,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11300,Rattus norvegicus,50597,,,Kidney,,N,9071,,,,2113.0,,1,10116.0,CHEMBL625171,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,11301,Rattus norvegicus,50597,,,Kidney,,N,9071,,,,2113.0,,1,10116.0,CHEMBL625172,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,11302,Rattus norvegicus,50597,,,Kidney,,N,9071,,,,2113.0,,1,10116.0,CHEMBL625173,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,11303,Rattus norvegicus,50597,,,Liver,,N,9071,,,,2107.0,,1,10116.0,CHEMBL625174,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,11304,Rattus norvegicus,50597,,,Liver,,N,9071,,,,2107.0,,1,10116.0,CHEMBL625175,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,11305,Rattus norvegicus,50597,,,Liver,,N,9071,,,,2107.0,,1,10116.0,CHEMBL625176,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11306,Rattus norvegicus,50597,,,Lung,,N,9071,,,,2048.0,,1,10116.0,CHEMBL625177,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,11307,Rattus norvegicus,50597,,,Lung,,N,9071,,,,2048.0,,1,10116.0,CHEMBL625178,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,11308,Rattus norvegicus,50597,,,Lung,,N,9071,,,,2048.0,,1,10116.0,CHEMBL625179,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,11309,Rattus norvegicus,50597,,,Lung,,N,9071,,,,2048.0,,1,10116.0,CHEMBL625180,Intermediate,
A,0,BAO_0000218,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",11310,,22224,,,,,U,10677,,,,,,1,,CHEMBL625181,Autocuration,
A,1,BAO_0000218,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,11311,Mus musculus,50594,,,Urine,,N,9750,,,,1088.0,,1,10090.0,CHEMBL625182,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11312,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL625183,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11313,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL875848,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11314,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL622260,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11315,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL622261,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11316,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL622262,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11317,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL622263,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11318,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL622418,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11319,Rattus norvegicus,50597,,,Liver,,N,8319,,,,2107.0,,1,10116.0,CHEMBL622419,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11320,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL623388,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11321,Mus musculus,50594,,,Liver,,N,13256,,,,2107.0,In vivo,1,10090.0,CHEMBL623389,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11322,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL623390,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11323,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL623391,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11324,Mus musculus,50594,,,Blood,,N,13256,,,,178.0,In vivo,1,10090.0,CHEMBL623392,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11325,Mus musculus,50594,,,Cerebellum,,N,13256,,,,2037.0,In vivo,1,10090.0,CHEMBL623393,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11326,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL623394,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11327,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL618885,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11328,Mus musculus,50594,,,Liver,,N,13256,,,,2107.0,In vivo,1,10090.0,CHEMBL618886,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11329,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL618887,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),11330,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL619535,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),11331,Mus musculus,50594,,,Blood,,N,13256,,,,178.0,In vivo,1,10090.0,CHEMBL619536,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),11332,Mus musculus,50594,,,Cerebellum,,N,13256,,,,2037.0,In vivo,1,10090.0,CHEMBL619537,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),11333,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL619705,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),11334,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL619706,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),11335,Mus musculus,50594,,,Liver,,N,13256,,,,2107.0,In vivo,1,10090.0,CHEMBL619707,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),11336,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL619708,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),11337,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL625219,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),11338,Mus musculus,50594,,,Blood,,N,13256,,,,178.0,In vivo,1,10090.0,CHEMBL625220,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),11339,Mus musculus,50594,,,Cerebellum,,N,13256,,,,2037.0,In vivo,1,10090.0,CHEMBL625221,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),11340,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL625222,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),11341,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL625223,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),11342,Mus musculus,50594,,,Liver,,N,13256,,,,2107.0,In vivo,1,10090.0,CHEMBL625224,Intermediate,
A,1,BAO_0000218,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),11343,Mus musculus,50594,,,,,N,13256,,,,,In vivo,1,10090.0,CHEMBL625225,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration,11344,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL625226,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,11345,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL625227,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration,11346,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL625228,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,11347,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL875354,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration,11348,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL625229,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,11349,Rattus norvegicus,50597,,,Blood,,N,8829,,,,178.0,In vivo,1,10116.0,CHEMBL625230,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration,11350,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625231,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,11351,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625900,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration,11352,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625901,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,11353,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625902,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration,11354,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625903,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,11355,Rattus norvegicus,50597,,,Heart,,N,8829,,,,948.0,In vivo,1,10116.0,CHEMBL625904,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration,11356,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL625905,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,11357,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL627861,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,11358,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL627862,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11359,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL627863,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration,11360,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL627769,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,11361,Canis lupus familiaris,50588,,,Plasma,,N,13249,,,,1969.0,In vivo,1,9615.0,CHEMBL627770,Intermediate,
A,1,BAO_0000218,Cmax in cynomolgus monkey (PO dose),11362,Macaca fascicularis,100710,,,,,N,13622,,,,,In vivo,1,9541.0,CHEMBL627771,Intermediate,
A,1,BAO_0000218,Cmax in rat (PO dose),11363,Rattus norvegicus,50597,,,,,N,13622,,,,,In vivo,1,10116.0,CHEMBL627772,Intermediate,
A,1,BAO_0000218,Cmax in rat (PO dose),11364,Rattus norvegicus,50597,,,,,N,13622,,,,,In vivo,1,10116.0,CHEMBL627773,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,11365,Rattus norvegicus,50597,,,Plasma,,N,13494,,,,1969.0,In vivo,1,10116.0,CHEMBL621922,Intermediate,
A,1,BAO_0000218,Cmax in rat plasma after oral dose (10 mg/kg),11366,Rattus norvegicus,50597,,,Plasma,,N,12170,,,,1969.0,In vivo,1,10116.0,CHEMBL621923,Intermediate,
A,0,BAO_0000218,Cmax in plasma after oral dose (10 mg/kg),11367,,22224,,,Plasma,,U,12170,,,,1969.0,In vivo,1,,CHEMBL621924,Autocuration,
A,1,BAO_0000218,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,11368,Canis lupus familiaris,50588,,,Plasma,,N,17025,,,,1969.0,In vivo,1,9615.0,CHEMBL621925,Intermediate,
A,0,BAO_0000218,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,11369,Simiiformes,22224,,,Plasma,,U,17025,,,,1969.0,In vivo,1,314293.0,CHEMBL621926,Autocuration,
A,1,BAO_0000218,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,11370,Oryctolagus cuniculus,50592,,,Plasma,,N,17025,,,,1969.0,In vivo,1,9986.0,CHEMBL621927,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,11371,Rattus norvegicus,50597,,,Plasma,,N,17025,,,,1969.0,In vivo,1,10116.0,CHEMBL621928,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,11372,Rattus norvegicus,50597,,,Plasma,,N,14187,,,,1969.0,In vivo,1,10116.0,CHEMBL621929,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,11373,Mus musculus,50594,,,Plasma,,N,14816,,,,1969.0,In vivo,1,10090.0,CHEMBL621930,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration after oral dosing in rat,11374,Rattus norvegicus,50597,,,Plasma,,N,17820,,,,1969.0,In vivo,1,10116.0,CHEMBL621931,Intermediate,
A,0,BAO_0000218,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11375,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621932,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11376,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621933,Autocuration,
A,1,BAO_0000218,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,11377,Canis lupus familiaris,50588,,,Plasma,,N,14691,,,,1969.0,In vivo,1,9615.0,CHEMBL621934,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,11378,Canis lupus familiaris,50588,,,Plasma,,N,14691,,,,1969.0,In vivo,1,9615.0,CHEMBL621935,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,11379,Rattus norvegicus,50597,,,Plasma,,N,13375,,,,1969.0,In vivo,1,10116.0,CHEMBL621936,Intermediate,
A,0,BAO_0000218,Maximum plasma concentration was determined,11380,,22224,,,Plasma,,U,6236,,,,1969.0,In vivo,1,,CHEMBL621937,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11381,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621938,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11382,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621939,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,11383,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621940,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,11384,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621941,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11385,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL621942,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11386,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL626178,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,11387,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL626179,Autocuration,
A,0,BAO_0000218,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,11388,,22224,,,Plasma,,U,14380,,,,1969.0,In vivo,1,,CHEMBL626180,Autocuration,
A,1,BAO_0000218,Plasma Cmax in rat (PO dose),11389,Rattus norvegicus,50597,,,Plasma,,N,13622,,,,1969.0,In vivo,1,10116.0,CHEMBL626181,Intermediate,
A,1,BAO_0000218,Maximum serum concentration after po dose of 5.22 mg/kg in rats,11390,Rattus norvegicus,50597,,,,,N,15372,,,,,In vivo,1,10116.0,CHEMBL626182,Intermediate,
A,1,BAO_0000218,Maximum serum concentration after po dose of 5.46 mg/kg in rats,11391,Rattus norvegicus,50597,,,,,N,15372,,,,,In vivo,1,10116.0,CHEMBL626183,Intermediate,
A,1,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,11392,Rattus norvegicus,50597,,,,,N,15372,,,,,In vivo,1,10116.0,CHEMBL626184,Intermediate,
A,1,BAO_0000218,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,11393,Rattus norvegicus,50597,,,,,N,15372,,,,,In vivo,1,10116.0,CHEMBL626185,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,11394,Canis lupus familiaris,50588,,,Plasma,,N,14925,,,,1969.0,In vivo,1,9615.0,CHEMBL626186,Intermediate,
A,1,BAO_0000218,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,11395,Canis lupus familiaris,50588,,,Plasma,,N,14925,,,,1969.0,In vivo,1,9615.0,CHEMBL877589,Intermediate,
A,0,BAO_0000218,Maximum concentration of the drug at 1 uM/dg administered intravenously,11396,,22224,,,,,U,11883,,,,,In vivo,1,,CHEMBL626187,Autocuration,
A,0,BAO_0000218,Maximum concentration of the drug at 20 uM/dg administered perorally,11397,,22224,,,,,U,11883,,,,,In vivo,1,,CHEMBL626188,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,11398,,22224,,,,,U,13391,,,,,In vivo,1,,CHEMBL626189,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11399,,22224,,,Blood,,U,13391,,,,178.0,In vivo,1,,CHEMBL626855,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11400,,22224,,,Blood,,U,13391,,,,178.0,In vivo,1,,CHEMBL623781,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11401,,22224,,,Blood,,U,13391,,,,178.0,In vivo,1,,CHEMBL623782,Autocuration,
A,1,BAO_0000218,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,11402,Rattus norvegicus,50597,,,Plasma,,N,16360,,,,1969.0,In vivo,1,10116.0,CHEMBL623783,Intermediate,
A,1,BAO_0000218,Cmax in dog plasma after 1mg/kg oral dose,11403,Canis lupus familiaris,50588,,,Plasma,,N,3673,,,,1969.0,In vivo,1,9615.0,CHEMBL623784,Intermediate,
A,1,BAO_0000218,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,11404,Canis lupus familiaris,50588,,,Plasma,,N,14431,,,,1969.0,In vivo,1,9615.0,CHEMBL623785,Intermediate,
A,1,BAO_0000218,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,11405,Rattus norvegicus,50597,,,Plasma,,N,14431,,,,1969.0,In vivo,1,10116.0,CHEMBL623786,Intermediate,
A,1,BAO_0000218,Oral maximum concentration in rat,11406,Rattus norvegicus,50597,,,,,N,14964,,,,,In vivo,1,10116.0,CHEMBL623787,Intermediate,
A,1,BAO_0000218,Oral maximum concentration in rat,11407,Rattus norvegicus,50597,,,,,N,14964,,,,,In vivo,1,10116.0,CHEMBL623788,Intermediate,
A,1,BAO_0000218,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,11408,Mus musculus,50594,,,Plasma,,N,14209,,,,1969.0,In vivo,1,10090.0,CHEMBL623789,Intermediate,
A,1,BAO_0000218,Peak concentration in blood after intravenous administration to mice,11409,Mus musculus,50594,,,Blood,,N,11355,,,,178.0,In vivo,1,10090.0,CHEMBL623790,Intermediate,
A,1,BAO_0000218,Peak concentration in blood after peroral administration to mice,11410,Mus musculus,50594,,,Blood,,N,11355,,,,178.0,In vivo,1,10090.0,CHEMBL623791,Intermediate,
A,1,BAO_0000218,Peak concentration in rat plasma was determined,11411,Rattus norvegicus,50597,,,Plasma,,N,11966,,,,1969.0,In vivo,1,10116.0,CHEMBL623792,Intermediate,
A,0,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,11412,Simiiformes,22224,,,Plasma,,U,8918,,,,1969.0,In vivo,1,314293.0,CHEMBL623793,Autocuration,
A,1,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,11413,Mus musculus,50594,,,Plasma,,N,8918,,,,1969.0,In vivo,1,10090.0,CHEMBL623794,Intermediate,
A,1,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,11414,Rattus norvegicus,50597,,,Plasma,,N,8918,,,,1969.0,In vivo,1,10116.0,CHEMBL623795,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",11415,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623796,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",11416,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623797,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",11417,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623798,Intermediate,
A,1,BAO_0000218,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",11418,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623799,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",11419,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624490,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",11420,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624491,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",11421,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624492,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",11422,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624493,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",11423,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL877595,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",11424,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624494,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",11425,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624495,Intermediate,
A,1,BAO_0000218,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",11426,Rattus norvegicus,50597,,,Intestine,,N,8684,,,,160.0,,1,10116.0,CHEMBL624681,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",11427,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624682,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",11428,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624683,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",11429,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624684,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",11430,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624685,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",11431,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624686,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",11432,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624687,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",11433,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624688,Intermediate,
A,1,BAO_0000218,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",11434,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL627161,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",11435,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL622127,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",11436,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL622128,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",11437,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL874384,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",11438,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624898,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",11439,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624899,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",11440,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624900,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",11441,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624901,Intermediate,
A,1,BAO_0000218,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",11442,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624902,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",11443,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624903,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",11444,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624904,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",11445,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624905,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",11446,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624906,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",11447,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624907,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",11448,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624908,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",11449,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624909,Intermediate,
A,1,BAO_0000218,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",11450,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL624910,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",11451,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL624911,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",11452,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL874388,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",11453,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL624912,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",11454,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL622930,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",11455,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL623121,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",11456,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL623122,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",11457,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL623123,Intermediate,
A,1,BAO_0000218,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",11458,Rattus norvegicus,50597,,,Muscle tissue,,N,8684,,,,2385.0,,1,10116.0,CHEMBL623124,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",11459,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623125,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",11460,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623126,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",11461,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623127,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",11462,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623128,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",11463,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623129,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",11464,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623130,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",11465,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623131,Intermediate,
A,1,BAO_0000218,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",11466,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL623132,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11467,Rattus norvegicus,50597,,,Liver,,N,8319,,,,2107.0,,1,10116.0,CHEMBL623133,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11468,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623134,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11469,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL874389,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11470,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623135,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11471,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623136,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11472,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623137,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11473,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623138,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11474,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL623139,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11475,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL623140,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11476,Rattus norvegicus,50597,,,Liver,,N,8319,,,,2107.0,,1,10116.0,CHEMBL623141,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11477,Rattus norvegicus,50597,,,Liver,,N,8319,,,,2107.0,,1,10116.0,CHEMBL623142,Intermediate,
A,1,BAO_0000218,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11478,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL623143,Intermediate,
A,1,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,11479,Mus musculus,50594,,,Urine,,N,14571,,,,1088.0,,1,10090.0,CHEMBL623144,Intermediate,
A,1,BAO_0000218,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,11480,Rattus norvegicus,50597,,,Urine,,N,14571,,,,1088.0,,1,10116.0,CHEMBL623405,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11481,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624074,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,11482,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624075,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11483,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624076,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,11484,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624077,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11485,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624078,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,11486,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL624079,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11487,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL624261,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,11488,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624262,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11489,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624263,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11490,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624264,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,11491,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624265,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,11492,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624266,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,11493,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624267,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,11494,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624268,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,11495,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL875227,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,11496,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL624269,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,11497,Rattus norvegicus,50597,,,Kidney,,N,8319,,,,2113.0,,1,10116.0,CHEMBL624270,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,11498,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624271,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,11499,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624272,Intermediate,
A,1,BAO_0000218,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,11500,Rattus norvegicus,50597,,,,,N,8319,,,,,,1,10116.0,CHEMBL624273,Intermediate,
A,1,BAO_0000218,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,11501,Rattus norvegicus,50597,,,Urine,,N,12064,,,,1088.0,,1,10116.0,CHEMBL624274,Intermediate,
A,1,BAO_0000218,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,11502,Rattus norvegicus,50597,,,Urine,,N,12064,,,,1088.0,,1,10116.0,CHEMBL624275,Intermediate,
A,1,BAO_0000218,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,11503,Rattus norvegicus,50597,,,Urine,,N,12064,,,,1088.0,,1,10116.0,CHEMBL624276,Intermediate,
A,1,BAO_0000218,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,11504,Rattus norvegicus,50597,,,Urine,,N,12038,,,,1088.0,,1,10116.0,CHEMBL624277,Intermediate,
A,0,BAO_0000019,% dose converted to 2-amino-5-chlorophenyl sulfate,11505,,22224,,,,,U,14314,,,,,,1,,CHEMBL624278,Autocuration,
A,0,BAO_0000019,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),11506,,22224,,,,,U,14314,,,,,,1,,CHEMBL624279,Autocuration,
A,1,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11507,Rattus norvegicus,50597,,,Feces,,N,11488,,,,1988.0,,1,10116.0,CHEMBL624280,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11508,Rattus norvegicus,50597,,,Feces,,N,11488,,,,1988.0,,1,10116.0,CHEMBL624281,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11509,Rattus norvegicus,50597,,,Feces,,N,11488,,,,1988.0,,1,10116.0,CHEMBL622933,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11510,Rattus norvegicus,50597,,,Feces,,N,11488,,,,1988.0,,1,10116.0,CHEMBL622934,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,11511,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL622935,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration,11512,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL622936,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,11513,Rattus norvegicus,50597,,,Liver,,N,8829,,,,2107.0,In vivo,1,10116.0,CHEMBL875228,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration,11514,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL622937,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,11515,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL622938,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration,11516,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL619736,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,11517,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL625117,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration,11518,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL625118,Intermediate,
A,1,BAO_0000218,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,11519,Rattus norvegicus,50597,,,Lung,,N,8829,,,,2048.0,In vivo,1,10116.0,CHEMBL625119,Intermediate,
A,1,BAO_0000218,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",11520,Rattus norvegicus,50597,,,Cerebellum,,N,14972,,,,2037.0,In vivo,1,10116.0,CHEMBL625120,Intermediate,
A,1,BAO_0000218,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",11521,Rattus norvegicus,50597,,,,,N,14972,,,,,In vivo,1,10116.0,CHEMBL625121,Intermediate,
A,1,BAO_0000218,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",11522,Rattus norvegicus,50597,,,Thalamus,,N,14972,,,,10000006.0,In vivo,1,10116.0,CHEMBL625122,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,11523,Rattus norvegicus,50597,,,Blood,,N,14608,,,,178.0,In vivo,1,10116.0,CHEMBL622204,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,11524,Rattus norvegicus,50597,,,Blood,,N,14608,,,,178.0,In vivo,1,10116.0,CHEMBL877503,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,11525,Rattus norvegicus,50597,,,Blood,,N,14608,,,,178.0,In vivo,1,10116.0,CHEMBL627127,Intermediate,
A,0,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,11526,,22224,,,Hippocampus,,U,14608,,,,10000000.0,In vivo,1,,CHEMBL627128,Autocuration,
A,0,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,11527,,22224,,,Hippocampus,,U,14608,,,,10000000.0,In vivo,1,,CHEMBL627129,Autocuration,
A,0,BAO_0000218,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,11528,,22224,,,Hippocampus,,U,14608,,,,10000000.0,In vivo,1,,CHEMBL627130,Autocuration,
A,1,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,11529,Rattus norvegicus,50597,,,Brain,,N,14608,,,,955.0,In vivo,1,10116.0,CHEMBL627131,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,11530,Rattus norvegicus,50597,,,Brain,,N,14608,,,,955.0,In vivo,1,10116.0,CHEMBL627132,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,11531,Rattus norvegicus,50597,,,Brain,,N,14608,,,,955.0,In vivo,1,10116.0,CHEMBL627133,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11532,Rattus norvegicus,50597,,,Cerebellum,,N,14608,,,,2037.0,In vivo,1,10116.0,CHEMBL627134,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11533,Rattus norvegicus,50597,,,Cerebellum,,N,14608,,,,2037.0,In vivo,1,10116.0,CHEMBL627135,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11534,Rattus norvegicus,50597,,,Cerebellum,,N,14608,,,,2037.0,In vivo,1,10116.0,CHEMBL627136,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,11535,Rattus norvegicus,50597,,,,,N,14608,,,,,In vivo,1,10116.0,CHEMBL628435,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,11536,Rattus norvegicus,50597,,,,,N,14608,,,,,In vivo,1,10116.0,CHEMBL628436,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,11537,Rattus norvegicus,50597,,,,,N,14608,,,,,In vivo,1,10116.0,CHEMBL628437,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,11538,Rattus norvegicus,50597,,,Heart,,N,14608,,,,948.0,In vivo,1,10116.0,CHEMBL628438,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,11539,Rattus norvegicus,50597,,,Heart,,N,14608,,,,948.0,In vivo,1,10116.0,CHEMBL628439,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,11540,Rattus norvegicus,50597,,,Heart,,N,14608,,,,948.0,In vivo,1,10116.0,CHEMBL628440,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,11541,Rattus norvegicus,50597,,,Hippocampus,,N,14608,,,,10000000.0,In vivo,1,10116.0,CHEMBL628441,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,11542,Rattus norvegicus,50597,,,Hippocampus,,N,14608,,,,10000000.0,In vivo,1,10116.0,CHEMBL628442,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,11543,Rattus norvegicus,50597,,,Hippocampus,,N,14608,,,,10000000.0,In vivo,1,10116.0,CHEMBL628443,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,11544,Rattus norvegicus,50597,,,Kidney,,N,14608,,,,2113.0,In vivo,1,10116.0,CHEMBL628444,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,11545,Rattus norvegicus,50597,,,Kidney,,N,14608,,,,2113.0,In vivo,1,10116.0,CHEMBL628445,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,11546,Rattus norvegicus,50597,,,Kidney,,N,14608,,,,2113.0,In vivo,1,10116.0,CHEMBL877504,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,11547,Rattus norvegicus,50597,,,Liver,,N,14608,,,,2107.0,In vivo,1,10116.0,CHEMBL628446,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,11548,Rattus norvegicus,50597,,,Liver,,N,14608,,,,2107.0,In vivo,1,10116.0,CHEMBL626874,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,11549,Rattus norvegicus,50597,,,Liver,,N,14608,,,,2107.0,In vivo,1,10116.0,CHEMBL626875,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,11550,Rattus norvegicus,50597,,,Lung,,N,14608,,,,2048.0,In vivo,1,10116.0,CHEMBL626876,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,11551,Rattus norvegicus,50597,,,Lung,,N,14608,,,,2048.0,In vivo,1,10116.0,CHEMBL626877,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,11552,Rattus norvegicus,50597,,,Lung,,N,14608,,,,2048.0,In vivo,1,10116.0,CHEMBL626878,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,11553,Rattus norvegicus,50597,,,Muscle tissue,,N,14608,,,,2385.0,In vivo,1,10116.0,CHEMBL626879,Intermediate,
A,0,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,11554,Simiiformes,22224,,,Plasma,,U,8918,,,,1969.0,In vivo,1,314293.0,CHEMBL626880,Autocuration,
A,1,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,11555,Mus musculus,50594,,,Plasma,,N,8918,,,,1969.0,In vivo,1,10090.0,CHEMBL626881,Intermediate,
A,1,BAO_0000218,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,11556,Rattus norvegicus,50597,,,Plasma,,N,8918,,,,1969.0,In vivo,1,10116.0,CHEMBL626882,Intermediate,
A,1,BAO_0000218,Peak plasma concentration was measured in dogs,11557,Canis lupus familiaris,50588,,,Plasma,,N,14470,,,,1969.0,In vivo,1,9615.0,CHEMBL626883,Intermediate,
A,1,BAO_0000218,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11558,Rattus norvegicus,50597,,,,,N,14393,,,,,In vivo,1,10116.0,CHEMBL626884,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,11559,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL626885,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,11560,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL626886,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,11561,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL626887,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,11562,Rattus norvegicus,50597,,,,,N,14393,,,,,In vivo,1,10116.0,CHEMBL626888,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,11563,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL626889,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,11564,Simiiformes,22224,,,,,U,13465,,,,,In vivo,1,314293.0,CHEMBL626761,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,11565,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL626762,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,11566,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL626763,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,11567,Rattus norvegicus,50597,,,,,N,13465,,,,,In vivo,1,10116.0,CHEMBL626764,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,11568,Rattus norvegicus,50597,,,,,N,13465,,,,,In vivo,1,10116.0,CHEMBL626765,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,11569,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL626766,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,11570,Rattus norvegicus,50597,,,,,N,13465,,,,,In vivo,1,10116.0,CHEMBL626767,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,11571,Rattus norvegicus,50597,,,,,N,13465,,,,,In vivo,1,10116.0,CHEMBL626768,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,11572,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL626769,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,11573,Canis lupus familiaris,50588,,,,,N,13465,,,,,In vivo,1,9615.0,CHEMBL874463,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,11574,Simiiformes,22224,,,,,U,13465,,,,,In vivo,1,314293.0,CHEMBL626770,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,11575,Simiiformes,22224,,,,,U,13465,,,,,In vivo,1,314293.0,CHEMBL626771,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,11576,Rattus norvegicus,50597,,,,,N,13465,,,,,In vivo,1,10116.0,CHEMBL626772,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11577,Macaca fascicularis,100710,,,,,N,14731,,,,,In vivo,1,9541.0,CHEMBL626773,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,11578,Mus musculus,50594,,,,,N,14731,,,,,In vivo,1,10090.0,CHEMBL626774,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,11579,Canis lupus familiaris,50588,,,,,N,13376,,,,,In vivo,1,9615.0,CHEMBL626775,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,11580,Canis lupus familiaris,50588,,,,,N,13376,,,,,In vivo,1,9615.0,CHEMBL626776,Intermediate,
A,1,BAO_0000218,Maximum concentration (Cmax) in rat when administered orally,11581,Rattus norvegicus,50597,,,,,N,14443,,,,,In vivo,1,10116.0,CHEMBL626777,Intermediate,
A,0,BAO_0000218,Maximal concentration in monkey plasma after 25 mg/kg oral dose,11582,Simiiformes,22224,,,Plasma,,U,13465,,,,1969.0,In vivo,1,314293.0,CHEMBL626778,Autocuration,
A,0,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",11583,Rattus norvegicus,22224,,,,,U,16359,,,,,In vivo,1,10116.0,CHEMBL626779,Autocuration,
A,0,BAO_0000218,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",11584,Rattus norvegicus,22224,,,,,U,16359,,,,,In vivo,1,10116.0,CHEMBL626780,Autocuration,
A,0,BAO_0000218,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,11585,,22224,,,Plasma,,U,15618,,,,1969.0,In vivo,1,,CHEMBL626781,Autocuration,
A,1,BAO_0000218,Pharmacokinetic profile Cmax was evaluated in rats,11586,Rattus norvegicus,50597,,,,,N,14554,,,,,In vivo,1,10116.0,CHEMBL632164,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),11587,Canis lupus familiaris,50588,,,,,N,11537,,,,,In vivo,1,9615.0,CHEMBL632165,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),11588,Mus musculus,50594,,,,,N,11537,,,,,In vivo,1,10090.0,CHEMBL632166,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),11589,Canis lupus familiaris,50588,,,,,N,11537,,,,,In vivo,1,9615.0,CHEMBL632167,Intermediate,
A,1,BAO_0000218,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),11590,Mus musculus,50594,,,,,N,11537,,,,,In vivo,1,10090.0,CHEMBL632168,Intermediate,
A,0,BAO_0000218,Cmax in rat plasma,11591,Rattus norvegicus,22224,,,Plasma,,U,2021,,,,1969.0,In vivo,1,10116.0,CHEMBL632169,Autocuration,
A,1,BAO_0000218,Cmax in dog plasma after 30mg/kg oral dose,11592,Canis lupus familiaris,50588,,,Plasma,,N,5932,,,,1969.0,In vivo,1,9615.0,CHEMBL632170,Intermediate,
A,1,BAO_0000218,Cmax in rat plasma after 30mg/kg oral dose,11593,Rattus norvegicus,50597,,,Plasma,,N,5932,,,,1969.0,In vivo,1,10116.0,CHEMBL632171,Intermediate,
A,1,BAO_0000218,Plasma level in rats at 30 mg/kg,11594,Rattus norvegicus,50597,,,Plasma,,N,17320,,,,1969.0,In vivo,1,10116.0,CHEMBL632172,Intermediate,
A,1,BAO_0000218,Tested for maximum plasma concentration in mice,11595,Mus musculus,50594,,,Plasma,,N,15831,,,,1969.0,In vivo,1,10090.0,CHEMBL632173,Intermediate,
A,1,BAO_0000218,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",11596,Rattus norvegicus,50597,,,,,N,15078,,,,,In vivo,1,10116.0,CHEMBL632174,Intermediate,
A,1,BAO_0000218,The Cmax values in female wistar rats.,11597,Rattus norvegicus,50597,,,,,N,14941,,,,,In vivo,1,10116.0,CHEMBL632175,Intermediate,
A,1,BAO_0000218,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,11598,Canis lupus familiaris,50588,,,Plasma,,N,15343,,,,1969.0,In vivo,1,9615.0,CHEMBL632176,Intermediate,
A,1,BAO_0000218,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,11599,Rattus norvegicus,50597,,,Plasma,,N,15343,,,,1969.0,In vivo,1,10116.0,CHEMBL632177,Intermediate,
A,1,BAO_0000218,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,11600,Rattus norvegicus,50597,,,Plasma,,N,14856,,,,1969.0,In vivo,1,10116.0,CHEMBL632178,Intermediate,
A,1,BAO_0000218,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,11601,Rattus norvegicus,50597,,,,,N,13129,,,,,In vivo,1,10116.0,CHEMBL632179,Intermediate,
A,1,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,11602,Rattus norvegicus,50597,,,Blood,,N,13098,,,,178.0,In vivo,1,10116.0,CHEMBL632180,Intermediate,
A,1,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,11603,Rattus norvegicus,50597,,,Blood,,N,13098,,,,178.0,In vivo,1,10116.0,CHEMBL632181,Intermediate,
A,1,BAO_0000218,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,11604,Rattus norvegicus,50597,,,Blood,,N,13098,,,,178.0,In vivo,1,10116.0,CHEMBL632182,Intermediate,
A,0,BAO_0000218,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,11605,Mus musculus,22224,,,Blood,,U,15478,,,,178.0,In vivo,1,10090.0,CHEMBL632183,Autocuration,
A,1,BAO_0000218,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,11606,Canis lupus familiaris,50588,,,,,N,15341,,,,,In vivo,1,9615.0,CHEMBL632184,Intermediate,
A,1,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,11607,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL874470,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",11608,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631302,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",11609,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631303,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",11610,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631304,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",11611,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631305,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",11612,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631306,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",11613,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631307,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",11614,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL631308,Intermediate,
A,1,BAO_0000218,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",11615,Rattus norvegicus,50597,,,,,N,8684,,,,,,1,10116.0,CHEMBL625557,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",11616,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625558,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",11617,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625559,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",11618,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625560,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",11619,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625561,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",11620,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625562,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",11621,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL875320,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",11622,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625563,Intermediate,
A,1,BAO_0000218,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",11623,Rattus norvegicus,50597,,,Spleen,,N,8684,,,,2106.0,,1,10116.0,CHEMBL625564,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",11624,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL625565,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",11625,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL625566,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",11626,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL625567,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",11627,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL625568,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",11628,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL628217,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",11629,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL628218,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",11630,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL628219,Intermediate,
A,1,BAO_0000218,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",11631,Rattus norvegicus,50597,,,Uterus,,N,8684,,,,995.0,,1,10116.0,CHEMBL628220,Intermediate,
A,0,BAO_0000019,Distribution in the blood after 120 min of intravenous administration,11632,,22224,,,,,U,8926,,,,,,1,,CHEMBL628221,Autocuration,
A,0,BAO_0000019,Distribution in the blood after 15 min of intravenous administration,11633,,22224,,,,,U,8926,,,,,,1,,CHEMBL628222,Autocuration,
A,0,BAO_0000019,Distribution in the blood after 30 min of intravenous administration,11634,,22224,,,,,U,8926,,,,,,1,,CHEMBL628223,Autocuration,
A,0,BAO_0000019,Distribution in the blood after 5 min of intravenous administration,11635,,22224,,,,,U,8926,,,,,,1,,CHEMBL628224,Autocuration,
A,0,BAO_0000019,Distribution in the blood after 60 min of intravenous administration,11636,,22224,,,,,U,8926,,,,,,1,,CHEMBL628225,Autocuration,
A,0,BAO_0000019,Distribution in the blood after 90 min of intravenous administration,11637,,22224,,,,,U,8926,,,,,,1,,CHEMBL628226,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 120 min of intravenous administration,11638,,22224,,,,,U,8926,,,,,,1,,CHEMBL628227,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 15 min of intravenous administration,11639,,22224,,,,,U,8926,,,,,,1,,CHEMBL875481,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 30 min of intravenous administration,11640,,22224,,,,,U,8926,,,,,,1,,CHEMBL628228,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 5 min of intravenous administration,11641,,22224,,,,,U,8926,,,,,,1,,CHEMBL628229,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 60 min of intravenous administration,11642,,22224,,,,,U,8926,,,,,,1,,CHEMBL628230,Autocuration,
A,0,BAO_0000019,Distribution in the bone after 90 min of intravenous administration,11643,,22224,,,,,U,8926,,,,,,1,,CHEMBL628231,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 120 min of intravenous administration,11644,,22224,,,,,U,8926,,,,,,1,,CHEMBL628232,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 15 min of intravenous administration,11645,,22224,,,,,U,8926,,,,,,1,,CHEMBL628233,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 30 min of intravenous administration,11646,,22224,,,,,U,8926,,,,,,1,,CHEMBL628234,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 5 min of intravenous administration,11647,,22224,,,,,U,8926,,,,,,1,,CHEMBL628235,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 60 min of intravenous administration,11648,,22224,,,,,U,8926,,,,,,1,,CHEMBL628236,Autocuration,
A,0,BAO_0000019,Distribution in the heart after 90 min of intravenous administration,11649,,22224,,,,,U,8926,,,,,,1,,CHEMBL628237,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 120 min of intravenous administration,11650,,22224,,,,,U,8926,,,,,,1,,CHEMBL628238,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 15 min of intravenous administration,11651,,22224,,,,,U,8926,,,,,,1,,CHEMBL628239,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 30 min of intravenous administration,11652,,22224,,,,,U,8926,,,,,,1,,CHEMBL628240,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 5 min of intravenous administration,11653,,22224,,,,,U,8926,,,,,,1,,CHEMBL628241,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 60 min of intravenous administration,11654,,22224,,,,,U,8926,,,,,,1,,CHEMBL628242,Autocuration,
A,0,BAO_0000019,Distribution in the kidneys after 90 min of intravenous administration,11655,,22224,,,,,U,8926,,,,,,1,,CHEMBL875482,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 120 min of intravenous administration,11656,,22224,,,,,U,8926,,,,,,1,,CHEMBL628243,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 15 min of intravenous administration,11657,,22224,,,,,U,8926,,,,,,1,,CHEMBL628244,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 30 min of intravenous administration,11658,,22224,,,,,U,8926,,,,,,1,,CHEMBL628245,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 5 min of intravenous administration,11659,,22224,,,,,U,8926,,,,,,1,,CHEMBL628246,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 60 min of intravenous administration,11660,,22224,,,,,U,8926,,,,,,1,,CHEMBL628247,Autocuration,
A,0,BAO_0000019,Distribution in the liver after 90 min of intravenous administration,11661,,22224,,,,,U,8926,,,,,,1,,CHEMBL628248,Autocuration,
A,0,BAO_0000019,Distribution in the lung after 120 min of intravenous administration,11662,,22224,,,,,U,8926,,,,,,1,,CHEMBL628249,Autocuration,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",11663,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL625452,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",11664,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL625453,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",11665,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL625454,Intermediate,
A,1,BAO_0000218,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",11666,Mus musculus,50594,,,,,N,14839,,,,,,1,10090.0,CHEMBL623844,Intermediate,
A,1,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,11667,Rattus norvegicus,50597,,,,,N,12178,,,,,,1,10116.0,CHEMBL623845,Intermediate,
A,1,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,11668,Rattus norvegicus,50597,,,,,N,12178,,,,,,1,10116.0,CHEMBL623846,Intermediate,
A,0,BAO_0000218,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,11669,,22224,,,,,U,12178,,,,,,1,,CHEMBL623847,Autocuration,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,11670,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL623848,Intermediate,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11671,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL623849,Intermediate,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,11672,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL623850,Intermediate,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,11673,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL623851,Intermediate,
A,0,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,11674,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL623852,Autocuration,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,11675,Mustela putorius furo,50506,,,,,N,12187,,,,,,1,9669.0,CHEMBL624551,Intermediate,
A,1,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",11676,Mustela putorius furo,50506,,,,,N,12187,,,,,,1,9669.0,CHEMBL624552,Intermediate,
A,0,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,11677,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL624553,Autocuration,
A,0,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,11678,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL624554,Autocuration,
A,1,BAO_0000218,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,11679,Rattus norvegicus,50597,,,,,N,12187,,,,,,1,10116.0,CHEMBL624555,Intermediate,
A,1,BAO_0000218,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",11680,Rattus norvegicus,50597,,,,,N,12187,,,,,,1,10116.0,CHEMBL624741,Intermediate,
A,1,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",11681,Canis lupus familiaris,50588,,,,,N,14122,,,,,,1,9615.0,CHEMBL624742,Intermediate,
A,1,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",11682,Cricetinae,100712,,,,,N,14122,,,,,,1,10026.0,CHEMBL624743,Intermediate,
A,1,BAO_0000218,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",11683,Rattus norvegicus,50597,,,,,N,14122,,,,,,1,10116.0,CHEMBL877606,Intermediate,
A,0,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,11684,,22224,,,,,U,13391,,,,,,1,,CHEMBL624744,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,11685,,22224,,,Blood,,U,13391,,,,178.0,,1,,CHEMBL624745,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,11686,,22224,,,Blood,,U,13391,,,,178.0,,1,,CHEMBL624746,Autocuration,
A,0,BAO_0000218,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,11687,,22224,,,Blood,,U,13391,,,,178.0,,1,,CHEMBL624747,Autocuration,
A,0,BAO_0000019,Oral absorption expressed as Area under curve was determined,11688,,22224,,,,,U,16360,,,,,,1,,CHEMBL624748,Autocuration,
A,1,BAO_0000218,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,11689,Canis lupus familiaris,50588,,,,,N,3673,,,,,,1,9615.0,CHEMBL622504,Intermediate,
A,1,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",11690,Canis lupus familiaris,50588,,,,,N,14122,,,,,,1,9615.0,CHEMBL622505,Intermediate,
A,1,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11691,Cricetinae,100712,,,,,N,14122,,,,,,1,10026.0,CHEMBL622506,Intermediate,
A,1,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",11692,Cricetinae,100712,,,,,N,14122,,,,,,1,10026.0,CHEMBL622507,Intermediate,
A,1,BAO_0000218,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",11693,Rattus norvegicus,50597,,,,,N,14122,,,,,,1,10116.0,CHEMBL622508,Intermediate,
A,0,BAO_0000019,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,11694,,22224,,,,,U,13889,,,,,,1,,CHEMBL622509,Autocuration,
A,1,BAO_0000218,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11695,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL622510,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),11696,Rattus norvegicus,50597,,,,,N,17279,,,,,,1,10116.0,CHEMBL622511,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,11697,Macaca fascicularis,100710,,,,,N,14548,,,,,,1,9541.0,CHEMBL622512,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,11698,Macaca fascicularis,100710,,,,,N,14548,,,,,,1,9541.0,CHEMBL622513,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,11699,Macaca fascicularis,100710,,,,,N,14548,,,,,,1,9541.0,CHEMBL622514,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,11700,Canis lupus familiaris,50588,,,,,N,14548,,,,,,1,9615.0,CHEMBL622515,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,11701,Canis lupus familiaris,50588,,,,,N,14548,,,,,,1,9615.0,CHEMBL622516,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,11702,Rattus norvegicus,50597,,,,,N,14548,,,,,,1,10116.0,CHEMBL622517,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,11703,Rattus norvegicus,50597,,,,,N,14548,,,,,,1,10116.0,CHEMBL622518,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,11704,Rattus norvegicus,50597,,,,,N,14548,,,,,,1,10116.0,CHEMBL622519,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,11705,Rattus norvegicus,50597,,,Muscle tissue,,N,14608,,,,2385.0,In vivo,1,10116.0,CHEMBL622520,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,11706,Rattus norvegicus,50597,,,Muscle tissue,,N,14608,,,,2385.0,In vivo,1,10116.0,CHEMBL622521,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,11707,Mus musculus,50594,,,Zone of skin,,N,14608,,,,14.0,In vivo,1,10090.0,CHEMBL625113,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,11708,Rattus norvegicus,50597,,,Zone of skin,,N,14608,,,,14.0,In vivo,1,10116.0,CHEMBL625114,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,11709,Rattus norvegicus,50597,,,Zone of skin,,N,14608,,,,14.0,In vivo,1,10116.0,CHEMBL874397,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,11710,Rattus norvegicus,50597,,,Spleen,,N,14608,,,,2106.0,In vivo,1,10116.0,CHEMBL625115,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,11711,Rattus norvegicus,50597,,,Spleen,,N,14608,,,,2106.0,In vivo,1,10116.0,CHEMBL625116,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,11712,Rattus norvegicus,50597,,,Spleen,,N,14608,,,,2106.0,In vivo,1,10116.0,CHEMBL623932,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,11713,Rattus norvegicus,50597,,,Striatum,,N,14608,,,,2435.0,In vivo,1,10116.0,CHEMBL623933,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,11714,Rattus norvegicus,50597,,,Striatum,,N,14608,,,,2435.0,In vivo,1,10116.0,CHEMBL623934,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,11715,Rattus norvegicus,50597,,,Striatum,,N,14608,,,,2435.0,In vivo,1,10116.0,CHEMBL623935,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,11716,Rattus norvegicus,50597,,,Thyroid gland,,N,14608,,,,2046.0,In vivo,1,10116.0,CHEMBL623936,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,11717,Rattus norvegicus,50597,,,Thyroid gland,,N,14608,,,,2046.0,In vivo,1,10116.0,CHEMBL623937,Intermediate,
A,1,BAO_0000218,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,11718,Rattus norvegicus,50597,,,Thyroid gland,,N,14608,,,,2046.0,In vivo,1,10116.0,CHEMBL623938,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11719,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL623939,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11720,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL623940,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11721,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL623941,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11722,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL627216,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11723,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL623942,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11724,Mus musculus,50594,,,Brain,,N,15383,,,,955.0,,1,10090.0,CHEMBL618793,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11725,Mus musculus,50594,,,Brain,,N,15383,,,,955.0,,1,10090.0,CHEMBL618794,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11726,Mus musculus,50594,,,Brain,,N,15383,,,,955.0,,1,10090.0,CHEMBL618795,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11727,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618796,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11728,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618797,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11729,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618798,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11730,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618799,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11731,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618800,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11732,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618801,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11733,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618802,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11734,Mus musculus,50594,,,Kidney,,N,15383,,,,2113.0,,1,10090.0,CHEMBL618803,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,11735,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618804,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11736,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618805,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11737,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618806,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11738,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618807,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11739,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618808,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11740,Mus musculus,50594,,,Liver,,N,15383,,,,2107.0,,1,10090.0,CHEMBL618809,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11741,Mus musculus,50594,,,Muscle tissue,,N,15383,,,,2385.0,,1,10090.0,CHEMBL618810,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,11742,Mus musculus,50594,,,Muscle tissue,,N,15383,,,,2385.0,,1,10090.0,CHEMBL618811,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11743,Mus musculus,50594,,,Muscle tissue,,N,15383,,,,2385.0,,1,10090.0,CHEMBL875844,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11744,Mus musculus,50594,,,Muscle tissue,,N,15383,,,,2385.0,,1,10090.0,CHEMBL618812,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11745,Mus musculus,50594,,,Muscle tissue,,N,15383,,,,2385.0,,1,10090.0,CHEMBL618813,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11746,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618814,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11747,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618815,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11748,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618816,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11749,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL618817,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11750,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL620544,Intermediate,
A,1,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,11751,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL626230,Intermediate,
A,1,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,11752,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL626231,Intermediate,
A,1,BAO_0000218,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,11753,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL626232,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,11754,Canis lupus familiaris,50588,,,Plasma,,N,14906,,,,1969.0,In vivo,1,9615.0,CHEMBL626233,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,11755,Rattus norvegicus,50597,,,Plasma,,N,14906,,,,1969.0,In vivo,1,10116.0,CHEMBL626234,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,11756,Rattus norvegicus,50597,,,Plasma,,N,14906,,,,1969.0,In vivo,1,10116.0,CHEMBL875341,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (100 mg/kg) administered orally in human,11757,Homo sapiens,50587,,,Plasma,,N,14215,,,,1969.0,In vivo,1,9606.0,CHEMBL626235,Intermediate,
A,0,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,11758,Callithrix,22224,,,Plasma,,U,14215,,,,1969.0,In vivo,1,9481.0,CHEMBL626236,Autocuration,
A,0,BAO_0000218,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,11759,Simiiformes,22224,,,Plasma,,U,14215,,,,1969.0,In vivo,1,314293.0,CHEMBL626237,Autocuration,
A,1,BAO_0000218,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,11760,Canis lupus familiaris,50588,,,Plasma,,N,14215,,,,1969.0,In vivo,1,9615.0,CHEMBL626238,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (200 mg/kg) administered orally in human,11761,Homo sapiens,50587,,,Plasma,,N,14215,,,,1969.0,In vivo,1,9606.0,CHEMBL622412,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,11762,Rattus norvegicus,50597,,,Plasma,,N,14215,,,,1969.0,In vivo,1,10116.0,CHEMBL623114,Intermediate,
A,0,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,11763,Callithrix,22224,,,Plasma,,U,14215,,,,1969.0,In vivo,1,9481.0,CHEMBL623115,Autocuration,
A,0,BAO_0000218,The maximum plasma concentration (25 mg/kg) administered orally in monkey,11764,Simiiformes,22224,,,Plasma,,U,14215,,,,1969.0,In vivo,1,314293.0,CHEMBL623116,Autocuration,
A,0,BAO_0000218,The maximum plasma concentration (30 mg/kg) administered orally in dog,11765,Canis lupus familiaris,22224,,,Plasma,,U,14215,,,,1969.0,In vivo,1,9615.0,CHEMBL623117,Autocuration,
A,1,BAO_0000218,The maximum plasma concentration (400 mg/kg) administered orally in human,11766,Homo sapiens,50587,,,Plasma,,N,14215,,,,1969.0,In vivo,1,9606.0,CHEMBL623118,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,11767,Rattus norvegicus,50597,,,Plasma,,N,14215,,,,1969.0,In vivo,1,10116.0,CHEMBL623119,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (50 mg/kg) administered orally in rat,11768,Rattus norvegicus,50597,,,Plasma,,N,14215,,,,1969.0,In vivo,1,10116.0,CHEMBL623120,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration (800 mg/kg) administered orally in human,11769,Homo sapiens,50587,,,Plasma,,N,14215,,,,1969.0,In vivo,1,9606.0,CHEMBL623286,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration was measured on rats,11770,Rattus norvegicus,50597,,,Plasma,,N,14067,,,,1969.0,In vivo,1,10116.0,CHEMBL623287,Intermediate,
A,1,BAO_0000218,The maximum plasma concentration was measured on rats after oral administration,11771,Rattus norvegicus,50597,,,Plasma,,N,12350,,,,1969.0,In vivo,1,10116.0,CHEMBL623288,Intermediate,
A,1,BAO_0000218,Plasma drug Cmax in rat (PO dose),11772,Rattus norvegicus,50597,,,Plasma,,N,14813,,,,1969.0,In vivo,1,10116.0,CHEMBL623289,Intermediate,
A,0,BAO_0000218,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,11773,,22224,,,,,U,12536,,,,,In vivo,1,,CHEMBL623290,Autocuration,
A,1,BAO_0000218,maximum Plasma concentration in Dog was determined after Peroral administration,11774,Canis lupus familiaris,50588,,,Plasma,,N,14169,,,,1969.0,In vivo,1,9615.0,CHEMBL623291,Intermediate,
A,1,BAO_0000218,maximum Plasma concentration in Rats was determined after Peroral administration,11775,Rattus norvegicus,50597,,,Plasma,,N,14169,,,,1969.0,In vivo,1,10116.0,CHEMBL623292,Intermediate,
A,1,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,11776,Canis lupus familiaris,50588,,,Plasma,,N,15604,,,,1969.0,In vivo,1,9615.0,CHEMBL623293,Intermediate,
A,0,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,11777,Simiiformes,22224,,,Plasma,,U,15604,,,,1969.0,In vivo,1,314293.0,CHEMBL623294,Autocuration,
A,1,BAO_0000218,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,11778,Rattus norvegicus,50597,,,Plasma,,N,15604,,,,1969.0,In vivo,1,10116.0,CHEMBL623295,Intermediate,
A,1,BAO_0000218,maximum concentration was measured when administered through oral route in mice,11779,Mus musculus,50594,,,,,N,14387,,,,,In vivo,1,10090.0,CHEMBL623296,Intermediate,
A,1,BAO_0000218,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,11780,Mus musculus,50594,,,,,N,15115,,,,,,1,10090.0,CHEMBL875349,Intermediate,
A,0,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,11781,Simiiformes,22224,,,,,U,15115,,,,,,1,314293.0,CHEMBL623297,Autocuration,
A,0,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,11782,Simiiformes,22224,,,,,U,15115,,,,,,1,314293.0,CHEMBL623298,Autocuration,
A,0,BAO_0000019,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,11783,Simiiformes,22224,,,,,U,15115,,,,,,1,314293.0,CHEMBL623299,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameter was evaluated in rats,11784,Rattus norvegicus,50597,,,,,N,16359,,,,,,1,10116.0,CHEMBL623300,Intermediate,
A,1,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11785,Mus musculus,50594,,,,,N,12829,,,,,,1,10090.0,CHEMBL623301,Intermediate,
A,1,BAO_0000218,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,11786,Mus musculus,50594,,,,,N,12829,,,,,,1,10090.0,CHEMBL623302,Intermediate,
A,1,BAO_0000218,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,11787,Mus musculus,50594,,,,,N,12829,,,,,,1,10090.0,CHEMBL623303,Intermediate,
A,1,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,11788,Mus musculus,50594,,,,,N,12829,,,,,,1,10090.0,CHEMBL623304,Intermediate,
A,1,BAO_0000218,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,11789,Mus musculus,50594,,,,,N,12829,,,,,,1,10090.0,CHEMBL623305,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,11790,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,,1,10116.0,CHEMBL623306,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,11791,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,,1,10116.0,CHEMBL623307,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,11792,Rattus norvegicus,50597,,,Plasma,,N,15137,,,,1969.0,,1,10116.0,CHEMBL623308,Intermediate,
A,1,BAO_0000218,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,11793,Mus musculus,50594,,,Plasma,,N,15137,,,,1969.0,,1,10090.0,CHEMBL623309,Intermediate,
A,1,BAO_0000218,Plasma Concentration after 120 min of oral administration to mice,11794,Mus musculus,50594,,,,,N,13509,,,,,,1,10090.0,CHEMBL623310,Intermediate,
A,1,BAO_0000218,Plasma Concentration after 30 min of oral administration to mice,11795,Mus musculus,50594,,,,,N,13509,,,,,,1,10090.0,CHEMBL623311,Intermediate,
A,1,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice,11796,Macaca fascicularis,100710,,,,,N,13509,,,,,,1,9541.0,CHEMBL623312,Intermediate,
A,1,BAO_0000218,Plasma Concentration after 60 min of oral administration to mice; Not determined,11797,Mus musculus,50594,,,,,N,13509,,,,,,1,10090.0,CHEMBL875350,Intermediate,
A,1,BAO_0000218,Plasma Concentration after 90 min of oral administration to mice,11798,Mus musculus,50594,,,,,N,13509,,,,,,1,10090.0,CHEMBL628635,Intermediate,
A,1,BAO_0000218,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,11799,Rattus norvegicus,50597,,,,,N,12064,,,,,,1,10116.0,CHEMBL628636,Intermediate,
A,1,BAO_0000218,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,11800,Rattus norvegicus,50597,,,,,N,12064,,,,,,1,10116.0,CHEMBL628637,Intermediate,
A,1,BAO_0000218,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,11801,Rattus norvegicus,50597,,,,,N,12064,,,,,,1,10116.0,CHEMBL628058,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,11802,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL628059,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,11803,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL628060,Intermediate,
A,0,BAO_0000019,Distribution in the lung after 15 min of intravenous administration,11804,,22224,,,,,U,8926,,,,,,1,,CHEMBL628061,Autocuration,
A,0,BAO_0000019,Distribution in the lung after 30 min of intravenous administration,11805,,22224,,,,,U,8926,,,,,,1,,CHEMBL628062,Autocuration,
A,0,BAO_0000019,Distribution in the lung after 5 min of intravenous administration,11806,,22224,,,,,U,8926,,,,,,1,,CHEMBL628063,Autocuration,
A,0,BAO_0000019,Distribution in the lung after 60 min of intravenous administration,11807,,22224,,,,,U,8926,,,,,,1,,CHEMBL628064,Autocuration,
A,0,BAO_0000019,Distribution in the lung after 90 min of intravenous administration,11808,,22224,,,,,U,8926,,,,,,1,,CHEMBL628065,Autocuration,
A,0,BAO_0000019,Distribution in the muscle after 120 min of intravenous administration,11809,,22224,,,Muscle tissue,,U,8926,,,,2385.0,,1,,CHEMBL628066,Autocuration,
A,0,BAO_0000019,Distribution in the muscle after 15 min of intravenous administration,11810,,22224,,,Muscle tissue,,U,8926,,,,2385.0,,1,,CHEMBL628067,Autocuration,
A,1,BAO_0000218,Distribution in the muscle after 30 min of intravenous administration,11811,Mus musculus,50594,,,Muscle tissue,,N,8926,,,,2385.0,,1,10090.0,CHEMBL874646,Intermediate,
A,0,BAO_0000019,Distribution in the muscle after 5 min of intravenous administration,11812,,22224,,,Muscle tissue,,U,8926,,,,2385.0,,1,,CHEMBL628068,Autocuration,
A,0,BAO_0000019,Distribution in the muscle after 60 min of intravenous administration,11813,,22224,,,Muscle tissue,,U,8926,,,,2385.0,,1,,CHEMBL628069,Autocuration,
A,0,BAO_0000019,Distribution in the muscle after 90 min of intravenous administration,11814,,22224,,,Muscle tissue,,U,8926,,,,2385.0,,1,,CHEMBL628070,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 120 min of intravenous administration,11815,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628071,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 15 min of intravenous administration,11816,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628072,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 30 min of intravenous administration,11817,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628073,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 5 min of intravenous administration,11818,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628074,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 60 min of intravenous administration,11819,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628075,Autocuration,
A,0,BAO_0000019,Distribution in the spleen after 90 min of intravenous administration,11820,,22224,,,Spleen,,U,8926,,,,2106.0,,1,,CHEMBL628076,Autocuration,
A,1,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,11821,Rattus norvegicus,50597,,,Adrenal cortex,,N,7570,,,,1235.0,,1,10116.0,CHEMBL628077,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,11822,Rattus norvegicus,50597,,,Blood,,N,7570,,,,178.0,,1,10116.0,CHEMBL628078,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,11823,Rattus norvegicus,50597,,,Liver,,N,7570,,,,2107.0,,1,10116.0,CHEMBL628079,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,11824,Rattus norvegicus,50597,,,Female gonad,,N,7570,,,,992.0,,1,10116.0,CHEMBL628080,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,11825,Rattus norvegicus,50597,,,Thyroid gland,,N,7570,,,,2046.0,,1,10116.0,CHEMBL628081,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,11826,Rattus norvegicus,50597,,,Adrenal cortex,,N,7570,,,,1235.0,,1,10116.0,CHEMBL628082,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,11827,Rattus norvegicus,50597,,,Blood,,N,7570,,,,178.0,,1,10116.0,CHEMBL874647,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,11828,Rattus norvegicus,50597,,,Liver,,N,7570,,,,2107.0,,1,10116.0,CHEMBL626406,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,11829,Rattus norvegicus,50597,,,Female gonad,,N,7570,,,,992.0,,1,10116.0,CHEMBL626407,Intermediate,
A,1,BAO_0000218,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,11830,Rattus norvegicus,50597,,,Thyroid gland,,N,7570,,,,2046.0,,1,10116.0,CHEMBL626408,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",11831,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626409,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",11832,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626410,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",11833,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626411,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",11834,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626412,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",11835,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626413,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",11836,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626414,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",11837,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626415,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",11838,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL626416,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",11839,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627062,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",11840,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627063,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",11841,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627064,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",11842,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627227,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",11843,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627228,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",11844,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL627229,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",11845,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL625792,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",11846,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL625793,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",11847,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL625794,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",11848,Rattus norvegicus,50597,,,Blood,,N,8608,,,,178.0,,1,10116.0,CHEMBL625795,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,11849,Mus musculus,50594,,,,,N,13792,,,,,,1,10090.0,CHEMBL625796,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,11850,Canis lupus familiaris,50588,,,,,N,13376,,,,,,1,9615.0,CHEMBL625797,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,11851,Canis lupus familiaris,50588,,,,,N,13376,,,,,,1,9615.0,CHEMBL625798,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11852,,22224,,,,,U,14380,,,,,,1,,CHEMBL875613,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,11853,,22224,,,,,U,14380,,,,,,1,,CHEMBL625799,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,11854,,22224,,,,,U,14380,,,,,,1,,CHEMBL625800,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,11855,,22224,,,,,U,14380,,,,,,1,,CHEMBL625801,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,11856,,22224,,,,,U,14380,,,,,,1,,CHEMBL625802,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,11857,,22224,,,,,U,14380,,,,,,1,,CHEMBL625803,Autocuration,
A,0,BAO_0000019,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,11858,,22224,,,,,U,14380,,,,,,1,,CHEMBL625804,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,11859,,22224,,,,,U,14380,,,,,,1,,CHEMBL622530,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,11860,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL622531,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11861,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL622532,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11862,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623176,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11863,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623177,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11864,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623178,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,11865,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623179,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),11866,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623180,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11867,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL623181,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11868,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624131,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),11869,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624132,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11870,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624133,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,11871,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624846,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),11872,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624847,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11873,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL624848,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),11874,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625012,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),11875,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625013,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,11876,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625014,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),11877,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625015,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),11878,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625016,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,11879,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625017,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),11880,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625018,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),11881,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625019,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),11882,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625020,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,11883,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL625021,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,11884,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL625022,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,11885,Mus musculus,50594,,,,,N,14731,,,,,,1,10090.0,CHEMBL625023,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,11886,Macaca fascicularis,100710,,,,,N,14731,,,,,,1,9541.0,CHEMBL625024,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,11887,Macaca fascicularis,100710,,,,,N,14731,,,,,,1,9541.0,CHEMBL627626,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,11888,,22224,,,Brain,,U,13758,,,,955.0,,1,,CHEMBL627627,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,11889,,22224,,,Serum,,U,13758,,,,1977.0,,1,,CHEMBL627628,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,11890,,22224,,,Brain,,U,13758,,,,955.0,,1,,CHEMBL627629,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,11891,,22224,,,Serum,,U,13758,,,,1977.0,,1,,CHEMBL627630,Autocuration,
A,0,BAO_0000019,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),11892,,22224,,,,,U,16359,,,,,,1,,CHEMBL627631,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),11893,,22224,,,,,U,16359,,,,,,1,,CHEMBL629515,Autocuration,
A,1,BAO_0000218,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11894,Mus musculus,50594,,,Spleen,,N,15383,,,,2106.0,,1,10090.0,CHEMBL629516,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11895,Mus musculus,50594,,,Spleen,,N,15383,,,,2106.0,,1,10090.0,CHEMBL629517,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11896,Mus musculus,50594,,,Spleen,,N,15383,,,,2106.0,,1,10090.0,CHEMBL629518,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,11897,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL877499,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,11898,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL629519,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,11899,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL629520,Intermediate,
A,1,BAO_0000218,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,11900,Mus musculus,50594,,,,,N,15383,,,,,,1,10090.0,CHEMBL629521,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),11901,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629522,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),11902,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629523,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),11903,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629524,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),11904,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629525,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),11905,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629526,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),11906,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629527,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),11907,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629528,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),11908,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629529,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),11909,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629530,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),11910,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL629531,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),11911,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL628656,Intermediate,
A,1,BAO_0000218,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),11912,Mus musculus,50594,,,,,N,14439,,,,,,1,10090.0,CHEMBL628657,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",11913,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628658,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",11914,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628659,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",11915,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL877500,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",11916,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628660,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11917,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628661,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",11918,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628662,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",11919,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628663,Intermediate,
A,1,BAO_0000218,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",11920,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL628664,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",11921,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628665,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",11922,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628666,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",11923,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628667,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11924,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628668,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",11925,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628669,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",11926,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628670,Intermediate,
A,1,BAO_0000218,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",11927,Rattus norvegicus,50597,,,Blood,,N,13751,,,,178.0,In vivo,1,10116.0,CHEMBL628671,Intermediate,
A,1,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",11928,Rattus norvegicus,50597,,,Bone,,N,13751,,,,10000001.0,In vivo,1,10116.0,CHEMBL628672,Intermediate,
A,1,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",11929,Rattus norvegicus,50597,,,Bone,,N,13751,,,,10000001.0,In vivo,1,10116.0,CHEMBL630300,Intermediate,
A,1,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11930,Rattus norvegicus,50597,,,Bone,,N,13751,,,,10000001.0,In vivo,1,10116.0,CHEMBL629787,Intermediate,
A,1,BAO_0000218,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",11931,Rattus norvegicus,50597,,,Bone,,N,13751,,,,10000001.0,In vivo,1,10116.0,CHEMBL629788,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",11932,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629789,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",11933,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629790,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",11934,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629791,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",11935,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629792,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",11936,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629793,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",11937,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629794,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,11938,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL874459,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,11939,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL629795,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,11940,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL629796,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,11941,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL629797,Intermediate,
A,1,BAO_0000218,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,11942,Rattus norvegicus,50597,,,,,N,10677,,,,,,1,10116.0,CHEMBL629798,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11943,Rattus norvegicus,50597,,,Adrenal gland,,N,10911,,,,2369.0,In vivo,1,10116.0,CHEMBL629799,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11944,Rattus norvegicus,50597,,,Adrenal gland,,N,10911,,,,2369.0,In vivo,1,10116.0,CHEMBL629800,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11945,Rattus norvegicus,50597,,,Adrenal gland,,N,10911,,,,2369.0,In vivo,1,10116.0,CHEMBL629801,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,11946,Rattus norvegicus,50597,,,Adrenal gland,,N,10911,,,,2369.0,In vivo,1,10116.0,CHEMBL629802,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11947,Rattus norvegicus,50597,,,Adrenal gland,,N,10911,,,,2369.0,In vivo,1,10116.0,CHEMBL629803,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11948,Rattus norvegicus,50597,,,Blood,,N,10911,,,,178.0,In vivo,1,10116.0,CHEMBL629804,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11949,Rattus norvegicus,50597,,,Blood,,N,10911,,,,178.0,In vivo,1,10116.0,CHEMBL629805,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11950,Rattus norvegicus,50597,,,Blood,,N,10911,,,,178.0,In vivo,1,10116.0,CHEMBL629806,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11951,Rattus norvegicus,50597,,,Blood,,N,10911,,,,178.0,In vivo,1,10116.0,CHEMBL629807,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11952,Rattus norvegicus,50597,,,Blood,,N,10911,,,,178.0,In vivo,1,10116.0,CHEMBL629808,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11953,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL629809,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11954,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL629810,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,11955,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL629811,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11956,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL629812,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,11957,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL629813,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11958,Rattus norvegicus,50597,,,Brain,,N,10911,,,,955.0,In vivo,1,10116.0,CHEMBL874460,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11959,Rattus norvegicus,50597,,,,,N,10911,,,,,In vivo,1,10116.0,CHEMBL629814,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11960,Rattus norvegicus,50597,,,,,N,10911,,,,,In vivo,1,10116.0,CHEMBL629815,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11961,Rattus norvegicus,50597,,,,,N,10911,,,,,In vivo,1,10116.0,CHEMBL629816,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11962,Rattus norvegicus,50597,,,,,N,10911,,,,,In vivo,1,10116.0,CHEMBL629817,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11963,Rattus norvegicus,50597,,,Kidney,,N,10911,,,,2113.0,In vivo,1,10116.0,CHEMBL626643,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11964,Rattus norvegicus,50597,,,Kidney,,N,10911,,,,2113.0,In vivo,1,10116.0,CHEMBL626644,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11965,Rattus norvegicus,50597,,,Kidney,,N,10911,,,,2113.0,In vivo,1,10116.0,CHEMBL626806,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11966,Rattus norvegicus,50597,,,Kidney,,N,10911,,,,2113.0,In vivo,1,10116.0,CHEMBL626807,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11967,Rattus norvegicus,50597,,,Liver,,N,10911,,,,2107.0,In vivo,1,10116.0,CHEMBL627261,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11968,Rattus norvegicus,50597,,,Liver,,N,10911,,,,2107.0,In vivo,1,10116.0,CHEMBL627262,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11969,Rattus norvegicus,50597,,,Liver,,N,10911,,,,2107.0,In vivo,1,10116.0,CHEMBL627263,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11970,Rattus norvegicus,50597,,,Liver,,N,10911,,,,2107.0,In vivo,1,10116.0,CHEMBL627264,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11971,Rattus norvegicus,50597,,,Lung,,N,10911,,,,2048.0,In vivo,1,10116.0,CHEMBL627265,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11972,Rattus norvegicus,50597,,,Lung,,N,10911,,,,2048.0,In vivo,1,10116.0,CHEMBL627266,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,11973,Rattus norvegicus,50597,,,Lung,,N,10911,,,,2048.0,In vivo,1,10116.0,CHEMBL627267,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,11974,Rattus norvegicus,50597,,,Lung,,N,10911,,,,2048.0,In vivo,1,10116.0,CHEMBL627268,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,11975,Rattus norvegicus,50597,,,Muscle tissue,,N,10911,,,,2385.0,In vivo,1,10116.0,CHEMBL627269,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,11976,Rattus norvegicus,50597,,,Muscle tissue,,N,10911,,,,2385.0,In vivo,1,10116.0,CHEMBL627270,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",11977,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627271,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",11978,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627946,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",11979,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL875472,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",11980,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627947,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",11981,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627948,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",11982,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628113,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",11983,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628114,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",11984,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628115,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",11985,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628116,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",11986,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628117,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",11987,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628118,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",11988,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628119,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",11989,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628120,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",11990,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628121,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",11991,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL628122,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",11992,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627297,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",11993,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627298,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",11994,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627299,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",11995,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627300,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",11996,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627301,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",11997,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627302,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",11998,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627303,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",11999,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627304,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",12000,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627305,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12001,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL627306,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",12002,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623982,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",12003,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623983,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",12004,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623984,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",12005,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623985,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",12006,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623986,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",12007,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623987,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",12008,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623988,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",12009,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL623989,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",12010,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL622215,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",12011,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL622216,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",12012,Rattus norvegicus,50597,,,,,N,8608,,,,,,1,10116.0,CHEMBL877481,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),12013,,22224,,,,,U,16359,,,,,,1,,CHEMBL622217,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),12014,Mus musculus,50594,,,,,N,13701,,,,,,1,10090.0,CHEMBL622218,Intermediate,
A,1,BAO_0000218,Pharmacokinetic profile AUC was evaluated in rats,12015,Rattus norvegicus,50597,,,,,N,14554,,,,,,1,10116.0,CHEMBL622219,Intermediate,
A,0,BAO_0000019,Pharmacokinetic property (Area under curve),12016,,22224,,,,,U,6241,,,,,,1,,CHEMBL622220,Autocuration,
A,1,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",12017,Canis lupus familiaris,50588,,,,,N,11537,,,,,,1,9615.0,CHEMBL622221,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",12018,Mus musculus,50594,,,,,N,11537,,,,,,1,10090.0,CHEMBL622222,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",12019,Canis lupus familiaris,50588,,,,,N,11537,,,,,,1,9615.0,CHEMBL622223,Intermediate,
A,1,BAO_0000218,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",12020,Mus musculus,50594,,,,,N,11537,,,,,,1,10090.0,CHEMBL622224,Intermediate,
A,0,BAO_0000019,Plasma concentration (AUC) was determined,12021,,22224,,,,,U,13118,,,,,,1,,CHEMBL622225,Autocuration,
A,0,BAO_0000019,Plasma concentration (AUC) was determined; Not detectable,12022,,22224,,,,,U,13118,,,,,,1,,CHEMBL622226,Autocuration,
A,1,BAO_0000218,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),12023,Cavia porcellus,50512,,,,,N,9562,,,,,,1,10141.0,CHEMBL624154,Intermediate,
A,1,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,12024,Rattus norvegicus,50597,,,,,N,10363,,,,,,1,10116.0,CHEMBL624155,Intermediate,
A,1,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,12025,Rattus norvegicus,50597,,,,,N,10363,,,,,,1,10116.0,CHEMBL624156,Intermediate,
A,1,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,12026,Rattus norvegicus,50597,,,,,N,10363,,,,,,1,10116.0,CHEMBL624157,Intermediate,
A,1,BAO_0000218,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,12027,Rattus norvegicus,50597,,,,,N,10363,,,,,,1,10116.0,CHEMBL624158,Intermediate,
A,1,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,12028,Rattus norvegicus,50597,,,,,N,12504,,,,,,1,10116.0,CHEMBL624159,Intermediate,
A,1,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,12029,Rattus norvegicus,50597,,,,,N,12504,,,,,,1,10116.0,CHEMBL624160,Intermediate,
A,1,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,12030,Rattus norvegicus,50597,,,,,N,12504,,,,,,1,10116.0,CHEMBL624161,Intermediate,
A,1,BAO_0000218,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,12031,Rattus norvegicus,50597,,,,,N,12504,,,,,,1,10116.0,CHEMBL624162,Intermediate,
A,1,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,12032,Canis lupus familiaris,50588,,,,,N,13317,,,,,,1,9615.0,CHEMBL624163,Intermediate,
A,1,BAO_0000218,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",12033,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL624164,Intermediate,
A,1,BAO_0000218,The AUC(0-infinity) values in female wistar rats.,12034,Rattus norvegicus,50597,,,,,N,14941,,,,,,1,10116.0,CHEMBL624165,Intermediate,
A,1,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",12035,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL624166,Intermediate,
A,1,BAO_0000218,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",12036,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL624167,Intermediate,
A,1,BAO_0000218,The AUC(0-t)values in female wistar rats.,12037,Rattus norvegicus,50597,,,,,N,14941,,,,,,1,10116.0,CHEMBL624168,Intermediate,
A,1,BAO_0000218,The Area under the concentration time curve of compound was measured on rats,12038,Rattus norvegicus,50597,,,,,N,14067,,,,,,1,10116.0,CHEMBL624169,Intermediate,
A,1,BAO_0000218,The area under curve (100 mg/kg) administered orally in humans,12039,Homo sapiens,50587,,,,,N,14215,,,,,,1,9606.0,CHEMBL624170,Intermediate,
A,0,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in marmoset,12040,Callithrix,22224,,,,,U,14215,,,,,,1,9481.0,CHEMBL624171,Autocuration,
A,0,BAO_0000218,The area under curve (12.5 mg/kg) administered intravenously in monkey,12041,Simiiformes,22224,,,,,U,14215,,,,,,1,314293.0,CHEMBL624172,Autocuration,
A,1,BAO_0000218,The area under curve (15 mg/kg) administered intravenously in dog,12042,Canis lupus familiaris,50588,,,,,N,14215,,,,,,1,9615.0,CHEMBL624173,Intermediate,
A,1,BAO_0000218,The area under curve (200 mg/kg) administered orally in humans,12043,Homo sapiens,50587,,,,,N,14215,,,,,,1,9606.0,CHEMBL877488,Intermediate,
A,1,BAO_0000218,The area under curve (25 mg/kg) administered intravenously in rat,12044,Rattus norvegicus,50597,,,,,N,14215,,,,,,1,10116.0,CHEMBL624174,Intermediate,
A,0,BAO_0000218,The area under curve (25 mg/kg) administered orally in marmoset,12045,Callithrix,22224,,,,,U,14215,,,,,,1,9481.0,CHEMBL624175,Autocuration,
A,0,BAO_0000218,The area under curve (25 mg/kg) administered orally in monkey,12046,Simiiformes,22224,,,,,U,14215,,,,,,1,314293.0,CHEMBL624176,Autocuration,
A,1,BAO_0000218,The area under curve (30 mg/kg) administered orally in dog,12047,Canis lupus familiaris,50588,,,,,N,14215,,,,,,1,9615.0,CHEMBL624177,Intermediate,
A,1,BAO_0000218,The area under curve (400 mg/kg) administered orally in humans,12048,Homo sapiens,50587,,,,,N,14215,,,,,,1,9606.0,CHEMBL624178,Intermediate,
A,1,BAO_0000218,The area under curve (50 mg/kg) administered orally in fasted rat,12049,Rattus norvegicus,50597,,,,,N,14215,,,,,,1,10116.0,CHEMBL624179,Intermediate,
A,1,BAO_0000218,The area under curve (50 mg/kg) administered orally in rat,12050,Rattus norvegicus,50597,,,,,N,14215,,,,,,1,10116.0,CHEMBL627689,Intermediate,
A,1,BAO_0000218,The area under curve (800 mg/kg) administered orally in humans,12051,Homo sapiens,50587,,,,,N,14215,,,,,,1,9606.0,CHEMBL627690,Intermediate,
A,0,BAO_0000019,The compound was evaluated for area under the curve,12052,,22224,,,,,U,11324,,,,,,1,,CHEMBL627691,Autocuration,
A,0,BAO_0000019,The compound was evaluated for area under the curve in marmosets,12053,Callithrix,22224,,,,,U,11324,,,,,,1,9481.0,CHEMBL627692,Autocuration,
A,0,BAO_0000019,The compound was evaluated for area under the curve in marmosets,12054,Callithrix,22224,,,,,U,11324,,,,,,1,9481.0,CHEMBL627693,Autocuration,
A,1,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12055,Rattus norvegicus,50597,,,,,N,13875,,,,,,1,10116.0,CHEMBL627694,Intermediate,
A,1,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,12056,Rattus norvegicus,50597,,,,,N,13875,,,,,,1,10116.0,CHEMBL627695,Intermediate,
A,0,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),12057,,22224,,,,,U,13875,,,,,,1,,CHEMBL627696,Autocuration,
A,1,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12058,Rattus norvegicus,50597,,,,,N,13875,,,,,,1,10116.0,CHEMBL627697,Intermediate,
A,1,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,12059,Rattus norvegicus,50597,,,,,N,13875,,,,,,1,10116.0,CHEMBL627698,Intermediate,
A,1,BAO_0000218,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,12060,Rattus norvegicus,50597,,,,,N,13875,,,,,,1,10116.0,CHEMBL627699,Intermediate,
A,1,BAO_0000218,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,12061,Rattus norvegicus,50597,,,,,N,13807,,,,,,1,10116.0,CHEMBL627700,Intermediate,
A,1,BAO_0000218,Total drug exposure is determined after oral dosing in rats.,12062,Rattus norvegicus,50597,,,,,N,14127,,,,,,1,10116.0,CHEMBL627701,Intermediate,
A,0,BAO_0000218,Total drug exposure (5 mg/kg) when administered intravenously,12063,,22224,,,,,U,15116,,,,,,1,,CHEMBL627702,Autocuration,
A,0,BAO_0000218,Total drug exposure (5 mg/kg) when administered orally,12064,,22224,,,,,U,15116,,,,,,1,,CHEMBL627703,Autocuration,
A,0,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,12065,Simiiformes,22224,,,,,U,15604,,,,,,1,314293.0,CHEMBL626873,Autocuration,
A,1,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,12066,Rattus norvegicus,50597,,,,,N,15604,,,,,,1,10116.0,CHEMBL629583,Intermediate,
A,1,BAO_0000218,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,12067,Canis lupus familiaris,50588,,,,,N,15604,,,,,,1,9615.0,CHEMBL629584,Intermediate,
A,1,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,12068,Canis lupus familiaris,50588,,,,,N,15604,,,,,,1,9615.0,CHEMBL629585,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",12069,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629586,Intermediate,
A,1,BAO_0000218,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",12070,Rattus norvegicus,50597,,,Brain,,N,13751,,,,955.0,In vivo,1,10116.0,CHEMBL629587,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",12071,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629588,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",12072,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629589,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",12073,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629590,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12074,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629591,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",12075,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629592,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",12076,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629593,Intermediate,
A,1,BAO_0000218,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",12077,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL629594,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",12078,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL629595,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",12079,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL630290,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",12080,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL627137,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12081,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL627138,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",12082,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL627139,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",12083,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL627140,Intermediate,
A,1,BAO_0000218,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",12084,Rattus norvegicus,50597,,,Heart,,N,13751,,,,948.0,In vivo,1,10116.0,CHEMBL627141,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",12085,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627142,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",12086,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627143,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",12087,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL874449,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12088,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627144,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",12089,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627145,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",12090,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627146,Intermediate,
A,1,BAO_0000218,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",12091,Rattus norvegicus,50597,,,Kidney,,N,13751,,,,2113.0,In vivo,1,10116.0,CHEMBL627147,Intermediate,
A,1,BAO_0000218,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",12092,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL627148,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",12093,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL627149,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",12094,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL632160,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",12095,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL632161,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12096,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL632162,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",12097,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL632163,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",12098,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL874469,Intermediate,
A,1,BAO_0000218,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",12099,Rattus norvegicus,50597,,,Lung,,N,13751,,,,2048.0,In vivo,1,10116.0,CHEMBL627182,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",12100,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627183,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",12101,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627184,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",12102,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627185,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12103,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627186,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",12104,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627187,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",12105,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627188,Intermediate,
A,1,BAO_0000218,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",12106,Rattus norvegicus,50597,,,Muscle tissue,,N,13751,,,,2385.0,In vivo,1,10116.0,CHEMBL627189,Intermediate,
A,1,BAO_0000218,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12107,Rattus norvegicus,50597,,,,,N,13751,,,,,In vivo,1,10116.0,CHEMBL627190,Intermediate,
A,1,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",12108,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL627191,Intermediate,
A,1,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",12109,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL627192,Intermediate,
A,1,BAO_0000218,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",12110,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL627193,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,12111,Rattus norvegicus,50597,,,Muscle tissue,,N,10911,,,,2385.0,In vivo,1,10116.0,CHEMBL874590,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12112,Rattus norvegicus,50597,,,Muscle tissue,,N,10911,,,,2385.0,In vivo,1,10116.0,CHEMBL627194,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12113,Rattus norvegicus,50597,,,Muscle tissue,,N,10911,,,,2385.0,In vivo,1,10116.0,CHEMBL627195,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12114,Rattus norvegicus,50597,,,Female gonad,,N,10911,,,,992.0,In vivo,1,10116.0,CHEMBL627196,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12115,Rattus norvegicus,50597,,,Female gonad,,N,10911,,,,992.0,In vivo,1,10116.0,CHEMBL627197,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12116,Rattus norvegicus,50597,,,Female gonad,,N,10911,,,,992.0,In vivo,1,10116.0,CHEMBL627198,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,12117,Rattus norvegicus,50597,,,Female gonad,,N,10911,,,,992.0,In vivo,1,10116.0,CHEMBL627199,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12118,Rattus norvegicus,50597,,,Female gonad,,N,10911,,,,992.0,In vivo,1,10116.0,CHEMBL627200,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12119,Rattus norvegicus,50597,,,Plasma,,N,10911,,,,1969.0,In vivo,1,10116.0,CHEMBL627201,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12120,Rattus norvegicus,50597,,,Plasma,,N,10911,,,,1969.0,In vivo,1,10116.0,CHEMBL627202,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12121,Rattus norvegicus,50597,,,Plasma,,N,10911,,,,1969.0,In vivo,1,10116.0,CHEMBL627203,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12122,Rattus norvegicus,50597,,,Plasma,,N,10911,,,,1969.0,In vivo,1,10116.0,CHEMBL627204,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12123,Rattus norvegicus,50597,,,Spleen,,N,10911,,,,2106.0,In vivo,1,10116.0,CHEMBL627205,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12124,Rattus norvegicus,50597,,,Spleen,,N,10911,,,,2106.0,In vivo,1,10116.0,CHEMBL627206,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12125,Rattus norvegicus,50597,,,Spleen,,N,10911,,,,2106.0,In vivo,1,10116.0,CHEMBL627207,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12126,Rattus norvegicus,50597,,,Spleen,,N,10911,,,,2106.0,In vivo,1,10116.0,CHEMBL627208,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12127,Rattus norvegicus,50597,,,Thyroid gland,,N,10911,,,,2046.0,In vivo,1,10116.0,CHEMBL627209,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12128,Rattus norvegicus,50597,,,Thyroid gland,,N,10911,,,,2046.0,In vivo,1,10116.0,CHEMBL627210,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12129,Rattus norvegicus,50597,,,Thyroid gland,,N,10911,,,,2046.0,In vivo,1,10116.0,CHEMBL627211,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12130,Rattus norvegicus,50597,,,Thyroid gland,,N,10911,,,,2046.0,In vivo,1,10116.0,CHEMBL627212,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,12131,Rattus norvegicus,50597,,,Uterus,,N,10911,,,,995.0,In vivo,1,10116.0,CHEMBL627213,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,12132,Rattus norvegicus,50597,,,Uterus,,N,10911,,,,995.0,In vivo,1,10116.0,CHEMBL626599,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,12133,Rattus norvegicus,50597,,,Uterus,,N,10911,,,,995.0,In vivo,1,10116.0,CHEMBL626600,Intermediate,
A,1,BAO_0000218,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,12134,Rattus norvegicus,50597,,,Uterus,,N,10911,,,,995.0,In vivo,1,10116.0,CHEMBL626601,Intermediate,
A,0,BAO_0000019,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,12135,,22224,,,,,U,8081,,,,,,1,,CHEMBL627484,Autocuration,
A,1,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),12136,Macaca fascicularis,100710,,,Plasma,,N,17248,,,,1969.0,,1,9541.0,CHEMBL627485,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,12137,Macaca fascicularis,100710,,,Plasma,,N,17248,,,,1969.0,,1,9541.0,CHEMBL628147,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,12138,Macaca fascicularis,100710,,,Plasma,,N,17248,,,,1969.0,,1,9541.0,CHEMBL628148,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),12139,Canis lupus familiaris,50588,,,Plasma,,N,17248,,,,1969.0,,1,9615.0,CHEMBL628149,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,12140,Canis lupus familiaris,50588,,,Plasma,,N,17248,,,,1969.0,,1,9615.0,CHEMBL628150,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,12141,Canis lupus familiaris,50588,,,Plasma,,N,17248,,,,1969.0,,1,9615.0,CHEMBL628318,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,12142,Canis lupus familiaris,50588,,,Plasma,,N,17248,,,,1969.0,,1,9615.0,CHEMBL628319,Intermediate,
A,1,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12143,Canis lupus familiaris,50588,,,,,N,15592,,,,,,1,9615.0,CHEMBL875609,Intermediate,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,12144,,22224,,,,,U,7040,,,,,,1,,CHEMBL628320,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,12145,,22224,,,,,U,7040,,,,,,1,,CHEMBL628321,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,12146,,22224,,,,,U,7040,,,,,,1,,CHEMBL628322,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,12147,,22224,,,,,U,7040,,,,,,1,,CHEMBL628323,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,12148,,22224,,,,,U,7040,,,,,,1,,CHEMBL628324,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,12149,,22224,,,,,U,7040,,,,,,1,,CHEMBL628325,Autocuration,
A,0,BAO_0000019,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,12150,,22224,,,,,U,7040,,,,,,1,,CHEMBL628326,Autocuration,
A,1,BAO_0000218,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",12151,Canis lupus familiaris,50588,,,Adrenal medulla,,N,9614,,,,1236.0,,1,9615.0,CHEMBL628327,Intermediate,
A,1,BAO_0000218,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",12152,Canis lupus familiaris,50588,,,Adrenal medulla,,N,9614,,,,1236.0,,1,9615.0,CHEMBL628328,Intermediate,
A,1,BAO_0000218,"Concentration of compound in blood of dog 1, after administering intravenously",12153,Canis lupus familiaris,50588,,,Blood,,N,9614,,,,178.0,,1,9615.0,CHEMBL628329,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",12154,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628330,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",12155,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628331,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",12156,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628332,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",12157,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628333,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",12158,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628334,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",12159,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628335,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",12160,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628336,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",12161,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628337,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",12162,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628338,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",12163,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL875610,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",12164,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628339,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",12165,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628340,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",12166,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL628341,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",12167,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL622214,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",12168,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL623167,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",12169,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL623168,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",12170,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL623169,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",12171,Rattus norvegicus,50597,,,Liver,,N,8608,,,,2107.0,,1,10116.0,CHEMBL623170,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",12172,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL627224,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",12173,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL875634,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",12174,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL627225,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",12175,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL627226,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",12176,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626083,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",12177,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626084,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",12178,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626085,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",12179,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626086,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",12180,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626087,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",12181,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626088,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",12182,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626089,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",12183,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626090,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",12184,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626091,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",12185,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626092,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",12186,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626093,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",12187,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626094,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",12188,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626095,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",12189,Rattus norvegicus,50597,,,Lung,,N,8608,,,,2048.0,,1,10116.0,CHEMBL626096,Intermediate,
A,0,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,12190,Simiiformes,22224,,,,,U,15604,,,,,,1,314293.0,CHEMBL626097,Autocuration,
A,1,BAO_0000218,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,12191,Rattus norvegicus,50597,,,,,N,15604,,,,,,1,10116.0,CHEMBL626098,Intermediate,
A,0,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,12192,,22224,,,Plasma,,U,1806,,,,1969.0,,1,,CHEMBL626099,Autocuration,
A,0,BAO_0000218,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,12193,,22224,,,Plasma,,U,1806,,,,1969.0,,1,,CHEMBL626100,Autocuration,
A,1,BAO_0000218,AUC 0-inf in dog,12194,Canis lupus familiaris,50588,,,Plasma,,N,17237,,,,1969.0,,1,9615.0,CHEMBL626101,Intermediate,
A,1,BAO_0000218,AUC 0-inf in guinea pig,12195,Cavia porcellus,50512,,,Plasma,,N,17237,,,,1969.0,,1,10141.0,CHEMBL626102,Intermediate,
A,1,BAO_0000218,AUC 0-t in dog,12196,Canis lupus familiaris,50588,,,Plasma,,N,17237,,,,1969.0,,1,9615.0,CHEMBL626103,Intermediate,
A,1,BAO_0000218,AUC 0-t in guinea pig,12197,Cavia porcellus,50512,,,Plasma,,N,17237,,,,1969.0,,1,10141.0,CHEMBL628391,Intermediate,
A,1,BAO_0000218,The compound was tested for brain to plasma partition in rat,12198,Rattus norvegicus,50597,,,,,N,15194,,,,,,1,10116.0,CHEMBL628392,Intermediate,
A,1,BAO_0000218,The compound was tested for brain to plasma partition in rat.,12199,Rattus norvegicus,50597,,,,,N,15194,,,,,,1,10116.0,CHEMBL628393,Intermediate,
A,0,BAO_0000019,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,12200,,22224,,,Blood,,U,8787,,,,178.0,,1,,CHEMBL628394,Autocuration,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,12201,Canis lupus familiaris,50588,,,,,N,17025,,,,,,1,9615.0,CHEMBL628395,Intermediate,
A,0,BAO_0000218,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,12202,Simiiformes,22224,,,,,U,17025,,,,,,1,314293.0,CHEMBL628396,Autocuration,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,12203,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,,1,9986.0,CHEMBL628397,Intermediate,
A,1,BAO_0000218,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,12204,Rattus norvegicus,50597,,,,,N,17025,,,,,,1,10116.0,CHEMBL628398,Intermediate,
A,1,BAO_0000218,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,12205,Macaca mulatta,50797,,,,,N,4236,,,,,,1,9544.0,CHEMBL628399,Intermediate,
A,1,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,12206,Canis lupus familiaris,50588,,,,,N,15343,,,,,,1,9615.0,CHEMBL628400,Intermediate,
A,1,BAO_0000218,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,12207,Rattus norvegicus,50597,,,,,N,15343,,,,,,1,10116.0,CHEMBL874907,Intermediate,
A,0,BAO_0000019,Area under curve of the compound was determined,12208,,22224,,,,,U,17720,,,,,,1,,CHEMBL628401,Autocuration,
A,0,BAO_0000218,AUC in monkeys at a dose of 1 mg/kg,12209,Simiiformes,22224,,,Plasma,,U,17788,,,,1969.0,,1,314293.0,CHEMBL628402,Autocuration,
A,1,BAO_0000218,AUC in rats at a dose of 1 mg/kg,12210,Rattus norvegicus,50597,,,Plasma,,N,17788,,,,1969.0,,1,10116.0,CHEMBL628403,Intermediate,
A,0,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 2,12211,,22224,,,,,U,8778,,,,,,1,,CHEMBL628404,Autocuration,
A,0,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 4,12212,,22224,,,,,U,8778,,,,,,1,,CHEMBL628405,Autocuration,
A,0,BAO_0000019,Compound was evaluated for the overall absorbance loss at pH of 7,12213,,22224,,,,,U,8778,,,,,,1,,CHEMBL628406,Autocuration,
A,1,BAO_0000218,Compound was evaluated for its absorption in the rats,12214,Rattus norvegicus,50597,,,,,N,2249,,,,,,1,10116.0,CHEMBL628407,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12215,Rattus norvegicus,50597,,,Urine,,N,8881,,,,1088.0,,1,10116.0,CHEMBL628408,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,12216,Rattus norvegicus,50597,,,Urine,,N,8881,,,,1088.0,,1,10116.0,CHEMBL629171,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,12217,Rattus norvegicus,50597,,,Urine,,N,8881,,,,1088.0,,1,10116.0,CHEMBL629172,Intermediate,
A,1,BAO_0000218,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,12218,Rattus norvegicus,50597,,,Urine,,N,8881,,,,1088.0,,1,10116.0,CHEMBL629173,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum,12219,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL629174,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-17,12220,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL629175,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-18,12221,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL629176,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 10-19,12222,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL629177,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 12-15,12223,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL629178,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 13-19,12224,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631869,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 14-17,12225,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631870,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 15-18,12226,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631871,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 2-5,12227,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631872,Intermediate,
A,0,BAO_0000221,In vitro percent permeability into rat ileum; Range is 23-42,12228,,22224,,,Ileum,,U,15286,,,,2116.0,,1,,CHEMBL875775,Autocuration,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 28-36,12229,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631873,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 29-35,12230,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631874,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 46-66,12231,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631875,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 50-68,12232,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631876,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; Range is 78-81,12233,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631877,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,12234,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631878,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; nd indicates not detected,12235,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631879,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not detected,12236,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631880,Intermediate,
A,1,BAO_0000218,In vitro percent permeability into rat ileum; nt indicates not tested,12237,Rattus norvegicus,50597,,,,,N,15286,,,,,,1,10116.0,CHEMBL631881,Intermediate,
A,1,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats,12238,Rattus norvegicus,50597,,,,,N,13770,,,,,,1,10116.0,CHEMBL631882,Intermediate,
A,1,BAO_0000218,Compound was tested for oral absorption in bile-duct cannulated rats.,12239,Rattus norvegicus,50597,,,,,N,13770,,,,,,1,10116.0,CHEMBL630749,Intermediate,
A,1,BAO_0000218,Oral absorption using Caco-2 cell monolayers.,12240,Homo sapiens,50587,,,,,N,5202,,,,,,1,9606.0,CHEMBL630750,Intermediate,
A,1,BAO_0000218,Percent of the drug absorbed after administration to humans was determined,12241,Homo sapiens,50587,,,,,N,14920,,,,,,1,9606.0,CHEMBL630253,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12242,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL630254,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12243,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL630255,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12244,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL630256,Intermediate,
A,1,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",12245,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL875781,Intermediate,
A,1,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",12246,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL630257,Intermediate,
A,1,BAO_0000218,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",12247,Rattus norvegicus,50597,,,Liver,,N,13751,,,,2107.0,In vivo,1,10116.0,CHEMBL630258,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",12248,Rattus norvegicus,50597,,,,,N,15807,,,,,,1,10116.0,CHEMBL630259,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",12249,Rattus norvegicus,50597,,,Striatum,,N,15807,,,,2435.0,,1,10116.0,CHEMBL630260,Intermediate,
A,1,BAO_0000218,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",12250,Rattus norvegicus,50597,,,Striatum,,N,15807,,,,2435.0,,1,10116.0,CHEMBL630261,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,12251,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630262,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,12252,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630263,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,12253,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630264,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,12254,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630265,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,12255,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630266,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,12256,Rattus norvegicus,50597,,,Kidney,,N,14950,,,,2113.0,,1,10116.0,CHEMBL630267,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,12257,Rattus norvegicus,50597,,,Kidney,,N,14950,,,,2113.0,,1,10116.0,CHEMBL630268,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,12258,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630269,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,12259,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630270,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,12260,Rattus norvegicus,50597,,,Lung,,N,14950,,,,2048.0,,1,10116.0,CHEMBL630141,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,12261,Rattus norvegicus,50597,,,Lung,,N,14950,,,,2048.0,,1,10116.0,CHEMBL630142,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,12262,Rattus norvegicus,50597,,,Muscle tissue,,N,14950,,,,2385.0,,1,10116.0,CHEMBL630143,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,12263,Rattus norvegicus,50597,,,Muscle tissue,,N,14950,,,,2385.0,,1,10116.0,CHEMBL630144,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,12264,Rattus norvegicus,50597,,,Prostate gland,,N,14950,,,,2367.0,,1,10116.0,CHEMBL630145,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,12265,Rattus norvegicus,50597,,,Prostate gland,,N,14950,,,,2367.0,,1,10116.0,CHEMBL630146,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,12266,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630147,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,12267,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630148,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,12268,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL630149,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,12269,Rattus norvegicus,50597,,,Spleen,,N,14950,,,,2106.0,,1,10116.0,CHEMBL630150,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,12270,Rattus norvegicus,50597,,,Spleen,,N,14950,,,,2106.0,,1,10116.0,CHEMBL630151,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,12271,Rattus norvegicus,50597,,,Thyroid gland,,N,14950,,,,2046.0,,1,10116.0,CHEMBL632031,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,12272,Rattus norvegicus,50597,,,Thyroid gland,,N,14950,,,,2046.0,,1,10116.0,CHEMBL632032,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,12273,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL632033,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,12274,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL632034,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,12275,Rattus norvegicus,50597,,,Muscle tissue,,N,14950,,,,2385.0,,1,10116.0,CHEMBL632035,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,12276,Rattus norvegicus,50597,,,,,N,14950,,,,,,1,10116.0,CHEMBL632036,Intermediate,
A,1,BAO_0000218,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,12277,Rattus norvegicus,50597,,,Thyroid gland,,N,14950,,,,2046.0,,1,10116.0,CHEMBL632037,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12278,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL632038,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12279,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL632039,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12280,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL632040,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12281,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL632041,Intermediate,
A,1,BAO_0000218,"Concentration of compound in blood of dog 2, after administering intravenously",12282,Canis lupus familiaris,50588,,,Blood,,N,9614,,,,178.0,,1,9615.0,CHEMBL632042,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left ventricle of dog 1, after administering intravenously",12283,Canis lupus familiaris,50588,,,,,N,9614,,,,,,1,9615.0,CHEMBL632043,Intermediate,
A,1,BAO_0000218,"Concentration of compound in left ventricle of dog 2, after administering intravenously",12284,Canis lupus familiaris,50588,,,,,N,9614,,,,,,1,9615.0,CHEMBL632044,Intermediate,
A,1,BAO_0000218,"Concentration of compound in liver of dog 1, after administering intravenously",12285,Canis lupus familiaris,50588,,,Liver,,N,9614,,,,2107.0,,1,9615.0,CHEMBL632045,Intermediate,
A,1,BAO_0000218,"Concentration of compound in liver of dog 2, after administering intravenously",12286,Canis lupus familiaris,50588,,,Liver,,N,9614,,,,2107.0,,1,9615.0,CHEMBL632046,Intermediate,
A,1,BAO_0000218,"Concentration of compound in lung of dog 1, after administering intravenously",12287,Canis lupus familiaris,50588,,,Lung,,N,9614,,,,2048.0,,1,9615.0,CHEMBL632047,Intermediate,
A,1,BAO_0000218,"Concentration of compound in lung of dog 2, after administering intravenously",12288,Canis lupus familiaris,50588,,,Lung,,N,9614,,,,2048.0,,1,9615.0,CHEMBL632048,Intermediate,
A,1,BAO_0000218,"Concentration of compound in muscle of dog 1, after administering intravenously",12289,Canis lupus familiaris,50588,,,Muscle tissue,,N,9614,,,,2385.0,,1,9615.0,CHEMBL632049,Intermediate,
A,1,BAO_0000218,"Concentration of compound in muscle of dog 2, after administering intravenously",12290,Canis lupus familiaris,50588,,,Muscle tissue,,N,9614,,,,2385.0,,1,9615.0,CHEMBL876418,Intermediate,
A,1,BAO_0000218,"Concentration of compound in spleen of dog 1,after administering intravenously",12291,Canis lupus familiaris,50588,,,Spleen,,N,9614,,,,2106.0,,1,9615.0,CHEMBL632050,Intermediate,
A,1,BAO_0000218,"Concentration of compound in spleen of dog 2, after administering intravenously",12292,Canis lupus familiaris,50588,,,Spleen,,N,9614,,,,2106.0,,1,9615.0,CHEMBL632051,Intermediate,
F,0,BAO_0000218,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,12293,,22224,,,,,U,10353,,,,,,1,,CHEMBL632052,Autocuration,
F,0,BAO_0000218,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,12294,,22224,,,,,U,10353,,,,,,1,,CHEMBL632053,Autocuration,
A,0,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12295,,22224,,,,,U,10353,,,,,,1,,CHEMBL632054,Autocuration,
F,0,BAO_0000218,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,12296,,22224,,,,,U,10353,,,,,,1,,CHEMBL632055,Autocuration,
F,0,BAO_0000218,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,12297,,22224,,,,,U,10353,,,,,,1,,CHEMBL631181,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,12298,,22224,,,,,U,9196,,,,,,1,,CHEMBL631182,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12299,,22224,,,,,U,9196,,,,,,1,,CHEMBL631183,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12300,,22224,,,,,U,9196,,,,,,1,,CHEMBL631184,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12301,,22224,,,,,U,9196,,,,,,1,,CHEMBL629774,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12302,,22224,,,,,U,9196,,,,,,1,,CHEMBL629775,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12303,,22224,,,,,U,9196,,,,,,1,,CHEMBL876549,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12304,,22224,,,,,U,9196,,,,,,1,,CHEMBL628172,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12305,,22224,,,,,U,9196,,,,,,1,,CHEMBL628173,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,12306,,22224,,,,,U,9196,,,,,,1,,CHEMBL628174,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,12307,,22224,,,,,U,9196,,,,,,1,,CHEMBL628175,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12308,,22224,,,,,U,9196,,,,,,1,,CHEMBL628176,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12309,,22224,,,,,U,9196,,,,,,1,,CHEMBL628177,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12310,,22224,,,,,U,9196,,,,,,1,,CHEMBL628178,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12311,,22224,,,,,U,9196,,,,,,1,,CHEMBL628179,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,12312,,22224,,,,,U,9196,,,,,,1,,CHEMBL628180,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,12313,,22224,,,,,U,9196,,,,,,1,,CHEMBL628181,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12314,,22224,,,,,U,9196,,,,,,1,,CHEMBL628182,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12315,,22224,,,,,U,9196,,,,,,1,,CHEMBL628183,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,12316,,22224,,,,,U,9196,,,,,,1,,CHEMBL628184,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12317,,22224,,,,,U,9196,,,,,,1,,CHEMBL628185,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12318,,22224,,,,,U,9196,,,,,,1,,CHEMBL875617,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12319,,22224,,,,,U,9196,,,,,,1,,CHEMBL628186,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12320,,22224,,,,,U,9196,,,,,,1,,CHEMBL628187,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12321,,22224,,,,,U,9196,,,,,,1,,CHEMBL628188,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12322,,22224,,,,,U,9196,,,,,,1,,CHEMBL628189,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,12323,,22224,,,,,U,9196,,,,,,1,,CHEMBL628190,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12324,,22224,,,,,U,9196,,,,,,1,,CHEMBL628191,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,12325,,22224,,,,,U,9196,,,,,,1,,CHEMBL626513,Autocuration,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",12326,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626514,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",12327,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626515,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",12328,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626516,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",12329,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626517,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",12330,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626518,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",12331,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626519,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",12332,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626520,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",12333,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626521,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",12334,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626522,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",12335,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626523,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",12336,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626524,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",12337,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626688,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",12338,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626689,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",12339,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626690,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",12340,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL626691,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",12341,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL627319,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",12342,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL624052,Intermediate,
A,1,BAO_0000218,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",12343,Rattus norvegicus,50597,,,Thyroid gland,,N,8608,,,,2046.0,,1,10116.0,CHEMBL624053,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12344,Rattus norvegicus,50597,,,,,N,8085,,,,,,1,10116.0,CHEMBL624054,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12345,Rattus norvegicus,50597,,,,,N,8085,,,,,,1,10116.0,CHEMBL624055,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12346,Rattus norvegicus,50597,,,,,N,8085,,,,,,1,10116.0,CHEMBL624056,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12347,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL624057,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12348,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622281,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12349,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622282,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12350,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622283,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,12351,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622284,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12352,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622285,Intermediate,
A,1,BAO_0000218,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,12353,Rattus norvegicus,50597,,,Uterus,,N,8085,,,,995.0,,1,10116.0,CHEMBL622286,Intermediate,
P,0,BAO_0000100,Distribution coefficient (D %) between octanol and buffer of pH 7.4,12354,,22224,,,,,U,7657,,,,,,1,,CHEMBL622287,Autocuration,
A,1,BAO_0000218,Partition coefficient (logD7.4),12355,Mus musculus,50594,,,,,N,8935,,,,,,1,10090.0,CHEMBL622288,Intermediate,
A,1,BAO_0000218,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12356,Mus musculus,50594,,,,,N,13792,,,,,,1,10090.0,CHEMBL622289,Intermediate,
A,1,BAO_0000218,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12357,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL622290,Intermediate,
A,1,BAO_0000218,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12358,Mus musculus,50594,,,,,N,13792,,,,,,1,10090.0,CHEMBL622291,Intermediate,
A,1,BAO_0000218,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12359,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL622292,Intermediate,
A,1,BAO_0000218,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",12360,Mus musculus,50594,,,,,N,13792,,,,,,1,10090.0,CHEMBL622293,Intermediate,
A,1,BAO_0000218,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",12361,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL622294,Intermediate,
A,1,BAO_0000218,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,12362,Mus musculus,50594,,,,,N,13792,,,,,,1,10090.0,CHEMBL622295,Intermediate,
A,1,BAO_0000218,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,12363,Rattus norvegicus,50597,,,Brain,,N,13792,,,,955.0,,1,10116.0,CHEMBL622296,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,12364,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL874409,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12365,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622297,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12366,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622298,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12367,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622299,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12368,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622300,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12369,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622301,Intermediate,
A,1,BAO_0000218,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12370,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622302,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,12371,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622303,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,12372,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622304,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,12373,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622305,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,12374,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL622306,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,12375,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626864,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,12376,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626865,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,12377,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626866,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,12378,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626867,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,12379,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626868,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,12380,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626869,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,12381,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626870,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,12382,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626871,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,12383,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL626872,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,12384,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL632185,Intermediate,
A,1,BAO_0000218,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,12385,Rattus norvegicus,50597,,,Plasma,,N,14103,,,,1969.0,,1,10116.0,CHEMBL632186,Intermediate,
A,0,BAO_0000019,Amount of acetic acid produced by the compound,12386,,22224,,,,,U,12904,,,,,,1,,CHEMBL629310,Autocuration,
A,0,BAO_0000019,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,12387,,22224,,,,,U,12904,,,,,,1,,CHEMBL629311,Autocuration,
A,1,BAO_0000218,Log of (Cbrain/Cblood) in rats,12388,Rattus norvegicus,50597,,,,,N,9663,,,,,,1,10116.0,CHEMBL629312,Intermediate,
A,0,BAO_0000221,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),12389,,22224,,,,,U,7652,,,,,,1,,CHEMBL629313,Autocuration,
A,0,BAO_0000221,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12390,,22224,,,,,U,7652,,,,,,1,,CHEMBL629314,Autocuration,
A,0,BAO_0000221,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),12391,,22224,,,,,U,7652,,,,,,1,,CHEMBL629315,Autocuration,
B,0,BAO_0000219,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),12392,,22224,,,,,U,7652,,,,,,1,,CHEMBL629316,Autocuration,
A,0,BAO_0000221,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12393,,22224,,,,,U,7652,,,,,,1,,CHEMBL629317,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),12394,,22224,,,,,U,7652,,,,,,1,,CHEMBL629318,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),12395,,22224,,,,,U,7652,,,,,,1,,CHEMBL877497,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),12396,,22224,,,,,U,7652,,,,,,1,,CHEMBL629319,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),12397,,22224,,,,,U,7652,,,,,,1,,CHEMBL629320,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),12398,,22224,,,,,U,7652,,,,,,1,,CHEMBL629496,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),12399,,22224,,,,,U,7652,,,,,,1,,CHEMBL629497,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),12400,,22224,,,,,U,7652,,,,,,1,,CHEMBL629498,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),12401,,22224,,,,,U,7652,,,,,,1,,CHEMBL629499,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),12402,,22224,,,,,U,7652,,,,,,1,,CHEMBL629500,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),12403,,22224,,,,,U,7652,,,,,,1,,CHEMBL629501,Autocuration,
A,0,BAO_0000019,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),12404,,22224,,,,,U,7652,,,,,,1,,CHEMBL629502,Autocuration,
F,0,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,12405,,22224,,,,,U,8267,,,,,In vivo,1,,CHEMBL629503,Autocuration,
A,1,BAO_0000218,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,12406,Canis lupus familiaris,50588,,,,,N,8267,,,,,,1,9615.0,CHEMBL629504,Intermediate,
A,0,BAO_0000019,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,12407,,22224,,,,,U,14479,,,,,,1,,CHEMBL629505,Autocuration,
A,0,BAO_0000019,Compound was evaluated for total body clearance,12408,,22224,,,,,U,17515,,,,,,1,,CHEMBL629506,Autocuration,
A,0,BAO_0000019,Compound was evaluated for volume of distribution at steady state,12409,,22224,,,,,U,17515,,,,,,1,,CHEMBL629507,Autocuration,
A,0,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,12410,,22224,,,,,U,8142,,,,,,1,,CHEMBL877498,Autocuration,
A,0,BAO_0000019,Percentage of the diamine which is monoprotonated at pH 7.4,12411,,22224,,,,,U,14849,,,,,,1,,CHEMBL629508,Autocuration,
A,0,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,12412,,22224,,,,,U,7653,,,,,,1,,CHEMBL629509,Autocuration,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12413,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL629510,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12414,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL629511,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12415,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL629512,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12416,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL629513,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12417,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL629514,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12418,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL628447,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,12419,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL628448,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,12420,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL628449,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,12421,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631119,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,12422,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631120,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,12423,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631121,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,12424,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL874458,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12425,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631122,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12426,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631123,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12427,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631124,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12428,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631125,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12429,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631290,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12430,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631291,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12431,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631292,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,12432,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631293,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,12433,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631294,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,12434,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631295,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,12435,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631296,Intermediate,
A,1,BAO_0000218,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,12436,Rattus norvegicus,50597,,,Blood,,N,8631,,,,178.0,,1,10116.0,CHEMBL631297,Intermediate,
A,0,BAO_0000218,Maximum biodistribution (Bmax) was determined.,12437,,22224,,,,,U,10263,,,,,,1,,CHEMBL631298,Autocuration,
A,1,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,12438,Mus musculus,50594,,,,,N,12364,,,,,,1,10090.0,CHEMBL631299,Intermediate,
A,1,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,12439,Mus musculus,50594,,,,,N,12364,,,,,,1,10090.0,CHEMBL631300,Intermediate,
A,1,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,12440,Mus musculus,50594,,,,,N,12364,,,,,,1,10090.0,CHEMBL631301,Intermediate,
A,1,BAO_0000218,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,12441,Mus musculus,50594,,,,,N,12364,,,,,,1,10090.0,CHEMBL630291,Intermediate,
A,0,BAO_0000218,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,12442,,22224,,,,,U,14793,,,,,,1,,CHEMBL630292,Autocuration,
A,0,BAO_0000218,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,12443,,22224,,,,,U,14793,,,,,,1,,CHEMBL630293,Autocuration,
A,0,BAO_0000218,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,12444,,22224,,,,,U,14793,,,,,,1,,CHEMBL630294,Autocuration,
A,0,BAO_0000218,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,12445,,22224,,,,,U,14793,,,,,,1,,CHEMBL630295,Autocuration,
A,0,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,12446,,22224,,,,,U,14793,,,,,,1,,CHEMBL630296,Autocuration,
A,0,BAO_0000218,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,12447,,22224,,,,,U,14793,,,,,,1,,CHEMBL626782,Autocuration,
A,0,BAO_0000218,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,12448,,22224,,,,,U,14793,,,,,,1,,CHEMBL626783,Autocuration,
A,0,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,12449,,22224,,,,,U,14793,,,,,,1,,CHEMBL626784,Autocuration,
A,0,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,12450,,22224,,,,,U,14793,,,,,,1,,CHEMBL626785,Autocuration,
A,0,BAO_0000218,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,12451,,22224,,,,,U,14793,,,,,,1,,CHEMBL626786,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12452,,22224,,,,,U,9196,,,,,,1,,CHEMBL626787,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,12453,,22224,,,,,U,9196,,,,,,1,,CHEMBL626788,Autocuration,
A,0,BAO_0000218,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12454,,22224,,,,,U,9196,,,,,,1,,CHEMBL625927,Autocuration,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12455,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625928,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12456,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625929,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12457,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625930,Intermediate,
A,1,BAO_0000218,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",12458,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625931,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,12459,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627230,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12460,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627231,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12461,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627232,Intermediate,
A,1,BAO_0000218,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,12462,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627233,Intermediate,
A,1,BAO_0000218,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12463,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL875470,Intermediate,
A,1,BAO_0000218,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12464,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627234,Intermediate,
A,1,BAO_0000218,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12465,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627235,Intermediate,
A,1,BAO_0000218,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12466,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627236,Intermediate,
A,1,BAO_0000218,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12467,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627237,Intermediate,
A,1,BAO_0000218,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12468,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627238,Intermediate,
A,1,BAO_0000218,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12469,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627239,Intermediate,
A,1,BAO_0000218,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12470,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627240,Intermediate,
A,1,BAO_0000218,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12471,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627241,Intermediate,
A,1,BAO_0000218,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12472,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627242,Intermediate,
A,1,BAO_0000218,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,12473,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627243,Intermediate,
A,1,BAO_0000218,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12474,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627244,Intermediate,
A,1,BAO_0000218,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12475,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627245,Intermediate,
A,1,BAO_0000218,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12476,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627246,Intermediate,
A,1,BAO_0000218,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12477,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627247,Intermediate,
A,1,BAO_0000218,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12478,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627248,Intermediate,
A,1,BAO_0000218,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12479,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627249,Intermediate,
A,1,BAO_0000218,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12480,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625569,Intermediate,
A,1,BAO_0000218,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12481,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625570,Intermediate,
A,1,BAO_0000218,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12482,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625571,Intermediate,
A,1,BAO_0000218,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,12483,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625572,Intermediate,
A,1,BAO_0000218,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12484,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625573,Intermediate,
A,1,BAO_0000218,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,12485,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL625574,Intermediate,
A,1,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,12486,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL626245,Intermediate,
A,1,BAO_0000218,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12487,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL626246,Intermediate,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12488,,22224,,,,,U,9196,,,,,,1,,CHEMBL626247,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12489,,22224,,,,,U,9196,,,,,,1,,CHEMBL626248,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12490,,22224,,,,,U,9196,,,,,,1,,CHEMBL626249,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12491,,22224,,,,,U,9196,,,,,,1,,CHEMBL626420,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12492,,22224,,,,,U,9196,,,,,,1,,CHEMBL626421,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12493,,22224,,,,,U,9196,,,,,,1,,CHEMBL626422,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12494,,22224,,,,,U,9196,,,,,,1,,CHEMBL626423,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12495,,22224,,,,,U,9196,,,,,,1,,CHEMBL626424,Autocuration,
A,1,BAO_0000218,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,12496,Canis lupus familiaris,50588,,,,,N,12023,,,,,,1,9615.0,CHEMBL626425,Intermediate,
A,1,BAO_0000218,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,12497,Rattus norvegicus,50597,,,,,N,12023,,,,,,1,10116.0,CHEMBL875476,Intermediate,
A,1,BAO_0000218,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,12498,Macaca fascicularis,100710,,,,,N,12023,,,,,,1,9541.0,CHEMBL626426,Intermediate,
P,0,BAO_0000100,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,12499,,22224,,,,,U,10580,,,,,,1,,CHEMBL626427,Autocuration,
P,0,BAO_0000100,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,12500,,22224,,,,,U,10580,,,,,,1,,CHEMBL626428,Autocuration,
A,0,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,12501,,22224,,,,,U,16032,,,,,,1,,CHEMBL626429,Autocuration,
A,0,BAO_0000019,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,12502,,22224,,,Urine,,U,16032,,,,1088.0,,1,,CHEMBL625025,Autocuration,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12503,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625026,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12504,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625027,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12505,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL874410,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12506,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625028,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12507,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625029,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12508,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625030,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12509,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625031,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12510,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625032,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12511,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625033,Intermediate,
A,1,BAO_0000218,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12512,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL625034,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12513,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624872,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12514,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624873,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12515,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624874,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12516,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624875,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12517,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624876,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12518,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624877,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12519,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624878,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12520,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624879,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12521,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624880,Intermediate,
A,1,BAO_0000218,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,12522,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624881,Intermediate,
A,1,BAO_0000218,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",12523,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL624882,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12524,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624883,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12525,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624884,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12526,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624885,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12527,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624886,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12528,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624887,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12529,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624888,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12530,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624889,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12531,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL624890,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12532,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL621964,Intermediate,
A,1,BAO_0000218,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12533,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL621965,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12534,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL621966,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12535,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL621967,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12536,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL622164,Intermediate,
A,0,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),12537,,22224,,,,,U,7653,,,,,,1,,CHEMBL623097,Autocuration,
A,0,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),12538,,22224,,,,,U,7653,,,,,,1,,CHEMBL623098,Autocuration,
A,0,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,12539,,22224,,,,,U,7653,,,,,,1,,CHEMBL623099,Autocuration,
A,0,BAO_0000019,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,12540,,22224,,,,,U,7653,,,,,,1,,CHEMBL623100,Autocuration,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",12541,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL628673,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",12542,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL628674,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",12543,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL628675,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",12544,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL627644,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",12545,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL627645,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",12546,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL627646,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",12547,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL627647,Intermediate,
A,1,BAO_0000218,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",12548,Rattus norvegicus,50597,,,,,N,9104,,,,,,1,10116.0,CHEMBL627648,Intermediate,
A,1,BAO_0000218,Free level in rat plasma,12549,Rattus norvegicus,50597,,,,,N,12902,,,,,,1,10116.0,CHEMBL627649,Intermediate,
A,0,BAO_0000019,Level reaching in blood plasma of rat or human was determined,12550,,22224,,,,,U,6614,,,,,,1,,CHEMBL628313,Autocuration,
A,1,BAO_0000218,Log (Cbrain/Cblood) in rats,12551,Rattus norvegicus,50597,,,,,N,9663,,,,,,1,10116.0,CHEMBL628314,Intermediate,
A,0,BAO_0000019,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,12552,,22224,,,,,U,17658,,,,,,1,,CHEMBL628315,Autocuration,
A,0,BAO_0000019,Mean percentage of compound transport through membrane; expressed as membrane transport,12553,,22224,,,,,U,17658,,,,,,1,,CHEMBL628316,Autocuration,
A,0,BAO_0000218,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,12554,,22224,,,,,U,14314,,,,,,1,,CHEMBL628317,Autocuration,
A,0,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,12555,,22224,,,,,U,7385,,,,,,1,,CHEMBL628473,Autocuration,
A,0,BAO_0000019,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",12556,,22224,,,,,U,7385,,,,,,1,,CHEMBL628474,Autocuration,
A,0,BAO_0000019,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,12557,,22224,,,,,U,7385,,,,,,1,,CHEMBL628475,Autocuration,
A,0,BAO_0000019,Net water uptake by a carrier mediated transport (%cm) mechanism,12558,,22224,,,,,U,1329,,,,,,1,,CHEMBL628476,Autocuration,
A,0,BAO_0000218,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12559,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL628477,Autocuration,
A,1,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12560,Mustela putorius furo,50506,,,,,N,12187,,,,,,1,9669.0,CHEMBL628478,Intermediate,
A,1,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12561,Mustela putorius furo,50506,,,,,N,12187,,,,,,1,9669.0,CHEMBL628479,Intermediate,
A,0,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12562,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL628480,Autocuration,
A,0,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",12563,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL628481,Autocuration,
A,1,BAO_0000218,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12564,Rattus norvegicus,50597,,,,,N,12187,,,,,,1,10116.0,CHEMBL628482,Intermediate,
A,1,BAO_0000218,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12565,Rattus norvegicus,50597,,,,,N,12187,,,,,,1,10116.0,CHEMBL628483,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12566,Rattus norvegicus,50597,,,Plasma,,N,9278,,,,1969.0,,1,10116.0,CHEMBL628484,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12567,Rattus norvegicus,50597,,,Plasma,,N,9278,,,,1969.0,,1,10116.0,CHEMBL628485,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",12568,Macaca fascicularis,100710,,,Plasma,,N,9278,,,,1969.0,,1,9541.0,CHEMBL628486,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",12569,Homo sapiens,50587,,,Plasma,,N,9278,,,,1969.0,,1,9606.0,CHEMBL628487,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",12570,Rattus norvegicus,50597,,,Plasma,,N,9278,,,,1969.0,,1,10116.0,CHEMBL628488,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12571,Rattus norvegicus,50597,,,Plasma,,N,9278,,,,1969.0,,1,10116.0,CHEMBL628489,Intermediate,
A,1,BAO_0000218,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",12572,Rattus norvegicus,50597,,,Plasma,,N,9278,,,,1969.0,,1,10116.0,CHEMBL628490,Intermediate,
A,1,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12573,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL628491,Intermediate,
A,1,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12574,Macaca fascicularis,100710,,,,,N,12186,,,,,,1,9541.0,CHEMBL877507,Intermediate,
A,0,BAO_0000218,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12575,,22224,,,,,U,12186,,,,,,1,,CHEMBL628492,Autocuration,
A,0,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/mL),12576,Simiiformes,22224,,,,,U,12041,,,,,,1,314293.0,CHEMBL628493,Autocuration,
A,0,BAO_0000019,% metabolized in monkey S-9 after 2 hours (1 ug/ml),12577,Simiiformes,22224,,,,,U,12041,,,,,,1,314293.0,CHEMBL628494,Autocuration,
A,0,BAO_0000019,% metabolized in monkey S-9 after 2 hours (10 ug/ml),12578,Simiiformes,22224,,,,,U,12041,,,,,,1,314293.0,CHEMBL628495,Autocuration,
A,1,BAO_0000218,Permeability in Caco-2 assay at 10E-6,12579,Homo sapiens,50587,,,,,N,6737,,,,,,1,9606.0,CHEMBL628496,Intermediate,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,12580,,22224,,,Brain,,U,13758,,,,955.0,,1,,CHEMBL628497,Autocuration,
A,0,BAO_0000218,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,12581,,22224,,,Brain,,U,13758,,,,955.0,,1,,CHEMBL628498,Autocuration,
A,0,BAO_0000019,Plasma protein binding was determined,12582,,22224,,,,,U,5676,,,,,,1,,CHEMBL628499,Autocuration,
A,0,BAO_0000218,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,12583,,22224,,,,,U,14793,,,,,,1,,CHEMBL627656,Autocuration,
A,0,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,12584,,22224,,,,,U,14793,,,,,,1,,CHEMBL627657,Autocuration,
A,0,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,12585,,22224,,,,,U,14793,,,,,,1,,CHEMBL626808,Autocuration,
A,0,BAO_0000218,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,12586,,22224,,,,,U,14793,,,,,,1,,CHEMBL626809,Autocuration,
A,0,BAO_0000218,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,12587,,22224,,,,,U,14793,,,,,,1,,CHEMBL626810,Autocuration,
A,0,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,12588,,22224,,,,,U,14793,,,,,,1,,CHEMBL626811,Autocuration,
A,0,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,12589,,22224,,,,,U,14793,,,,,,1,,CHEMBL874465,Autocuration,
A,0,BAO_0000218,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,12590,,22224,,,,,U,14793,,,,,,1,,CHEMBL626812,Autocuration,
A,0,BAO_0000218,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,12591,,22224,,,,,U,14793,,,,,,1,,CHEMBL626813,Autocuration,
A,0,BAO_0000218,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,12592,,22224,,,,,U,14793,,,,,,1,,CHEMBL626814,Autocuration,
A,0,BAO_0000019,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,12593,,22224,,,,,U,14000,,,,,,1,,CHEMBL626815,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),12594,,22224,,,,,U,5948,,,,,,1,,CHEMBL628566,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),12595,,22229,,,,,U,13824,,,,,,1,,CHEMBL628567,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12596,,22229,,,,,U,10778,,,,,,1,,CHEMBL628568,Autocuration,
A,1,BAO_0000218,C max in dog,12597,Canis lupus familiaris,50588,,,,,N,17237,,,,,In vivo,1,9615.0,CHEMBL628569,Intermediate,
A,1,BAO_0000218,C max in guinea pig,12598,Cavia porcellus,50512,,,,,N,17237,,,,,In vivo,1,10141.0,CHEMBL628570,Intermediate,
A,0,BAO_0000218,C max value was evaluated,12599,,22224,,,,,U,2809,,,,,In vivo,1,,CHEMBL628571,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 0.1 mg//kg,12600,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628572,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 0.3 mg/kg,12601,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628573,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 1 mg/kg,12602,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628574,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 10 mg/kg,12603,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628575,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 23.4 mg/kg,12604,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628576,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 3 mg/kg,12605,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628577,Autocuration,
A,0,BAO_0000218,Cmax value after oral dose of 3.87 mg/kg,12606,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL628578,Autocuration,
A,1,BAO_0000218,Cmax value in female Beagle dogs,12607,Canis lupus familiaris,50588,,,,,N,12768,,,,,In vivo,1,9615.0,CHEMBL874466,Intermediate,
A,1,BAO_0000218,Cmax value in male rats,12608,Rattus norvegicus,50597,,,,,N,12768,,,,,In vivo,1,10116.0,CHEMBL628579,Intermediate,
A,1,BAO_0000218,Cmax value in rat plasma when administered 20 mg/kg perorally,12609,Rattus norvegicus,50597,,,Plasma,,N,12780,,,,1969.0,In vivo,1,10116.0,CHEMBL628580,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12610,Canis lupus familiaris,50588,,,Plasma,,N,15592,,,,1969.0,In vivo,1,9615.0,CHEMBL628581,Intermediate,
A,1,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,12611,Canis lupus familiaris,50588,,,Plasma,,N,15592,,,,1969.0,In vivo,1,9615.0,CHEMBL628582,Intermediate,
A,1,BAO_0000218,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,12612,Canis lupus familiaris,50588,,,,,N,17025,,,,,,1,9615.0,CHEMBL628583,Intermediate,
A,0,BAO_0000218,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,12613,Simiiformes,22224,,,,,U,17025,,,,,,1,314293.0,CHEMBL625782,Autocuration,
A,1,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,12614,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,,1,9986.0,CHEMBL625783,Intermediate,
A,1,BAO_0000218,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,12615,Rattus norvegicus,50597,,,,,N,17025,,,,,,1,10116.0,CHEMBL625784,Intermediate,
A,1,BAO_0000218,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,12616,Macaca mulatta,50797,,,Plasma,,N,4236,,,,1969.0,,1,9544.0,CHEMBL625785,Intermediate,
A,1,BAO_0000218,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,12617,Rattus norvegicus,50597,,,,,N,15791,,,,,,1,10116.0,CHEMBL625786,Intermediate,
A,0,BAO_0000019,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,12618,,22224,,,,,U,11149,,,,,,1,,CHEMBL874467,Autocuration,
A,1,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",12619,Canis lupus familiaris,50588,,,,,N,15592,,,,,,1,9615.0,CHEMBL625787,Intermediate,
A,1,BAO_0000218,cytotoxicity against HIV protease enzyme.,12620,Human immunodeficiency virus,50677,,,,,N,15778,,,,,,1,12721.0,CHEMBL625964,Intermediate,
A,1,BAO_0000218,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,12621,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL625965,Intermediate,
A,1,BAO_0000218,Apparent clearance in mice after oral administration of 100 mg/kg of dose,12622,Mus musculus,50594,,,,,N,12745,,,,,,1,10090.0,CHEMBL625966,Intermediate,
A,1,BAO_0000218,The plasma clearance in dog.,12623,Canis lupus familiaris,50588,,,Plasma,,N,13941,,,,1969.0,In vivo,1,9615.0,CHEMBL625967,Intermediate,
A,1,BAO_0000218,The plasma clearance in rat.,12624,Rattus norvegicus,50597,,,Plasma,,N,13941,,,,1969.0,In vivo,1,10116.0,CHEMBL625968,Intermediate,
A,1,BAO_0000218,Clearance from plasma in male Sprague-Dawley rats,12625,Rattus norvegicus,50597,,,Plasma,,N,16449,,,,1969.0,In vivo,1,10116.0,CHEMBL625969,Intermediate,
A,1,BAO_0000218,Clearance from plasma in male cynomolgus monkeys,12626,Macaca fascicularis,100710,,,Plasma,,N,16449,,,,1969.0,In vivo,1,9541.0,CHEMBL625970,Intermediate,
A,1,BAO_0000218,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",12627,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL625971,Intermediate,
A,1,BAO_0000218,Clearance of compound in dog plasma,12628,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL625972,Intermediate,
A,1,BAO_0000218,Clearance of compound in human plasma,12629,Homo sapiens,50587,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9606.0,CHEMBL625973,Intermediate,
A,1,BAO_0000218,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,12630,Canis lupus familiaris,50588,,,,,N,14317,,,,,In vivo,1,9615.0,CHEMBL625974,Intermediate,
A,1,BAO_0000218,Clearance of compound when administered intravenously as an individual dose to a single dog.,12631,Canis lupus familiaris,50588,,,,,N,14317,,,,,In vivo,1,9615.0,CHEMBL625975,Intermediate,
A,1,BAO_0000218,"Clearance (10 mg/kg, intravenously) in dog plasma",12632,Canis lupus familiaris,50588,,,Plasma,,N,14224,,,,1969.0,In vivo,1,9615.0,CHEMBL625976,Intermediate,
A,1,BAO_0000218,Clearance value in dog,12633,Canis lupus familiaris,50588,,,,,N,17237,,,,,In vivo,1,9615.0,CHEMBL625977,Intermediate,
A,1,BAO_0000218,Clearance value in guinea pig,12634,Cavia porcellus,50512,,,,,N,17237,,,,,In vivo,1,10141.0,CHEMBL625978,Intermediate,
A,1,BAO_0000218,Clearance values in rats after iv administration.,12635,Rattus norvegicus,50597,,,,,N,14187,,,,,In vivo,1,10116.0,CHEMBL874468,Intermediate,
A,0,BAO_0000218,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,12636,,22224,,,Plasma,,U,4806,,,,1969.0,In vivo,1,,CHEMBL625421,Autocuration,
A,1,BAO_0000218,In vivo clearance (5 mg/kg) was determined in rabbits,12637,Oryctolagus cuniculus,50592,,,,,N,15025,,,,,In vivo,1,9986.0,CHEMBL625422,Intermediate,
A,1,BAO_0000218,Plasma Clearance rate was determined for the compound in rats,12638,Rattus norvegicus,50597,,,,,N,13197,,,,,In vivo,1,10116.0,CHEMBL625423,Intermediate,
A,0,BAO_0000218,Plasma Clearance rate was determined for the compound in squirrel monkeys,12639,Saimiri,22224,,,,,U,13197,,,,,In vivo,1,9520.0,CHEMBL625424,Autocuration,
A,1,BAO_0000218,Plasma clearance in rat,12640,Rattus norvegicus,50597,,,,,N,13960,,,,,In vivo,1,10116.0,CHEMBL625425,Intermediate,
A,0,BAO_0000218,Plasma clearance of the compound,12641,,22224,,,,,U,17820,,,,,In vivo,1,,CHEMBL625426,Autocuration,
A,1,BAO_0000218,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,12642,Cavia porcellus,50512,,,,,N,14706,,,,,In vivo,1,10141.0,CHEMBL625427,Intermediate,
A,1,BAO_0000218,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,12643,Cavia porcellus,50512,,,,,N,14706,,,,,In vivo,1,10141.0,CHEMBL625428,Intermediate,
A,0,BAO_0000218,Plasma clearance was determined,12644,,22224,,,,,U,6504,,,,,In vivo,1,,CHEMBL625429,Autocuration,
A,1,BAO_0000218,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,12645,Canis lupus familiaris,50588,,,,,N,14925,,,,,In vivo,1,9615.0,CHEMBL625430,Intermediate,
A,1,BAO_0000218,Plasma clearance rate was determined for the compound in rats,12646,Rattus norvegicus,50597,,,,,N,13197,,,,,In vivo,1,10116.0,CHEMBL625431,Intermediate,
A,0,BAO_0000218,Plasma clearance rate was determined for the compound in squirrel monkeys,12647,Saimiri,22224,,,,,U,13197,,,,,In vivo,1,9520.0,CHEMBL627307,Autocuration,
A,0,BAO_0000218,Slow clearance (CL) was determined,12648,,22224,,,,,U,3437,,,,,In vivo,1,,CHEMBL627308,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,12649,,22224,,,,,U,9196,,,,,,1,,CHEMBL627309,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,12650,,22224,,,,,U,9196,,,,,,1,,CHEMBL627310,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12651,,22224,,,,,U,9196,,,,,,1,,CHEMBL627311,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,12652,,22224,,,,,U,9196,,,,,,1,,CHEMBL627312,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12653,,22224,,,,,U,9196,,,,,,1,,CHEMBL627313,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12654,,22224,,,,,U,9196,,,,,,1,,CHEMBL627314,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12655,,22224,,,,,U,9196,,,,,,1,,CHEMBL627315,Autocuration,
A,0,BAO_0000218,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12656,,22224,,,,,U,9196,,,,,,1,,CHEMBL627316,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,12657,,22224,,,,,U,9196,,,,,,1,,CHEMBL627317,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,12658,,22224,,,,,U,9196,,,,,,1,,CHEMBL627318,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,12659,,22224,,,,,U,9196,,,,,,1,,CHEMBL627999,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,12660,,22224,,,,,U,9196,,,,,,1,,CHEMBL628000,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,12661,,22224,,,,,U,9196,,,,,,1,,CHEMBL628001,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,12662,,22224,,,,,U,9196,,,,,,1,,CHEMBL628002,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,12663,,22224,,,,,U,9196,,,,,,1,,CHEMBL625610,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,12664,,22224,,,,,U,9196,,,,,,1,,CHEMBL625611,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,12665,,22224,,,,,U,9196,,,,,,1,,CHEMBL625612,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,12666,,22224,,,,,U,9196,,,,,,1,,CHEMBL625613,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,12667,,22224,,,,,U,9196,,,,,,1,,CHEMBL875479,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,12668,,22224,,,,,U,9196,,,,,,1,,CHEMBL625614,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,12669,,22224,,,,,U,9196,,,,,,1,,CHEMBL625615,Autocuration,
A,0,BAO_0000218,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,12670,,22224,,,,,U,9196,,,,,,1,,CHEMBL626302,Autocuration,
A,1,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,12671,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL626303,Intermediate,
A,1,BAO_0000218,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,12672,Rattus norvegicus,50597,,,Blood,,N,8374,,,,178.0,,1,10116.0,CHEMBL627420,Intermediate,
A,1,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,12673,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL627421,Intermediate,
A,1,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,12674,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL625695,Intermediate,
A,1,BAO_0000218,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,12675,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL625696,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice brain was measured after 1 hr,12676,Mus musculus,50594,,,Brain,,N,10009,,,,955.0,,1,10090.0,CHEMBL875606,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice brain was measured after 24 hr r,12677,Mus musculus,50594,,,Brain,,N,10009,,,,955.0,,1,10090.0,CHEMBL625697,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice brain was measured after 2 hr,12678,Mus musculus,50594,,,Brain,,N,10009,,,,955.0,,1,10090.0,CHEMBL625698,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice brain was measured after 3 hr,12679,Mus musculus,50594,,,Brain,,N,10009,,,,955.0,,1,10090.0,CHEMBL625699,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice brain was measured after 6 hr,12680,Mus musculus,50594,,,Brain,,N,10009,,,,955.0,,1,10090.0,CHEMBL625700,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice liver was measured after 1 hr,12681,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625701,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,12682,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625702,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice liver was measured after 2 hr,12683,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625703,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice liver was measured after 3 hr,12684,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625704,Intermediate,
A,1,BAO_0000218,Distribution of compound in mice liver was measured after 6 hr,12685,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625705,Intermediate,
A,1,BAO_0000218,Distribution in dog adrenal medulla 30 min after administration.,12686,Canis lupus familiaris,50588,,,Adrenal medulla,,N,8170,,,,1236.0,,1,9615.0,CHEMBL625706,Intermediate,
A,1,BAO_0000218,Distribution in dog adrenal medulla 72 hours after administration.,12687,Canis lupus familiaris,50588,,,Adrenal medulla,,N,8170,,,,1236.0,,1,9615.0,CHEMBL625707,Intermediate,
A,1,BAO_0000218,Distribution in female dog Ovary 24 hours after administration.,12688,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL625708,Intermediate,
A,1,BAO_0000218,Distribution in female dog Ovary 72 hours after administration.,12689,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL625709,Intermediate,
A,1,BAO_0000218,Distribution in female dog adipose 24 hours after administration.,12690,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624180,Intermediate,
A,1,BAO_0000218,Distribution in female dog adipose 72 hours after administration.,12691,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624181,Intermediate,
A,1,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,12692,Canis lupus familiaris,50588,,,Adrenal cortex,,N,8170,,,,1235.0,,1,9615.0,CHEMBL624182,Intermediate,
A,1,BAO_0000218,Distribution in female dog adrenal cortex 72 hours after administration.,12693,Canis lupus familiaris,50588,,,Adrenal cortex,,N,8170,,,,1235.0,,1,9615.0,CHEMBL624183,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12694,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL624184,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12695,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL877489,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12696,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL624185,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12697,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL624186,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12698,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL624187,Intermediate,
A,1,BAO_0000218,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12699,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL624188,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12700,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624189,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12701,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624190,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12702,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624191,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12703,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624192,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12704,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624193,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12705,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624194,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12706,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624891,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12707,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624892,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12708,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL624893,Intermediate,
A,1,BAO_0000218,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12709,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL627632,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12710,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627633,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12711,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627634,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12712,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627635,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12713,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627636,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12714,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626816,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12715,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626817,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12716,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626818,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12717,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626819,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12718,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626820,Intermediate,
A,1,BAO_0000218,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12719,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL626821,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,12720,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626822,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,12721,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626823,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,12722,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626824,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,12723,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626825,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,12724,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626826,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,12725,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626827,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,12726,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626828,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,12727,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626829,Intermediate,
A,1,BAO_0000218,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12728,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL626830,Intermediate,
A,1,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12729,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627150,Intermediate,
A,1,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12730,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627151,Intermediate,
A,1,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,12731,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627152,Intermediate,
A,1,BAO_0000218,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,12732,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL627153,Intermediate,
A,0,BAO_0000019,Rate of acetate production by the compound was determined,12733,,22224,,,,,U,12904,,,,,,1,,CHEMBL627154,Autocuration,
A,0,BAO_0000019,Rate of acetate production by the compound was determined; Not determined,12734,,22224,,,,,U,12904,,,,,,1,,CHEMBL627155,Autocuration,
A,0,BAO_0000019,Rate of hydrolysis of nitrocefin by compound was evaluated in water,12735,,22224,,,,,U,3730,,,,,,1,,CHEMBL627156,Autocuration,
A,0,BAO_0000019,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,12736,,22224,,,,,U,3627,,,,,,1,,CHEMBL627157,Autocuration,
A,1,BAO_0000218,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12737,Oryctolagus cuniculus,50592,,,,,N,13799,,,,,,1,9986.0,CHEMBL627158,Intermediate,
A,1,BAO_0000218,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,12738,Oryctolagus cuniculus,50592,,,Plasma,,N,13799,,,,1969.0,,1,9986.0,CHEMBL627159,Intermediate,
A,1,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12739,Mus musculus,50594,,,,,N,13799,,,,,,1,10090.0,CHEMBL627160,Intermediate,
A,1,BAO_0000218,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12740,Rattus norvegicus,50597,,,,,N,13799,,,,,,1,10116.0,CHEMBL628540,Intermediate,
A,1,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,12741,Rattus norvegicus,50597,,,Plasma,,N,13799,,,,1969.0,,1,10116.0,CHEMBL628541,Intermediate,
A,1,BAO_0000218,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,12742,Rattus norvegicus,50597,,,Plasma,,N,13799,,,,1969.0,,1,10116.0,CHEMBL628542,Intermediate,
P,0,BAO_0000100,Solubility after at a pH 1.2,12743,,22229,,,,,U,6629,,,,,,1,,CHEMBL628543,Autocuration,
P,0,BAO_0000100,Solubility after at pH 1.2,12744,,22229,,,,,U,6629,,,,,,1,,CHEMBL628544,Autocuration,
P,0,BAO_0000100,Solubility after injection of water,12745,,22229,,,,,U,6629,,,,,,1,,CHEMBL628545,Autocuration,
A,0,BAO_0000019,Statistical significance of IC 50 values; Expressed as R value,12746,,22224,,,,,U,14000,,,,,,1,,CHEMBL628546,Autocuration,
A,0,BAO_0000019,Systemic availability with respect to methyldopa was determined,12747,,22224,,,,,U,8267,,,,,,1,,CHEMBL874455,Autocuration,
A,1,BAO_0000218,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,12748,Rattus norvegicus,50597,,,,,N,13799,,,,,,1,10116.0,CHEMBL628547,Intermediate,
A,1,BAO_0000218,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,12749,Rattus norvegicus,50597,,,Plasma,,N,13799,,,,1969.0,,1,10116.0,CHEMBL628548,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",12750,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628549,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",12751,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628550,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",12752,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628551,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",12753,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628552,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",12754,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628553,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",12755,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628554,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",12756,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628555,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",12757,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628556,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",12758,Oryctolagus cuniculus,50592,,,Kidney,,N,7132,,,,2113.0,,1,9986.0,CHEMBL628557,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",12759,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628558,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",12760,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628559,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",12761,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628560,Intermediate,
A,1,BAO_0000218,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",12762,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL874456,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",12763,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628561,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",12764,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL628562,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",12765,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628563,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",12766,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628564,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",12767,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL628565,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",12768,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL631248,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",12769,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL631249,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",12770,Oryctolagus cuniculus,50592,,,Kidney,,N,7132,,,,2113.0,,1,9986.0,CHEMBL627214,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",12771,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL874591,Intermediate,
A,1,BAO_0000218,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",12772,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL627215,Intermediate,
A,1,BAO_0000218,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,12773,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL625471,Intermediate,
A,1,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,12774,Oryctolagus cuniculus,50592,,,,,N,7132,,,,,,1,9986.0,CHEMBL625472,Intermediate,
A,1,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,12775,Oryctolagus cuniculus,50592,,,,,N,7132,,,,,,1,9986.0,CHEMBL625473,Intermediate,
A,1,BAO_0000218,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,12776,Canis lupus familiaris,50588,,,,,N,13317,,,,,In vivo,1,9615.0,CHEMBL625474,Intermediate,
A,1,BAO_0000218,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,12777,Canis lupus familiaris,50588,,,,,N,15341,,,,,In vivo,1,9615.0,CHEMBL625475,Intermediate,
A,1,BAO_0000218,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,12778,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL625476,Intermediate,
A,1,BAO_0000218,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,12779,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL625477,Intermediate,
A,1,BAO_0000218,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,12780,Rattus norvegicus,50597,,,,,N,15341,,,,,In vivo,1,10116.0,CHEMBL625478,Intermediate,
A,1,BAO_0000218,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,12781,Rattus norvegicus,50597,,,esophageal tunica muscularis mucosae,,N,12801,,,,,In vitro,1,10116.0,CHEMBL625479,Intermediate,
A,1,BAO_0000218,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,12782,Rattus norvegicus,50597,,,esophageal tunica muscularis mucosae,,N,12801,,,,,In vitro,1,10116.0,CHEMBL625480,Intermediate,
A,1,BAO_0000218,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,12783,Rattus norvegicus,50597,,,Plasma,,N,14856,,,,1969.0,In vivo,1,10116.0,CHEMBL625481,Intermediate,
A,1,BAO_0000218,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,12784,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL625482,Intermediate,
A,1,BAO_0000218,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,12785,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL625483,Intermediate,
A,1,BAO_0000218,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,12786,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL625484,Intermediate,
A,1,BAO_0000218,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,12787,Rattus norvegicus,50597,,,,,N,14062,,,,,In vivo,1,10116.0,CHEMBL625485,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,12788,Canis lupus familiaris,50588,,,Plasma,,N,14346,,,,1969.0,In vivo,1,9615.0,CHEMBL625486,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,12789,Rattus norvegicus,50597,,,Plasma,,N,14346,,,,1969.0,In vivo,1,10116.0,CHEMBL625487,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,12790,Rattus norvegicus,50597,,,Plasma,,N,14346,,,,1969.0,In vivo,1,10116.0,CHEMBL625488,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,12791,Rattus norvegicus,50597,,,Plasma,,N,14346,,,,1969.0,In vivo,1,10116.0,CHEMBL625489,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,12792,Rattus norvegicus,50597,,,Plasma,,N,14346,,,,1969.0,In vivo,1,10116.0,CHEMBL625490,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,12793,Canis lupus familiaris,50588,,,Plasma,,N,14346,,,,1969.0,In vivo,1,9615.0,CHEMBL625491,Intermediate,
A,1,BAO_0000218,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,12794,Rattus norvegicus,50597,,,Plasma,,N,14346,,,,1969.0,In vivo,1,10116.0,CHEMBL625492,Intermediate,
A,1,BAO_0000218,plasma clearance in human,12795,Homo sapiens,50587,,,Plasma,,N,15711,,,,1969.0,In vivo,1,9606.0,CHEMBL625493,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,12796,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL625494,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,12797,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL625495,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,12798,Rattus norvegicus,50597,,,,,N,14886,,,,,In vivo,1,10116.0,CHEMBL625496,Intermediate,
P,0,BAO_0000100,1-Octanol/water partition coefficient measured at 7.4,12799,,22229,,,,,U,4115,,,,,,1,,CHEMBL625497,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12800,,22229,,,,,U,13733,,,,,,1,,CHEMBL625498,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),12801,,22224,,,,,U,12102,,,,,,1,,CHEMBL625499,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12802,,22229,,,,,U,12676,,,,,,1,,CHEMBL625500,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12803,,22229,,,,,U,13733,,,,,,1,,CHEMBL625501,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12804,,22229,,,,,U,13740,,,,,,1,,CHEMBL625502,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (relative to BAY K 8644),12805,,22229,,,,,U,12766,,,,,,1,,CHEMBL625503,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12806,,22229,,,,,U,2764,,,,,,1,,CHEMBL625504,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12807,,22229,,,,,U,12355,,,,,,1,,CHEMBL625505,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient of the compound,12808,,22229,,,,,U,11314,,,,,,1,,CHEMBL625506,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),12809,,22224,,,,,U,12706,,,,,,1,,CHEMBL625507,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12810,,22229,,,,,U,12645,,,,,,1,,CHEMBL625508,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12811,,22229,,,,,U,13668,,,,,,1,,CHEMBL625509,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12812,,22229,,,,,U,12819,,,,,,1,,CHEMBL625510,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12813,,22229,,,,,U,13668,,,,,,1,,CHEMBL883125,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12814,,22229,,,,,U,13017,,,,,,1,,CHEMBL625511,Autocuration,
A,0,BAO_0000019,Partition coefficient of the compound,12815,,22224,,,,,U,2448,,,,,,1,,CHEMBL874650,Autocuration,
A,0,BAO_0000019,Partition coefficient of the compound,12816,,22224,,,,,U,11526,,,,,,1,,CHEMBL625512,Autocuration,
A,0,BAO_0000019,Partition coefficient of compound was determined,12817,,22224,,,,,U,12426,,,,,,1,,CHEMBL625513,Autocuration,
A,0,BAO_0000019,Partition coefficient was determined,12818,,22224,,,,,U,2448,,,,,,1,,CHEMBL625514,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12819,,22229,,,,,U,12001,,,,,,1,,CHEMBL625515,Autocuration,
P,0,BAO_0000100,partition coefficient of compound was determined,12820,,22229,,,,,U,12426,,,,,,1,,CHEMBL625516,Autocuration,
A,1,BAO_0000218,The total body administered intravenously in dog,12821,Canis lupus familiaris,50588,,,,,N,13204,,,,,In vivo,1,9615.0,CHEMBL625517,Intermediate,
A,1,BAO_0000218,The total body administered intravenously in rats,12822,Rattus norvegicus,50597,,,,,N,13204,,,,,In vivo,1,10116.0,CHEMBL625518,Intermediate,
A,1,BAO_0000218,Time taken for the administration to female NIH mice weighing 25-30 g.,12823,Mus musculus,50594,,,,,N,13889,,,,,,1,10090.0,CHEMBL625519,Intermediate,
A,0,BAO_0000019,Time taken for the administration,12824,,22224,,,,,U,13889,,,,,,1,,CHEMBL625520,Autocuration,
A,1,BAO_0000218,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,12825,Canis lupus familiaris,50588,,,,,N,17025,,,,,In vivo,1,9615.0,CHEMBL874651,Intermediate,
A,0,BAO_0000218,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,12826,Simiiformes,22224,,,,,U,17025,,,,,In vivo,1,314293.0,CHEMBL625521,Autocuration,
A,1,BAO_0000218,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,12827,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,In vivo,1,9986.0,CHEMBL623171,Intermediate,
A,1,BAO_0000218,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,12828,Rattus norvegicus,50597,,,,,N,17025,,,,,In vivo,1,10116.0,CHEMBL623853,Intermediate,
A,0,BAO_0000019,Plasma clearance for the compound was determined.,12829,,22224,,,,,U,15067,,,,,,1,,CHEMBL623854,Autocuration,
P,0,BAO_0000100,CLog P value of the compound,12830,,22224,,,,,U,3091,,,,,,1,,CHEMBL874405,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12831,,22229,,,,,U,15592,,,,,,1,,CHEMBL623855,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12832,,22229,,,,,U,14738,,,,,,1,,CHEMBL623856,Autocuration,
P,0,BAO_0000100,ClogP value of the compound; nd ='no data',12833,,22224,,,,,U,14738,,,,,,1,,CHEMBL623857,Autocuration,
P,0,BAO_0000100,ClogP value of the compound; nd ='not determined',12834,,22224,,,,,U,14738,,,,,,1,,CHEMBL623858,Autocuration,
P,0,BAO_0000100,CLog P was determined,12835,,22224,,,,,U,6076,,,,,,1,,CHEMBL623859,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12836,,22229,,,,,U,17840,,,,,,1,,CHEMBL839829,Autocuration,
A,0,BAO_0000019,CLogP was calculated,12837,,22224,,,,,U,13589,,,,,,1,,CHEMBL623860,Autocuration,
A,0,BAO_0000019,CLogP value was determined,12838,,22224,,,,,U,17655,,,,,,1,,CHEMBL623861,Autocuration,
A,0,BAO_0000019,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,12839,,22224,,,,,U,5867,,,,,,1,,CHEMBL623862,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12840,,22229,,,,,U,5867,,,,,,1,,CHEMBL874406,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12841,,22229,,,,,U,10783,,,,,,1,,CHEMBL623863,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12842,,22229,,,,,U,14849,,,,,,1,,CHEMBL624021,Autocuration,
A,1,BAO_0000218,Distribution in female dog adrenal medulla 24 hours after administration.,12843,Canis lupus familiaris,50588,,,Adrenal medulla,,N,8170,,,,1236.0,,1,9615.0,CHEMBL624022,Intermediate,
A,1,BAO_0000218,Distribution in female dog adrenal medulla 72 hours after administration.,12844,Canis lupus familiaris,50588,,,Adrenal medulla,,N,8170,,,,1236.0,,1,9615.0,CHEMBL624023,Intermediate,
A,1,BAO_0000218,Distribution in female dog bile 24 hours after administration.,12845,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624024,Intermediate,
A,1,BAO_0000218,Distribution in female dog bile 72 hr after administration.,12846,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624025,Intermediate,
A,1,BAO_0000218,Distribution in female dog blood 24 hours after administration.,12847,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624026,Intermediate,
A,1,BAO_0000218,Distribution in female dog blood 72 hours after administration.,12848,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624027,Intermediate,
A,1,BAO_0000218,Distribution in female dog heart 24 hours after administration.,12849,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624028,Intermediate,
A,1,BAO_0000218,Distribution in female dog heart 72 hours after administration.,12850,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624029,Intermediate,
A,1,BAO_0000218,Distribution in female dog kidney 24 hours after administration.,12851,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624030,Intermediate,
A,1,BAO_0000218,Distribution in female dog kidney 72 hours after administration.,12852,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624031,Intermediate,
A,1,BAO_0000218,Distribution in female dog large intestine 24 hours after administration.,12853,Canis lupus familiaris,50588,,,Intestine,,N,8170,,,,160.0,,1,9615.0,CHEMBL624032,Intermediate,
A,1,BAO_0000218,Distribution in female dog large intestine 72 hours after administration.,12854,Canis lupus familiaris,50588,,,Intestine,,N,8170,,,,160.0,,1,9615.0,CHEMBL874407,Intermediate,
A,1,BAO_0000218,Distribution in female dog liver 24 hours after administration.,12855,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624033,Intermediate,
A,1,BAO_0000218,Distribution in female dog liver 72 hours after administration.,12856,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624034,Intermediate,
A,1,BAO_0000218,Distribution in female dog lung 24 hours after administration.,12857,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624035,Intermediate,
A,1,BAO_0000218,Distribution in female dog lung 72 hours after administration.,12858,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624036,Intermediate,
A,1,BAO_0000218,Distribution in female dog muscle 24 hours after administration.,12859,Canis lupus familiaris,50588,,,Muscle tissue,,N,8170,,,,2385.0,,1,9615.0,CHEMBL624037,Intermediate,
A,1,BAO_0000218,Distribution in female dog muscle 72 hours after administration.,12860,Canis lupus familiaris,50588,,,Muscle tissue,,N,8170,,,,2385.0,,1,9615.0,CHEMBL624038,Intermediate,
A,1,BAO_0000218,Distribution in female dog pancreas 24 hours after administration.,12861,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624039,Intermediate,
A,1,BAO_0000218,Distribution in female dog pancreas 72 hours after administration.,12862,Canis lupus familiaris,50588,,,,,N,8170,,,,,,1,9615.0,CHEMBL624040,Intermediate,
A,1,BAO_0000218,Distribution in female dog small intestine 24 hours after administration.,12863,Canis lupus familiaris,50588,,,Intestine,,N,8170,,,,160.0,,1,9615.0,CHEMBL624041,Intermediate,
A,1,BAO_0000218,Distribution in female dog small intestine 72 hours after administration.,12864,Canis lupus familiaris,50588,,,Intestine,,N,8170,,,,160.0,,1,9615.0,CHEMBL624042,Intermediate,
A,1,BAO_0000218,Distribution in female dog spleen 24 hours after administration.,12865,Canis lupus familiaris,50588,,,Spleen,,N,8170,,,,2106.0,,1,9615.0,CHEMBL624043,Intermediate,
A,1,BAO_0000218,Distribution in female dog spleen 72 hours after administration.,12866,Canis lupus familiaris,50588,,,Spleen,,N,8170,,,,2106.0,,1,9615.0,CHEMBL624044,Intermediate,
A,1,BAO_0000218,Distribution in female dog stomach 24 hours after administration.,12867,Canis lupus familiaris,50588,,,Stomach,,N,8170,,,,945.0,,1,9615.0,CHEMBL624045,Intermediate,
A,1,BAO_0000218,Distribution in female dog stomach 72 hours after administration.,12868,Canis lupus familiaris,50588,,,Stomach,,N,8170,,,,945.0,,1,9615.0,CHEMBL624046,Intermediate,
A,1,BAO_0000218,Distribution in female dog thyroid 24 hours after administration.,12869,Canis lupus familiaris,50588,,,Thyroid gland,,N,8170,,,,2046.0,,1,9615.0,CHEMBL624047,Intermediate,
A,1,BAO_0000218,Distribution in female dog thyroid 72 hours after administration.,12870,Canis lupus familiaris,50588,,,Thyroid gland,,N,8170,,,,2046.0,,1,9615.0,CHEMBL624048,Intermediate,
A,1,BAO_0000218,Distribution in female dog urine 24 hours after administration.,12871,Canis lupus familiaris,50588,,,Urine,,N,8170,,,,1088.0,,1,9615.0,CHEMBL874408,Intermediate,
A,1,BAO_0000218,Distribution in female dog urine 72 hr after administration.,12872,Canis lupus familiaris,50588,,,Urine,,N,8170,,,,1088.0,,1,9615.0,CHEMBL624049,Intermediate,
A,0,BAO_0000218,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,12873,,22224,,,Plasma,,U,14283,,,,1969.0,,1,,CHEMBL624050,Autocuration,
A,0,BAO_0000019,Plasma concentration at 7 hr after intravenous dosing,12874,,22224,,,,,U,5623,,,,,,1,,CHEMBL624051,Autocuration,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,12875,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623278,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,12876,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623279,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 1 hr in rats,12877,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623280,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 2 hr in rats,12878,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623963,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 4 hr in rats,12879,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623964,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg iv after 6 hr in rats,12880,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623965,Intermediate,
A,1,BAO_0000218,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,12881,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623966,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,12882,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL874415,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,12883,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623967,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,12884,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623968,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,12885,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL623969,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,12886,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL628409,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,12887,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL628410,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,12888,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL628411,Intermediate,
A,1,BAO_0000218,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,12889,Rattus norvegicus,50597,,,,,N,13477,,,,,,1,10116.0,CHEMBL628412,Intermediate,
A,0,BAO_0000019,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,12890,,22224,,,,,U,12553,,,,,,1,,CHEMBL628413,Autocuration,
A,0,BAO_0000019,The concentration in plasmat; Not determined,12891,,22224,,,Plasma,,U,14548,,,,1969.0,,1,,CHEMBL628414,Autocuration,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in blood,12892,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL628415,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in brown fat,12893,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL628416,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in heart,12894,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL628417,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in liver,12895,Rattus norvegicus,50597,,,Liver,,N,14393,,,,2107.0,,1,10116.0,CHEMBL874908,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in plasma,12896,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL628418,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,12897,Rattus norvegicus,50597,,,Muscle tissue,,N,14393,,,,2385.0,,1,10116.0,CHEMBL628419,Intermediate,
A,1,BAO_0000218,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,12898,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL628420,Intermediate,
A,0,BAO_0000019,Water solubility at 37 degree C.,12899,,22224,,,,,U,1629,,,,,,1,,CHEMBL628421,Autocuration,
P,0,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,12900,,22229,,,,,U,8194,,,,,,1,,CHEMBL626726,Autocuration,
P,0,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,12901,,22229,,,,,U,8194,,,,,,1,,CHEMBL626727,Autocuration,
A,1,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12902,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL626728,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12903,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL626729,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12904,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL626730,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12905,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL626731,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12906,Rattus norvegicus,50597,,,Blood,,N,8594,,,,178.0,,1,10116.0,CHEMBL626732,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12907,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL626733,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12908,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL626734,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12909,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL626735,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12910,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL874909,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12911,Rattus norvegicus,50597,,,Heart,,N,8594,,,,948.0,,1,10116.0,CHEMBL626736,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12912,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL626737,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12913,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL630999,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12914,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL631000,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12915,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL631001,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12916,Rattus norvegicus,50597,,,Kidney,,N,8594,,,,2113.0,,1,10116.0,CHEMBL631002,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12917,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL631003,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12918,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL631004,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12919,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL631005,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12920,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL631006,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12921,Rattus norvegicus,50597,,,Liver,,N,8594,,,,2107.0,,1,10116.0,CHEMBL631007,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12922,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL631008,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12923,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL631009,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12924,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL631010,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12925,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL631011,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12926,Rattus norvegicus,50597,,,Lung,,N,8594,,,,2048.0,,1,10116.0,CHEMBL631012,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,12927,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL630271,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,12928,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL630272,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,12929,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL630273,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,12930,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL630274,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,12931,Rattus norvegicus,50597,,,Thyroid gland,,N,8594,,,,2046.0,,1,10116.0,CHEMBL630275,Intermediate,
A,1,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,12932,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL875782,Intermediate,
A,1,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,12933,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL630276,Intermediate,
A,1,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,12934,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL630277,Intermediate,
A,1,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,12935,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL630278,Intermediate,
A,1,BAO_0000218,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,12936,Rattus norvegicus,50597,,,,,N,8594,,,,,,1,10116.0,CHEMBL630279,Intermediate,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,12937,,22224,,,,,U,8151,,,,,,1,,CHEMBL630280,Autocuration,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,12938,,22224,,,,,U,8151,,,,,,1,,CHEMBL630281,Autocuration,
A,1,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,12939,Oryctolagus cuniculus,50592,,,,,N,7132,,,,,,1,9986.0,CHEMBL630282,Intermediate,
A,1,BAO_0000218,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,12940,Oryctolagus cuniculus,50592,,,,,N,7132,,,,,,1,9986.0,CHEMBL630283,Intermediate,
A,0,BAO_0000019,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),12941,,22224,,,,,U,5797,,,,,,1,,CHEMBL630284,Autocuration,
A,0,BAO_0000019,Alkylating activity was determined,12942,,22224,,,,,U,7849,,,,,,1,,CHEMBL630285,Autocuration,
A,0,BAO_0000251,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),12943,,22224,,,,,U,14220,,,,,,1,,CHEMBL630286,Autocuration,Microsomes
A,1,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",12944,Oryctolagus cuniculus,50592,,,,,N,8650,,,,,,1,9986.0,CHEMBL630069,Intermediate,
A,1,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",12945,Oryctolagus cuniculus,50592,,,,,N,8650,,,,,,1,9986.0,CHEMBL630070,Intermediate,
A,1,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",12946,Oryctolagus cuniculus,50592,,,,,N,8650,,,,,,1,9986.0,CHEMBL630071,Intermediate,
A,1,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",12947,Oryctolagus cuniculus,50592,,,,,N,8650,,,,,,1,9986.0,CHEMBL630072,Intermediate,
A,1,BAO_0000218,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",12948,Oryctolagus cuniculus,50592,,,,,N,8650,,,,,,1,9986.0,CHEMBL875110,Intermediate,
A,1,BAO_0000218,Compound was tested for antidiuretic activity in rats,12949,Rattus norvegicus,50597,,,,,N,7116,,,,,,1,10116.0,CHEMBL630073,Intermediate,
A,0,BAO_0000019,Compound was tested for inactivation kinetic values,12950,,22224,,,,,U,14131,,,,,,1,,CHEMBL630074,Autocuration,
A,0,BAO_0000218,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,12951,,22224,,,,,U,7415,,,,,In vivo,1,,CHEMBL630075,Autocuration,
A,0,BAO_0000019,Dissociation rate calculated from the first-order equation using the t1/2 value,12952,,22224,,,,,U,13178,,,,,,1,,CHEMBL630076,Autocuration,
P,0,BAO_0000100,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,12953,,22229,,,,,U,8815,,,,,,1,,CHEMBL630077,Autocuration,
P,0,BAO_0000100,Aqueous solubility was measured,12954,,22229,,,,,U,1450,,,,,,1,,CHEMBL630078,Autocuration,
P,0,BAO_0000100,Aqueous solubility was measured at a pH 4,12955,,22229,,,,,U,1450,,,,,,1,,CHEMBL630079,Autocuration,
P,0,BAO_0000100,Aqueous solubility (pH 7),12956,,22229,,,,,U,1450,,,,,,1,,CHEMBL630080,Autocuration,
P,0,BAO_0000100,Aqueous solubility was measured at a pH 9,12957,,22229,,,,,U,1450,,,,,,1,,CHEMBL630081,Autocuration,
A,0,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",12958,,22224,,,,,U,12711,,,,,,1,,CHEMBL630082,Autocuration,
A,0,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12959,,22224,,,,,U,12711,,,,,,1,,CHEMBL630083,Autocuration,
A,0,BAO_0000019,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12960,,22224,,,,,U,12711,,,,,,1,,CHEMBL630084,Autocuration,
P,0,BAO_0000100,Aqueous solubility of the compound,12961,,22229,,,,,U,15032,,,,,,1,,CHEMBL629198,Autocuration,
P,0,BAO_0000100,Aqueous solubility at 37 degree Celsius at pH 7.38,12962,,22229,,,,,U,9964,,,,,,1,,CHEMBL629199,Autocuration,
P,0,BAO_0000100,Aqueous solubility in pH 7.4 phosphate buffer,12963,,22229,,,,,U,14962,,,,,,1,,CHEMBL629200,Autocuration,
A,1,BAO_0000218,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,12964,Canis lupus familiaris,50588,,,,,N,12487,,,,,,1,9615.0,CHEMBL629201,Intermediate,
A,1,BAO_0000218,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,12965,Canis lupus familiaris,50588,,,,,N,12487,,,,,,1,9615.0,CHEMBL629202,Intermediate,
A,1,BAO_0000218,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,12966,Homo sapiens,50587,,,,,N,10026,,,,,,1,9606.0,CHEMBL875111,Intermediate,
A,1,BAO_0000218,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,12967,Homo sapiens,50587,,,,,N,10026,,,,,,1,9606.0,CHEMBL629203,Intermediate,
A,1,BAO_0000218,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,12968,Homo sapiens,50587,,,,,N,10026,,,,,,1,9606.0,CHEMBL629204,Intermediate,
A,1,BAO_0000218,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,12969,Homo sapiens,50587,,,,,N,10026,,,,,,1,9606.0,CHEMBL629205,Intermediate,
A,1,BAO_0000218,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,12970,Homo sapiens,50587,,,,,N,10026,,,,,,1,9606.0,CHEMBL629206,Intermediate,
A,0,BAO_0000019,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,12971,,22224,,,,,U,10026,,,,,,1,,CHEMBL631185,Autocuration,
A,1,BAO_0000218,Compound was evaluated for the average bile flow rat in rats,12972,Rattus norvegicus,50597,,,,,N,7415,,,,,,1,10116.0,CHEMBL631186,Intermediate,
A,1,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12973,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,,1,9986.0,CHEMBL631187,Intermediate,
A,1,BAO_0000218,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",12974,Oryctolagus cuniculus,50592,,,,,N,17025,,,,,,1,9986.0,CHEMBL631188,Intermediate,
A,0,BAO_0000019,Average half life period was determined,12975,,22224,,,,,U,10184,,,,,,1,,CHEMBL876419,Autocuration,
A,0,BAO_0000019,Average half life period was determined,12976,,22224,,,,,U,10184,,,,,,1,,CHEMBL631189,Autocuration,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12977,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL631190,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,12978,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL631191,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,12979,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL631192,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,12980,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632400,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12981,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL630564,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,12982,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL630565,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,12983,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL630566,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,12984,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL631229,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,12985,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL631230,Intermediate,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12986,,22229,,,,,U,6030,,,,,,1,,CHEMBL876428,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12987,,22229,,,,,U,6147,,,,,,1,,CHEMBL631231,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),12988,,22229,,,,,U,14556,,,,,,1,,CHEMBL631232,Autocuration,
A,0,BAO_0000019,Hydrophilicity was determined,12989,,22224,,,,,U,768,,,,,,1,,CHEMBL631233,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12990,,22229,,,,,U,14452,,,,,,1,,CHEMBL631234,Autocuration,
A,0,BAO_0000019,Increased absorption was determined,12991,,22224,,,,,U,5237,,,,,,1,,CHEMBL883126,Autocuration,
P,0,BAO_0000100,Lipophilicity value was evaluated,12992,,22224,,,,,U,14378,,,,,,1,,CHEMBL631235,Autocuration,
P,0,BAO_0000100,Log P value of the compound.,12993,,22224,,,,,U,14418,,,,,,1,,CHEMBL631236,Autocuration,
A,0,BAO_0000019,Partition coefficient of compound was determined,12994,,22224,,,,,U,5249,,,,,,1,,CHEMBL631237,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12995,,22229,,,,,U,14621,,,,,,1,,CHEMBL631238,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12996,,22229,,,,,U,12542,,,,,,1,,CHEMBL876429,Autocuration,
A,0,BAO_0000019,Partition coefficient was measured by medchem software; Not calculated,12997,,22224,,,,,U,12542,,,,,,1,,CHEMBL631414,Autocuration,
P,0,BAO_0000100,Partition coefficient was measured by octanol-water using standard shake-flask method,12998,,22224,,,,,U,12542,,,,,,1,,CHEMBL631415,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),12999,,22229,,,,,U,15462,,,,,,1,,CHEMBL631416,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),13000,,22224,,,,,U,14884,,,,,,1,,CHEMBL631417,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13001,,22229,,,,,U,16526,,,,,,1,,CHEMBL631418,Autocuration,
P,0,BAO_0000100,The Octanol/Water partition coefficient CLogP,13002,,22229,,,,,U,13693,,,,,,1,,CHEMBL631419,Autocuration,
A,0,BAO_0000019,The pharmacokinetic parameter C Log p was reported,13003,,22224,,,,,U,13693,,,,,,1,,CHEMBL631420,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13004,,22229,,,,,U,13779,,,,,,1,,CHEMBL631421,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13005,,22229,,,,,U,14772,,,,,,1,,CHEMBL631422,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13006,,22229,,,,,U,14393,,,,,,1,,CHEMBL631423,Autocuration,
A,1,BAO_0000218,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13007,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,In vivo,1,10116.0,CHEMBL876430,Intermediate,
A,1,BAO_0000218,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,13008,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,In vivo,1,10116.0,CHEMBL631424,Intermediate,
A,1,BAO_0000218,Compound was administered intravenously in dog to evaluate plasma clearance values,13009,Canis lupus familiaris,50588,,,Plasma,,N,13744,,,,1969.0,In vivo,1,9615.0,CHEMBL631425,Intermediate,
A,0,BAO_0000218,Compound was administered intravenously in monkey to evaluate plasma clearance values,13010,Simiiformes,22224,,,Plasma,,U,13744,,,,1969.0,In vivo,1,314293.0,CHEMBL631426,Autocuration,
A,1,BAO_0000218,Compound was administered intravenously in mouse to evaluate plasma clearance values,13011,Mus musculus,50594,,,Plasma,,N,13744,,,,1969.0,In vivo,1,10090.0,CHEMBL631427,Intermediate,
A,1,BAO_0000218,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,13012,Canis lupus familiaris,50588,,,Plasma,,N,13207,,,,1969.0,In vivo,1,9615.0,CHEMBL631428,Intermediate,
A,1,BAO_0000218,Intrinsic clearance in Rhesus liver microsome,13013,Macaca mulatta,50797,,,Liver,,N,5669,,,,2107.0,In vitro,1,9544.0,CHEMBL631429,Intermediate,Microsomes
A,1,BAO_0000218,Intrinsic clearance in dog liver microsome,13014,Canis lupus familiaris,50588,,,Liver,,N,5669,,,,2107.0,In vitro,1,9615.0,CHEMBL631430,Intermediate,Microsomes
A,1,BAO_0000218,Intrinsic clearance in rat liver microsome,13015,Rattus norvegicus,50597,,,Liver,,N,5669,,,,2107.0,In vitro,1,10116.0,CHEMBL631431,Intermediate,Microsomes
A,1,BAO_0000218,Low plasma clearance was calculated in rhesus monkey,13016,Macaca mulatta,50797,,,Plasma,,N,4853,,,,1969.0,In vivo,1,9544.0,CHEMBL631432,Intermediate,
A,1,BAO_0000218,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,13017,Canis lupus familiaris,50588,,,,,N,16452,,,,,In vivo,1,9615.0,CHEMBL631433,Intermediate,
A,0,BAO_0000218,Plasma clearance after intravenous dose of 0.3 mg/kg,13018,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL631434,Autocuration,
A,0,BAO_0000218,Plasma clearance after intravenous dose of 1 mg/kg,13019,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL631435,Autocuration,
A,0,BAO_0000218,Plasma clearance after intravenous dose of 3 mg/kg,13020,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL631436,Autocuration,
A,0,BAO_0000218,Plasma clearance after intravenous dose of 3.87 mg/kg,13021,,22224,,,,,U,11954,,,,,In vivo,1,,CHEMBL631437,Autocuration,
A,1,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rat,13022,Rattus norvegicus,50597,,,,,N,5669,,,,,In vivo,1,10116.0,CHEMBL631438,Intermediate,
A,1,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in Rhesus,13023,Macaca mulatta,50797,,,,,N,5669,,,,,In vivo,1,9544.0,CHEMBL876431,Intermediate,
A,1,BAO_0000218,Plasma clearance after peroral administration at 10 mpk in dog,13024,Canis lupus familiaris,50588,,,,,N,5669,,,,,In vivo,1,9615.0,CHEMBL631439,Intermediate,
A,1,BAO_0000218,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,13025,Rattus norvegicus,50597,,,,,N,13662,,,,,In vivo,1,10116.0,CHEMBL631440,Intermediate,
A,0,BAO_0000019,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),13026,,22224,,,,,U,8272,,,,,,1,,CHEMBL631441,Autocuration,
A,0,BAO_0000019,Critical Micellar concentration was determined,13027,,22224,,,,,U,13410,,,,,,1,,CHEMBL631442,Autocuration,
A,0,BAO_0000019,Critical Micellar concentration of the compound. was determined,13028,,22224,,,,,U,13410,,,,,,1,,CHEMBL626525,Autocuration,
A,0,BAO_0000019,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,13029,,22224,,,,,U,12628,,,,,,1,,CHEMBL627168,Autocuration,
A,0,BAO_0000019,Critical micellar concentration was measured in water by the dye solubilization method,13030,,22224,,,,,U,9675,,,,,,1,,CHEMBL875618,Autocuration,
B,0,BAO_0000019,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,13031,,22224,,,,,U,12628,,,,,,1,,CHEMBL626612,Autocuration,
A,0,BAO_0000019,CMR value (relative to BAY K 8644),13032,,22224,,,,,U,12766,,,,,,1,,CHEMBL626613,Autocuration,
A,0,BAO_0000019,Carbamoylating activity was determined,13033,,22224,,,,,U,7849,,,,,,1,,CHEMBL626614,Autocuration,
A,0,BAO_0000218,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,13034,Simiiformes,22224,,,,,U,12187,,,,,,1,314293.0,CHEMBL626615,Autocuration,
A,0,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,13035,,22224,,,,,U,2040,,,,,,1,,CHEMBL626616,Autocuration,
A,0,BAO_0000019,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,13036,,22224,,,,,U,2040,,,,,,1,,CHEMBL626617,Autocuration,
A,1,BAO_0000218,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,13037,Canis lupus familiaris,50588,,,Plasma,,N,14180,,,,1969.0,In vivo,1,9615.0,CHEMBL626618,Intermediate,
A,1,BAO_0000218,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,13038,Rattus norvegicus,50597,,,Plasma,,N,14180,,,,1969.0,In vivo,1,10116.0,CHEMBL626619,Intermediate,
A,1,BAO_0000218,"Clearance rate at 0.46 mg/kg, iv, in dogs",13039,Canis lupus familiaris,50588,,,,,N,14474,,,,,In vivo,1,9615.0,CHEMBL626620,Intermediate,
A,1,BAO_0000218,"Clearance rate at 5.5 mg/kg, iv, in rat",13040,Rattus norvegicus,50597,,,,,N,14474,,,,,In vivo,1,10116.0,CHEMBL626621,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,13041,Macaca fascicularis,100710,,,,,N,14548,,,,,In vivo,1,9541.0,CHEMBL626622,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,13042,Macaca fascicularis,100710,,,,,N,14548,,,,,In vivo,1,9541.0,CHEMBL626623,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,13043,Canis lupus familiaris,50588,,,,,N,14548,,,,,In vivo,1,9615.0,CHEMBL626624,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,13044,Rattus norvegicus,50597,,,,,N,14548,,,,,In vivo,1,10116.0,CHEMBL626625,Intermediate,
A,1,BAO_0000218,Clearance rate constant using isolated perfused rat liver (IPRL) assay,13045,Rattus norvegicus,50597,,,Liver,,N,6125,,,,2107.0,Ex vivo,1,10116.0,CHEMBL626626,Intermediate,
A,0,BAO_0000218,Tested for the total clearance of the compound,13046,,22224,,,,,U,6874,,,,,In vivo,1,,CHEMBL626627,Autocuration,
A,1,BAO_0000218,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,13047,Canis lupus familiaris,50588,,,,,N,15343,,,,,In vivo,1,9615.0,CHEMBL626628,Intermediate,
A,0,BAO_0000218,Total body clearance was determined,13048,,22224,,,,,U,6236,,,,,In vivo,1,,CHEMBL626629,Autocuration,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13049,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626630,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13050,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626631,Intermediate,
P,0,BAO_0000100,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13051,,22229,,,,,U,8194,,,,,,1,,CHEMBL626632,Autocuration,
P,0,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13052,,22229,,,,,U,8194,,,,,,1,,CHEMBL626633,Autocuration,
P,0,BAO_0000100,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,13053,,22229,,,,,U,8194,,,,,,1,,CHEMBL626634,Autocuration,
P,0,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,13054,,22229,,,,,U,8194,,,,,,1,,CHEMBL626635,Autocuration,
P,0,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,13055,,22229,,,,,U,8194,,,,,,1,,CHEMBL626636,Autocuration,
P,0,BAO_0000100,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,13056,,22229,,,,,U,8194,,,,,,1,,CHEMBL626637,Autocuration,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),13057,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL626638,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,13058,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL626639,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,13059,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL626640,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,13060,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL626641,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,13061,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL627272,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,13062,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL627273,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),13063,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL627441,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),13064,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL628355,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),13065,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL628356,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),13066,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL628357,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),13067,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL628358,Intermediate,
A,1,BAO_0000218,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),13068,Pneumocystis carinii,50339,,,,,N,13273,,,,,,1,4754.0,CHEMBL622307,Intermediate,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,13069,,22224,,,,,U,13118,,,,,,1,,CHEMBL622527,Autocuration,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,13070,,22224,,,,,U,13118,,,,,,1,,CHEMBL622528,Autocuration,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,13071,,22224,,,,,U,13118,,,,,,1,,CHEMBL622529,Autocuration,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,13072,,22224,,,,,U,13118,,,,,,1,,CHEMBL622992,Autocuration,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,13073,,22224,,,,,U,13118,,,,,,1,,CHEMBL622993,Autocuration,
A,0,BAO_0000019,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,13074,,22224,,,,,U,13118,,,,,,1,,CHEMBL622994,Autocuration,
A,1,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",13075,Rattus norvegicus,50597,,,,,N,10633,,,,,,1,10116.0,CHEMBL622995,Intermediate,
A,1,BAO_0000218,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",13076,Rattus norvegicus,50597,,,,,N,10633,,,,,,1,10116.0,CHEMBL622996,Intermediate,
A,1,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",13077,Rattus norvegicus,50597,,,,,N,10633,,,,,,1,10116.0,CHEMBL622997,Intermediate,
A,1,BAO_0000218,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",13078,Rattus norvegicus,50597,,,,,N,10633,,,,,,1,10116.0,CHEMBL622998,Intermediate,
A,0,BAO_0000218,Cp max following ip administration at 1 mg/kg,13079,,22224,,,,,U,5767,,,,,,1,,CHEMBL622999,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma was reported at 0.5 hour,13080,,22224,,,Plasma,,U,3302,,,,1969.0,In vivo,1,,CHEMBL623000,Autocuration,
A,0,BAO_0000218,Maximum concentration in plasma was reported at 2 hour,13081,,22224,,,Plasma,,U,3302,,,,1969.0,In vivo,1,,CHEMBL623001,Autocuration,
A,1,BAO_0000218,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,13082,Mus musculus,50594,,,,,N,12467,,,,,,1,10090.0,CHEMBL623002,Intermediate,
P,0,BAO_0000100,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),13083,,22229,,,,,U,11778,,,,,,1,,CHEMBL623003,Autocuration,
A,0,BAO_0000019,Steady state concentration was evaluated,13084,,22224,,,,,U,4321,,,,,,1,,CHEMBL623004,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),13085,,22224,,,,,U,14884,,,,,,1,,CHEMBL623005,Autocuration,
A,0,BAO_0000019,Partition coefficient (logD7.4),13086,,22224,,,,,U,15234,,,,,,1,,CHEMBL623006,Autocuration,
A,1,BAO_0000218,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,13087,Rattus norvegicus,50597,,,Liver,,N,14198,,,,2107.0,In vivo,1,10116.0,CHEMBL623007,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,13088,Rattus norvegicus,50597,,,Bone,,N,14198,,,,10000001.0,In vivo,1,10116.0,CHEMBL623008,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,13089,Rattus norvegicus,50597,,,Cerebellum,,N,14198,,,,2037.0,In vivo,1,10116.0,CHEMBL876654,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,13090,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL623009,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,13091,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL623010,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,13092,Rattus norvegicus,50597,,,Heart,,N,14198,,,,948.0,In vivo,1,10116.0,CHEMBL623011,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,13093,Rattus norvegicus,50597,,,Intestine,,N,14198,,,,160.0,In vivo,1,10116.0,CHEMBL623012,Intermediate,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13094,,22224,,,,,U,8151,,,,,,1,,CHEMBL623013,Autocuration,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13095,,22224,,,,,U,8151,,,,,,1,,CHEMBL623014,Autocuration,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,13096,,22224,,,Urine,,U,8151,,,,1088.0,,1,,CHEMBL623015,Autocuration,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,13097,,22224,,,Urine,,U,8151,,,,1088.0,,1,,CHEMBL623016,Autocuration,
A,0,BAO_0000019,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,13098,,22224,,,Urine,,U,8151,,,,1088.0,,1,,CHEMBL624858,Autocuration,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,13099,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL624859,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,13100,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL624860,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13101,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL624861,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,13102,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL624862,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,13103,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL624863,Intermediate,
A,1,BAO_0000218,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,13104,Rattus norvegicus,50597,,,,,N,8151,,,,,,1,10116.0,CHEMBL876655,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13105,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624864,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13106,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624865,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13107,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624866,Intermediate,
F,1,BAO_0000218,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,13108,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624867,Expert,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13109,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL624868,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,13110,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628450,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13111,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628451,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13112,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628452,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13113,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628453,Intermediate,
A,1,BAO_0000218,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,13114,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628454,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,13115,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628455,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,13116,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628456,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,13117,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628457,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,13118,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL877505,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,13119,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628458,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,13120,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628459,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,13121,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628460,Intermediate,
A,1,BAO_0000218,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,13122,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628461,Intermediate,
B,0,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",13123,,22224,,,,,U,6996,,,,,,1,,CHEMBL628462,Autocuration,
A,1,BAO_0000218,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13124,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL628463,Intermediate,
F,1,BAO_0000218,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",13125,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625666,Expert,
B,0,BAO_0000218,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13126,,22224,,,,,U,6996,,,,,,1,,CHEMBL625667,Autocuration,
A,1,BAO_0000218,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13127,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625668,Expert,
A,1,BAO_0000218,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,13128,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL625669,Intermediate,
A,0,BAO_0000019,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,13129,,22224,,,,,U,7114,,,,,,1,,CHEMBL625670,Autocuration,
A,1,BAO_0000218,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,13130,Rattus norvegicus,50597,,,,,N,7114,,,,,,1,10116.0,CHEMBL625671,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,13131,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL625672,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,13132,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL625673,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,13133,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL625674,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,13134,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL625675,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13135,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627637,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,13136,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627638,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,13137,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627639,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,13138,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627640,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,13139,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627641,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13140,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL627642,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,13141,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL877506,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,13142,Mus musculus,50594,,,,,N,8613,,,,,,1,10090.0,CHEMBL627275,Intermediate,
A,1,BAO_0000218,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",13143,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL627643,Intermediate,
A,1,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13144,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL631246,Intermediate,
A,1,BAO_0000218,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",13145,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL631247,Intermediate,
A,1,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13146,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL629532,Intermediate,
A,1,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,13147,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL629533,Intermediate,
A,1,BAO_0000218,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,13148,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL629534,Intermediate,
A,1,BAO_0000218,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,13149,Mustela putorius furo,50506,,,,,N,11219,,,,,,1,9669.0,CHEMBL629535,Intermediate,
A,0,BAO_0000019,Pharmacokinetic parameter :drug bound to plasma was reported,13150,,22224,,,,,U,14837,,,,,,1,,CHEMBL625932,Autocuration,
A,0,BAO_0000019,compound was evaluated for drug bound in plasma,13151,,22224,,,,,U,14837,,,,,,1,,CHEMBL625933,Autocuration,
A,1,BAO_0000218,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,13152,Rattus norvegicus,50597,,,,,N,15343,,,,,,1,10116.0,CHEMBL625934,Intermediate,
A,0,BAO_0000218,Bioavailability,13153,Eutheria,22224,,,,,U,13761,,,,,,1,9347.0,CHEMBL625935,Autocuration,
A,1,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,13154,Rattus norvegicus,50597,,,,,N,14810,,,,,,1,10116.0,CHEMBL625936,Intermediate,
A,1,BAO_0000218,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,13155,Rattus norvegicus,50597,,,,,N,14810,,,,,,1,10116.0,CHEMBL625937,Intermediate,
A,1,BAO_0000218,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13156,Canis lupus familiaris,50588,,,,,N,13249,,,,,,1,9615.0,CHEMBL625938,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,13157,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL625939,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,13158,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL625940,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,13159,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL874464,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,13160,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL625941,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,13161,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL625942,Intermediate,
A,1,BAO_0000218,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,13162,Rattus norvegicus,50597,,,Bile,,N,9267,,,,1970.0,,1,10116.0,CHEMBL625943,Intermediate,
A,1,BAO_0000218,In vitro protein binding in human serum at 5 ug/ml,13163,Homo sapiens,50587,,,Serum,,N,15549,,,,1977.0,,1,9606.0,CHEMBL625944,Intermediate,
A,0,BAO_0000019,Serum protein binding ability was measured,13164,,22224,,,,,U,10929,,,,,,1,,CHEMBL625945,Autocuration,
A,0,BAO_0000019,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),13165,,22224,,,,,U,15444,,,,,,1,,CHEMBL625946,Autocuration,
A,0,BAO_0000218,Oral bioavailability in dog,13166,Canis lupus familiaris,22224,,,,,U,12860,,,,,In vivo,1,9615.0,CHEMBL625947,Autocuration,
A,1,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13167,Rattus norvegicus,50597,,,,,N,12170,,,,,In vivo,1,10116.0,CHEMBL625948,Intermediate,
A,0,BAO_0000218,Absolute oral bioavailability at an iv dose of 14 mg/kg,13168,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL625949,Autocuration,
A,0,BAO_0000218,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,13169,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL625950,Autocuration,
A,0,BAO_0000218,Oral bioavailability (dose 15 mg/kg i.v.),13170,Eutheria,22224,,,,,U,15173,,,,,In vivo,1,9347.0,CHEMBL625951,Autocuration,
A,0,BAO_0000218,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,13171,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL625952,Autocuration,
A,0,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,13172,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL625953,Autocuration,
A,0,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,13173,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL625954,Autocuration,
A,0,BAO_0000218,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,13174,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL882959,Autocuration,
A,1,BAO_0000218,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,13175,Canis lupus familiaris,50588,,,,,N,11767,,,,,In vivo,1,9615.0,CHEMBL625955,Intermediate,
A,0,BAO_0000218,Bioavailability in ferret,13176,Mustela putorius furo,22224,,,,,U,11219,,,,,In vivo,1,9669.0,CHEMBL625956,Autocuration,
A,1,BAO_0000218,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,13177,Macaca fascicularis,100710,,,,,N,12186,,,,,In vivo,1,9541.0,CHEMBL625957,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13178,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL625958,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13179,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL625959,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13180,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626642,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13181,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL631330,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13182,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL631331,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13183,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL631332,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13184,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL631333,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13185,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632018,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13186,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632019,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13187,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632020,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13188,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632021,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13189,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632022,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13190,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632023,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13191,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632024,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13192,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL874472,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13193,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632025,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13194,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632026,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13195,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632027,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13196,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL632028,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13197,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626430,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13198,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626431,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13199,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626432,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13200,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626433,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13201,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626434,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13202,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627280,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13203,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627281,Intermediate,
A,1,BAO_0000218,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13204,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627282,Intermediate,
A,0,BAO_0000019,Total body clearance was measured at given dose,13205,,22224,,,,,U,7199,,,,,,1,,CHEMBL627283,Autocuration,
A,0,BAO_0000218,Total body clearance was measured at given dose.,13206,,22224,,,,,U,7199,,,,,,1,,CHEMBL627284,Autocuration,
A,1,BAO_0000218,Metabolic clearance from the body in rat,13207,Rattus norvegicus,50597,,,,,N,7095,,,,,,1,10116.0,CHEMBL627285,Intermediate,
A,0,BAO_0000218,Renal clearance from the body,13208,,22224,,,,,U,7095,,,,,In vivo,1,,CHEMBL627286,Autocuration,
A,1,BAO_0000218,Renal clearance from the body in rat,13209,Rattus norvegicus,50597,,,,,N,7095,,,,,In vivo,1,10116.0,CHEMBL875477,Intermediate,
A,1,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,13210,Rattus norvegicus,50597,,,,,N,12528,,,,,In vivo,1,10116.0,CHEMBL627287,Intermediate,
A,1,BAO_0000218,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,13211,Canis lupus familiaris,50588,,,,,N,12528,,,,,In vivo,1,9615.0,CHEMBL627288,Intermediate,
A,1,BAO_0000218,Total clearance from the body in rat,13212,Rattus norvegicus,50597,,,,,N,7095,,,,,,1,10116.0,CHEMBL627289,Intermediate,
A,1,BAO_0000218,Clearance into cortex from rat plasma or PBS,13213,Rattus norvegicus,50597,,,Plasma,,N,14223,,,,1969.0,In vivo,1,10116.0,CHEMBL627290,Intermediate,
A,0,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,13214,,22224,,,,,U,13569,,,,,In vivo,1,,CHEMBL627291,Autocuration,
A,0,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,13215,,22224,,,,,U,13569,,,,,In vivo,1,,CHEMBL627292,Autocuration,
A,0,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,13216,,22224,,,,,U,13569,,,,,In vivo,1,,CHEMBL627293,Autocuration,
A,0,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13217,,22224,,,,,U,13569,,,,,In vivo,1,,CHEMBL627294,Autocuration,
A,0,BAO_0000218,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,13218,,22224,,,,,U,13569,,,,,In vivo,1,,CHEMBL875478,Autocuration,
A,0,BAO_0000218,Clearance was determined,13219,,22224,,,,,U,13979,,,,,In vivo,1,,CHEMBL627295,Autocuration,
A,1,BAO_0000218,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,13220,Mus musculus,50594,,,,,N,14315,,,,,In vivo,1,10090.0,CHEMBL627296,Intermediate,
A,1,BAO_0000218,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,13221,Oryctolagus cuniculus,50592,,,,,N,14315,,,,,In vivo,1,9986.0,CHEMBL626119,Intermediate,
A,1,BAO_0000218,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,13222,Rattus norvegicus,50597,,,,,N,14315,,,,,In vivo,1,10116.0,CHEMBL626120,Intermediate,
A,1,BAO_0000218,Clearance in rat after iv dose (100 ug/kg),13223,Rattus norvegicus,50597,,,,,N,12174,,,,,In vivo,1,10116.0,CHEMBL626121,Intermediate,
A,0,BAO_0000218,Clearance in guinea pig,13224,Cavia porcellus,22224,,,,,U,12797,,,,,In vivo,1,10141.0,CHEMBL626122,Autocuration,
A,1,BAO_0000218,Compound was evaluated for clearance in rat,13225,Rattus norvegicus,50597,,,,,N,12797,,,,,In vivo,1,10116.0,CHEMBL626123,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the clearance in dog,13226,Canis lupus familiaris,50588,,,,,N,12797,,,,,In vivo,1,9615.0,CHEMBL623456,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the clearance in rat,13227,Rattus norvegicus,50597,,,,,N,12797,,,,,In vivo,1,10116.0,CHEMBL623457,Intermediate,
A,1,BAO_0000218,Compound was tested in vivo for clearance after iv administration in the rat,13228,Rattus norvegicus,50597,,,,,N,11500,,,,,In vivo,1,10116.0,CHEMBL623458,Intermediate,
A,0,BAO_0000218,IV clearance determined at an iv dose of 14 mg/kg,13229,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL623459,Autocuration,
A,0,BAO_0000218,IV clearance determined at an iv dose of 15.2 mg/kg,13230,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL875484,Autocuration,
A,0,BAO_0000218,IV clearance determined at an iv dose of 15 mg/kg,13231,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL623460,Autocuration,
A,0,BAO_0000218,IV clearance determined at an peroral dose of 30 mg/kg.,13232,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL623461,Autocuration,
A,0,BAO_0000218,IV clearance determined at an peroral dose of 30.2 mg/kg.,13233,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL623462,Autocuration,
A,0,BAO_0000218,IV clearance determined at an peroral dose of 30.3 mg/kg.,13234,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL627386,Autocuration,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,13235,Rattus norvegicus,50597,,,Kidney,,N,14198,,,,2113.0,In vivo,1,10116.0,CHEMBL627387,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,13236,Rattus norvegicus,50597,,,Liver,,N,14198,,,,2107.0,In vivo,1,10116.0,CHEMBL627388,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,13237,Rattus norvegicus,50597,,,Lung,,N,14198,,,,2048.0,In vivo,1,10116.0,CHEMBL627389,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,13238,Rattus norvegicus,50597,,,Muscle tissue,,N,14198,,,,2385.0,In vivo,1,10116.0,CHEMBL627390,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,13239,Rattus norvegicus,50597,,,Plasma,,N,14198,,,,1969.0,In vivo,1,10116.0,CHEMBL627391,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,13240,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL627392,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,13241,Rattus norvegicus,50597,,,Spleen,,N,14198,,,,2106.0,In vivo,1,10116.0,CHEMBL627393,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,13242,Rattus norvegicus,50597,,,Trachea,,N,14198,,,,3126.0,In vivo,1,10116.0,CHEMBL627394,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,13243,Rattus norvegicus,50597,,,Bone,,N,14198,,,,10000001.0,In vivo,1,10116.0,CHEMBL627395,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,13244,Rattus norvegicus,50597,,,Cerebellum,,N,14198,,,,2037.0,In vivo,1,10116.0,CHEMBL875485,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,13245,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL627396,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,13246,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL627397,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,13247,Rattus norvegicus,50597,,,Heart,,N,14198,,,,948.0,In vivo,1,10116.0,CHEMBL627398,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,13248,Rattus norvegicus,50597,,,Bone,,N,14198,,,,10000001.0,In vivo,1,10116.0,CHEMBL627399,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,13249,Rattus norvegicus,50597,,,Kidney,,N,14198,,,,2113.0,In vivo,1,10116.0,CHEMBL627400,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,13250,Rattus norvegicus,50597,,,Liver,,N,14198,,,,2107.0,In vivo,1,10116.0,CHEMBL627401,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,13251,Rattus norvegicus,50597,,,Lung,,N,14198,,,,2048.0,In vivo,1,10116.0,CHEMBL627402,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,13252,Rattus norvegicus,50597,,,Muscle tissue,,N,14198,,,,2385.0,In vivo,1,10116.0,CHEMBL627403,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,13253,Rattus norvegicus,50597,,,Plasma,,N,14198,,,,1969.0,In vivo,1,10116.0,CHEMBL627404,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,13254,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL623101,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,13255,Rattus norvegicus,50597,,,Spleen,,N,14198,,,,2106.0,In vivo,1,10116.0,CHEMBL877480,Intermediate,
A,1,BAO_0000218,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,13256,Rattus norvegicus,50597,,,Trachea,,N,14198,,,,3126.0,In vivo,1,10116.0,CHEMBL623102,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,13257,Rattus norvegicus,50597,,,Bone,,N,14198,,,,10000001.0,In vivo,1,10116.0,CHEMBL623103,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,13258,Rattus norvegicus,50597,,,Cerebellum,,N,14198,,,,2037.0,In vivo,1,10116.0,CHEMBL623104,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,13259,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL623105,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,13260,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL623106,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,13261,Rattus norvegicus,50597,,,Heart,,N,14198,,,,948.0,In vivo,1,10116.0,CHEMBL623107,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,13262,Rattus norvegicus,50597,,,Intestine,,N,14198,,,,160.0,In vivo,1,10116.0,CHEMBL623108,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,13263,Rattus norvegicus,50597,,,Kidney,,N,14198,,,,2113.0,In vivo,1,10116.0,CHEMBL623109,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,13264,Rattus norvegicus,50597,,,Liver,,N,14198,,,,2107.0,In vivo,1,10116.0,CHEMBL623110,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,13265,Rattus norvegicus,50597,,,Lung,,N,14198,,,,2048.0,In vivo,1,10116.0,CHEMBL623111,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,13266,Rattus norvegicus,50597,,,Muscle tissue,,N,14198,,,,2385.0,In vivo,1,10116.0,CHEMBL625060,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,13267,Rattus norvegicus,50597,,,Plasma,,N,14198,,,,1969.0,In vivo,1,10116.0,CHEMBL625061,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,13268,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL625062,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,13269,Rattus norvegicus,50597,,,Spleen,,N,14198,,,,2106.0,In vivo,1,10116.0,CHEMBL625063,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,13270,Rattus norvegicus,50597,,,Trachea,,N,14198,,,,3126.0,In vivo,1,10116.0,CHEMBL625064,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,13271,Rattus norvegicus,50597,,,Bone,,N,14198,,,,10000001.0,In vivo,1,10116.0,CHEMBL625065,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,13272,Rattus norvegicus,50597,,,Cerebellum,,N,14198,,,,2037.0,In vivo,1,10116.0,CHEMBL625066,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,13273,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL625067,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,13274,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL625068,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,13275,Rattus norvegicus,50597,,,Heart,,N,14198,,,,948.0,In vivo,1,10116.0,CHEMBL622159,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,13276,Rattus norvegicus,50597,,,Intestine,,N,14198,,,,160.0,In vivo,1,10116.0,CHEMBL622160,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,13277,Rattus norvegicus,50597,,,Kidney,,N,14198,,,,2113.0,In vivo,1,10116.0,CHEMBL622161,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,13278,Rattus norvegicus,50597,,,Lung,,N,14198,,,,2048.0,In vivo,1,10116.0,CHEMBL622162,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,13279,Rattus norvegicus,50597,,,Muscle tissue,,N,14198,,,,2385.0,In vivo,1,10116.0,CHEMBL622163,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,13280,Rattus norvegicus,50597,,,Plasma,,N,14198,,,,1969.0,In vivo,1,10116.0,CHEMBL622313,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,13281,Rattus norvegicus,50597,,,,,N,14198,,,,,In vivo,1,10116.0,CHEMBL622314,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,13282,Rattus norvegicus,50597,,,Spleen,,N,14198,,,,2106.0,In vivo,1,10116.0,CHEMBL622315,Intermediate,
A,1,BAO_0000218,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,13283,Rattus norvegicus,50597,,,Trachea,,N,14198,,,,3126.0,In vivo,1,10116.0,CHEMBL622316,Intermediate,
A,1,BAO_0000218,Normal diffusion coefficient in water for Escherichia coli,13284,Escherichia coli,50212,,,,,N,15599,,,,,,1,562.0,CHEMBL877486,Intermediate,
A,0,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined,13285,,22224,,,,,U,8204,,,,,,1,,CHEMBL622317,Autocuration,
A,0,BAO_0000019,Average max percent decrease in RVR (renal vascular resistance) was determined.,13286,,22224,,,,,U,8204,,,,,,1,,CHEMBL622318,Autocuration,
A,0,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,13287,,22224,,,,,U,6154,,,,,,1,,CHEMBL622319,Autocuration,
A,0,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,13288,,22224,,,,,U,6154,,,,,,1,,CHEMBL622320,Autocuration,
A,0,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,13289,,22224,,,,,U,6154,,,,,,1,,CHEMBL622321,Autocuration,
A,0,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,13290,,22224,,,,,U,6154,,,,,,1,,CHEMBL622322,Autocuration,
A,0,BAO_0000019,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,13291,,22224,,,,,U,7114,,,,,,1,,CHEMBL622323,Autocuration,
A,1,BAO_0000218,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,13292,Rattus norvegicus,50597,,,,,N,7114,,,,,,1,10116.0,CHEMBL622324,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13293,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622325,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13294,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622326,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",13295,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL877487,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13296,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622327,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",13297,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622328,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13298,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622329,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13299,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622330,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13300,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622331,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13301,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622332,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",13302,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL622333,Intermediate,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13303,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL627658,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",13304,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL630428,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13305,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL630429,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",13306,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL630430,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",13307,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL630431,Autocuration,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13308,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL630432,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13309,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL630433,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13310,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL630434,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13311,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629372,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",13312,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629553,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13313,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629554,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13314,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL874447,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13315,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629555,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13316,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629556,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",13317,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629557,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13318,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629558,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13319,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629559,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13320,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629560,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",13321,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629561,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13322,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629562,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",13323,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629563,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13324,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629564,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13325,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629565,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13326,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629566,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",13327,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629567,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13328,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629568,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",13329,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629569,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13330,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL629570,Intermediate,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13331,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL629571,Autocuration,
A,0,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13332,Rattus norvegicus,22224,,,,,U,12170,,,,,In vivo,1,10116.0,CHEMBL629572,Autocuration,
A,0,BAO_0000218,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,13333,Rattus norvegicus,22224,,,,,U,12170,,,,,In vivo,1,10116.0,CHEMBL629573,Autocuration,
A,0,BAO_0000218,Bioavailability (dose 20 mg/kg),13334,Eutheria,22224,,,,,U,4985,,,,,In vivo,1,9347.0,CHEMBL629574,Autocuration,
A,0,BAO_0000218,Bioavailability in dog,13335,Canis lupus familiaris,22224,,,,,U,15145,,,,,In vivo,1,9615.0,CHEMBL629575,Autocuration,
A,0,BAO_0000218,Bioavailability in rat (Sprague-Dawley) (male),13336,Rattus norvegicus,22224,,,,,U,14080,,,,,In vivo,1,10116.0,CHEMBL874448,Autocuration,
A,0,BAO_0000218,Bioavailability in monkey (dose 10 mg/kg i.d.),13337,Primates,22224,,,,,U,11219,,,,,In vivo,1,9443.0,CHEMBL629576,Autocuration,
A,0,BAO_0000218,Bioavailability in rat,13338,Rattus norvegicus,22224,,,,,U,15145,,,,,In vivo,1,10116.0,CHEMBL629577,Autocuration,
A,0,BAO_0000218,Bioavailability in rat,13339,Rattus norvegicus,22224,,,,,U,15145,,,,,In vivo,1,10116.0,CHEMBL629578,Autocuration,
A,0,BAO_0000218,Bioavailability in dog (dose 3.0 mg/kg p.o.),13340,Canis lupus familiaris,22224,,,,,U,1202,,,,,In vivo,1,9615.0,CHEMBL629579,Autocuration,
A,0,BAO_0000218,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,13341,Canis lupus familiaris,22224,,,,,U,1202,,,,,In vivo,1,9615.0,CHEMBL882958,Autocuration,
A,1,BAO_0000218,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,13342,Pan troglodytes,50505,,,,,N,1202,,,,,In vivo,1,9598.0,CHEMBL629580,Intermediate,
A,0,BAO_0000218,Bioavailability,13343,Eutheria,22224,,,,,U,4026,,,,,In vivo,1,9347.0,CHEMBL629581,Autocuration,
A,0,BAO_0000218,Bioavailability in squirrel monkey,13344,Saimiri,22224,,,,,U,1492,,,,,In vivo,1,9520.0,CHEMBL629582,Autocuration,
A,1,BAO_0000218,Bioavailability was evaluated in dog,13345,Canis lupus familiaris,50588,,,,,N,12793,,,,,In vivo,1,9615.0,CHEMBL628522,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in hamster,13346,Cricetinae,100712,,,,,N,12793,,,,,In vivo,1,10026.0,CHEMBL625432,Intermediate,
A,0,BAO_0000218,Bioavailability in rat,13347,Rattus norvegicus,22224,,,,,U,12793,,,,,In vivo,1,10116.0,CHEMBL625433,Autocuration,
A,1,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,13348,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,In vivo,1,10116.0,CHEMBL625434,Intermediate,
A,1,BAO_0000218,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,13349,Rattus norvegicus,50597,,,Plasma,,N,14793,,,,1969.0,In vivo,1,10116.0,CHEMBL625435,Intermediate,
A,0,BAO_0000218,Bioavailability in rat (dose 10 mg/kg p.o.),13350,Rattus norvegicus,22224,,,,,U,14793,,,,,In vivo,1,10116.0,CHEMBL625436,Autocuration,
A,1,BAO_0000218,Bioavailability was measured in cynomolgus monkeys.,13351,Macaca fascicularis,100710,,,,,N,14731,,,,,In vivo,1,9541.0,CHEMBL874588,Intermediate,
A,1,BAO_0000218,Bioavailability was measured in nude mice.,13352,Mus musculus,50594,,,,,N,14731,,,,,In vivo,1,10090.0,CHEMBL625437,Intermediate,
A,0,BAO_0000218,Bioavailability in ferret (dose 10 mg/kg i.d.),13353,Mustela putorius furo,22224,,,,,U,12187,,,,,In vivo,1,9669.0,CHEMBL625438,Autocuration,
A,0,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),13354,Simiiformes,22224,,,,,U,12187,,,,,In vivo,1,314293.0,CHEMBL625439,Autocuration,
A,0,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",13355,Simiiformes,22224,,,,,U,12187,,,,,In vivo,1,314293.0,CHEMBL625440,Autocuration,
A,0,BAO_0000218,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),13356,Simiiformes,22224,,,,,U,12187,,,,,In vivo,1,314293.0,CHEMBL625441,Autocuration,
A,0,BAO_0000218,Bioavailability in rat (dose 10 mg/kg i.d.),13357,Rattus norvegicus,22224,,,,,U,12187,,,,,In vivo,1,10116.0,CHEMBL625442,Autocuration,
A,1,BAO_0000218,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",13358,Rattus norvegicus,50597,,,,,N,12187,,,,,In vivo,1,10116.0,CHEMBL625443,Intermediate,
A,0,BAO_0000218,Bioavailability was determined; extremely poor,13359,,22224,,,,,U,17431,,,,,In vivo,1,,CHEMBL625444,Autocuration,
A,1,BAO_0000218,% bioavailability in mice after oral administration of prodrug,13360,Mus musculus,50594,,,,,N,13318,,,,,In vivo,1,10090.0,CHEMBL625445,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,13361,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625446,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,13362,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL882960,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,13363,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625447,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,13364,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625448,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,13365,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625449,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),13366,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL874589,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,13367,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625450,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,13368,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625451,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,13369,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626584,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,13370,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626585,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,13371,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626586,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,13372,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626587,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,13373,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626588,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,13374,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626589,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,13375,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626590,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,13376,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL626591,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,13377,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL627181,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,13378,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628083,Intermediate,
A,0,BAO_0000218,IV clearance determined at an peroral dose of 15 mg/kg.,13379,,22224,,,,,U,15173,,,,,In vivo,1,,CHEMBL628084,Autocuration,
F,1,BAO_0000218,Mouse oral clearance was measured against Hymenolepiasis nana.,13380,Hymenolepis nana,50064,,,,,N,7732,,,,,In vivo,1,102285.0,CHEMBL628085,Expert,
F,1,BAO_0000218,Mouse oral clearance was measured against Nematospiroides dubius,13381,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL628086,Expert,
F,0,BAO_0000218,Mouse oral clearance was measured against N. dubius; NT is Not Tested,13382,,22224,,,,,U,7732,,,,,In vivo,1,,CHEMBL628087,Autocuration,
A,1,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,13383,Mus musculus,50594,,,,,N,7732,,,,,In vivo,1,10090.0,CHEMBL628088,Intermediate,
B,0,BAO_0000218,Mouse oral clearance was measured against N. nana; NT is Not Tested,13384,,22224,,,,,U,7732,,,,,In vivo,1,,CHEMBL628089,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,13385,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL628090,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,13386,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL628091,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,13387,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL628092,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,13388,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL628093,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,13389,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL875607,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,13390,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL625710,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,13391,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL625711,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,13392,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL625712,Autocuration,
A,0,BAO_0000218,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,13393,,22224,,,,,U,8328,,,,,In vivo,1,,CHEMBL625713,Autocuration,
A,1,BAO_0000218,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,13394,Canis lupus familiaris,50588,,,,,N,13376,,,,,In vivo,1,9615.0,CHEMBL625714,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,13395,Macaca mulatta,50797,,,,,N,13477,,,,,In vivo,1,9544.0,CHEMBL625715,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,13396,Rattus norvegicus,50597,,,,,N,13477,,,,,In vivo,1,10116.0,CHEMBL625716,Intermediate,
A,1,BAO_0000218,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,13397,Rattus norvegicus,50597,,,,,N,13477,,,,,In vivo,1,10116.0,CHEMBL625717,Intermediate,
A,1,BAO_0000218,Plasma clearance was determined for the compound in rats,13398,Rattus norvegicus,50597,,,,,N,13313,,,,,In vivo,1,10116.0,CHEMBL625718,Intermediate,
A,1,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,13399,Rattus norvegicus,50597,,,,,N,12504,,,,,In vivo,1,10116.0,CHEMBL625719,Intermediate,
A,1,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,13400,Rattus norvegicus,50597,,,,,N,12504,,,,,In vivo,1,10116.0,CHEMBL625720,Intermediate,
A,1,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,13401,Rattus norvegicus,50597,,,,,N,12504,,,,,In vivo,1,10116.0,CHEMBL625721,Intermediate,
A,1,BAO_0000218,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,13402,Rattus norvegicus,50597,,,,,N,12504,,,,,In vivo,1,10116.0,CHEMBL625722,Intermediate,
A,1,BAO_0000218,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,13403,Rattus norvegicus,50597,,,,,N,13129,,,,,In vivo,1,10116.0,CHEMBL625723,Intermediate,
A,1,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,13404,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL625724,Intermediate,
A,1,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,13405,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL625725,Intermediate,
A,1,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,13406,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL625726,Intermediate,
A,1,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,13407,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL875608,Intermediate,
A,1,BAO_0000218,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,13408,Heligmosomoides polygyrus,50545,,,,,N,7732,,,,,In vivo,1,6339.0,CHEMBL625727,Intermediate,
A,0,BAO_0000218,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,13409,Rattus norvegicus,22224,,,Urine,,U,9278,,,,1088.0,In vivo,1,10116.0,CHEMBL625728,Autocuration,
A,0,BAO_0000218,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13410,Rattus norvegicus,22224,,,,,U,9278,,,,,In vivo,1,10116.0,CHEMBL625729,Autocuration,
A,0,BAO_0000218,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,13411,Rattus norvegicus,22224,,,,,U,9278,,,,,In vivo,1,10116.0,CHEMBL625730,Autocuration,
A,0,BAO_0000218,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,13412,Rattus norvegicus,22224,,,Urine,,U,9278,,,,1088.0,In vivo,1,10116.0,CHEMBL625731,Autocuration,
A,0,BAO_0000218,Urinary clearance was determined in rat at 25 mg/kg os dosage,13413,Rattus norvegicus,22224,,,Urine,,U,9278,,,,1088.0,In vivo,1,10116.0,CHEMBL626417,Autocuration,
A,1,BAO_0000218,Urinary clearance was determined at 100 mg/kg oral dosage in human,13414,Homo sapiens,50587,,,Urine,,N,9278,,,,1088.0,In vivo,1,9606.0,CHEMBL626418,Intermediate,
A,1,BAO_0000218,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,13415,Canis lupus familiaris,50588,,,Urine,,N,9278,,,,1088.0,In vivo,1,9615.0,CHEMBL626419,Intermediate,
A,1,BAO_0000218,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,13416,Canis lupus familiaris,50588,,,Plasma,,N,5932,,,,1969.0,In vivo,1,9615.0,CHEMBL626592,Intermediate,
A,1,BAO_0000218,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,13417,Rattus norvegicus,50597,,,Plasma,,N,5932,,,,1969.0,In vivo,1,10116.0,CHEMBL626593,Intermediate,
A,1,BAO_0000218,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,13418,Rattus norvegicus,50597,,,,,N,5182,,,,,In vivo,1,10116.0,CHEMBL626594,Intermediate,
A,1,BAO_0000218,Clearance rate in dogs,13419,Canis lupus familiaris,50588,,,,,N,10499,,,,,In vivo,1,9615.0,CHEMBL625035,Intermediate,
A,0,BAO_0000019,Compound was measured for intrinsic clearance,13420,,22224,,,,,U,6051,,,,,In vitro,1,,CHEMBL625036,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13421,,22229,,,,,U,17508,,,,,,1,,CHEMBL625037,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13422,,22229,,,,,U,6228,,,,,,1,,CHEMBL625038,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13423,,22229,,,,,U,6231,,,,,,1,,CHEMBL625039,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13424,,22229,,,,,U,17740,,,,,,1,,CHEMBL625040,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13425,,22229,,,,,U,6495,,,,,,1,,CHEMBL625041,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13426,,22229,,,,,U,2171,,,,,,1,,CHEMBL625042,Autocuration,
A,0,BAO_0000019,Partition coefficient of the compound,13427,,22224,,,,,U,3255,,,,,,1,,CHEMBL874411,Autocuration,
A,0,BAO_0000019,Permeability,13428,,22224,,,,,U,6821,,,,,,1,,CHEMBL625043,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13429,,22229,,,,,U,2685,,,,,,1,,CHEMBL625044,Autocuration,
A,0,BAO_0000019,Partition coefficient (logD),13430,,22224,,,,,U,17584,,,,,,1,,CHEMBL625045,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13431,,22229,,,,,U,13824,,,,,,1,,CHEMBL625046,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13432,,22229,,,,,U,13824,,,,,,1,,CHEMBL625047,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13433,,22229,,,,,U,16479,,,,,,1,,CHEMBL625048,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13434,,22229,,,,,U,11997,,,,,,1,,CHEMBL625049,Autocuration,
P,0,BAO_0000100,Calculated logarithm of partition coefficient (P) was determined,13435,,22229,,,,,U,2988,,,,,,1,,CHEMBL625050,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13436,,22229,,,,,U,931,,,,,,1,,CHEMBL625051,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13437,,22229,,,,,U,4381,,,,,,1,,CHEMBL874412,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13438,,22229,,,,,U,4397,,,,,,1,,CHEMBL625052,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13439,,22229,,,,,U,5889,,,,,,1,,CHEMBL625053,Autocuration,
A,0,BAO_0000019,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,13440,,22224,,,,,U,6154,,,,,,1,,CHEMBL623250,Autocuration,
A,0,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,13441,,22224,,,,,U,6154,,,,,,1,,CHEMBL623251,Autocuration,
A,0,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,13442,,22224,,,,,U,6154,,,,,,1,,CHEMBL623252,Autocuration,
A,0,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,13443,,22224,,,,,U,6154,,,,,,1,,CHEMBL623253,Autocuration,
A,0,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,13444,,22224,,,,,U,6154,,,,,,1,,CHEMBL623254,Autocuration,
A,0,BAO_0000019,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,13445,,22224,,,,,U,6154,,,,,,1,,CHEMBL623255,Autocuration,
A,0,BAO_0000019,Percent degradation of compound at a pH of 1 over a 18 hr period,13446,,22224,,,,,U,6887,,,,,,1,,CHEMBL626831,Autocuration,
A,0,BAO_0000019,Percent degradation of compound at pH of 1 over an 18 hr period,13447,,22224,,,,,U,6887,,,,,,1,,CHEMBL877494,Autocuration,
A,0,BAO_0000019,Delta Logarithm of Partition Coefficient value was determined.,13448,,22224,,,,,U,14116,,,,,,1,,CHEMBL626832,Autocuration,
A,0,BAO_0000019,Delta logPoct-cyc,13449,,22224,,,,,U,11137,,,,,,1,,CHEMBL626833,Autocuration,
P,0,BAO_0000100,Lipophilicity estimated on reversed phase TLC,13450,,22224,,,,,U,7230,,,,,,1,,CHEMBL626834,Autocuration,
A,0,BAO_0000019,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,13451,,22224,,,,,U,15741,,,,,,1,,CHEMBL626835,Autocuration,
A,0,BAO_0000019,Delta logPoct-cyc,13452,,22224,,,,,U,9663,,,,,,1,,CHEMBL626836,Autocuration,
P,0,BAO_0000100,Change in logarithm of partition coefficient of the compound,13453,,22229,,,,,U,9663,,,,,,1,,CHEMBL626837,Autocuration,
A,0,BAO_0000019,Delta logD (pH 6.5),13454,,22224,,,,,U,13807,,,,,,1,,CHEMBL626838,Autocuration,
P,0,BAO_0000100,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",13455,,22224,,,,,U,13807,,,,,,1,,CHEMBL626839,Autocuration,
A,0,BAO_0000019,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,13456,,22224,,,,,U,17425,,,,,,1,,CHEMBL626840,Autocuration,
A,0,BAO_0000019,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),13457,,22224,,,,,U,12143,,,,,,1,,CHEMBL626841,Autocuration,
A,0,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,13458,,22224,,,,,U,12608,,,,,,1,,CHEMBL626842,Autocuration,
A,0,BAO_0000219,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,13459,,22224,,,,,U,12608,,,,,,1,,CHEMBL626843,Autocuration,
A,1,BAO_0000218,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,13460,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL626844,Intermediate,
A,1,BAO_0000218,Amount of deuterium retained was reported after normal workup in rats,13461,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL877495,Intermediate,
A,1,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,13462,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL626845,Intermediate,
A,1,BAO_0000218,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,13463,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL626846,Intermediate,
A,1,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13464,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL626847,Intermediate,
A,1,BAO_0000218,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,13465,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL628677,Intermediate,
A,1,BAO_0000218,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,13466,Rattus norvegicus,50597,,,,,N,8649,,,,,,1,10116.0,CHEMBL628678,Intermediate,
A,0,BAO_0000019,Compound was subjected to electrochemical oxidation,13467,,22224,,,,,U,9659,,,,,,1,,CHEMBL628679,Autocuration,
A,0,BAO_0000019,Compound was subjected to photochemical oxidation,13468,,22224,,,,,U,9659,,,,,,1,,CHEMBL628680,Autocuration,
A,0,BAO_0000019,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,13469,,22224,,,,,U,9659,,,,,,1,,CHEMBL628681,Autocuration,
A,0,BAO_0000019,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,13470,,22224,,,,,U,9659,,,,,,1,,CHEMBL628682,Autocuration,
A,0,BAO_0000019,Oxidation of compound by methemoglobin in presence of hydroperoxide,13471,,22224,,,,,U,9659,,,,,,1,,CHEMBL628683,Autocuration,
A,1,BAO_0000218,Percent diffusion through fuzzy rat skin after 48 h of incubation,13472,Rattus norvegicus,50597,,,,,N,9607,,,,,,1,10116.0,CHEMBL628684,Intermediate,
P,0,BAO_0000100,Dissociation constant (pKa),13473,,22229,,,,,U,7057,,,,,,1,,CHEMBL877501,Autocuration,
P,0,BAO_0000100,Dissociation constant value of the compound; ND means not determined.,13474,,22224,,,,,U,7057,,,,,,1,,CHEMBL628685,Autocuration,
A,1,BAO_0000218,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,13475,Rattus norvegicus,50597,,,Blood,,N,7911,,,,178.0,,1,10116.0,CHEMBL628686,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13476,Rattus norvegicus,50597,,,Blood,,N,7911,,,,178.0,,1,10116.0,CHEMBL628687,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,13477,Rattus norvegicus,50597,,,,,N,7911,,,,,,1,10116.0,CHEMBL628688,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13478,Rattus norvegicus,50597,,,,,N,7911,,,,,,1,10116.0,CHEMBL628689,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,13479,Rattus norvegicus,50597,,,Liver,,N,7911,,,,2107.0,,1,10116.0,CHEMBL628690,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13480,Rattus norvegicus,50597,,,Liver,,N,7911,,,,2107.0,,1,10116.0,CHEMBL629363,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,13481,Rattus norvegicus,50597,,,Spleen,,N,7911,,,,2106.0,,1,10116.0,CHEMBL629364,Intermediate,
A,1,BAO_0000218,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13482,Rattus norvegicus,50597,,,Spleen,,N,7911,,,,2106.0,,1,10116.0,CHEMBL629365,Intermediate,
A,1,BAO_0000218,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,13483,Rattus norvegicus,50597,,,,,N,7911,,,,,,1,10116.0,CHEMBL629366,Intermediate,
A,1,BAO_0000218,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,13484,Rattus norvegicus,50597,,,Urine,,N,7911,,,,1088.0,,1,10116.0,CHEMBL629367,Intermediate,
A,1,BAO_0000218,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,13485,Rattus norvegicus,50597,,,Feces,,N,7911,,,,1988.0,,1,10116.0,CHEMBL629368,Intermediate,
A,1,BAO_0000218,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,13486,Rattus norvegicus,50597,,,Urine,,N,7911,,,,1088.0,,1,10116.0,CHEMBL877502,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,13487,Mus musculus,50594,,,Cerebellum,,N,13792,,,,2037.0,,1,10090.0,CHEMBL629369,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,13488,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL629370,Intermediate,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",13489,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL629371,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13490,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL626276,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13491,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL626277,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13492,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL631250,Autocuration,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13493,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631251,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",13494,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631252,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",13495,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631253,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",13496,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631254,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13497,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631255,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",13498,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631256,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",13499,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL631257,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",13500,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628009,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",13501,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628010,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13502,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628011,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",13503,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628012,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",13504,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628013,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",13505,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628014,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",13506,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628015,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",13507,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628016,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",13508,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL874461,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",13509,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628017,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",13510,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628018,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",13511,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628019,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",13512,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628020,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",13513,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628021,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",13514,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628022,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",13515,Canis lupus familiaris,50588,,,Urine,,N,8133,,,,1088.0,,1,9615.0,CHEMBL628023,Intermediate,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",13516,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL628024,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",13517,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL628025,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",13518,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL628026,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",13519,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL628027,Autocuration,
A,0,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",13520,Simiiformes,22224,,,Urine,,U,8133,,,,1088.0,,1,314293.0,CHEMBL628028,Autocuration,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",13521,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628029,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",13522,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628030,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",13523,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628031,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",13524,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628032,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",13525,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628033,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",13526,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628034,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",13527,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628035,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",13528,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL628036,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",13529,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL874462,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,13530,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628037,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,13531,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628123,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,13532,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628124,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,13533,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628125,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,13534,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628126,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),13535,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628127,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,13536,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628128,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,13537,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628129,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,13538,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628130,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,13539,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628131,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,13540,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628132,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,13541,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628133,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,13542,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628134,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,13543,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628135,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,13544,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628136,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,13545,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628137,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,13546,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628138,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,13547,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628139,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,13548,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628140,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,13549,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628141,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,13550,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628142,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,13551,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628143,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,13552,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628144,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,13553,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628145,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,13554,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL628146,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,13555,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625355,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,13556,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625356,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,13557,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625357,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,13558,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625527,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),13559,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL875473,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,13560,Canis lupus familiaris,50588,,,,,N,9025,,,,,In vivo,1,9615.0,CHEMBL625528,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,13561,Rattus norvegicus,50597,,,,,N,9025,,,,,In vivo,1,10116.0,CHEMBL626304,Intermediate,
A,1,BAO_0000218,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,13562,Canis lupus familiaris,50588,,,Artery,,N,9025,,,,1637.0,In vivo,1,9615.0,CHEMBL624138,Intermediate,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13563,,22229,,,,,U,6448,,,,,,1,,CHEMBL624139,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13564,,22229,,,,,U,17221,,,,,,1,,CHEMBL624140,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13565,,22229,,,,,U,6545,,,,,,1,,CHEMBL624141,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13566,,22229,,,,,U,577,,,,,,1,,CHEMBL624142,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13567,,22229,,,,,U,6285,,,,,,1,,CHEMBL624143,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13568,,22229,,,,,U,6500,,,,,,1,,CHEMBL624144,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13569,,22229,,,,,U,6716,,,,,,1,,CHEMBL624145,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13570,,22229,,,,,U,13658,,,,,,1,,CHEMBL624146,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13571,,22229,,,,,U,6549,,,,,,1,,CHEMBL624147,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (MacLogP),13572,,22229,,,,,U,14685,,,,,,1,,CHEMBL883123,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),13573,,22224,,,,,U,6893,,,,,,1,,CHEMBL624148,Autocuration,
A,0,BAO_0000019,Kinetic parameter was determined,13574,,22224,,,,,U,3687,,,,,,1,,CHEMBL874416,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13575,,22229,,,,,U,4207,,,,,,1,,CHEMBL624149,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13576,,22229,,,,,U,4626,,,,,,1,,CHEMBL624150,Autocuration,
P,0,BAO_0000100,Lipophilicity was determined,13577,,22224,,,,,U,1021,,,,,,1,,CHEMBL624151,Autocuration,
P,0,BAO_0000100,Lipophilicity was determined,13578,,22224,,,,,U,3777,,,,,,1,,CHEMBL624152,Autocuration,
P,0,BAO_0000100,Lipophilicity was determined,13579,,22224,,,,,U,17533,,,,,,1,,CHEMBL622139,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13580,,22229,,,,,U,6524,,,,,,1,,CHEMBL622140,Autocuration,
P,0,BAO_0000100,Lipophilicity was determined,13581,,22224,,,,,U,17533,,,,,,1,,CHEMBL622141,Autocuration,
P,0,BAO_0000100,Lipophilicity in octanol-water,13582,,22224,,,,,U,6480,,,,,,1,,CHEMBL622142,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13583,,22229,,,,,U,17606,,,,,,1,,CHEMBL622143,Autocuration,
P,0,BAO_0000100,Octanol-water partition coefficient was determined,13584,,22229,,,,,U,6863,,,,,,1,,CHEMBL622144,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),13585,,22224,,,,,U,1356,,,,,,1,,CHEMBL877473,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13586,,22229,,,,,U,3326,,,,,,1,,CHEMBL622145,Autocuration,
A,0,BAO_0000019,Partition coefficient was determined; ND means not determined,13587,,22224,,,,,U,1356,,,,,,1,,CHEMBL622146,Autocuration,
P,0,BAO_0000100,Calculated partition coefficient (clogP),13588,,22229,,,,,U,12984,,,,,,1,,CHEMBL622147,Autocuration,
A,0,BAO_0000019,Partition coefficient of the compound,13589,,22224,,,,,U,17363,,,,,,1,,CHEMBL622148,Autocuration,
A,0,BAO_0000019,Permeability was determined,13590,,22224,,,,,U,6827,,,,,,1,,CHEMBL883124,Autocuration,
P,0,BAO_0000100,The compound was evaluated for the partition coefficient,13591,,22229,,,,,U,261,,,,,,1,,CHEMBL622149,Autocuration,
A,0,BAO_0000019,Partition coefficient (logP),13592,,22224,,,,,U,2685,,,,,,1,,CHEMBL622150,Autocuration,
P,0,BAO_0000100,The lipophilicity was reported,13593,,22224,,,,,U,414,,,,,,1,,CHEMBL622151,Autocuration,
P,0,BAO_0000100,logarithm of the octanol-water partition coefficient for the compound,13594,,22229,,,,,U,15769,,,,,,1,,CHEMBL622152,Autocuration,
A,0,BAO_0000019,Clogp value was determined,13595,,22224,,,,,U,17248,,,,,,1,,CHEMBL622153,Autocuration,
A,0,BAO_0000218,Clp at a dose of 1.5 mg/kg,13596,,22224,,,,,U,16935,,,,,In vivo,1,,CHEMBL877474,Autocuration,
A,0,BAO_0000218,Clp at a dose of 2.0 mg/kg,13597,,22224,,,,,U,16935,,,,,In vivo,1,,CHEMBL622154,Autocuration,
A,0,BAO_0000218,"Clp, plasma clearance at a dose of 10 mg/kg",13598,,22224,,,Plasma,,U,14832,,,,1969.0,In vivo,1,,CHEMBL622155,Autocuration,
A,0,BAO_0000218,"Clp, plasma clearance at a dose of 50 mg/kg",13599,,22224,,,Plasma,,U,14832,,,,1969.0,In vivo,1,,CHEMBL622156,Autocuration,
A,1,BAO_0000218,Compound was tested for plasma clearance in rat,13600,Rattus norvegicus,50597,,,Plasma,,N,2399,,,,1969.0,In vivo,1,10116.0,CHEMBL622157,Intermediate,
A,1,BAO_0000218,Compound was tested for plasma clearance in rat; Not determined,13601,Rattus norvegicus,50597,,,Plasma,,N,2399,,,,1969.0,In vivo,1,10116.0,CHEMBL622158,Intermediate,
A,1,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,13602,Rattus norvegicus,50597,,,,,N,6227,,,,,In vivo,1,10116.0,CHEMBL622807,Intermediate,
A,1,BAO_0000218,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,13603,Macaca mulatta,50797,,,,,N,6227,,,,,In vivo,1,9544.0,CHEMBL622808,Intermediate,
A,0,BAO_0000218,Plasma clearance by iv administration at a dose 0.003 ug/mL,13604,,22224,,,,,U,5623,,,,,In vivo,1,,CHEMBL622809,Autocuration,
A,0,BAO_0000218,Plasma clearance determined,13605,,22224,,,,,U,4854,,,,,In vivo,1,,CHEMBL622810,Autocuration,
A,1,BAO_0000218,Plasma clearance after iv administration at 3 mg/kg in hamster,13606,Cricetinae,100712,,,,,N,4493,,,,,In vivo,1,10026.0,CHEMBL876653,Intermediate,
A,1,BAO_0000218,Plasma clearance after iv administration at 4 mg/kg in hamster,13607,Cricetinae,100712,,,,,N,4493,,,,,In vivo,1,10026.0,CHEMBL622811,Intermediate,
A,1,BAO_0000218,Rate of clearance in rat was determined,13608,Rattus norvegicus,50597,,,,,N,14956,,,,,In vivo,1,10116.0,CHEMBL622986,Intermediate,
A,1,BAO_0000218,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,13609,Rattus norvegicus,50597,,,Plasma,,N,15372,,,,1969.0,In vivo,1,10116.0,CHEMBL622987,Intermediate,
A,1,BAO_0000218,Total plasma clearance after iv dose of 5.10 mg/kg in rats,13610,Rattus norvegicus,50597,,,Plasma,,N,15372,,,,1969.0,In vivo,1,10116.0,CHEMBL622988,Intermediate,
A,1,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,13611,Rattus norvegicus,50597,,,Plasma,,N,15372,,,,1969.0,In vivo,1,10116.0,CHEMBL622989,Intermediate,
A,1,BAO_0000218,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,13612,Rattus norvegicus,50597,,,Plasma,,N,15372,,,,1969.0,In vivo,1,10116.0,CHEMBL622990,Intermediate,
A,0,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,13613,Simiiformes,22224,,,Plasma,,U,15604,,,,1969.0,In vivo,1,314293.0,CHEMBL622991,Autocuration,
A,1,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,13614,Rattus norvegicus,50597,,,Plasma,,N,15604,,,,1969.0,In vivo,1,10116.0,CHEMBL622227,Intermediate,
A,1,BAO_0000218,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,13615,Canis lupus familiaris,50588,,,Plasma,,N,15604,,,,1969.0,In vivo,1,9615.0,CHEMBL622228,Intermediate,
A,1,BAO_0000218,Clpl value in rat,13616,Rattus norvegicus,50597,,,,,N,14964,,,,,In vivo,1,10116.0,CHEMBL622229,Intermediate,
A,1,BAO_0000218,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,13617,Cavia porcellus,50512,,,,,N,15240,,,,,In vivo,1,10141.0,CHEMBL622230,Intermediate,
A,1,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,13618,Rattus norvegicus,50597,,,,,N,16449,,,,,In vivo,1,10116.0,CHEMBL622231,Intermediate,
A,1,BAO_0000218,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,13619,Macaca fascicularis,100710,,,,,N,16449,,,,,In vivo,1,9541.0,CHEMBL622232,Intermediate,
A,0,BAO_0000218,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,13620,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622233,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,13621,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622234,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,13622,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622235,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,13623,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622236,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,13624,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622237,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a po dose of 10.0(pmol/g/h).,13625,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL877482,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a po dose of 20.0(pmol/g/h).,13626,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622238,Autocuration,
A,0,BAO_0000218,Cmax in minutes at a po dose of 40.0(pmol/g/h).,13627,,22224,,,,,U,12902,,,,,In vivo,1,,CHEMBL622239,Autocuration,
A,0,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood,13628,,22224,,,Blood,,U,11149,,,,178.0,In vivo,1,,CHEMBL622240,Autocuration,
A,0,BAO_0000218,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,13629,,22224,,,Blood,,U,11149,,,,178.0,In vivo,1,,CHEMBL622241,Autocuration,
A,1,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rat,13630,Rattus norvegicus,50597,,,,,N,5669,,,,,In vivo,1,10116.0,CHEMBL631013,Intermediate,
A,1,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in Rhesus,13631,Macaca mulatta,50797,,,,,N,5669,,,,,In vivo,1,9544.0,CHEMBL631014,Intermediate,
A,1,BAO_0000218,Cmax was determine after peroral administration at 10 mpk in dog,13632,Canis lupus familiaris,50588,,,,,N,5669,,,,,In vivo,1,9615.0,CHEMBL631015,Intermediate,
A,1,BAO_0000218,Cmax was determine after peroral administration at 160 mpk in Rat,13633,Rattus norvegicus,50597,,,,,N,5669,,,,,In vivo,1,10116.0,CHEMBL631016,Intermediate,
A,1,BAO_0000218,Cmax was determine after peroral administration at 20 mpk in Rat,13634,Rattus norvegicus,50597,,,,,N,5669,,,,,In vivo,1,10116.0,CHEMBL631017,Intermediate,
A,1,BAO_0000218,Cmax was determine after peroral administration at 50 mpk in Rat,13635,Rattus norvegicus,50597,,,,,N,5669,,,,,In vivo,1,10116.0,CHEMBL631018,Intermediate,
A,0,BAO_0000218,Cmax was determined,13636,,22224,,,,,U,4236,,,,,In vivo,1,,CHEMBL631019,Autocuration,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,13637,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL875761,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,13638,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL631020,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,13639,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL631669,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,13640,Mus musculus,50594,,,Brain,,N,13792,,,,955.0,,1,10090.0,CHEMBL631670,Intermediate,
A,1,BAO_0000218,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,13641,Mus musculus,50594,,,Striatum,,N,13792,,,,2435.0,,1,10090.0,CHEMBL631671,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,13642,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631672,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,13643,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631673,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,13644,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631856,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,13645,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631857,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,13646,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631858,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,13647,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631859,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,13648,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631860,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,13649,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631861,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,13650,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631862,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,13651,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631863,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,13652,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631864,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,13653,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631865,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,13654,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL631866,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,13655,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL629360,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,13656,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL629361,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,13657,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL629362,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,13658,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL630740,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,13659,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL630741,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,13660,Rattus norvegicus,50597,,,Blood,,N,8418,,,,178.0,,1,10116.0,CHEMBL630742,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,13661,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630743,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,13662,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630744,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,13663,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630745,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,13664,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630746,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,13665,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630747,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,13666,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL630748,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,13667,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632056,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,13668,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632057,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,13669,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632058,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,13670,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632059,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,13671,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632060,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,13672,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL632061,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,13673,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629207,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,13674,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629208,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,13675,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629209,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,13676,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629210,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,13677,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629211,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,13678,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629212,Intermediate,
A,1,BAO_0000218,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,13679,Rattus norvegicus,50597,,,,,N,8418,,,,,,1,10116.0,CHEMBL629213,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",13680,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629214,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",13681,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL629215,Intermediate,
A,1,BAO_0000218,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",13682,Rattus norvegicus,50597,,,Urine,,N,8133,,,,1088.0,,1,10116.0,CHEMBL635154,Intermediate,
A,1,BAO_0000218,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13683,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629216,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,13684,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629217,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13685,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629218,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),13686,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629219,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),13687,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629220,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),13688,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL629221,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),13689,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631127,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,13690,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631128,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13691,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631129,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),13692,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631130,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),13693,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631131,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),13694,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631132,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),13695,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631133,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,13696,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631134,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13697,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL875120,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),13698,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631135,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),13699,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631136,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),13700,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631137,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),13701,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631138,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,13702,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631139,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13703,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631140,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),13704,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631141,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),13705,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631142,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),13706,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631143,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),13707,Rattus norvegicus,50597,,,,,N,6996,,,,,,1,10116.0,CHEMBL631144,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,13708,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631145,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),13709,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631146,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,13710,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631147,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),13711,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631148,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),13712,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631149,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),13713,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631150,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),13714,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631151,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),13715,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631152,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),13716,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631443,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),13717,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631444,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),13718,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631445,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),13719,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631446,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),13720,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631447,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),13721,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631448,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,13722,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631449,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),13723,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL631450,Intermediate,
A,1,BAO_0000218,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),13724,Canis lupus familiaris,50588,,,,,N,6996,,,,,,1,9615.0,CHEMBL629724,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13725,Mus musculus,50594,,,Zone of skin,,N,9716,,,,14.0,In vivo,1,10090.0,CHEMBL629725,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13726,Mus musculus,50594,,,Zone of skin,,N,9716,,,,14.0,In vivo,1,10090.0,CHEMBL629726,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13727,Mus musculus,50594,,,Spleen,,N,9716,,,,2106.0,In vivo,1,10090.0,CHEMBL629727,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13728,Mus musculus,50594,,,Spleen,,N,9716,,,,2106.0,In vivo,1,10090.0,CHEMBL630404,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13729,Mus musculus,50594,,,Spleen,,N,9716,,,,2106.0,In vivo,1,10090.0,CHEMBL630405,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13730,Mus musculus,50594,,,Spleen,,N,9716,,,,2106.0,In vivo,1,10090.0,CHEMBL630406,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13731,Mus musculus,50594,,,Stomach,,N,9716,,,,945.0,In vivo,1,10090.0,CHEMBL630407,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13732,Mus musculus,50594,,,Stomach,,N,9716,,,,945.0,In vivo,1,10090.0,CHEMBL630573,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13733,Mus musculus,50594,,,Stomach,,N,9716,,,,945.0,In vivo,1,10090.0,CHEMBL630574,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13734,Mus musculus,50594,,,Stomach,,N,9716,,,,945.0,In vivo,1,10090.0,CHEMBL630575,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13735,Mus musculus,50594,,,,,N,9716,,,,,In vivo,1,10090.0,CHEMBL630576,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13736,Mus musculus,50594,,,,,N,9716,,,,,In vivo,1,10090.0,CHEMBL630577,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13737,Mus musculus,50594,,,,,N,9716,,,,,In vivo,1,10090.0,CHEMBL630578,Intermediate,
A,1,BAO_0000218,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",13738,Mus musculus,50594,,,,,N,9716,,,,,In vivo,1,10090.0,CHEMBL630579,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),13739,Mus musculus,50594,,,Kidney,,N,12192,,,,2113.0,,1,10090.0,CHEMBL630580,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,13740,Mus musculus,50594,,,Kidney,,N,12192,,,,2113.0,,1,10090.0,CHEMBL630581,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),13741,Mus musculus,50594,,,Kidney,,N,12192,,,,2113.0,,1,10090.0,CHEMBL630582,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,13742,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630583,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),13743,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630584,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,13744,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630585,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),13745,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630586,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,13746,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630587,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),13747,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630588,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,13748,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630589,Intermediate,
A,1,BAO_0000218,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),13749,Mus musculus,50594,,,,,N,12192,,,,,,1,10090.0,CHEMBL630590,Intermediate,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 h,13750,,22224,,,Feces,,U,12192,,,,1988.0,,1,,CHEMBL630591,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),13751,,22224,,,Feces,,U,12192,,,,1988.0,,1,,CHEMBL630592,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,13752,,22224,,,,,U,12192,,,,,,1,,CHEMBL630593,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),13753,,22224,,,,,U,12192,,,,,,1,,CHEMBL630594,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),13754,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630595,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),13755,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630596,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 h,13756,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630597,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),13757,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630598,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 h,13758,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630599,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),13759,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630600,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 h,13760,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630601,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),13761,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630602,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),13762,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630603,Autocuration,
A,0,BAO_0000019,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),13763,,22224,,,Urine,,U,12192,,,,1088.0,,1,,CHEMBL630604,Autocuration,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13764,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL624869,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13765,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL624870,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13766,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL623189,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13767,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL623190,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13768,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL623191,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13769,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL623192,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13770,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL623193,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13771,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL623194,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13772,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL623195,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13773,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL623196,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,13774,Rattus norvegicus,50597,,,,,N,11836,,,,,,1,10116.0,CHEMBL623197,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13775,Rattus norvegicus,50597,,,,,N,11836,,,,,,1,10116.0,CHEMBL623198,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13776,Rattus norvegicus,50597,,,,,N,11836,,,,,,1,10116.0,CHEMBL623199,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,13777,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623200,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,13778,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623201,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,13779,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623202,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,13780,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623203,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,13781,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623204,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,13782,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623205,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13783,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623206,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,13784,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623207,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,13785,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623208,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13786,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623209,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,13787,Rattus norvegicus,50597,,,Muscle tissue,,N,11836,,,,2385.0,,1,10116.0,CHEMBL623210,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,13788,Rattus norvegicus,50597,,,,,N,11836,,,,,,1,10116.0,CHEMBL623211,Intermediate,
A,1,BAO_0000218,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,13789,Rattus norvegicus,50597,,,Uterus,,N,11836,,,,995.0,,1,10116.0,CHEMBL623212,Intermediate,
A,0,BAO_0000019,Tested in vitro for intrinsic activity relative to quinpirole,13790,,22224,,,,,U,12640,,,,,,1,,CHEMBL623213,Autocuration,
A,0,BAO_0000019,"Relative ion enhancement, determined in pulsed ultrafiltration",13791,,22224,,,,,U,14218,,,,,,1,,CHEMBL623214,Autocuration,
A,0,BAO_0000019,% ionization at the pH 7.4 at 37 degree Centigrade,13792,,22224,,,,,U,11296,,,,,,1,,CHEMBL623215,Autocuration,
A,0,BAO_0000019,Percentage ionization was measured,13793,,22224,,,,,U,10929,,,,,,1,,CHEMBL623216,Autocuration,
A,1,BAO_0000218,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,13794,Bos taurus,50591,,,,,N,13841,,,,,,1,9913.0,CHEMBL623217,Intermediate,
A,0,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,13795,,22224,,,,,U,10431,,,,,,1,,CHEMBL623218,Autocuration,
A,0,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,13796,,22224,,,,,U,10431,,,,,,1,,CHEMBL623913,Autocuration,
A,0,BAO_0000019,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,13797,,22224,,,,,U,10431,,,,,,1,,CHEMBL623914,Autocuration,
P,0,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water,13798,,22229,,,,,U,8826,,,,,,1,,CHEMBL623915,Autocuration,
P,0,BAO_0000100,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),13799,,22229,,,,,U,8826,,,,,,1,,CHEMBL624080,Autocuration,
A,0,BAO_0000019,Equilibrium constant measured by the pulse radiolysis at pH 7,13800,,22224,,,,,U,9884,,,,,,1,,CHEMBL624081,Autocuration,
A,1,BAO_0000218,In vitro hydrolytic rate constant determined in human blood,13801,Homo sapiens,50587,,,,,N,9827,,,,,,1,9606.0,CHEMBL624082,Intermediate,
A,1,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,13802,Homo sapiens,50587,,,,,N,10009,,,,,,1,9606.0,CHEMBL625054,Intermediate,
A,0,BAO_0000019,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,13803,,22224,,,,,U,10009,,,,,,1,,CHEMBL877485,Autocuration,
A,1,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,13804,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625055,Intermediate,
A,1,BAO_0000218,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,13805,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625056,Intermediate,
A,1,BAO_0000218,In vitro oxidation of compound in presence of human plasma,13806,Homo sapiens,50587,,,,,N,10009,,,,,,1,9606.0,CHEMBL625057,Intermediate,
A,0,BAO_0000019,In vitro oxidation of compound in presence of hydrogen peroxide,13807,,22224,,,,,U,10009,,,,,,1,,CHEMBL625058,Autocuration,
A,1,BAO_0000218,In vitro oxidation of compound in presence of mouse brain homogenate,13808,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL625059,Intermediate,
A,1,BAO_0000218,In vitro oxidation of compound in presence of mouse liver homogenate,13809,Mus musculus,50594,,,,,N,10009,,,,,,1,10090.0,CHEMBL629536,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,13810,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629537,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,13811,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629538,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,13812,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629539,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,13813,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL874445,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,13814,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629540,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,13815,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629541,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,13816,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629542,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,13817,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630243,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,13818,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630244,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,13819,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630245,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,13820,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630246,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,13821,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630247,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,13822,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630248,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood at 240 minutes after dose administration.,13823,Rattus norvegicus,50597,,,Blood,,N,13100,,,,178.0,In vivo,1,10116.0,CHEMBL630249,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood at 30 minutes after dose administration.,13824,Rattus norvegicus,50597,,,Blood,,N,13100,,,,178.0,In vivo,1,10116.0,CHEMBL630250,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood at 360 minutes after dose administration.,13825,Rattus norvegicus,50597,,,Blood,,N,13100,,,,178.0,In vivo,1,10116.0,CHEMBL630251,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood at 3 hr after dose administration.,13826,Rattus norvegicus,50597,,,Blood,,N,13100,,,,178.0,In vivo,1,10116.0,CHEMBL630252,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood at 60 minutes after dose administration.,13827,Rattus norvegicus,50597,,,Blood,,N,13100,,,,178.0,In vivo,1,10116.0,CHEMBL630408,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 120 minutes after dose administration.,13828,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630409,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,13829,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL874446,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 15 minutes after dose administration.,13830,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630410,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 240 minutes after dose administration.,13831,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630411,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 30 minutes after dose administration.,13832,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630412,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 360 minutes after dose administration.,13833,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630413,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 3 hr after dose administration.,13834,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630414,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cerebellum at 60 minutes after dose administration.,13835,Rattus norvegicus,50597,,,Cerebellum,,N,13100,,,,2037.0,In vivo,1,10116.0,CHEMBL630415,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 120 minutes after dose administration.,13836,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630416,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 1440 minutes after dose administration.,13837,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630417,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 15 minutes after dose administration.,13838,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630418,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 240 minutes after dose administration.,13839,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630419,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 30 minutes after dose administration.,13840,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630420,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 360 minutes after dose administration.,13841,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630421,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 3 hr after dose administration.,13842,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630422,Intermediate,
A,1,BAO_0000218,Biodistribution in rat cortex at 60 minutes after dose administration.,13843,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL630423,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 120 minutes after dose administration.,13844,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL630424,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 15 minutes after dose administration.,13845,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL630425,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 240 minutes after dose administration.,13846,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL629462,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 30 minutes after dose administration.,13847,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL630426,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 360 minutes after dose administration.,13848,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL630427,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 3 hr after dose administration.,13849,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL625877,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart at 60 minutes after dose administration.,13850,Rattus norvegicus,50597,,,Heart,,N,13100,,,,948.0,In vivo,1,10116.0,CHEMBL625878,Intermediate,
A,1,BAO_0000218,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,13851,Rattus norvegicus,50597,,,Hippocampus,,N,13100,,,,10000000.0,In vivo,1,10116.0,CHEMBL625879,Intermediate,
A,1,BAO_0000218,Biodistribution in rat hippocampus at 240 minutes after dose administration.,13852,Rattus norvegicus,50597,,,Hippocampus,,N,13100,,,,10000000.0,In vivo,1,10116.0,CHEMBL625880,Intermediate,
A,1,BAO_0000218,Biodistribution in rat hippocampus at 30 minutes after dose administration.,13853,Rattus norvegicus,50597,,,Hippocampus,,N,13100,,,,10000000.0,In vivo,1,10116.0,CHEMBL625881,Intermediate,
A,1,BAO_0000218,Biodistribution in rat hippocampus at 360 minutes after dose administration.,13854,Rattus norvegicus,50597,,,Hippocampus,,N,13100,,,,10000000.0,In vivo,1,10116.0,CHEMBL625882,Intermediate,
A,1,BAO_0000218,Biodistribution in rat hippocampus at 15 minutes after dose administration.,13855,Rattus norvegicus,50597,,,Hippocampus,,N,13100,,,,10000000.0,In vivo,1,10116.0,CHEMBL625883,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 120 minutes after dose administration.,13856,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL625884,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 1440 minutes after dose administration.,13857,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL625885,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 15 minutes after dose administration.,13858,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL628649,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 240 minutes after dose administration.,13859,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL628650,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 30 minutes after dose administration.,13860,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL628651,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 360 minutes after dose administration.,13861,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL628652,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney at 60 minutes after dose administration.,13862,Rattus norvegicus,50597,,,Kidney,,N,13100,,,,2113.0,In vivo,1,10116.0,CHEMBL628653,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 120 minutes after dose administration.,13863,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL628654,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 1440 minutes after dose administration.,13864,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL628655,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 15 minutes after dose administration.,13865,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL625238,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 240 minutes after dose administration.,13866,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL625239,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 30 minutes after dose administration.,13867,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL625240,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 360 minutes after dose administration.,13868,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL625241,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver at 60 minutes after dose administration.,13869,Rattus norvegicus,50597,,,Liver,,N,13100,,,,2107.0,In vivo,1,10116.0,CHEMBL625242,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 120 minutes after dose administration.,13870,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL874587,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 1440 minutes after dose administration.,13871,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL625405,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 15 minutes after dose administration.,13872,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL625406,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 240 minutes after dose administration.,13873,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL625407,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 30 minutes after dose administration.,13874,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL625408,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung at 360 minutes after dose administration.,13875,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL625409,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,13876,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625410,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,13877,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625411,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,13878,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625412,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,13879,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625413,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound in rat thoracic aorta strips v,13880,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625414,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,13881,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625415,Intermediate,
A,1,BAO_0000218,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,13882,Rattus norvegicus,50597,,,Thoracic aorta,,N,12361,,,,1515.0,,1,10116.0,CHEMBL625416,Intermediate,
A,1,BAO_0000218,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,13883,Rattus norvegicus,50597,,,Urine,,N,12712,,,,1088.0,,1,10116.0,CHEMBL625417,Intermediate,
A,1,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,13884,Rattus norvegicus,50597,,,Feces,,N,7415,,,,1988.0,,1,10116.0,CHEMBL625418,Intermediate,
A,1,BAO_0000218,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,13885,Rattus norvegicus,50597,,,Urine,,N,7415,,,,1088.0,,1,10116.0,CHEMBL625419,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,13886,Rattus norvegicus,50597,,,,,N,7415,,,,,,1,10116.0,CHEMBL625420,Intermediate,
A,1,BAO_0000218,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,13887,Rattus norvegicus,50597,,,,,N,7415,,,,,,1,10116.0,CHEMBL626996,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",13888,Rattus norvegicus,50597,,,Feces,,N,7415,,,,1988.0,,1,10116.0,CHEMBL626997,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",13889,Rattus norvegicus,50597,,,Urine,,N,7415,,,,1088.0,,1,10116.0,CHEMBL626998,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",13890,Rattus norvegicus,50597,,,,,N,7415,,,,,,1,10116.0,CHEMBL626999,Intermediate,
A,1,BAO_0000218,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,13891,Mus musculus,50594,,,,,N,8050,,,,,,1,10090.0,CHEMBL627000,Intermediate,
A,1,BAO_0000218,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,13892,Mus musculus,50594,,,,,N,8050,,,,,,1,10090.0,CHEMBL627001,Intermediate,
A,1,BAO_0000218,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,13893,Mus musculus,50594,,,,,N,8050,,,,,,1,10090.0,CHEMBL627002,Intermediate,
A,1,BAO_0000218,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,13894,Mus musculus,50594,,,,,N,8050,,,,,,1,10090.0,CHEMBL627003,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,13895,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627004,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,13896,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627005,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,13897,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL874594,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,13898,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627006,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,13899,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627007,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,13900,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627884,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,13901,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627885,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,13902,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627886,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,13903,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627887,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,13904,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627888,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,13905,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL628057,Intermediate,
A,1,BAO_0000218,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,13906,Mus musculus,50594,,,Urine,,N,8050,,,,1088.0,,1,10090.0,CHEMBL627405,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,13907,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627406,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,13908,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627407,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,13909,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627408,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,13910,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627409,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,13911,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL875486,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,13912,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627410,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,13913,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627411,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,13914,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627412,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,13915,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627413,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,13916,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627414,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,13917,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627415,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,13918,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627416,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,13919,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627417,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,13920,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627418,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,13921,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627419,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,13922,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627320,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,13923,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627321,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13924,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL627322,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13925,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL627323,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13926,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL627491,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13927,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL627492,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13928,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL627493,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13929,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL627494,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13930,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL627495,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13931,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL627496,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13932,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL627497,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13933,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL627498,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13934,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL627499,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13935,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL627500,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13936,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL627501,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13937,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL625616,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13938,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL625617,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13939,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL625618,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13940,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL625619,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13941,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL625620,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13942,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL625621,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13943,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL625622,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13944,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL625788,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13945,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL625789,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13946,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL625790,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13947,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL625791,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13948,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL622334,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13949,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL622335,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13950,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL622336,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13951,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL622337,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13952,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL622338,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13953,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL622339,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13954,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL624153,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13955,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL628430,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),13956,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL628431,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13957,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL628432,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,13958,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL628433,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13959,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL628434,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13960,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL626789,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",13961,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL626790,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13962,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL626791,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13963,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL626792,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",13964,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL626793,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,13965,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627436,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,13966,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627437,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,13967,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627438,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,13968,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627439,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,13969,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627440,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,13970,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627602,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,13971,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627603,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,13972,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627604,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,13973,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627605,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,13974,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627606,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,13975,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627607,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,13976,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627608,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,13977,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627609,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,13978,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627610,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,13979,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627611,Intermediate,
A,1,BAO_0000218,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,13980,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL627612,Intermediate,
P,0,BAO_0000100,Octanol:water partition coefficient is evaluated,13981,,22229,,,,,U,8362,,,,,,1,,CHEMBL627613,Autocuration,
P,0,BAO_0000100,Partition coefficient in 1-octanol/water system,13982,,22224,,,,,U,8257,,,,,,1,,CHEMBL627614,Autocuration,
P,0,BAO_0000100,Partition coefficient in 1-octanol/water system measured using radio active compounds,13983,,22224,,,,,U,8257,,,,,,1,,CHEMBL627615,Autocuration,
P,0,BAO_0000100,Partition coefficient in octanol/water system was determined,13984,,22224,,,,,U,9468,,,,,,1,,CHEMBL627616,Autocuration,
P,0,BAO_0000100,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,13985,,22224,,,,,U,9468,,,,,,1,,CHEMBL627617,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,13986,,22224,,,,,U,10568,,,,,,1,,CHEMBL627618,Autocuration,
A,0,BAO_0000019,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",13987,,22224,,,,,U,10568,,,,,,1,,CHEMBL627619,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant of the compound,13988,,22224,,,,,U,15359,,,,,,1,,CHEMBL627620,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant with 1-min time point,13989,,22224,,,,,U,15359,,,,,,1,,CHEMBL627621,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant without 1-min time point,13990,,22224,,,,,U,15359,,,,,,1,,CHEMBL627622,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,13991,,22224,,,,,U,10431,,,,,,1,,CHEMBL627623,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,13992,,22224,,,,,U,10431,,,,,,1,,CHEMBL627624,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,13993,,22224,,,,,U,10431,,,,,,1,,CHEMBL627625,Autocuration,
A,0,BAO_0000019,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,13994,,22224,,,,,U,15704,,,,,,1,,CHEMBL628523,Autocuration,
A,0,BAO_0000019,The alkaline hydrolysis second order rate constant(K OH) of the compound,13995,,22224,,,,,U,15287,,,,,,1,,CHEMBL628524,Autocuration,
A,0,BAO_0000019,The efflux rate constant of the compound,13996,,22224,,,,,U,7516,,,,,,1,,CHEMBL628525,Autocuration,
A,0,BAO_0000019,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13997,,22224,,,,,U,12973,,,,,,1,,CHEMBL625732,Autocuration,
A,0,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13998,,22224,,,,,U,12973,,,,,,1,,CHEMBL625733,Autocuration,
F,0,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,13999,,22224,,,,,U,12973,,,,,,1,,CHEMBL625734,Autocuration,
A,0,BAO_0000019,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,14000,,22224,,,,,U,12973,,,,,,1,,CHEMBL625913,Autocuration,
A,0,BAO_0000019,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,14001,,22224,,,,,U,8696,,,,,,1,,CHEMBL625914,Autocuration,
A,0,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,14002,,22224,,,,,U,15052,,,,,,1,,CHEMBL625915,Autocuration,
A,0,BAO_0000019,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,14003,,22224,,,,,U,15052,,,,,,1,,CHEMBL625916,Autocuration,
A,0,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),14004,,22224,,,,,U,10503,,,,,,1,,CHEMBL625917,Autocuration,
A,0,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14005,,22224,,,,,U,8354,,,,,,1,,CHEMBL625918,Autocuration,
A,0,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14006,,22224,,,,,U,8354,,,,,,1,,CHEMBL625919,Autocuration,
A,0,BAO_0000019,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14007,,22224,,,,,U,8354,,,,,,1,,CHEMBL625920,Autocuration,
A,0,BAO_0000019,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14008,,22224,,,,,U,8354,,,,,,1,,CHEMBL874453,Autocuration,
A,0,BAO_0000019,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",14009,,22224,,,,,U,8354,,,,,,1,,CHEMBL625921,Autocuration,
A,0,BAO_0000019,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,14010,,22224,,,,,U,10503,,,,,,1,,CHEMBL625922,Autocuration,
A,0,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",14011,,22224,,,,,U,8354,,,,,,1,,CHEMBL625923,Autocuration,
A,0,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",14012,,22224,,,,,U,8354,,,,,,1,,CHEMBL625924,Autocuration,
A,0,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",14013,,22224,,,,,U,8354,,,,,,1,,CHEMBL625925,Autocuration,
A,0,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",14014,,22224,,,,,U,8354,,,,,,1,,CHEMBL625926,Autocuration,
A,1,BAO_0000218,Biodistribution in rat lung at 60 minutes after dose administration.,14015,Rattus norvegicus,50597,,,Lung,,N,13100,,,,2048.0,In vivo,1,10116.0,CHEMBL627704,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,14016,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL627705,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,14017,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL627706,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,14018,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL627707,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,14019,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL627708,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,14020,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL628361,Intermediate,
A,1,BAO_0000218,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,14021,Rattus norvegicus,50597,,,,,N,13100,,,,,In vivo,1,10116.0,CHEMBL628362,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 120 minutes after dose administration.,14022,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628363,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 1440 minutes after dose administration.,14023,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628364,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 15 minutes after dose administration.,14024,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628365,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 240 minutes after dose administration.,14025,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL874454,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 30 minutes after dose administration.,14026,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628531,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 360 minutes after dose administration.,14027,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628532,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 3 hr after dose administration.,14028,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628533,Intermediate,
A,1,BAO_0000218,Biodistribution in rat striatum at 60 minutes after dose administration.,14029,Rattus norvegicus,50597,,,Striatum,,N,13100,,,,2435.0,In vivo,1,10116.0,CHEMBL628534,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 120 minutes after dose administration.,14030,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL628535,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 1440 minutes after dose administration.,14031,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL628536,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 15 minutes after dose administration.,14032,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL628537,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 240 minutes after dose administration.,14033,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL628538,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 30 minutes after dose administration.,14034,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL628539,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 360 minutes after dose administration.,14035,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL630297,Intermediate,
A,1,BAO_0000218,Biodistribution in rat thyroid at 60 minutes after dose administration.,14036,Rattus norvegicus,50597,,,Thyroid gland,,N,13100,,,,2046.0,In vivo,1,10116.0,CHEMBL630298,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat 120 minutes after dose administration.,14037,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL630299,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,14038,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL628094,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,14039,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL628095,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,14040,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL874648,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,14041,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL628096,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,14042,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL628097,Intermediate,
A,1,BAO_0000218,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,14043,Rattus norvegicus,50597,,,Brain,,N,13100,,,,955.0,In vivo,1,10116.0,CHEMBL628098,Intermediate,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",14044,,22224,,,,,U,13331,,,,,,1,,CHEMBL628099,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14045,,22224,,,,,U,13331,,,,,,1,,CHEMBL628100,Autocuration,
A,0,BAO_0000019,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),14046,,22224,,,,,U,13331,,,,,,1,,CHEMBL628101,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",14047,,22224,,,,,U,13331,,,,,,1,,CHEMBL628102,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",14048,,22224,,,,,U,13331,,,,,,1,,CHEMBL628103,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",14049,,22224,,,,,U,13331,,,,,,1,,CHEMBL628104,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",14050,,22224,,,,,U,13331,,,,,,1,,CHEMBL628105,Autocuration,
A,0,BAO_0000019,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",14051,,22224,,,,,U,13331,,,,,,1,,CHEMBL628106,Autocuration,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14052,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL628107,Intermediate,
F,0,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,14053,,22224,,,Urine,,U,10086,,,,1088.0,,1,,CHEMBL628108,Autocuration,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14054,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL628109,Intermediate,
F,0,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,14055,,22224,,,Urine,,U,10086,,,,1088.0,,1,,CHEMBL625299,Autocuration,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,14056,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL625300,Intermediate,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,14057,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL625301,Intermediate,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,14058,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL625302,Intermediate,
A,1,BAO_0000218,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,14059,Rattus norvegicus,50597,,,Urine,,N,10086,,,,1088.0,,1,10116.0,CHEMBL874649,Intermediate,
A,1,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,14060,Rattus norvegicus,50597,,,,,N,13248,,,,,,1,10116.0,CHEMBL625303,Intermediate,
A,1,BAO_0000218,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,14061,Rattus norvegicus,50597,,,,,N,13248,,,,,,1,10116.0,CHEMBL625463,Intermediate,
A,1,BAO_0000218,In vitro metabolism in human liver microsomes,14062,Homo sapiens,50587,,,Liver,,N,14527,,,,2107.0,,1,9606.0,CHEMBL625464,Intermediate,
A,1,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,14063,Homo sapiens,50587,,,,,N,3008,,,,,,1,9606.0,CHEMBL625465,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14064,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625466,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14065,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625467,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14066,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625468,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,14067,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625469,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,14068,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625470,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,14069,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL632418,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,14070,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627250,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,14071,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627251,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,14072,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627252,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,14073,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627253,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,14074,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627254,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,14075,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875471,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,14076,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627255,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,14077,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627256,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,14078,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627257,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,14079,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627258,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,14080,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627259,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,14081,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627260,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,14082,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623256,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,14083,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL874413,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,14084,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623257,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,14085,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623258,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,14086,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623259,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,14087,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623260,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,14088,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623261,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,14089,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623262,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,14090,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623263,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,14091,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623264,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,14092,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623265,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,14093,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623266,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,14094,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623267,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,14095,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623268,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,14096,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623269,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,14097,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623270,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,14098,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623271,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,14099,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623272,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,14100,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623273,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,14101,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623274,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,14102,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL874414,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,14103,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623275,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,14104,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL629150,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,14105,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623276,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,14106,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623277,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,14107,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623112,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,14108,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623113,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,14109,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623800,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,14110,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623801,Intermediate,
A,1,BAO_0000218,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",14111,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL623802,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14112,Rattus norvegicus,50597,,,Uterus,,N,12017,,,,995.0,In vivo,1,10116.0,CHEMBL623803,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14113,Rattus norvegicus,50597,,,Uterus,,N,12017,,,,995.0,In vivo,1,10116.0,CHEMBL623970,Intermediate,
A,1,BAO_0000218,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14114,Rattus norvegicus,50597,,,Uterus,,N,12017,,,,995.0,In vivo,1,10116.0,CHEMBL623971,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),14115,Rattus norvegicus,50597,,,Blood,,N,14045,,,,178.0,In vivo,1,10116.0,CHEMBL623972,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),14116,Rattus norvegicus,50597,,,Blood,,N,14045,,,,178.0,In vivo,1,10116.0,CHEMBL623973,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),14117,Rattus norvegicus,50597,,,Blood,,N,14045,,,,178.0,In vivo,1,10116.0,CHEMBL623974,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),14118,Rattus norvegicus,50597,,,Blood,,N,14045,,,,178.0,In vivo,1,10116.0,CHEMBL623975,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),14119,Rattus norvegicus,50597,,,Brain,,N,14045,,,,955.0,In vivo,1,10116.0,CHEMBL623976,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),14120,Rattus norvegicus,50597,,,Brain,,N,14045,,,,955.0,In vivo,1,10116.0,CHEMBL623977,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),14121,Rattus norvegicus,50597,,,Brain,,N,14045,,,,955.0,In vivo,1,10116.0,CHEMBL623978,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),14122,Rattus norvegicus,50597,,,Brain,,N,14045,,,,955.0,In vivo,1,10116.0,CHEMBL623979,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),14123,Rattus norvegicus,50597,,,,,N,14045,,,,,In vivo,1,10116.0,CHEMBL623980,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),14124,Rattus norvegicus,50597,,,,,N,14045,,,,,In vivo,1,10116.0,CHEMBL623981,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),14125,Rattus norvegicus,50597,,,,,N,14045,,,,,In vivo,1,10116.0,CHEMBL626278,Intermediate,
A,1,BAO_0000218,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),14126,Rattus norvegicus,50597,,,,,N,14045,,,,,In vivo,1,10116.0,CHEMBL626279,Intermediate,
A,1,BAO_0000218,Biodistribution in mice bladder plus excreted urine was determined,14127,Mus musculus,50594,,,,,N,14045,,,,,In vivo,1,10090.0,CHEMBL626280,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse blood, 10 minutes post injection",14128,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626281,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse blood, 30 minutes post injection",14129,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626282,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse blood, 5 minutes post injection",14130,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626283,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse blood, 60 minutes post injection",14131,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626284,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse brain, 10 minutes post injection",14132,Mus musculus,50594,,,Brain,,N,14045,,,,955.0,,1,10090.0,CHEMBL626285,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse brain, 30 minutes post injection",14133,Mus musculus,50594,,,Brain,,N,14045,,,,955.0,,1,10090.0,CHEMBL626286,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse brain, 5 minutes post injection",14134,Mus musculus,50594,,,Brain,,N,14045,,,,955.0,,1,10090.0,CHEMBL626287,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse brain, 60 minutes post injection",14135,Mus musculus,50594,,,Brain,,N,14045,,,,955.0,,1,10090.0,CHEMBL626288,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse heart, 10 minutes post injection",14136,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626289,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse heart, 30 minutes post injection",14137,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626290,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse heart, 5 minutes post injection",14138,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL626291,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse heart, 60 minutes post injection",14139,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL839888,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse intestine, 10 minutes post injection",14140,Mus musculus,50594,,,Intestine,,N,14045,,,,160.0,,1,10090.0,CHEMBL626292,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse intestine, 30 minutes post injection",14141,Mus musculus,50594,,,Intestine,,N,14045,,,,160.0,,1,10090.0,CHEMBL626293,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse intestine, 5 minutes post injection",14142,Mus musculus,50594,,,Intestine,,N,14045,,,,160.0,,1,10090.0,CHEMBL626294,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse intestine, 60 minutes post injection",14143,Mus musculus,50594,,,Intestine,,N,14045,,,,160.0,,1,10090.0,CHEMBL626295,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse liver, 10 minutes post injection",14144,Mus musculus,50594,,,Liver,,N,14045,,,,2107.0,,1,10090.0,CHEMBL627659,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse liver, 30 minutes of post injection",14145,Mus musculus,50594,,,Liver,,N,14045,,,,2107.0,,1,10090.0,CHEMBL627660,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse liver, 5 minutes post injection",14146,Mus musculus,50594,,,Liver,,N,14045,,,,2107.0,,1,10090.0,CHEMBL627661,Intermediate,
A,1,BAO_0000218,Biodistribution in mice liver at 60 minutes of post injection,14147,Mus musculus,50594,,,Liver,,N,14045,,,,2107.0,In vivo,1,10090.0,CHEMBL627662,Intermediate,
A,1,BAO_0000218,Biodistribution in mice lungs at 10 min of post injection,14148,Mus musculus,50594,,,Lung,,N,14045,,,,2048.0,In vivo,1,10090.0,CHEMBL627663,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mouse lung, 30 minutes post injection",14149,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL627664,Intermediate,
A,1,BAO_0000218,"Percentage biodistribution in mousee lung, 5 minutes post injection",14150,Mus musculus,50594,,,,,N,14045,,,,,,1,10090.0,CHEMBL627665,Intermediate,
A,1,BAO_0000218,Biodistribution in mice lungs at 60 min of post injection,14151,Mus musculus,50594,,,Lung,,N,14045,,,,2048.0,In vivo,1,10090.0,CHEMBL627666,Intermediate,
A,1,BAO_0000218,Percentage biodistribution in mouse spleen,14152,Mus musculus,50594,,,Spleen,,N,14045,,,,2106.0,,1,10090.0,CHEMBL627667,Intermediate,
A,1,BAO_0000218,Percentage biodistribution in mouse stomach,14153,Mus musculus,50594,,,Stomach,,N,14045,,,,945.0,,1,10090.0,CHEMBL627668,Intermediate,
A,1,BAO_0000218,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,14154,Mus musculus,50594,,,Urine,,N,11745,,,,1088.0,,1,10090.0,CHEMBL627669,Intermediate,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,14155,,22224,,,Urinary bladder,,U,13257,,,,1255.0,In vivo,1,,CHEMBL627670,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,14156,,22224,,,Blood,,U,13257,,,,178.0,In vivo,1,,CHEMBL627671,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,14157,,22224,,,Bone element,,U,13257,,,,1474.0,In vivo,1,,CHEMBL627672,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,14158,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL627673,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,14159,,22224,,,Kidney,,U,13257,,,,2113.0,In vivo,1,,CHEMBL627674,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,14160,,22224,,,Liver,,U,13257,,,,2107.0,In vivo,1,,CHEMBL627675,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,14161,,22224,,,Lung,,U,13257,,,,2048.0,In vivo,1,,CHEMBL627676,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,14162,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627677,Autocuration,
A,0,BAO_0000019,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",14163,,22224,,,,,U,8354,,,,,,1,,CHEMBL627678,Autocuration,
A,1,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum,14164,Rattus norvegicus,50597,,,Serum,,N,7095,,,,1977.0,,1,10116.0,CHEMBL627679,Intermediate,
A,0,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14165,,22224,,,,,U,12185,,,,,,1,,CHEMBL627680,Autocuration,
A,0,BAO_0000019,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14166,,22224,,,,,U,12185,,,,,,1,,CHEMBL627681,Autocuration,
A,0,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,14167,,22224,,,,,U,12185,,,,,,1,,CHEMBL627682,Autocuration,
A,0,BAO_0000019,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,14168,,22224,,,,,U,12185,,,,,,1,,CHEMBL627683,Autocuration,
A,0,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,14169,,22224,,,,,U,12686,,,,,,1,,CHEMBL627684,Autocuration,
A,0,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14170,,22224,,,,,U,12686,,,,,,1,,CHEMBL874441,Autocuration,
A,0,BAO_0000019,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,14171,,22224,,,,,U,12686,,,,,,1,,CHEMBL627685,Autocuration,
A,0,BAO_0000019,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",14172,,22224,,,,,U,12686,,,,,,1,,CHEMBL627686,Autocuration,
A,0,BAO_0000019,Apparent rate constant Koff for inactivation of dTMP synthase.,14173,,22224,,,,,U,8057,,,,,,1,,CHEMBL627687,Autocuration,
A,0,BAO_0000019,The irreversible inhibitor activity by second order rate equation.,14174,,22224,,,,,U,15778,,,,,,1,,CHEMBL627688,Autocuration,
A,1,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,14175,Rattus norvegicus,50597,,,,,N,12375,,,,,,1,10116.0,CHEMBL628038,Intermediate,
A,1,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,14176,Rattus norvegicus,50597,,,,,N,12375,,,,,,1,10116.0,CHEMBL628039,Intermediate,
A,1,BAO_0000218,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,14177,Rattus norvegicus,50597,,,,,N,12375,,,,,,1,10116.0,CHEMBL628040,Intermediate,
A,0,BAO_0000019,Dissociation rate calculated from the first-order equation using t1/2 value,14178,,22224,,,,,U,13588,,,,,,1,,CHEMBL628041,Autocuration,
A,0,BAO_0000019,The compound was tested for Binding constant against DNA,14179,,22224,,,,,U,15039,,,,,,1,,CHEMBL630226,Autocuration,
A,0,BAO_0000019,First order rate constant for cyclization of the compound,14180,,22224,,,,,U,9500,,,,,,1,,CHEMBL628042,Autocuration,
A,0,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14181,,22224,,,,,U,10014,,,,,,1,,CHEMBL625232,Autocuration,
A,0,BAO_0000019,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14182,,22224,,,,,U,10014,,,,,,1,,CHEMBL625233,Autocuration,
A,0,BAO_0000019,Hydrolysis rate constant was determined,14183,,22224,,,,,U,568,,,,,,1,,CHEMBL625979,Autocuration,
A,0,BAO_0000019,Observed first order rate constant,14184,,22224,,,,,U,10026,,,,,,1,,CHEMBL625980,Autocuration,
A,0,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14185,,22224,,,,,U,10281,,,,,,1,,CHEMBL625981,Autocuration,
A,0,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14186,,22224,,,,,U,10281,,,,,,1,,CHEMBL625982,Autocuration,
A,0,BAO_0000019,Second-order rate constant for attack on PNPA at 25 degree Centigrade,14187,,22224,,,,,U,9680,,,,,,1,,CHEMBL625983,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14188,,22224,,,,,U,13028,,,,,,1,,CHEMBL625984,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14189,,22224,,,,,U,13028,,,,,,1,,CHEMBL625985,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14190,,22224,,,,,U,13028,,,,,,1,,CHEMBL625986,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14191,,22224,,,,,U,13028,,,,,,1,,CHEMBL625987,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14192,,22224,,,,,U,13028,,,,,,1,,CHEMBL625988,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14193,,22224,,,,,U,13028,,,,,,1,,CHEMBL625989,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14194,,22224,,,,,U,13028,,,,,,1,,CHEMBL625990,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14195,,22224,,,,,U,13028,,,,,,1,,CHEMBL625991,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14196,,22224,,,,,U,13028,,,,,,1,,CHEMBL625992,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14197,,22224,,,,,U,13028,,,,,,1,,CHEMBL625993,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14198,,22224,,,,,U,13028,,,,,,1,,CHEMBL631973,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14199,,22224,,,,,U,13028,,,,,,1,,CHEMBL632143,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14200,,22224,,,,,U,13028,,,,,,1,,CHEMBL632144,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14201,,22224,,,,,U,13028,,,,,,1,,CHEMBL632145,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14202,,22224,,,,,U,13028,,,,,,1,,CHEMBL632146,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14203,,22224,,,,,U,13028,,,,,,1,,CHEMBL632147,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14204,,22224,,,,,U,13028,,,,,,1,,CHEMBL632148,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14205,,22224,,,,,U,13028,,,,,,1,,CHEMBL632149,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14206,,22224,,,,,U,13028,,,,,,1,,CHEMBL632150,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14207,,22224,,,,,U,13028,,,,,,1,,CHEMBL632151,Autocuration,
A,1,BAO_0000218,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,14208,Homo sapiens,50587,,,,,N,3008,,,,,,1,9606.0,CHEMBL632152,Intermediate,
A,1,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14209,Homo sapiens,50587,,,,,N,4509,,,,,,1,9606.0,CHEMBL632153,Intermediate,
A,1,BAO_0000218,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,14210,Homo sapiens,50587,,,,,N,4509,,,,,,1,9606.0,CHEMBL632154,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,14211,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632155,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,14212,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632156,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,14213,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632157,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,14214,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632158,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,14215,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL632159,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,14216,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626305,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,14217,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626306,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,14218,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626307,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,14219,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626308,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,14220,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626479,Intermediate,
A,1,BAO_0000218,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,14221,Human herpesvirus 1,50602,,,,,N,8613,,,,,,1,10298.0,CHEMBL626480,Intermediate,
P,0,BAO_0000100,Calculated partition coefficient (clogP) (MlogP),14222,,22229,,,,,U,6021,,,,,,1,,CHEMBL626481,Autocuration,
A,0,BAO_0000019,Equipotent potent ratio relative to carbachol (nicotinic activity),14223,,22224,,,,,U,9348,,,,,,1,,CHEMBL626482,Autocuration,
A,1,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",14224,Canis lupus familiaris,50588,,,,,N,15592,,,,,,1,9615.0,CHEMBL626483,Intermediate,
A,1,BAO_0000218,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",14225,Canis lupus familiaris,50588,,,,,N,15592,,,,,,1,9615.0,CHEMBL626484,Intermediate,
P,0,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes available,14226,,22229,,,,,U,15592,,,,,,1,,CHEMBL626485,Autocuration,
P,0,BAO_0000100,Solubility at pH 7.4 in micro g/mL;NA denotes not available,14227,,22229,,,,,U,15592,,,,,,1,,CHEMBL626486,Autocuration,
P,0,BAO_0000100,Solubility at pH 7.4 in ug/mL;NA denotes not available,14228,,22229,,,,,U,15592,,,,,,1,,CHEMBL626487,Autocuration,
A,1,BAO_0000218,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,14229,Canis lupus familiaris,50588,,,Plasma,,N,15592,,,,1969.0,In vivo,1,9615.0,CHEMBL626488,Intermediate,
A,1,BAO_0000218,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,14230,Rattus norvegicus,50597,,,Serum,,N,7095,,,,1977.0,,1,10116.0,CHEMBL626489,Intermediate,
A,0,BAO_0000019,Area under the MAP curve measured over 5 min; ND means Not determined,14231,,22224,,,,,U,16618,,,,,,1,,CHEMBL626490,Autocuration,
P,0,BAO_0000100,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,14232,,22224,,,,,U,16835,,,,,,1,,CHEMBL626491,Autocuration,
P,0,BAO_0000100,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,14233,,22229,,,,,U,15284,,,,,,1,,CHEMBL626492,Autocuration,
A,0,BAO_0000019,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,14234,,22224,,,,,U,15750,,,,,,1,,CHEMBL626493,Autocuration,
A,1,BAO_0000218,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,14235,Rattus norvegicus,50597,,,,,N,16618,,,,,In vivo,1,10116.0,CHEMBL626494,Intermediate,
A,0,BAO_0000218,Half life after oral tested,14236,,22224,,,,,U,16618,,,,,In vivo,1,,CHEMBL626495,Autocuration,
A,1,BAO_0000218,Half life was determined in plasma of rat; NT indicates not tested,14237,Rattus norvegicus,50597,,,Plasma,,N,15812,,,,1969.0,,1,10116.0,CHEMBL626496,Intermediate,
A,1,BAO_0000218,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,14238,Rattus norvegicus,50597,,,,,N,16618,,,,,In vivo,1,10116.0,CHEMBL626497,Intermediate,
A,0,BAO_0000218,Oral bioavailability after oral tested,14239,,22224,,,,,U,16618,,,,,In vivo,1,,CHEMBL626498,Autocuration,
A,1,BAO_0000218,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),14240,Rattus norvegicus,50597,,,,,N,13098,,,,,,1,10116.0,CHEMBL626499,Intermediate,
A,1,BAO_0000218,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),14241,Rattus norvegicus,50597,,,,,N,13098,,,,,,1,10116.0,CHEMBL626500,Intermediate,
A,1,BAO_0000218,half life was determined in plasma of rat; NT indicates not tested,14242,Rattus norvegicus,50597,,,Plasma,,N,15812,,,,1969.0,,1,10116.0,CHEMBL626501,Intermediate,
A,1,BAO_0000218,half life was determined in plasma of rat; NT means not tested,14243,Rattus norvegicus,50597,,,Plasma,,N,15812,,,,1969.0,,1,10116.0,CHEMBL626502,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,14244,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626503,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); inactive,14245,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626504,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,14246,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626505,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,14247,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626506,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,14248,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626507,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,14249,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626508,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,14250,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626509,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,14251,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL875480,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,14252,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626510,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,14253,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626511,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,14254,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL626512,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,14255,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628208,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,14256,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628209,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,14257,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628210,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,14258,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628211,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,14259,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628212,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,14260,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL628213,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,14261,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628214,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,14262,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628215,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,14263,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628216,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,14264,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626595,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,14265,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626596,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,14266,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626597,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,14267,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626598,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,14268,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622242,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,14269,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622243,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,14270,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622244,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,14271,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622245,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,14272,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622246,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,14273,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622247,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,14274,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622248,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,14275,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL877483,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,14276,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL622249,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14277,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622250,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14278,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622251,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14279,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622252,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14280,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622253,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14281,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622254,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14282,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622255,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14283,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622256,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14284,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622257,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14285,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622258,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14286,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622259,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14287,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622927,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14288,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622928,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14289,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL622929,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,14290,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL623182,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14291,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL623183,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,14292,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623184,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14293,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623185,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14294,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL877484,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14295,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL627274,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,14296,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623186,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,14297,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623187,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14298,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL623188,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,14299,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628055,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14300,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628056,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,14301,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628200,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14302,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628201,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,14303,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628202,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14304,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628203,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,14305,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628204,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14306,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628205,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,14307,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628206,Intermediate,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),14308,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL628207,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,14309,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627220,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,14310,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627221,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),14311,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627222,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,14312,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL627223,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,14313,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL632062,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,14314,,22224,,,Spleen,,U,13257,,,,2106.0,In vivo,1,,CHEMBL632063,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,14315,,22224,,,Urinary bladder,,U,13257,,,,1255.0,In vivo,1,,CHEMBL632064,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,14316,,22224,,,Blood,,U,13257,,,,178.0,In vivo,1,,CHEMBL632065,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,14317,,22224,,,Bone element,,U,13257,,,,1474.0,In vivo,1,,CHEMBL632066,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,14318,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL632067,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,14319,,22224,,,Kidney,,U,13257,,,,2113.0,In vivo,1,,CHEMBL629188,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,14320,,22224,,,Liver,,U,13257,,,,2107.0,In vivo,1,,CHEMBL629189,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,14321,,22224,,,Lung,,U,13257,,,,2048.0,In vivo,1,,CHEMBL629190,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,14322,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629191,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),14323,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629192,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,14324,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629193,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),14325,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629194,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,14326,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL629195,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,14327,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629373,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,14328,,22224,,,Spleen,,U,13257,,,,2106.0,In vivo,1,,CHEMBL629374,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,14329,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629375,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,14330,,22224,,,Urinary bladder,,U,13257,,,,1255.0,In vivo,1,,CHEMBL629376,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,14331,,22224,,,Blood,,U,13257,,,,178.0,In vivo,1,,CHEMBL629377,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,14332,,22224,,,Bone element,,U,13257,,,,1474.0,In vivo,1,,CHEMBL629378,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,14333,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL629379,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,14334,,22224,,,Kidney,,U,13257,,,,2113.0,In vivo,1,,CHEMBL629151,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,14335,,22224,,,Liver,,U,13257,,,,2107.0,In vivo,1,,CHEMBL629152,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,14336,,22224,,,Lung,,U,13257,,,,2048.0,In vivo,1,,CHEMBL629153,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,14337,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629154,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),14338,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629155,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,14339,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629156,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,14340,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629157,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),14341,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL629158,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,14342,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL629159,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,14343,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629160,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,14344,,22224,,,Spleen,,U,13257,,,,2106.0,In vivo,1,,CHEMBL629161,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,14345,,22224,,,Urinary bladder,,U,13257,,,,1255.0,In vivo,1,,CHEMBL629162,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,14346,,22224,,,Blood,,U,13257,,,,178.0,In vivo,1,,CHEMBL629163,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,14347,,22224,,,Bone element,,U,13257,,,,1474.0,In vivo,1,,CHEMBL629164,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,14348,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL629165,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,14349,,22224,,,Liver,,U,13257,,,,2107.0,In vivo,1,,CHEMBL629166,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,14350,,22224,,,Lung,,U,13257,,,,2048.0,In vivo,1,,CHEMBL629167,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,14351,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL629168,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,14352,,22224,,,,,U,2193,,,,,,1,,CHEMBL629169,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,14353,,22224,,,,,U,2193,,,,,,1,,CHEMBL629170,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,14354,,22224,,,,,U,2193,,,,,,1,,CHEMBL631153,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,14355,,22224,,,,,U,2193,,,,,,1,,CHEMBL875121,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,14356,,22224,,,,,U,2193,,,,,,1,,CHEMBL631154,Autocuration,
A,0,BAO_0000019,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,14357,,22224,,,,,U,2193,,,,,,1,,CHEMBL631155,Autocuration,
A,0,BAO_0000019,Hydrolysis rate constant was determined,14358,,22224,,,,,U,568,,,,,,1,,CHEMBL631156,Autocuration,
A,0,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",14359,,22224,,,,,U,9680,,,,,,1,,CHEMBL631157,Autocuration,
A,0,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14360,,22224,,,,,U,9680,,,,,,1,,CHEMBL631158,Autocuration,
A,0,BAO_0000019,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14361,,22224,,,,,U,9680,,,,,,1,,CHEMBL631159,Autocuration,
A,0,BAO_0000019,Observed second order rate constant,14362,,22224,,,,,U,10026,,,,,,1,,CHEMBL631160,Autocuration,
A,0,BAO_0000019,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,14363,,22224,,,,,U,10281,,,,,,1,,CHEMBL631161,Autocuration,
A,0,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,14364,,22224,,,,,U,10014,,,,,,1,,CHEMBL631162,Autocuration,
A,0,BAO_0000019,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,14365,,22224,,,,,U,10014,,,,,,1,,CHEMBL630313,Autocuration,
A,0,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",14366,,22224,,,,,U,9680,,,,,,1,,CHEMBL630314,Autocuration,
A,0,BAO_0000019,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",14367,,22224,,,,,U,9680,,,,,,1,,CHEMBL630315,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14368,,22224,,,,,U,13028,,,,,,1,,CHEMBL630316,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14369,,22224,,,,,U,13028,,,,,,1,,CHEMBL630986,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,14370,,22224,,,,,U,13028,,,,,,1,,CHEMBL630987,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,14371,,22224,,,,,U,13028,,,,,,1,,CHEMBL630988,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14372,,22224,,,,,U,13028,,,,,,1,,CHEMBL630989,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,14373,,22224,,,,,U,13028,,,,,,1,,CHEMBL630990,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,14374,,22224,,,,,U,13028,,,,,,1,,CHEMBL630991,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14375,,22224,,,,,U,13028,,,,,,1,,CHEMBL630992,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,14376,,22224,,,,,U,13028,,,,,,1,,CHEMBL630993,Autocuration,
A,0,BAO_0000019,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,14377,,22224,,,,,U,13028,,,,,,1,,CHEMBL630994,Autocuration,
A,1,BAO_0000218,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,14378,Rattus norvegicus,50597,,,,,N,10014,,,,,,1,10116.0,CHEMBL630995,Intermediate,
A,0,BAO_0000019,Association constant for compound at 31 degree C was determined,14379,,22224,,,,,U,9962,,,,,,1,,CHEMBL629252,Autocuration,
A,0,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound,14380,,22224,,,,,U,12029,,,,,,1,,CHEMBL629253,Autocuration,
A,0,BAO_0000019,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,14381,,22224,,,,,U,12029,,,,,,1,,CHEMBL629944,Autocuration,
A,1,BAO_0000218,Dissociation constants vs LTE4 on guinea pig trachea,14382,Cavia porcellus,50512,,,Trachea,,N,10583,,,,3126.0,,1,10141.0,CHEMBL629945,Intermediate,
A,0,BAO_0000019,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",14383,,22224,,,,,U,568,,,,,,1,,CHEMBL629946,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",14384,,22224,,,,,U,568,,,,,,1,,CHEMBL629947,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",14385,,22224,,,,,U,568,,,,,,1,,CHEMBL629948,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",14386,,22224,,,,,U,568,,,,,,1,,CHEMBL856024,Autocuration,
A,0,BAO_0000019,Affinity constant KD value was derived from TMP,14387,,22224,,,,,U,7493,,,,,,1,,CHEMBL629949,Autocuration,
A,0,BAO_0000019,Apparent dissociation (binding) rate constant was evaluated,14388,,22224,,,,,U,8371,,,,,,1,,CHEMBL629950,Autocuration,
P,0,BAO_0000100,Dissociation constant (KD) of the compound,14389,,22224,,,,,U,13114,,,,,,1,,CHEMBL630127,Autocuration,
P,0,BAO_0000100,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,14390,,22224,,,,,U,15515,,,,,,1,,CHEMBL630128,Autocuration,
P,0,BAO_0000100,Dissociation constant from ESR titration experiments,14391,,22224,,,,,U,522,,,,,,1,,CHEMBL630129,Autocuration,
,0,BAO_0000019,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),14392,,22224,,,,,U,13888,,,,,,1,,CHEMBL630130,Autocuration,
P,0,BAO_0000100,Dissociation constant was evaluated.,14393,,22224,,,,,U,2616,,,,,,1,,CHEMBL875234,Autocuration,
P,0,BAO_0000100,Dissociation constant was reported,14394,,22224,,,,,U,3798,,,,,,1,,CHEMBL630131,Autocuration,
A,1,BAO_0000218,Dissociation constant was determined in rat pituitary cells.,14395,Rattus norvegicus,50597,,,,,N,8731,,,,,,1,10116.0,CHEMBL630132,Intermediate,
A,0,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,14396,,22224,,,,,U,11892,,,,,,1,,CHEMBL630133,Autocuration,
A,0,BAO_0000019,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,14397,,22224,,,,,U,11892,,,,,,1,,CHEMBL630134,Autocuration,
A,0,BAO_0000019,Equilibrium dissociation constant of the compound,14398,,22224,,,,,U,2582,,,,,,1,,CHEMBL630135,Autocuration,
A,0,BAO_0000019,Equilibrium dissociation constant was determined,14399,,22224,,,,,U,11892,,,,,,1,,CHEMBL630136,Autocuration,
A,0,BAO_0000019,Kinetic constant KD was evaluated,14400,,22224,,,,,U,13396,,,,,,1,,CHEMBL630137,Autocuration,
A,0,BAO_0000019,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,14401,,22224,,,,,U,603,,,,,,1,,CHEMBL630138,Autocuration,
A,0,BAO_0000019,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,14402,,22224,,,,,U,15673,,,,,,1,,CHEMBL630139,Autocuration,
A,0,BAO_0000019,Rate constant for hydrolysis in aqueous acetone.,14403,,22224,,,,,U,10368,,,,,,1,,CHEMBL630140,Autocuration,
A,0,BAO_0000019,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,14404,,22224,,,,,U,14228,,,,,,1,,CHEMBL875235,Autocuration,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,14405,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL876439,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,14406,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630605,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,14407,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630606,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,14408,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630607,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,14409,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630608,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,14410,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630609,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,14411,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630610,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,14412,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL630611,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,14413,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629552,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,14414,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629733,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,14415,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629734,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,14416,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629735,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,14417,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629736,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,14418,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629737,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,14419,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629738,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,14420,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629739,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,14421,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629740,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,14422,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629741,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,14423,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629742,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,14424,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629743,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,14425,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629744,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,14426,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629745,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,14427,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629746,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,14428,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629747,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,14429,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629748,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,14430,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629749,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,14431,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629750,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,14432,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629751,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,14433,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629752,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,14434,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629753,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,14435,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629754,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,14436,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629755,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,14437,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629756,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,14438,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629757,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,14439,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629758,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,14440,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629759,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,14441,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL629760,Intermediate,
A,1,BAO_0000218,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,14442,Rattus norvegicus,50597,,,,,N,11510,,,,,,1,10116.0,CHEMBL876443,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,14443,Canis lupus familiaris,50588,,,,,N,8310,,,,,,1,9615.0,CHEMBL629761,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,14444,Canis lupus familiaris,50588,,,,,N,8310,,,,,,1,9615.0,CHEMBL629762,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14445,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629763,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14446,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629764,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14447,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629765,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,14448,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629766,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14449,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629767,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,14450,Canis lupus familiaris,50588,,,,,N,8310,,,,,,1,9615.0,CHEMBL629768,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,14451,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629769,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,14452,Canis lupus familiaris,50588,,,,,N,8310,,,,,,1,9615.0,CHEMBL629770,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,14453,Canis lupus familiaris,50588,,,,,N,8310,,,,,,1,9615.0,CHEMBL629771,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14454,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629772,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,14455,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL629773,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,14456,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL625455,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,14457,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL625456,Intermediate,
A,1,BAO_0000218,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,14458,Mus musculus,50594,,,,,N,8310,,,,,,1,10090.0,CHEMBL625457,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14459,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625458,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,14460,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625459,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14461,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875483,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,14462,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL634779,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,14463,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625460,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14464,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626117,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,14465,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626118,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,14466,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628342,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14467,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628343,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,14468,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628344,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14469,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628345,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,14470,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628346,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,14471,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628347,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14472,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628348,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14473,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628349,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,14474,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875611,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,14475,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628350,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14476,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628351,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,14477,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628352,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14478,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628353,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,14479,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628354,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14480,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626667,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14481,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626668,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14482,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626669,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,14483,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626670,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,14484,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626671,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14485,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626672,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,14486,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626673,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14487,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626674,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14488,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626675,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,14489,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626676,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,14490,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626677,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14491,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626678,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14492,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626679,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14493,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875612,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14494,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626680,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14495,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626681,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14496,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626682,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14497,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626683,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14498,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626684,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14499,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626685,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14500,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626686,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14501,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626687,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14502,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL624978,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14503,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL624979,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14504,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL624980,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14505,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL624981,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,14506,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL624982,Intermediate,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),14507,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627564,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),14508,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627565,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,14509,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL627566,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,14510,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627567,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,14511,,22224,,,Spleen,,U,13257,,,,2106.0,In vivo,1,,CHEMBL627568,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,14512,,22224,,,Kidney,,U,13257,,,,2113.0,In vivo,1,,CHEMBL627569,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,14513,,22224,,,Urinary bladder,,U,13257,,,,1255.0,In vivo,1,,CHEMBL627570,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,14514,,22224,,,Blood,,U,13257,,,,178.0,In vivo,1,,CHEMBL627571,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,14515,,22224,,,Bone element,,U,13257,,,,1474.0,In vivo,1,,CHEMBL627572,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,14516,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL627573,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,14517,,22224,,,Kidney,,U,13257,,,,2113.0,In vivo,1,,CHEMBL627574,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,14518,,22224,,,Liver,,U,13257,,,,2107.0,In vivo,1,,CHEMBL627575,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,14519,,22224,,,Lung,,U,13257,,,,2048.0,In vivo,1,,CHEMBL627576,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,14520,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627577,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),14521,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627578,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,14522,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627579,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,14523,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627580,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),14524,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627581,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,14525,,22224,,,,,U,13257,,,,,In vivo,1,,CHEMBL627582,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,14526,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627583,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,14527,,22224,,,Spleen,,U,13257,,,,2106.0,In vivo,1,,CHEMBL627584,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,14528,,22224,,,Prostate gland,,U,13257,,,,2367.0,In vivo,1,,CHEMBL627585,Autocuration,
A,0,BAO_0000218,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,14529,,22224,,,Muscle tissue,,U,13257,,,,2385.0,In vivo,1,,CHEMBL627586,Autocuration,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,14530,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL627587,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14531,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL627588,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,14532,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628250,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14533,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628251,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,14534,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL628252,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14535,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL628253,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,14536,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL628254,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14537,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL877493,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14538,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628255,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14539,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628256,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14540,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL628257,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,14541,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL628258,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,14542,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628259,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,14543,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL628429,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,14544,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL626862,Intermediate,
A,1,BAO_0000218,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,14545,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL626863,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,14546,Rattus norvegicus,50597,,,Cerebellum,,N,15413,,,,2037.0,In vivo,1,10116.0,CHEMBL625886,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,14547,Rattus norvegicus,50597,,,Cerebellum,,N,15413,,,,2037.0,In vivo,1,10116.0,CHEMBL625887,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex,14548,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL625888,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,14549,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL625889,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,14550,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL625890,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,14551,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL625891,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,14552,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL625892,Intermediate,
A,1,BAO_0000218,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,14553,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL625893,Intermediate,
A,1,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,14554,Rattus norvegicus,50597,,,Cerebellum,,N,15413,,,,2037.0,In vivo,1,10116.0,CHEMBL625894,Intermediate,
A,1,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat cortex,14555,Rattus norvegicus,50597,,,,,N,15413,,,,,In vivo,1,10116.0,CHEMBL625895,Intermediate,
A,0,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,14556,,22224,,,,,U,12404,,,,,,1,,CHEMBL625896,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",14557,,22224,,,,,U,568,,,,,,1,,CHEMBL625897,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14558,,22224,,,,,U,568,,,,,,1,,CHEMBL625898,Autocuration,
A,0,BAO_0000019,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",14559,,22224,,,,,U,568,,,,,,1,,CHEMBL625899,Autocuration,
A,0,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,14560,,22224,,,,,U,12404,,,,,,1,,CHEMBL626124,Autocuration,
A,1,BAO_0000218,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,14561,Escherichia coli,50212,,,,,N,7624,,,,,,1,562.0,CHEMBL628500,Intermediate,
A,1,BAO_0000218,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",14562,Rattus norvegicus,50597,,,,,N,7624,,,,,,1,10116.0,CHEMBL857856,Intermediate,
A,1,BAO_0000218,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",14563,Rattus norvegicus,50597,,,,,N,7624,,,,,,1,10116.0,CHEMBL628501,Intermediate,
A,0,BAO_0000019,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",14564,,22224,,,,,U,4643,,,,,,1,,CHEMBL628502,Autocuration,
A,0,BAO_0000019,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,14565,,22224,,,,,U,11532,,,,,,1,,CHEMBL628503,Autocuration,
A,0,BAO_0000019,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,14566,,22224,,,,,U,11018,,,,,,1,,CHEMBL628504,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14567,,22224,,,,,U,2276,,,,,,1,,CHEMBL628505,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",14568,,22224,,,,,U,2276,,,,,,1,,CHEMBL874452,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",14569,,22224,,,,,U,2276,,,,,,1,,CHEMBL628506,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",14570,,22224,,,,,U,2276,,,,,,1,,CHEMBL628507,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",14571,,22224,,,,,U,2276,,,,,,1,,CHEMBL628508,Autocuration,
A,0,BAO_0000019,Michaelis constant (KM) was evaluated,14572,,22224,,,,,U,8949,,,,,,1,,CHEMBL628509,Autocuration,
A,0,BAO_0000019,Reaction rate parameter value for phosphate with transfer with respect to ATP,14573,,22224,,,,,U,12404,,,,,,1,,CHEMBL628510,Autocuration,
B,0,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase I,14574,,22224,,,,,U,7625,,,,,,1,,CHEMBL628511,Autocuration,
B,0,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase II,14575,,22224,,,,,U,7625,,,,,,1,,CHEMBL628512,Autocuration,
B,0,BAO_0000019,Substrate concentration for half maximal velocity was reported for rat hexokinase III,14576,,22224,,,,,U,7625,,,,,,1,,CHEMBL628513,Autocuration,
B,0,BAO_0000019,Substrate concentration for half maximal velocity was reported for yeast hexokinase,14577,,22224,,,,,U,7625,,,,,,1,,CHEMBL628514,Autocuration,
A,0,BAO_0000019,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,14578,,22224,,,,,U,12908,,,,,,1,,CHEMBL628515,Autocuration,
A,0,BAO_0000019,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,14579,,22224,,,,,U,10368,,,,,,1,,CHEMBL628516,Autocuration,
A,0,BAO_0000019,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14580,,22224,,,,,U,13108,,,,,,1,,CHEMBL628517,Autocuration,
A,0,BAO_0000019,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),14581,,22224,,,,,U,13108,,,,,,1,,CHEMBL628518,Autocuration,
A,0,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,14582,,22224,,,,,U,15217,,,,,,1,,CHEMBL628519,Autocuration,
A,0,BAO_0000019,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,14583,,22224,,,,,U,15217,,,,,,1,,CHEMBL628520,Autocuration,
A,0,BAO_0000019,Binding constant was determined,14584,,22224,,,,,U,10933,,,,,,1,,CHEMBL628521,Autocuration,
A,0,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,14585,,22224,,,,,U,2363,,,,,,1,,CHEMBL630443,Autocuration,
A,0,BAO_0000019,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,14586,,22224,,,,,U,2363,,,,,,1,,CHEMBL630444,Autocuration,
A,0,BAO_0000019,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,14587,,22224,,,,,U,2276,,,,,,1,,CHEMBL857732,Autocuration,
P,0,BAO_0000100,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,14588,,22224,,,,,U,14915,,,,,,1,,CHEMBL630445,Autocuration,
A,0,BAO_0000019,Catalytic rate constant of the compound,14589,,22224,,,,,U,8847,,,,,,1,,CHEMBL630446,Autocuration,
B,0,BAO_0000019,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,14590,,22224,,,,,U,15357,,,,,,1,,CHEMBL630447,Autocuration,
A,0,BAO_0000019,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),14591,,22224,,,,,U,2869,,,,,,1,,CHEMBL630448,Autocuration,
A,0,BAO_0000019,Catalytic rate constant against phospholipase A2 was determined,14592,,22224,,,,,U,3484,,,,,,1,,CHEMBL630449,Autocuration,
A,0,BAO_0000019,"Compound was evaluated for catalytic constant, Kcat",14593,,22224,,,,,U,1373,,,,,,1,,CHEMBL630450,Autocuration,
A,0,BAO_0000019,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,14594,,22224,,,,,U,8142,,,,,,1,,CHEMBL630451,Autocuration,
A,0,BAO_0000019,Kcat calculated from 0.693/T1/2,14595,,22224,,,,,U,14131,,,,,,1,,CHEMBL630452,Autocuration,
A,0,BAO_0000019,Kcat was determined,14596,,22224,,,,,U,17269,,,,,,1,,CHEMBL630453,Autocuration,
A,0,BAO_0000019,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,14597,,22224,,,,,U,3485,,,,,,1,,CHEMBL630454,Autocuration,
A,0,BAO_0000019,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,14598,,22224,,,,,U,3485,,,,,,1,,CHEMBL630455,Autocuration,
A,0,BAO_0000019,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,14599,,22224,,,,,U,3485,,,,,,1,,CHEMBL631487,Autocuration,
A,0,BAO_0000019,Kcat value was determined,14600,,22224,,,,,U,5962,,,,,,1,,CHEMBL631488,Autocuration,
A,0,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,14601,,22224,,,,,U,3133,,,,,,1,,CHEMBL876440,Autocuration,
A,0,BAO_0000019,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,14602,,22224,,,,,U,3133,,,,,,1,,CHEMBL631489,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14603,,22224,,,,,U,2276,,,,,,1,,CHEMBL857742,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",14604,,22224,,,,,U,2276,,,,,,1,,CHEMBL631490,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",14605,,22224,,,,,U,2276,,,,,,1,,CHEMBL631491,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",14606,,22224,,,,,U,2276,,,,,,1,,CHEMBL631492,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",14607,,22224,,,,,U,2276,,,,,,1,,CHEMBL631493,Autocuration,
A,0,BAO_0000019,Kinetic parameter for rate of conversion to PABA was determined,14608,,22224,,,,,U,4892,,,,,,1,,CHEMBL631494,Autocuration,
A,0,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14609,,22224,,,,,U,3133,,,,,,1,,CHEMBL631495,Autocuration,
A,1,BAO_0000218,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14610,Rattus norvegicus,50597,,,Feces,,N,11488,,,,1988.0,,1,10116.0,CHEMBL631496,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",14611,Rattus norvegicus,50597,,,Urine,,N,11488,,,,1088.0,,1,10116.0,CHEMBL631497,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",14612,Rattus norvegicus,50597,,,Urine,,N,11488,,,,1088.0,,1,10116.0,CHEMBL631498,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",14613,Rattus norvegicus,50597,,,Urine,,N,11488,,,,1088.0,,1,10116.0,CHEMBL629776,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",14614,Rattus norvegicus,50597,,,Urine,,N,11488,,,,1088.0,,1,10116.0,CHEMBL629777,Intermediate,
A,1,BAO_0000218,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",14615,Rattus norvegicus,50597,,,Urine,,N,11488,,,,1088.0,,1,10116.0,CHEMBL629778,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,14616,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630456,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,14617,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630457,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,14618,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630458,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,14619,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630459,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,14620,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630460,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,14621,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL876550,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,14622,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630461,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,14623,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630462,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,14624,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630463,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,14625,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630464,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,14626,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630465,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,14627,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630466,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,14628,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630467,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,14629,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630633,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,14630,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630634,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,14631,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630635,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,14632,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630636,Intermediate,
A,1,BAO_0000218,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,14633,Rattus norvegicus,50597,,,,,N,11488,,,,,,1,10116.0,CHEMBL630637,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14634,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL630638,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14635,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL630639,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14636,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL630640,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14637,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL876551,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",14638,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL630641,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14639,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL630642,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14640,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL630643,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14641,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL630644,Intermediate,
A,1,BAO_0000218,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14642,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL630645,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",14643,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL625599,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",14644,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL625600,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",14645,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL625601,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",14646,Oryctolagus cuniculus,50592,,,Feces,,N,7132,,,,1988.0,,1,9986.0,CHEMBL625602,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",14647,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL627470,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",14648,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL627471,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",14649,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL627472,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",14650,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL627473,Intermediate,
A,1,BAO_0000218,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",14651,Oryctolagus cuniculus,50592,,,Urine,,N,7132,,,,1088.0,,1,9986.0,CHEMBL627474,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14652,Rattus norvegicus,50597,,,Blood,,N,13925,,,,178.0,In vivo,1,10116.0,CHEMBL627475,Intermediate,
A,1,BAO_0000218,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14653,Rattus norvegicus,50597,,,Blood,,N,13925,,,,178.0,In vivo,1,10116.0,CHEMBL627476,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,14654,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627477,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,14655,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627478,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,14656,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627479,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,14657,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627480,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,14658,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627481,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,14659,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627482,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,14660,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL627483,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,14661,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL875636,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,14662,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625764,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,14663,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625765,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,14664,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625766,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,14665,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625767,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,14666,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625768,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,14667,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625769,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,14668,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625770,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,14669,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625771,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,14670,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625772,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,14671,Canis lupus familiaris,50588,,,Urine,,N,12582,,,,1088.0,,1,9615.0,CHEMBL625773,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,14672,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625774,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,14673,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625775,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,14674,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625776,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,14675,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625777,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,14676,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625778,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,14677,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625779,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,14678,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625780,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,14679,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL625781,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,14680,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875637,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,14681,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626473,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,14682,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626474,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,14683,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626475,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,14684,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626476,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,14685,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL634397,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,14686,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL626477,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,14687,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631069,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,14688,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631070,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,14689,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631071,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,14690,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631072,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,14691,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631073,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,14692,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631074,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,14693,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631075,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,14694,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631725,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,14695,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631726,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,14696,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631727,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,14697,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631728,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,14698,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631729,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,14699,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631730,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,14700,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631731,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,14701,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631910,Intermediate,
A,1,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,14702,Rattus norvegicus,50597,,,Hippocampus,,N,15413,,,,10000000.0,In vivo,1,10116.0,CHEMBL631911,Intermediate,
A,1,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,14703,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL631912,Intermediate,
A,1,BAO_0000218,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,14704,Rattus norvegicus,50597,,,Hypothalamus,,N,15413,,,,1898.0,In vivo,1,10116.0,CHEMBL631913,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14705,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631914,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14706,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631915,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14707,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL875778,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14708,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631916,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14709,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631917,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14710,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631918,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14711,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631919,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14712,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631920,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14713,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631921,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14714,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631922,Intermediate,
A,1,BAO_0000218,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14715,Rattus norvegicus,50597,,,Blood,,N,12017,,,,178.0,In vivo,1,10116.0,CHEMBL631923,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14716,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL631924,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14717,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630234,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14718,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630235,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14719,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630236,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14720,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630237,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14721,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630238,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14722,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630239,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14723,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630303,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14724,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630304,Intermediate,
A,1,BAO_0000218,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14725,Rattus norvegicus,50597,,,,,N,12017,,,,,In vivo,1,10116.0,CHEMBL630305,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14726,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL630306,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14727,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL630307,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14728,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL630308,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14729,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL630309,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14730,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL629309,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14731,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL629993,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14732,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL629994,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14733,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL629995,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14734,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL631993,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14735,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL631994,Intermediate,
A,1,BAO_0000218,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14736,Rattus norvegicus,50597,,,Kidney,,N,12017,,,,2113.0,In vivo,1,10116.0,CHEMBL631995,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14737,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL631996,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14738,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL631997,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14739,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL631998,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14740,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL631999,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14741,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL632000,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14742,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL632001,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14743,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL874424,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14744,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL632002,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14745,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL632003,Intermediate,
A,0,BAO_0000019,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,14746,,22224,,,,,U,3133,,,,,,1,,CHEMBL632004,Autocuration,
A,0,BAO_0000019,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,14747,,22224,,,,,U,2742,,,,,,1,,CHEMBL632005,Autocuration,
A,0,BAO_0000019,Compound was tested for amidase rate in the presence of N62C screen enzyme,14748,,22224,,,,,U,2742,,,,,,1,,CHEMBL632006,Autocuration,
A,0,BAO_0000019,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,14749,,22224,,,,,U,2742,,,,,,1,,CHEMBL632007,Autocuration,
A,0,BAO_0000019,Compound was tested for amidase rate in the presence of S166C screen enzyme,14750,,22224,,,,,U,2742,,,,,,1,,CHEMBL632008,Autocuration,
A,0,BAO_0000019,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,14751,,22224,,,,,U,2742,,,,,,1,,CHEMBL632009,Autocuration,
A,0,BAO_0000019,Compound was tested for esterase rate in the presence of N62C screen enzyme,14752,,22224,,,,,U,2742,,,,,,1,,CHEMBL632010,Autocuration,
A,0,BAO_0000019,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,14753,,22224,,,,,U,2742,,,,,,1,,CHEMBL857750,Autocuration,
A,0,BAO_0000019,Compound was tested for esterase rate in the presence of S166C screen enzyme,14754,,22224,,,,,U,2742,,,,,,1,,CHEMBL632011,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14755,,22224,,,,,U,2276,,,,,,1,,CHEMBL632012,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14756,,22224,,,,,U,2276,,,,,,1,,CHEMBL632013,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",14757,,22224,,,,,U,2276,,,,,,1,,CHEMBL632014,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14758,,22224,,,,,U,2276,,,,,,1,,CHEMBL629622,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",14759,,22224,,,,,U,2276,,,,,,1,,CHEMBL629623,Autocuration,
A,0,BAO_0000019,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",14760,,22224,,,,,U,2276,,,,,,1,,CHEMBL629624,Autocuration,
A,0,BAO_0000019,Ratio of Kcat to that of Km was determined,14761,,22224,,,,,U,17269,,,,,,1,,CHEMBL629625,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14762,,22224,,,,,U,2276,,,,,,1,,CHEMBL629626,Autocuration,
A,0,BAO_0000019,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",14763,,22224,,,,,U,2276,,,,,,1,,CHEMBL629627,Autocuration,
A,0,BAO_0000019,"Compound was evaluated for constant, Kd",14764,,22224,,,,,U,15917,,,,,,1,,CHEMBL629628,Autocuration,
A,0,BAO_0000019,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,14765,,22224,,,,,U,10933,,,,,,1,,CHEMBL629629,Autocuration,
A,0,BAO_0000019,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,14766,,22224,,,,,U,10933,,,,,,1,,CHEMBL629630,Autocuration,
A,0,BAO_0000019,Dissociation Constant of compound determined,14767,,22224,,,,,U,14293,,,,,,1,,CHEMBL856030,Autocuration,
B,0,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,14768,,22224,,,,,U,6698,,,,,,1,,CHEMBL629631,Autocuration,
B,0,BAO_0000019,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,14769,,22224,,,,,U,6698,,,,,,1,,CHEMBL629632,Autocuration,
P,0,BAO_0000100,Dissociation constant of compound with Fructose was determined,14770,,22224,,,,,U,4318,,,,,,1,,CHEMBL629633,Autocuration,
P,0,BAO_0000100,Dissociation constant of compound with Fructose was determined; Not determined,14771,,22224,,,,,U,4318,,,,,,1,,CHEMBL629634,Autocuration,
P,0,BAO_0000100,Dissociation constant of compound with Lactulose was determined,14772,,22224,,,,,U,4318,,,,,,1,,CHEMBL629635,Autocuration,
P,0,BAO_0000100,Dissociation constant of compound with Lactulose was determined; Not determined,14773,,22224,,,,,U,4318,,,,,,1,,CHEMBL629636,Autocuration,
P,0,BAO_0000100,Dissociation constant of the Compound,14774,,22224,,,,,U,14959,,,,,,1,,CHEMBL629637,Autocuration,
P,0,BAO_0000100,Dissociation constant by non-linear regression analysis,14775,,22224,,,,,U,5913,,,,,,1,,CHEMBL629638,Autocuration,
P,0,BAO_0000100,Dissociation constant was determined,14776,,22224,,,,,U,14218,,,,,,1,,CHEMBL629639,Autocuration,
P,0,BAO_0000100,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,14777,,22224,,,,,U,10689,,,,,,1,,CHEMBL629640,Autocuration,
P,0,BAO_0000100,Dissociation constant was determined,14778,,22224,,,,,U,13925,,,,,,1,,CHEMBL629641,Autocuration,
P,0,BAO_0000100,Dissociation constant was determined,14779,,22224,,,,,U,16359,,,,,,1,,CHEMBL631344,Autocuration,
A,1,BAO_0000218,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,14780,Rattus norvegicus,50597,,,Muscle tissue,,N,10944,,,,2385.0,,1,10116.0,CHEMBL631345,Intermediate,
A,0,BAO_0000019,The dissociation constant determined by fluorescence displacement assay,14781,,22224,,,,,U,11080,,,,,,1,,CHEMBL631346,Autocuration,
A,0,BAO_0000019,kd value surface plasmon resonance (SPR) method,14782,,22224,,,,,U,17805,,,,,,1,,CHEMBL631524,Autocuration,
A,1,BAO_0000218,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,14783,Rattus norvegicus,50597,,,Muscle tissue,,N,10944,,,,2385.0,,1,10116.0,CHEMBL631525,Intermediate,
F,0,BAO_0000019,First dissociation constant of the binding of compound to V30M TTR,14784,,22224,,,,,U,16645,,,,,,1,,CHEMBL631526,Autocuration,
F,0,BAO_0000019,Second dissociation constant of the binding of compound to V30M TTR,14785,,22224,,,,,U,16645,,,,,,1,,CHEMBL631527,Autocuration,
A,0,BAO_0000019,"Compound was evaluated for equilibrium constant, Ke",14786,,22224,,,,,U,7793,,,,,,1,,CHEMBL631528,Autocuration,
A,0,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,14787,,22224,,,Hypothalamus,,U,12199,,,,1898.0,,1,,CHEMBL631529,Autocuration,
A,0,BAO_0000019,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,14788,,22224,,,Hypothalamus,,U,12199,,,,1898.0,,1,,CHEMBL631530,Autocuration,
A,0,BAO_0000019,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,14789,,22224,,,,,U,9680,,,,,,1,,CHEMBL631531,Autocuration,
A,0,BAO_0000019,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,14790,,22224,,,,,U,9680,,,,,,1,,CHEMBL631532,Autocuration,
A,0,BAO_0000019,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,14791,,22224,,,,,U,9680,,,,,,1,,CHEMBL631533,Autocuration,
A,1,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14792,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL876552,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14793,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631534,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14794,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631535,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14795,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631536,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,14796,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631537,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,14797,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631538,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,14798,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631539,Intermediate,
A,1,BAO_0000218,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,14799,Mus musculus,50594,,,,,N,13758,,,,,,1,10090.0,CHEMBL631540,Intermediate,
A,1,BAO_0000218,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14800,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL625637,Intermediate,
A,1,BAO_0000218,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14801,Rattus norvegicus,50597,,,,,N,14393,,,,,,1,10116.0,CHEMBL625638,Intermediate,
A,1,BAO_0000218,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",14802,Rattus norvegicus,50597,,,,,N,15078,,,,,,1,10116.0,CHEMBL625639,Intermediate,
A,1,BAO_0000218,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14803,Rattus norvegicus,50597,,,Brain,,N,13925,,,,955.0,In vivo,1,10116.0,CHEMBL625640,Intermediate,
A,1,BAO_0000218,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14804,Rattus norvegicus,50597,,,Brain,,N,13925,,,,955.0,In vivo,1,10116.0,CHEMBL625641,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14805,Rattus norvegicus,50597,,,Heart,,N,13925,,,,948.0,In vivo,1,10116.0,CHEMBL625642,Intermediate,
A,1,BAO_0000218,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14806,Rattus norvegicus,50597,,,Heart,,N,13925,,,,948.0,In vivo,1,10116.0,CHEMBL625643,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14807,Rattus norvegicus,50597,,,Kidney,,N,13925,,,,2113.0,In vivo,1,10116.0,CHEMBL625644,Intermediate,
A,1,BAO_0000218,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14808,Rattus norvegicus,50597,,,Kidney,,N,13925,,,,2113.0,In vivo,1,10116.0,CHEMBL625645,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14809,Rattus norvegicus,50597,,,Liver,,N,13925,,,,2107.0,In vivo,1,10116.0,CHEMBL625646,Intermediate,
A,1,BAO_0000218,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14810,Rattus norvegicus,50597,,,Liver,,N,13925,,,,2107.0,In vivo,1,10116.0,CHEMBL625647,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14811,Rattus norvegicus,50597,,,Lung,,N,13925,,,,2048.0,In vivo,1,10116.0,CHEMBL625648,Intermediate,
A,1,BAO_0000218,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,14812,Rattus norvegicus,50597,,,Lung,,N,13925,,,,2048.0,In vivo,1,10116.0,CHEMBL625649,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14813,Rattus norvegicus,50597,,,Muscle tissue,,N,13925,,,,2385.0,In vivo,1,10116.0,CHEMBL625650,Intermediate,
A,1,BAO_0000218,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14814,Rattus norvegicus,50597,,,Muscle tissue,,N,13925,,,,2385.0,In vivo,1,10116.0,CHEMBL625651,Intermediate,
A,1,BAO_0000218,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14815,Rattus norvegicus,50597,,,Zone of skin,,N,13925,,,,14.0,In vivo,1,10116.0,CHEMBL625652,Intermediate,
A,1,BAO_0000218,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14816,Rattus norvegicus,50597,,,Zone of skin,,N,13925,,,,14.0,In vivo,1,10116.0,CHEMBL625653,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14817,Rattus norvegicus,50597,,,Spleen,,N,13925,,,,2106.0,In vivo,1,10116.0,CHEMBL625654,Intermediate,
A,1,BAO_0000218,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,14818,Rattus norvegicus,50597,,,Spleen,,N,13925,,,,2106.0,In vivo,1,10116.0,CHEMBL625655,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat blood after 15 minutes of administration,14819,Rattus norvegicus,50597,,,Blood,,N,9712,,,,178.0,In vivo,1,10116.0,CHEMBL625656,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat blood after 2 minutes of administration,14820,Rattus norvegicus,50597,,,Blood,,N,9712,,,,178.0,In vivo,1,10116.0,CHEMBL625657,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat brain after 15 minutes of administration,14821,Rattus norvegicus,50597,,,Brain,,N,9712,,,,955.0,In vivo,1,10116.0,CHEMBL625658,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat brain after 2 minutes of administration,14822,Rattus norvegicus,50597,,,Brain,,N,9712,,,,955.0,In vivo,1,10116.0,CHEMBL625659,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat heart after 15 minutes of administration,14823,Rattus norvegicus,50597,,,Heart,,N,9712,,,,948.0,In vivo,1,10116.0,CHEMBL625660,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat heart after 2 minutes of administration,14824,Rattus norvegicus,50597,,,Heart,,N,9712,,,,948.0,In vivo,1,10116.0,CHEMBL625661,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat liver after 15 minutes of administration,14825,Rattus norvegicus,50597,,,Liver,,N,9712,,,,2107.0,In vivo,1,10116.0,CHEMBL625662,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat liver after 2 minutes of administration,14826,Rattus norvegicus,50597,,,Liver,,N,9712,,,,2107.0,In vivo,1,10116.0,CHEMBL625663,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat lung after 15 minutes of administration,14827,Rattus norvegicus,50597,,,Lung,,N,9712,,,,2048.0,In vivo,1,10116.0,CHEMBL875621,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat lung after 2 minutes of administration,14828,Rattus norvegicus,50597,,,Lung,,N,9712,,,,2048.0,In vivo,1,10116.0,CHEMBL628382,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat muscle after 15 minutes of administration,14829,Rattus norvegicus,50597,,,Muscle tissue,,N,9712,,,,2385.0,In vivo,1,10116.0,CHEMBL628383,Intermediate,
A,1,BAO_0000218,Biodistribution of Compound in rat muscle after 2 minutes of administration,14830,Rattus norvegicus,50597,,,Muscle tissue,,N,9712,,,,2385.0,In vivo,1,10116.0,CHEMBL628384,Intermediate,
A,1,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,14831,Rattus norvegicus,50597,,,,,N,13925,,,,,,1,10116.0,CHEMBL628385,Intermediate,
A,1,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,14832,Rattus norvegicus,50597,,,,,N,13925,,,,,,1,10116.0,CHEMBL875753,Intermediate,
A,1,BAO_0000218,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,14833,Rattus norvegicus,50597,,,,,N,13925,,,,,,1,10116.0,CHEMBL628386,Intermediate,
A,1,BAO_0000218,Organ distribution in rat blood 2 minutes after intravenous injection,14834,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL628387,Intermediate,
A,1,BAO_0000218,Organ distribution in rat blood 2 hr after intravenous injection,14835,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL628388,Intermediate,
A,1,BAO_0000218,Organ distribution in rat blood 30 minutes after intravenous injection,14836,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL628389,Intermediate,
A,1,BAO_0000218,Organ distribution in rat blood 30 min after intravenous injection,14837,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL632756,Intermediate,
A,1,BAO_0000218,Organ distribution in rat brain 2 minutes after intravenous injection,14838,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL628390,Intermediate,
A,1,BAO_0000218,Organ distribution in rat brain 2 hr after intravenous injection,14839,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631811,Intermediate,
A,1,BAO_0000218,Organ distribution in rat brain 30 minutes after intravenous injection,14840,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631812,Intermediate,
A,1,BAO_0000218,Organ distribution in rat heart 2 minutes after intravenous injection,14841,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631813,Intermediate,
A,1,BAO_0000218,Organ distribution in rat heart 2 hr after intravenous injection,14842,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631814,Intermediate,
A,1,BAO_0000218,Organ distribution in rat heart 30 minutes after intravenous injection,14843,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631815,Intermediate,
A,1,BAO_0000218,Organ distribution in rat kidney 2 minutes after intravenous injection,14844,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631816,Intermediate,
A,1,BAO_0000218,Organ distribution in rat kidney 2 hr after intravenous injection,14845,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL875758,Intermediate,
A,1,BAO_0000218,Organ distribution in rat kidney 30 minutes after intravenous injection,14846,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631817,Intermediate,
A,1,BAO_0000218,Organ distribution in rat liver 2 minutes after intravenous injection,14847,Rattus norvegicus,50597,,,Liver,,N,6941,,,,2107.0,,1,10116.0,CHEMBL631818,Intermediate,
A,1,BAO_0000218,Organ distribution in rat liver 2 hr after intravenous injection,14848,Rattus norvegicus,50597,,,Liver,,N,6941,,,,2107.0,,1,10116.0,CHEMBL631819,Intermediate,
A,1,BAO_0000218,Organ distribution in rat liver 30 minutes after intravenous injection,14849,Rattus norvegicus,50597,,,Liver,,N,6941,,,,2107.0,,1,10116.0,CHEMBL631820,Intermediate,
A,1,BAO_0000218,Organ distribution in rat lung 2 minutes after intravenous injection,14850,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631821,Intermediate,
A,1,BAO_0000218,Organ distribution in rat lung 2 hr after intravenous injection,14851,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631822,Intermediate,
A,1,BAO_0000218,Organ distribution in rat lung 30 minutes after intravenous injection,14852,Rattus norvegicus,50597,,,,,N,6941,,,,,,1,10116.0,CHEMBL631823,Intermediate,
A,1,BAO_0000218,Organ distribution in rat muscle 2 minutes after intravenous injection,14853,Rattus norvegicus,50597,,,Muscle tissue,,N,6941,,,,2385.0,,1,10116.0,CHEMBL631824,Intermediate,
A,1,BAO_0000218,Organ distribution in rat muscle 2 hr after intravenous injection,14854,Rattus norvegicus,50597,,,Muscle tissue,,N,6941,,,,2385.0,,1,10116.0,CHEMBL631825,Intermediate,
A,1,BAO_0000218,Organ distribution in rat muscle 30 minutes after intravenous injection,14855,Rattus norvegicus,50597,,,Muscle tissue,,N,6941,,,,2385.0,,1,10116.0,CHEMBL631826,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),14856,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL631827,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),14857,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL631828,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),14858,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL631829,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,14859,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875759,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,14860,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631830,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,14861,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631831,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,14862,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631832,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,14863,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631833,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,14864,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631834,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,14865,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631835,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,14866,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631836,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,14867,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631837,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,14868,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631838,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,14869,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631839,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,14870,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631840,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,14871,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631841,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,14872,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631842,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,14873,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631843,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,14874,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631844,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,14875,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631845,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,14876,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631846,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,14877,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL875760,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,14878,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL632199,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,14879,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631847,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,14880,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL631848,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,14881,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628707,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,14882,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628708,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,14883,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628709,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,14884,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628710,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,14885,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628711,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,14886,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628712,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,14887,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628713,Intermediate,
A,1,BAO_0000218,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,14888,Rattus norvegicus,50597,,,Urine,,N,12582,,,,1088.0,,1,10116.0,CHEMBL628714,Intermediate,
A,1,BAO_0000218,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",14889,Rattus norvegicus,50597,,,,,N,7415,,,,,,1,10116.0,CHEMBL628715,Intermediate,
A,0,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,14890,,22224,,,,,U,7313,,,,,,1,,CHEMBL629179,Autocuration,
A,0,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,14891,,22224,,,,,U,7313,,,,,,1,,CHEMBL629180,Autocuration,
A,0,BAO_0000019,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,14892,,22224,,,,,U,7313,,,,,,1,,CHEMBL875108,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14893,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629181,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,14894,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629182,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,14895,,22224,,,,,U,7570,,,,,,1,,CHEMBL629183,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,14896,,22224,,,,,U,7570,,,,,,1,,CHEMBL629184,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14897,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629185,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,14898,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629186,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,14899,,22224,,,,,U,7570,,,,,,1,,CHEMBL629187,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,14900,,22224,,,,,U,7570,,,,,,1,,CHEMBL629887,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,14901,,22224,,,,,U,7570,,,,,,1,,CHEMBL629888,Autocuration,
A,0,BAO_0000019,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,14902,,22224,,,,,U,7570,,,,,,1,,CHEMBL629889,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,14903,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629890,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,14904,,22224,,,,,U,7570,,,,,,1,,CHEMBL629891,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,14905,,22224,,,,,U,7570,,,,,,1,,CHEMBL629892,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,14906,,22224,,,Adrenal cortex,,U,7570,,,,1235.0,,1,,CHEMBL629893,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,14907,,22224,,,,,U,7570,,,,,,1,,CHEMBL629894,Autocuration,
A,0,BAO_0000019,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,14908,,22224,,,,,U,7570,,,,,,1,,CHEMBL629895,Autocuration,
A,0,BAO_0000218,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",14909,Canis lupus familiaris,22224,,,,,U,14122,,,,,In vivo,1,9615.0,CHEMBL875109,Autocuration,
A,0,BAO_0000218,Absolute bioavailability in male cynomolgus monkeys,14910,Macaca fascicularis,22224,,,,,U,16449,,,,,In vivo,1,9541.0,CHEMBL629896,Autocuration,
A,0,BAO_0000218,Absolute bioavailability in maleSprague-Dawley rats,14911,Rattus norvegicus,22224,,,,,U,16449,,,,,In vivo,1,10116.0,CHEMBL629897,Autocuration,
A,1,BAO_0000218,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14912,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL629898,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14913,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL630057,Intermediate,
A,1,BAO_0000218,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14914,Rattus norvegicus,50597,,,Liver,,N,12017,,,,2107.0,In vivo,1,10116.0,CHEMBL630058,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14915,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630059,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14916,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630060,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14917,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630061,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14918,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630062,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14919,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630063,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14920,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630064,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14921,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630065,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14922,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630066,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14923,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630067,Intermediate,
A,1,BAO_0000218,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14924,Rattus norvegicus,50597,,,Lung,,N,12017,,,,2048.0,In vivo,1,10116.0,CHEMBL630068,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14925,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL631113,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14926,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL631114,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14927,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL631115,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14928,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL631116,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14929,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630528,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14930,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630529,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14931,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630530,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14932,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630531,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14933,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630532,Intermediate,
A,1,BAO_0000218,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14934,Rattus norvegicus,50597,,,Muscle tissue,,N,12017,,,,2385.0,In vivo,1,10116.0,CHEMBL630533,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice blood after 120 hr,14935,Mus musculus,50594,,,Blood,,N,15045,,,,178.0,In vivo,1,10090.0,CHEMBL630534,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice blood after 24 hr,14936,Mus musculus,50594,,,Blood,,N,15045,,,,178.0,In vivo,1,10090.0,CHEMBL630535,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice blood after 4 hr,14937,Mus musculus,50594,,,Blood,,N,15045,,,,178.0,In vivo,1,10090.0,CHEMBL630536,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice bone after 120 hr,14938,Mus musculus,50594,,,Bone,,N,15045,,,,10000001.0,In vivo,1,10090.0,CHEMBL630537,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice bone after 24 hr,14939,Mus musculus,50594,,,Bone,,N,15045,,,,10000001.0,In vivo,1,10090.0,CHEMBL630538,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice bone after 4 hr,14940,Mus musculus,50594,,,Bone,,N,15045,,,,10000001.0,In vivo,1,10090.0,CHEMBL630539,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice heart after 120 hr,14941,Mus musculus,50594,,,Heart,,N,15045,,,,948.0,In vivo,1,10090.0,CHEMBL630540,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice heart after 24 hr,14942,Mus musculus,50594,,,Heart,,N,15045,,,,948.0,In vivo,1,10090.0,CHEMBL630541,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice heart after 4 hr,14943,Mus musculus,50594,,,Heart,,N,15045,,,,948.0,In vivo,1,10090.0,CHEMBL630542,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice kidney after 120 hr,14944,Mus musculus,50594,,,Kidney,,N,15045,,,,2113.0,In vivo,1,10090.0,CHEMBL630543,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice kidney after 24 hr,14945,Mus musculus,50594,,,Kidney,,N,15045,,,,2113.0,In vivo,1,10090.0,CHEMBL630544,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice kidney after 4 hr,14946,Mus musculus,50594,,,Kidney,,N,15045,,,,2113.0,In vivo,1,10090.0,CHEMBL630545,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice liver after 120 hr,14947,Mus musculus,50594,,,Liver,,N,15045,,,,2107.0,In vivo,1,10090.0,CHEMBL630546,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice liver after 24 hr,14948,Mus musculus,50594,,,Liver,,N,15045,,,,2107.0,In vivo,1,10090.0,CHEMBL630547,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice liver after 4 hr,14949,Mus musculus,50594,,,Liver,,N,15045,,,,2107.0,In vivo,1,10090.0,CHEMBL630548,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice spleen after 120 hr,14950,Mus musculus,50594,,,Spleen,,N,15045,,,,2106.0,In vivo,1,10090.0,CHEMBL630549,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice spleen after 24 hr,14951,Mus musculus,50594,,,Spleen,,N,15045,,,,2106.0,In vivo,1,10090.0,CHEMBL630550,Intermediate,
A,1,BAO_0000218,Biodistribution in normal mice spleen after 4 hr,14952,Mus musculus,50594,,,Spleen,,N,15045,,,,2106.0,In vivo,1,10090.0,CHEMBL876426,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14953,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630551,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14954,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630552,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14955,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630553,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14956,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630554,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14957,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630555,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14958,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630556,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14959,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630557,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),14960,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630558,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14961,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630559,Intermediate,
A,1,BAO_0000218,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14962,Rattus norvegicus,50597,,,Spleen,,N,12017,,,,2106.0,In vivo,1,10116.0,CHEMBL630560,Intermediate,
A,1,BAO_0000218,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,14963,Rattus norvegicus,50597,,,Thyroid gland,,N,12017,,,,2046.0,In vivo,1,10116.0,CHEMBL876427,Intermediate,
A,1,BAO_0000218,The Kel values in female wistar rats.,14964,Rattus norvegicus,50597,,,,,N,14941,,,,,,1,10116.0,CHEMBL630561,Intermediate,
A,0,BAO_0000019,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,14965,,22224,,,,,U,4646,,,,,,1,,CHEMBL630562,Autocuration,
A,0,BAO_0000019,Hydrolysis rate constant of the compound,14966,,22224,,,,,U,8847,,,,,,1,,CHEMBL630563,Autocuration,
P,0,BAO_0000100,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,14967,,22229,,,,,U,11778,,,,,,1,,CHEMBL629673,Autocuration,
A,0,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",14968,,22224,,,,,U,2363,,,,,,1,,CHEMBL629674,Autocuration,
A,0,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",14969,,22224,,,,,U,2363,,,,,,1,,CHEMBL629675,Autocuration,
A,0,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",14970,,22224,,,,,U,2363,,,,,,1,,CHEMBL629676,Autocuration,
A,0,BAO_0000019,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",14971,,22224,,,,,U,2363,,,,,,1,,CHEMBL629677,Autocuration,
A,0,BAO_0000019,Apparent inactivation rate constant was evaluated,14972,,22224,,,,,U,8371,,,,,,1,,CHEMBL629678,Autocuration,
A,0,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,14973,,22224,,,,,U,14883,,,,,,1,,CHEMBL629679,Autocuration,
A,0,BAO_0000019,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,14974,,22224,,,,,U,14883,,,,,,1,,CHEMBL629680,Autocuration,
A,0,BAO_0000019,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,14975,,22224,,,,,U,4643,,,,,,1,,CHEMBL629681,Autocuration,
A,0,BAO_0000019,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,14976,,22224,,,,,U,3519,,,,,,1,,CHEMBL629682,Autocuration,
A,0,BAO_0000019,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,14977,,22224,,,,,U,10600,,,,,,1,,CHEMBL629683,Autocuration,
F,0,BAO_0000019,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,14978,,22224,,,,,U,8501,,,,,,1,,CHEMBL629684,Autocuration,
P,0,BAO_0000100,Dissociation constant was determined,14979,,22224,,,,,U,8505,,,,,,1,,CHEMBL629685,Autocuration,
P,0,BAO_0000100,Dissociation constant was determined,14980,,22224,,,,,U,9778,,,,,,1,,CHEMBL629686,Autocuration,
P,0,BAO_0000100,Dissociation constant at pH 7.4,14981,,22224,,,,,U,9778,,,,,,1,,CHEMBL872932,Autocuration,
P,0,BAO_0000100,Dissociation constant in presence of 1 mM dithiothreitol,14982,,22224,,,,,U,9778,,,,,,1,,CHEMBL629687,Autocuration,
A,0,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14983,,22224,,,,,U,13007,,,,,,1,,CHEMBL872931,Autocuration,
A,0,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,14984,,22224,,,,,U,13007,,,,,,1,,CHEMBL628151,Autocuration,
A,0,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14985,,22224,,,,,U,13007,,,,,,1,,CHEMBL628152,Autocuration,
A,0,BAO_0000019,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,14986,,22224,,,,,U,13007,,,,,,1,,CHEMBL628153,Autocuration,
A,0,BAO_0000019,Kinetic constant for aromatization of androstenedione,14987,,22224,,,,,U,11482,,,,,,1,,CHEMBL628154,Autocuration,
A,0,BAO_0000019,Kinetic constant for aromatization of testosterone,14988,,22224,,,,,U,11482,,,,,,1,,CHEMBL628155,Autocuration,
A,0,BAO_0000019,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,14989,,22224,,,,,U,2303,,,,,,1,,CHEMBL628156,Autocuration,
A,0,BAO_0000019,Local inhibition constant was determined,14990,,22224,,,,,U,11964,,,,,,1,,CHEMBL628157,Autocuration,
A,1,BAO_0000218,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,14991,Saccharomyces cerevisiae,50347,,,,,N,3140,,,,,,1,4932.0,CHEMBL857533,Intermediate,
P,0,BAO_0000100,Dissociation constant value of the compound,14992,,22224,,,,,U,10650,,,,,,1,,CHEMBL628158,Autocuration,
A,0,BAO_0000019,In vitro permeability through cornea without epithelium,14993,,22224,,,Cornea,,U,4667,,,,964.0,,1,,CHEMBL628159,Autocuration,
A,0,BAO_0000019,In vitro permeability through intact cornea,14994,,22224,,,Cornea,,U,4667,,,,964.0,,1,,CHEMBL875616,Autocuration,
A,1,BAO_0000218,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,14995,Oryctolagus cuniculus,50592,,,Cornea,,N,9199,,,,964.0,,1,9986.0,CHEMBL628160,Intermediate,
A,0,BAO_0000019,Rate of enzyme inactivation for the compound was determined,14996,,22224,,,,,U,11966,,,,,,1,,CHEMBL628161,Autocuration,
A,0,BAO_0000019,In vitro permeability through cornea without epithelium,14997,,22224,,,Cornea,,U,4667,,,,964.0,,1,,CHEMBL628162,Autocuration,
A,0,BAO_0000019,In vitro permeability through intact cornea,14998,,22224,,,Cornea,,U,4667,,,,964.0,,1,,CHEMBL628163,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",14999,,22224,,,,,U,8354,,,,,,1,,CHEMBL628164,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15000,,22224,,,,,U,8354,,,,,,1,,CHEMBL628165,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15001,,22224,,,,,U,8354,,,,,,1,,CHEMBL628166,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15002,,22224,,,,,U,8354,,,,,,1,,CHEMBL628167,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",15003,,22224,,,,,U,8354,,,,,,1,,CHEMBL628168,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15004,,22224,,,,,U,8354,,,,,,1,,CHEMBL628169,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",15005,,22224,,,,,U,8354,,,,,,1,,CHEMBL628170,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",15006,,22224,,,,,U,8354,,,,,,1,,CHEMBL628171,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",15007,,22224,,,,,U,8354,,,,,,1,,CHEMBL627434,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",15008,,22224,,,,,U,8354,,,,,,1,,CHEMBL627435,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",15009,,22224,,,,,U,8354,,,,,,1,,CHEMBL628110,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",15010,,22224,,,,,U,8354,,,,,,1,,CHEMBL628111,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",15011,,22224,,,,,U,8354,,,,,,1,,CHEMBL628112,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",15012,,22224,,,,,U,8354,,,,,,1,,CHEMBL628260,Autocuration,
A,0,BAO_0000019,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",15013,,22224,,,,,U,8354,,,,,,1,,CHEMBL628261,Autocuration,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),15014,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628262,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,15015,Homo sapiens,50587,,,,,N,14439,,,,,In vivo,1,9606.0,CHEMBL628263,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),15016,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628264,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),15017,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628265,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),15018,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628266,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),15019,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628267,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,15020,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628268,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),15021,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628269,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),15022,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628270,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),15023,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628271,Intermediate,
A,1,BAO_0000218,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),15024,Mus musculus,50594,,,,,N,14439,,,,,In vivo,1,10090.0,CHEMBL628272,Intermediate,
